Document:

Indenture

 Exhibit 4.1 

EXECUTION COPY 

INDENTURE 
 Dated
as of May 27, 2009 
 Among 

APRIA HEALTHCARE GROUP INC., 

THE GUARANTORS NAMED ON THE SIGNATURE PAGES HERETO, 

and 
 U.S. BANK
NATIONAL ASSOCIATION, 
 as Trustee 

11.25% SENIOR SECURED NOTES DUE 2014 (Series A-1) 

SENIOR SECURED NOTES DUE 2014 (Series A-2) 

Reference is made to: (i) the Lien Subordination and Intercreditor Agreement, dated as of October 28, 2008, among Bank of America, N.A., as
collateral agent for the Revolving Facility Secured Parties referred to therein, Bank of America, N.A., as Notes/Term Collateral Agent, Sky Acquisition LLC, Apria Healthcare Group Inc., and the other subsidiaries of Apria Healthcare Group Inc. named
therein (the “ABL Intercreditor Agreement”) and (ii) the Intercreditor and Collateral Agency Agreement, dated as of May 27, 2009, among Apria Healthcare Group Inc., Banc of America Bridge LLC, as Bridge Loan Agent, Bank of
America, N.A., as Notes/Term Collateral Agent, and U.S. Bank National Association, as Trustee (the “Notes/Term Intercreditor Agreement”). Each Holder, by its acceptance of a Note, (a) consents to the subordination of Liens
provided for in the ABL Intercreditor Agreement, (b) consents to the priority of payment provisions as between the Series A-1 Notes and the Series A-2 Debt in the Notes/Term Intercreditor Agreement, (c) agrees that it will be bound by and
will take no actions contrary to the provisions of the ABL Intercreditor Agreement or the Notes/Term Intercreditor Agreement and (d) authorizes and instructs the Notes/Term Collateral Agent to enter into the ABL Intercreditor Agreement and the
Notes/Term Intercreditor Agreement as collateral agent on behalf of such Holder and the other holders of Series A-2 Debt. The foregoing provisions of the ABL Intercreditor Agreement are intended as an inducement to the lenders under the ABL Facility
to extend credit and such lenders are intended third party beneficiaries of such provisions and the provisions of the ABL Intercreditor Agreement. 

 CROSS-REFERENCE TABLE* 

 

			
	 Trust Indenture Act Section
	  	Indenture Section
	 310    (a)(1)
	  	7.10
	           (a)(2)
	  	7.10
	           (a)(3)
	  	N.A.
	           (a)(4)
	  	N.A.
	           (a)(5)
	  	7.10
	           (b)
	  	7.10
	           (c)
	  	N.A.
	 311    (a)
	  	7.11
	           (b)
	  	7.11
	           (c)
	  	N.A.
	 312    (a)
	  	2.05
	           (b)
	  	14.03
	           (c)
	  	14.03
	 313    (a)
	  	7.06; 10.04
	           (b)(1)
	  	7.06; 10.04
	           (b)(2)
	  	7.06; 7.07
	           (c)
	  	7.06; 14.02
	           (d)
	  	7.06
	 314    (a)
	  	4.03;10.04;14.02;14.05
	           (b)
	  	10.02
	           (c)(1)
	  	14.04
	           (c)(2)
	  	14.04
	           (c)(3)
	  	N.A.
	           (d)
	  	10.03; 10.04; 10.05
	           (e)
	  	14.05
	           (f)
	  	N.A.
	 315    (a)
	  	7.01
	           (b)
	  	7.05;14.02
	           (c)
	  	7.01
	           (d)(1)
	  	7.01
	           (d)(2)
	  	7.01
	           (d)(3)
	  	N.A.
	           (e)
	  	6.14
	 316    (a)(last sentence)
	  	2.09
	           (a)(1)(A)
	  	N.A.
	           (a)(1)(B)
	  	N.A.
	           (a)(2)
	  	N.A.
	           (b)
	  	6.07
	           (c)
	  	2.12;9.05
	 317    (a)(1)
	  	6.08
	           (a)(2)
	  	6.12
	           (b)
	  	2.04
	 318    (a)
	  	14.01
	           (b)
	  	N.A.
	           (c)
	  	14.01

 N.A. means not applicable.

  

	*	This Cross-Reference Table is not part of the Indenture. 

 TABLE OF CONTENTS 

 

					
	 ARTICLE 1

	
	 DEFINITIONS AND INCORPORATION BY REFERENCE

			
	 Section 1.01
	 	Definitions.	  	1
	 Section 1.02
	 	Other Definitions.	  	37
	 Section 1.03
	 	Incorporation by Reference of Trust Indenture Act.	  	38
	 Section 1.04
	 	Rules of Construction.	  	38
	 Section 1.05
	 	Acts of Holders.	  	39
	 Section 1.06
	 	Timing of Payment.	  	40
	
	 ARTICLE 2

	
	 THE NOTES

			
	 Section 2.01
	 	Form and Dating; Terms.	  	40
	 Section 2.02
	 	Execution and Authentication.	  	42
	 Section 2.03
	 	Registrar and Paying Agent.	  	43
	 Section 2.04
	 	Paying Agent to Hold Money in Trust.	  	43
	 Section 2.05
	 	Holder Lists.	  	43
	 Section 2.06
	 	Transfer and Exchange.	  	44
	 Section 2.07
	 	Replacement Notes.	  	56
	 Section 2.08
	 	Outstanding Notes.	  	57
	 Section 2.09
	 	Treasury Notes.	  	57
	 Section 2.10
	 	Temporary Notes.	  	57
	 Section 2.11
	 	Cancellation.	  	58
	 Section 2.12
	 	Defaulted Interest.	  	58
	 Section 2.13
	 	CUSIP and ISIN Numbers.	  	58
	
	ARTICLE 3
	
	REDEMPTION
			
	 Section 3.01
	 	Notices to Trustee.	  	59
	 Section 3.02
	 	Selection of Notes to Be Redeemed or Purchased.	  	59
	 Section 3.03
	 	Notice of Redemption.	  	59
	 Section 3.04
	 	Effect of Notice of Redemption.	  	60
	 Section 3.05
	 	Deposit of Redemption or Purchase Price.	  	60
	 Section 3.06
	 	Notes Redeemed or Purchased in Part.	  	61
	 Section 3.07
	 	Optional Redemption.	  	61
	 Section 3.08
	 	Mandatory Redemption.	  	62
	 Section 3.09
	 	Offers to Repurchase by Application of Excess Proceeds.	  	62

  

 i 

					
	 ARTICLE 4

	
	 COVENANTS

			
	 Section 4.01
	 	Payment of Notes.	  	64
	 Section 4.02
	 	Maintenance of Office or Agency.	  	64
	 Section 4.03
	 	Reports and Other Information.	  	65
	 Section 4.04
	 	Compliance Certificate.	  	66
	 Section 4.05
	 	Taxes.	  	67
	 Section 4.06
	 	Stay, Extension and Usury Laws.	  	67
	 Section 4.07
	 	Limitation on Restricted Payments.	  	67
	 Section 4.08
	 	Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries.	  	74
	 Section 4.09
	 	Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock.	  	76
	 Section 4.10
	 	Asset Sales.	  	82
	 Section 4.11
	 	Transactions with Affiliates.	  	85
	 Section 4.12
	 	Liens.	  	87
	 Section 4.13
	 	Corporate Existence.	  	88
	 Section 4.14
	 	Offer to Repurchase Upon Change of Control.	  	88
	 Section 4.15
	 	Events of Loss	  	90
	 Section 4.16
	 	Limitation on Guarantees of Indebtedness by Restricted Subsidiaries.	  	91
	 Section 4.17
	 	Reserved.	  	91
	 Section 4.18
	 	Impairment of Security Interests.	  	91
	 Section 4.19
	 	After-Acquired Property.	  	92
	 Section 4.20
	 	Information Regarding Collateral.	  	92
	 Section 4.21
	 	Further Assurances.	  	92
	
	 ARTICLE 5

	
	 SUCCESSORS

			
	 Section 5.01
	 	Merger, Consolidation or Sale of All or Substantially All Assets.	  	93
	 Section 5.02
	 	Successor Corporation Substituted.	  	95
	
	 ARTICLE 6

	
	 DEFAULTS AND REMEDIES

			
	 Section 6.01
	 	Events of Default.	  	96
	 Section 6.02
	 	Acceleration.	  	98
	 Section 6.03
	 	Other Remedies.	  	99
	 Section 6.04
	 	Waiver of Past Defaults.	  	99
	 Section 6.05
	 	Control by Majority.	  	100
	 Section 6.06
	 	Limitation on Suits.	  	100
	 Section 6.07
	 	Rights of Holders of Notes to Receive Payment.	  	101

  

 ii 

					
	 Section 6.08
	 	Collection Suit by Trustee.	  	101
	 Section 6.09
	 	Restoration of Rights and Remedies.	  	101
	 Section 6.10
	 	Rights and Remedies Cumulative.	  	101
	 Section 6.11
	 	Delay or Omission Not Waiver.	  	101
	 Section 6.12
	 	Trustee May File Proofs of Claim.	  	102
	 Section 6.13
	 	Priorities.	  	102
	 Section 6.14
	 	Undertaking for Costs.	  	103
	
	 ARTICLE 7

	
	 TRUSTEE

			
	 Section 7.01
	 	Duties of Trustee.	  	103
	 Section 7.02
	 	Rights of Trustee.	  	104
	 Section 7.03
	 	Individual Rights of Trustee.	  	105
	 Section 7.04
	 	Trustee’s Disclaimer.	  	106
	 Section 7.05
	 	Notice of Defaults.	  	106
	 Section 7.06
	 	Reports by Trustee to Holders of the Notes.	  	106
	 Section 7.07
	 	Compensation and Indemnity.	  	106
	 Section 7.08
	 	Replacement of Trustee.	  	107
	 Section 7.09
	 	Successor Trustee by Merger, etc.	  	108
	 Section 7.10
	 	Eligibility; Disqualification.	  	108
	 Section 7.11
	 	Preferential Collection of Claims Against Company.	  	108
	 Section 7.12
	 	Intercreditor Agreements, Security Agreement and Other Collateral Documents.	  	109
	
	 ARTICLE 8

	
	 LEGAL DEFEASANCE AND COVENANT DEFEASANCE

			
	 Section 8.01
	 	Option to Effect Legal Defeasance or Covenant Defeasance.	  	109
	 Section 8.02
	 	Legal Defeasance and Discharge.	  	109
	 Section 8.03
	 	Covenant Defeasance.	  	110
	 Section 8.04
	 	Conditions to Legal or Covenant Defeasance.	  	110
	 Section 8.05
	 	Deposited Money and Government Securities to Be Held in Trust; Other Miscellaneous Provisions.	  	112
	 Section 8.06
	 	Repayment to Company.	  	112
	 Section 8.07
	 	Reinstatement.	  	113
	
	 ARTICLE 9

	
	 AMENDMENT, SUPPLEMENT AND WAIVER

			
	 Section 9.01
	 	Without Consent of Holders of Notes.	  	113
	 Section 9.02
	 	With Consent of Holders of Notes.	  	115
	 Section 9.03
	 	Class Voting.	  	117

  

 iii 

					
	 Section 9.04
	 	Compliance with Trust Indenture Act.	  	117
	 Section 9.05
	 	Revocation and Effect of Consents.	  	117
	 Section 9.06
	 	Notation on or Exchange of Notes.	  	117
	 Section 9.07
	 	Trustee to Sign Amendments, etc.	  	118
	 Section 9.08
	 	Payment for Consent.	  	118
	
	 ARTICLE 10

	
	 COLLATERAL DOCUMENTS

			
	 Section 10.01
	 	Collateral and Collateral Documents.	  	118
	 Section 10.02
	 	Recordings and Opinions.	  	120
	 Section 10.03
	 	Release of Collateral.	  	120
	 Section 10.04
	 	Permitted Releases Not To Impair Lien; Trust Indenture Act Requirements.	  	121
	 Section 10.05
	 	Certificates of the Trustee.	  	122
	 Section 10.06
	 	Suits To Protect the Collateral.	  	122
	 Section 10.07
	 	Authorization of Receipt of Funds by the Trustee Under the Collateral Documents.	  	122
	 Section 10.08
	 	Purchaser Protected.	  	122
	 Section 10.09
	 	Powers Exercisable by Receiver or Trustee.	  	123
	 Section 10.10
	 	Release Upon Termination of the Company’s Obligations.	  	123
	 Section 10.11
	 	Notes/Term Collateral Agent.	  	123
	 Section 10.12
	 	Designations.	  	126
	
	 ARTICLE 11

	
	 GUARANTEES

			
	 Section 11.01
	 	Guarantee.	  	126
	 Section 11.02
	 	Limitation on Guarantor Liability.	  	128
	 Section 11.03
	 	Execution and Delivery.	  	128
	 Section 11.04
	 	Subrogation.	  	128
	 Section 11.05
	 	Benefits Acknowledged.	  	129
	 Section 11.06
	 	Release of Guarantees.	  	129
	
	 ARTICLE 12

	
	 [RESERVED]

	
	 ARTICLE 13

	
	 SATISFACTION AND DISCHARGE

			
	 Section 13.01
	 	Satisfaction and Discharge.	  	130
	 Section 13.02
	 	Application of Trust Money.	  	131

  

 iv 

					
	
	 ARTICLE 14

	
	 MISCELLANEOUS

			
	 Section 14.01
	 	Trust Indenture Act Controls.	  	131
	 Section 14.02
	 	Notices.	  	131
	 Section 14.03
	 	Communication by Holders of Notes with Other Holders of Notes.	  	132
	 Section 14.04
	 	Certificate and Opinion as to Conditions Precedent.	  	132
	 Section 14.05
	 	Statements Required in Certificate or Opinion.	  	133
	 Section 14.06
	 	Rules by Trustee and Agents.	  	133
	 Section 14.07
	 	No Personal Liability of Directors, Officers, Employees and Stockholders.	  	133
	 Section 14.08
	 	Governing Law.	  	133
	 Section 14.09
	 	Waiver of Jury Trial.	  	134
	 Section 14.10
	 	Force Majeure.	  	134
	 Section 14.11
	 	No Adverse Interpretation of Other Agreements.	  	134
	 Section 14.12
	 	Successors.	  	134
	 Section 14.13
	 	Severability.	  	134
	 Section 14.14
	 	Counterpart Originals.	  	134
	 Section 14.15
	 	Table of Contents, Headings, etc.	  	134
	 Section 14.16
	 	Qualification of Indenture.	  	134
	 Section 14.17
	 	Intercreditor Agreements Govern.	  	135

  

			
	EXHIBITS	  	
		
	Exhibit A	  	Form of Series A-1 Note
	Exhibit B	  	Form of Certificate of Transfer
	Exhibit C	  	Form of Certificate of Exchange
	Exhibit D	  	Form of Supplemental Indenture to Be Delivered by Subsequent Guarantors
	Exhibit E	  	Form of Supplemental Indenture for the Issuance of Series A-2 Notes
	Annex A	  	Form of Series A-2 Note
	Schedule A	  	Unrestricted Subsidiaries as of the Issue Date

  

 v 

 INDENTURE, dated as of May 27, 2009, among APRIA HEALTHCARE GROUP INC., a Delaware
corporation (the “Company”), the Guarantors (as defined herein) listed on the signature pages hereto, and U.S. Bank National Association, as trustee (the “Trustee”). 

W I T N E S S E T H 

WHEREAS, the Company has duly authorized the creation of an issue of $700,000,000 initial aggregate principal amount of 11.25%
Senior Secured Notes due 2014 (Series A-1) (the “Initial Series A-1 Notes”); 
 WHEREAS, the Company may issue
up to $310,000,000 initial aggregate principal amount of Senior Secured Notes due 2014 (Series A-2) (plus up to an additional $15.0 million in the circumstances described elsewhere herein) (the “Initial Series A-2 Notes” and,
together with the Initial Series A-1 Notes, the “Initial Notes”), which the Company may issue at any time and from time to time pursuant to a board resolution or the Form of Supplemental Indenture for the Issuance of Series A-2
Notes attached hereto as Exhibit E; and 
 WHEREAS, the Company and each of the Guarantors has duly authorized the
execution and delivery of this Indenture. 
 NOW, THEREFORE, the Company, each of the Guarantors and the Trustee agree as
follows for the benefit of each other and for the equal and ratable benefit of the Holders of the Notes. 
 ARTICLE 1 

DEFINITIONS AND INCORPORATION BY REFERENCE 

Section 1.01 Definitions. 

“144A Global Note” means a Global Note substantially in the form of, in the case of Series A-1 Notes, Exhibit A
attached hereto and, in the case of Series A-2 Notes (if issued), the form approved in the board resolution authorizing such Series A-2 Note or Annex A attached to the Form of Supplemental Indenture for the Issuance of Series A-2 Notes
attached hereto as Exhibit E, bearing the Global Note Legend and the Private Placement Legend and deposited with or on behalf of, and registered in the name of, the Depositary or its nominee that will be issued in a denomination equal to the
outstanding principal amount of the Series A-1 Notes and Series A-2 Notes, as applicable, sold in reliance on Rule 144A. 

“ABL Collateral” means “Revolving Facility First Lien Collateral” as defined in the ABL Intercreditor
Agreement. 
 “ABL Collateral Agent” means Bank of America, N.A. and any successor collateral agent under the
ABL Facility, or if there is no ABL Facility, the “ABL Collateral Agent” designated pursuant to the terms of the ABL Lenders Debt. 

“ABL Facility” means the Credit Facility dated as of October 28, 2008, by and among the Company, the other
borrowers from time to time party thereto, the Guarantors, the lenders party thereto in their capacities as lenders thereunder and Bank of America, N.A., as Administrative Agent, including any guarantees, collateral documents, instruments and
agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals, restatements, refundings or refinancings thereof and any indentures or credit facilities or commercial

  

 1 

 
paper facilities with banks or other institutional lenders or investors that replace, refund or refinance any part of the loans, notes, other credit facilities or commitments thereunder,
including any such replacement, refunding or refinancing facility or indenture that increases the amount borrowable thereunder or alters the maturity thereof (provided that such increase in borrowings is permitted under Section 4.09
hereof). 
 “ABL Intercreditor Agreement” means the Lien Subordination and Intercreditor Agreement, dated as
of October 28, 2008, among the ABL Collateral Agent, the Notes/Term Collateral Agent, Sky Acquisition LLC, Sky Merger Sub Corporation, the Company and each Guarantor, as it may be amended from time to time in accordance with this Indenture.

 “ABL Lenders Debt” means (i) any Indebtedness outstanding from time to time under the ABL Facility,
(ii) any Indebtedness which has a senior priority security interest relative to the Series A-1 Notes and Series A-2 Debt in the ABL Collateral, (iii) all obligations with respect to such Indebtedness and any Hedging Obligations directly
related to any ABL Lenders Debt entered into with any lender (or its affiliates) under the ABL Facility and (iv) all Bank Products entered into with any lender (or its affiliates) under the ABL Facility. 

“Acquired Indebtedness” means, with respect to any specified Person, 

(1) Indebtedness of any other Person existing at the time such other Person is merged with or into or became a Restricted
Subsidiary of such specified Person, including Indebtedness incurred in connection with, or in contemplation of, such other Person merging with or into or becoming a Restricted Subsidiary of such specified Person, and 

(2) Indebtedness secured by a Lien encumbering any asset acquired by such specified Person. 

“Acquisition” means the acquisition of the Company by the Investors on October 28, 2008 and the related
transactions contemplated by the Transaction Agreement. 
 “Additional Interest” means all additional interest
then owing pursuant to the Registration Rights Agreement. 
 “Additional Notes” means additional Notes (other
than the Initial Notes and other than Exchange Notes for such Initial Notes) issued from time to time under this Indenture in accordance with Sections 2.01, 4.09 and 4.12 hereof. Additional Notes may be Series A-1 Notes and/or Series A-2 Notes.

 “Additional Note Obligations” means Obligations of the Company with respect to Additional Notes permitted
to be incurred under this Indenture which are secured by a Lien on the Collateral equally and ratably with the Initial Notes, provided that such Lien is permitted to be incurred under this Indenture. 

“Affiliate” of any specified Person means any other Person directly or indirectly controlling or controlled by or under
direct or indirect common control with such specified Person. For purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and “under common control
with”), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of voting securities, by
agreement or otherwise. 
  

 2 

 “After-Acquired Property” means any and all assets or property (other than
Excluded Assets) acquired after the Issue Date, including any property or assets acquired by the Company or a Guarantor from another Guarantor, which in each case constitutes Collateral. 

“Agent” means any Registrar or Paying Agent. 

“Agent’s Message” means a message transmitted by DTC to, and received by, the Depositary and forming a part of the
Book-Entry Confirmation, which states that DTC has received an express acknowledgment from each participant in DTC tendering the Notes that such participants have received the Letter of Transmittal and agree to be bound by the terms of the Letter of
Transmittal and the Company may enforce such agreement against such participants. 
 “Applicable Procedures”
means, with respect to any transfer or exchange of or for beneficial interests in any Global Note, the rules and procedures of the Depositary, Euroclear and/or Clearstream that apply to such transfer or exchange. 

“Asset Sale” means: 

(1) the sale, conveyance, transfer or other disposition, whether in a single transaction or a series of related
transactions, of property or assets (including by way of a Sale and Lease-Back Transaction) of the Company or any of its Restricted Subsidiaries (each referred to in this definition as a “disposition”); or 

(2) the issuance or sale of Equity Interests of any Restricted Subsidiary (other than Preferred Stock of Restricted
Subsidiaries issued in compliance with Section 4.09 hereof), whether in a single transaction or a series of related transactions; 
 in
each case, other than: 
 (a) any disposition of Cash Equivalents or Investment Grade Securities or surplus,
obsolete or worn out equipment in the ordinary course of business or any disposition of inventory or goods (or other assets) held for sale in the ordinary course of business or any disposition of ABL Collateral; 

(b) the disposition of all or substantially all of the assets of the Company governed by, and in a manner permitted
pursuant to, the provisions described under Section 5.01 hereof or any disposition that constitutes a Change of Control pursuant to this Indenture; 

(c) the making of any Restricted Payment or Permitted Investment that is permitted to be made, and is made, under
Section 4.07 hereof; 
 (d) any disposition of assets or issuance or sale of Equity Interests of any
Restricted Subsidiary in any transaction or series of transactions with an aggregate fair market value of less than $15.0 million; 

(e) any disposition of property or assets or issuance of securities by a Restricted Subsidiary of the Company to the
Company or by the Company or a Restricted Subsidiary of the Company to another Restricted Subsidiary of the Company; 
  

 3 

 (f) to the extent allowable under Section 1031 of the Internal Revenue
Code of 1986 or comparable law or regulation, any exchange of like property (excluding any boot thereon) for use in a Similar Business; 

(g) the lease, assignment or sub-lease of any real or personal property in the ordinary course of business; 

(h) any issuance or sale of Equity Interests in, or Indebtedness or other securities of, an Unrestricted Subsidiary;

 (i) foreclosures, condemnations or any similar action on assets; 

(j) sales of accounts receivable, or participations therein, in connection with any Receivables Facility; 

(k) any financing transaction with respect to the acquisition or construction of property by the Company or any
Restricted Subsidiary after the Issue Date, including Sale and Lease-Back Transactions and asset securitizations permitted by this Indenture; and 

(l) the licensing and sub-licensing of intellectual property or other general intangibles in the ordinary course of
business or consistent with past practice. 
 “Bank Products” means any facilities or services related to cash
management, including treasury, depository, overdraft, credit or debit card, purchase card, electronic funds transfer and other cash management arrangements. 

“Bankruptcy Law” means Title 11, U.S. Code or any similar federal or state law for the relief of debtors. 

“Borrowing Base” means, as of any date, an amount equal to: 

(1) 50% of the value of all net accounts receivable owned by the Company and its Restricted Subsidiaries as of the end of the most
recent fiscal quarter preceding such date; plus 
 (2) 50% of the value of all net inventory owned by the Company and
its Restricted Subsidiaries as of the end of the most recent fiscal quarter preceding such date; 
 all calculated on a consolidated basis and
in accordance with GAAP. 
 “Bridge Loan Agent” means Banc of America Bridge LLC, in its capacity as
“Bridge Loan Agent” under the Notes/Term Intercreditor Agreement, and any successor thereto in such capacity. 

“Broker-Dealer” has the meaning set forth in the Registration Rights Agreement. 

“Business Day” means each day which is not a Legal Holiday. 

“Capital Stock” means: 

(1) in the case of a corporation, corporate stock; 

 

 4 

 (2) in the case of an association or business entity, any and all shares,
interests, participations, rights or other equivalents (however designated) of corporate stock; 
 (3) in the
case of a partnership or limited liability company, partnership or membership interests (whether general or limited); and 

(4) any other interest or participation that confers on a Person the right to receive a share of the profits and losses
of, or distributions of assets of, the issuing Person. 
 “Capitalized Lease Obligation” means, at the time
any determination thereof is to be made, the amount of the liability in respect of a capital lease that would at such time be required to be capitalized and reflected as a liability on a balance sheet (excluding the footnotes thereto) in accordance
with GAAP. 
 “Cash Equivalents” means: 

(1) United States dollars; 

(2) (a) €, or any national currency of any participating member state of the EMU; or 

(b) such local currencies held by the Company or any Restricted Subsidiary from time to time in the ordinary course of
business; 
 (3) securities issued or directly and fully and unconditionally guaranteed or insured by the U.S.
government (or any agency or instrumentality thereof the securities of which are unconditionally guaranteed as a full faith and credit obligation of the U.S. government) with maturities of 24 months or less from the date of acquisition; 

(4) certificates of deposit, time deposits and Eurodollar time deposits with maturities of one year or less from the date
of acquisition, bankers’ acceptances with maturities not exceeding one year and overnight bank deposits, in each case with any commercial bank having capital and surplus of not less than $500.0 million in the case of U.S. banks and $100.0
million (or the U.S. dollar equivalent as of the date of determination) in the case of non-U.S. banks; 
 (5)
repurchase obligations for underlying securities of the types described in clauses (3) and (4) entered into with any financial institution meeting the qualifications specified in clause (4) above; 

(6) commercial paper rated at least P-1 by Moody’s or at least A-1 by S&P and in each case maturing within 24
months after the date of creation thereof; 
 (7) marketable short-term money market and similar securities
having a rating of at least P-2 or A-2 from either Moody’s or S&P, respectively (or, if at any time neither Moody’s nor S&P shall be rating such obligations, an equivalent rating from another Rating Agency) and in each case
maturing within 24 months after the date of creation thereof; 
  

 5 

 (8) investment funds investing 95% of their assets in securities of the
types described in clauses (1) through (7) above; 
 (9) readily marketable direct obligations issued
by any state, commonwealth or territory of the United States or any political subdivision or taxing authority thereof having an Investment Grade Rating from either Moody’s or S&P with maturities of 24 months or less from the date of
acquisition; 
 (10) Indebtedness or Preferred Stock issued by Persons with a rating of “A” or higher
from S&P or “A2” or higher from Moody’s with maturities of 24 months or less from the date of acquisition; and 

(11) Investments with average maturities of 24 months or less from the date of acquisition in money market funds rated
AAA- (or the equivalent thereof) or better by S&P or Aaa3 (or the equivalent thereof) or better by Moody’s. 

Notwithstanding the foregoing, Cash Equivalents shall include amounts denominated in currencies other than those set forth in
clauses (1) and (2) above, provided that such amounts are converted into any currency listed in clauses (1) and (2) as promptly as practicable and in any event within ten Business Days following the receipt of such
amounts. 
 “Casualty” means any casualty, loss, damage, destruction or other similar loss with respect to
real or personal property or improvements. 
 “Change of Control” means the occurrence of any of the
following: 
 (1) the sale, lease or transfer, in one or a series of related transactions, of all or
substantially all of the assets of the Company and its Subsidiaries, taken as a whole, to any Person other than a Permitted Holder; or 

(2) the Company becomes aware (by way of a report or any other filing pursuant to Section 13(d) of the Exchange Act,
proxy, vote, written notice or otherwise) of the acquisition by any Person or group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act, or any successor provision), including any group acting for the purpose of
acquiring, holding or disposing of securities (within the meaning of Rule 13d-5(b)(1) under the Exchange Act), other than the Permitted Holders, in a single transaction or in a related series of transactions, by way of merger, consolidation or
other business combination or purchase of beneficial ownership (within the meaning of Rule 13d-3 under the Exchange Act, or any successor provision) of 50% or more of the total voting power of the Voting Stock of the Company or any of its direct or
indirect parent companies. 
 “Clearstream” means Clearstream Banking, Société Anonyme.

 “Collateral” means all of the assets and properties subject to the Liens created by the Collateral
Documents. 
 “Collateral Documents” means, collectively, the security agreements, pledge agreements,
mortgages, collateral assignments, deeds of trust and all other pledges, agreements, financing statements, patent, trademark or copyright filings, mortgages or other filings or documents that create or purport to create a Lien in the Collateral in
favor of the Notes/Term Collateral Agent and/or the Trustee 
  

 6 

 
(for the benefit of the Holders of Series A-1 Notes and Series A-2 Notes), the ABL Intercreditor Agreement and the Notes/Term Intercreditor Agreement, in each case as they may be amended from
time to time, and any instruments of assignment, control agreements, lockbox letters or other instruments or agreements executed pursuant to the foregoing. 

“Company” has the meaning set forth in the recitals hereto until a successor Person shall have become such pursuant to
the applicable provisions of this Indenture, and thereafter “Company” shall mean such successor Person. 

“Company Order” means a written request or order signed on behalf of the Company by an Officer of the Company, who must
be the principal executive officer, the principal financial officer, the treasurer, the principal accounting officer or an executive vice president of the Company, and delivered to the Trustee. 

“Condemnation” means any taking by a Governmental Authority of property or assets, or any part thereof or interest
therein, for public or quasi-public use under the power of eminent domain, by reason of any public improvement or condemnation or in any other manner. 

“Condemnation Award” means all proceeds of any Condemnation or transfer in lieu thereof. 

“Consolidated Depreciation and Amortization Expense” means with respect to any Person for any period, the total amount
of depreciation and amortization expense, including the amortization of deferred financing fees of such Person and its Restricted Subsidiaries for such period on a consolidated basis and otherwise determined in accordance with GAAP. 

“Consolidated Interest Expense” means, with respect to any Person for any period, without duplication, the sum of:

 (1) consolidated interest expense of such Person and its Restricted Subsidiaries for such period, to the
extent such expense was deducted (and not added back) in computing Consolidated Net Income (including (a) amortization of original issue discount resulting from the issuance of Indebtedness at less than par, (b) all commissions, discounts
and other fees and charges owed with respect to letters of credit or bankers acceptances, (c) non-cash interest payments (but excluding any non-cash interest expense attributable to the movement in the mark to market valuation of Hedging
Obligations or other derivative instruments pursuant to GAAP), (d) the interest component of Capitalized Lease Obligations and (e) net payments, if any, pursuant to interest rate Hedging Obligations with respect to Indebtedness and
excluding (u) accretion or accrual of discounted liabilities not constituting Indebtedness, (v) any expense resulting from the discounting of any outstanding Indebtedness in connection with the application of purchase accounting in
connection with any acquisition, (w) any Additional Interest, (x) amortization of deferred financing fees, debt issuance costs, commissions, fees and expenses, (y) any expensing of bridge, commitment and other financing fees and
(z) commissions, discounts, yield and other fees and charges (including any interest expense) related to any Receivables Facility); plus 

(2) consolidated capitalized interest of such Person and its Restricted Subsidiaries for such period, whether paid or
accrued; less 
 (3) interest income for such period. 

 

 7 

 For purposes of this definition, interest on a Capitalized Lease Obligation shall be deemed
to accrue at an interest rate reasonably determined by such Person to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP. 

“Consolidated Net Income” means, with respect to any Person for any period, the aggregate of the Net Income, of such
Person and its Restricted Subsidiaries for such period, on a consolidated basis, and otherwise determined in accordance with GAAP; provided, however, that, without duplication, 

(1) any after-tax effect of extraordinary, non-recurring or unusual gains or losses (less all fees and expenses relating
thereto) or expenses (including relating to the Transaction), severance, relocation costs and curtailments or modifications to pension and post-retirement employee benefit plans and other restructuring costs shall be excluded, 

(2) the cumulative effect of a change in accounting principles during such period shall be excluded, 

(3) any after-tax effect of income (loss) from disposed, abandoned, transferred, closed or discontinued operations and any
net after-tax gains or losses on disposal of disposed, abandoned, transferred, closed or discontinued operations shall be excluded, 

(4) any after-tax effect of gains or losses (less all fees and expenses relating thereto) attributable to asset
dispositions other than in the ordinary course of business, as determined in good faith by the Company, shall be excluded, 

(5) the Net Income for such period of any Person that is not a Subsidiary, or is an Unrestricted Subsidiary, or that is
accounted for by the equity method of accounting, shall be excluded; provided that Consolidated Net Income of the Company shall be increased by the amount of dividends or distributions or other payments that are actually paid in cash (or to the
extent converted into cash) to the referent Person or a Restricted Subsidiary thereof in respect of such period, 

(6) solely for the purpose of determining the amount available for Restricted Payments under clause (3)(a) of
Section 4.07(a) hereof, the Net Income for such period of any Restricted Subsidiary (other than any Guarantor) shall be excluded to the extent that the declaration or payment of dividends or similar distributions by that Restricted Subsidiary
of its Net Income is not at the date of determination permitted without any prior governmental approval (which has not been obtained) or, directly or indirectly, by the operation of the terms of its charter or any agreement, instrument, judgment,
decree, order, statute, rule, or governmental regulation applicable to that Restricted Subsidiary or its stockholders, unless such restriction with respect to the payment of dividends or similar distributions has been legally waived, provided
that Consolidated Net Income of the Company will be increased by the amount of dividends or other distributions or other payments actually paid in cash (or to the extent converted into cash) or Cash Equivalents to the Company or a Restricted
Subsidiary thereof in respect of such period, to the extent not already included therein, 
 (7) effects of
adjustments (including the effects of such adjustments pushed down to the Company and its Restricted Subsidiaries) in the property and equipment, 

 

 8 

 
inventory and other intangible assets, deferred revenue and debt line items in such Person’s consolidated financial statements pursuant to GAAP resulting from the application of purchase
accounting in relation to the Transaction or any consummated acquisition or the amortization or write-off of any amounts thereof, net of taxes, shall be excluded, 

(8) any after-tax effect of income (loss) from the early extinguishment of Indebtedness or Hedging Obligations or other
derivative instruments shall be excluded, 
 (9) any impairment charge or asset write-off, in each case, pursuant
to GAAP and the amortization of intangibles arising pursuant to GAAP shall be excluded, 
 (10) any non-cash
compensation expense recorded from grants of stock appreciation or similar rights, stock options, restricted stock or other rights shall be excluded, 

(11) any fees and expenses incurred during such period, or any amortization thereof for such period, in connection with
any acquisition, disposition, recapitalization, Investment, Asset Sale, issuance or repayment of Indebtedness, issuance of Equity Interests, refinancing transaction or amendment or modification of any debt instrument (in each case, including any
such transaction consummated prior to the Issue Date and any such transaction undertaken but not completed) and any charges or non-recurring merger costs incurred during such period as a result of any such transaction shall be excluded, and

 (12) accruals and reserves that are established or adjusted within twelve months of the Issue Date that are so
required to be established or adjusted as a result of the Transaction in accordance with GAAP or changes as a result of a modification of accounting policies shall be excluded. 

Notwithstanding the foregoing, for the purpose of Section 4.07 hereof only (other than clause (3)(d) of Section 4.07(a)
hereof), there shall be excluded from Consolidated Net Income any income arising from any sale or other disposition of Restricted Investments made by the Company and its Restricted Subsidiaries, any repurchases and redemptions of Restricted
Investments from the Company and its Restricted Subsidiaries, any repayments of loans and advances which constitute Restricted Investments by the Company or any of its Restricted Subsidiaries, any sale of the stock of an Unrestricted Subsidiary or
any distribution or dividend from an Unrestricted Subsidiary, in each case only to the extent such amounts increase the amount of Restricted Payments permitted under clause (3)(d) of Section 4.07(a) hereof. 

“Contingent Obligations” means, with respect to any Person, any obligation of such Person guaranteeing any leases,
dividends or other obligations that do not constitute Indebtedness (“primary obligations”) of any other Person (the “primary obligor”) in any manner, whether directly or indirectly, including, without limitation,
any obligation of such Person, whether or not contingent, 
 (1) to purchase any such primary obligation or any
property constituting direct or indirect security therefor, 
 (2) to advance or supply funds 

(a) for the purchase or payment of any such primary obligation, or 

 

 9 

 (b) to maintain working capital or equity capital of the primary obligor or
otherwise to maintain the net worth or solvency of the primary obligor, or 
 (3) to purchase property,
securities or services primarily for the purpose of assuring the owner of any such primary obligation of the ability of the primary obligor to make payment of such primary obligation against loss in respect thereof. 

“Corporate Trust Office of the Trustee” shall be at the address of the Trustee specified in Section 14.02 hereof
or such other address as to which the Trustee may give notice to the Holders and the Company. 
 “Coram
Acquisition” means the acquisition by the Company of Coram, Inc. completed on December 3, 2007. 

“Credit Facilities” means, with respect to the Company or any of its Restricted Subsidiaries, one or more debt
facilities, including the ABL Facility and the Term Loan Facility, or other financing arrangements (including, without limitation, commercial paper facilities or indentures), providing for revolving credit loans, term loans, letters of credit or
other long-term indebtedness, including any notes, mortgages, guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions, renewals, restatements or
refundings thereof and any indentures or credit facilities or commercial paper facilities that replace, refund or refinance any part of the loans, notes, other credit facilities or commitments thereunder, including any such replacement, refunding or
refinancing facility or indenture that increases the amount permitted to be borrowed thereunder or alters the maturity thereof (provided that such increase in borrowings is permitted under Section 4.09 hereof) or adds Restricted
Subsidiaries as additional borrowers or guarantors thereunder and whether by the same or any other agent, lender or group of lenders. 

“Custodian” means the Trustee, as custodian with respect to the Notes in global form, or any successor entity thereto.

 “Default” means any event that is, or with the passage of time or the giving of notice or both would be, an
Event of Default. 
 “Definitive Note” means a certificated Note registered in the name of the Holder thereof
and issued in accordance with Section 2.06(c) hereof, substantially in the form of, in the case of Series A-1 Notes, Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved in the board
resolution authorizing such Series A-2 Notes or Annex A attached to the Form of Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E, except that such Note shall not bear the Global Note Legend and
shall not have the “Schedule of Exchanges of Interests in the Global Note” attached thereto. 

“Depositary” means, with respect to the Notes issuable or issued in whole or in part in global form, the Person
specified in Section 2.03 hereof as the Depositary with respect to the Notes, and any and all successors thereto appointed as Depositary hereunder and having become such pursuant to the applicable provision of this Indenture. 

“Designated Non-cash Consideration” means the fair market value of non-cash consideration received by the Company or a
Restricted Subsidiary in connection with an Asset Sale that is so designated as Designated Non-cash Consideration pursuant to an Officer’s Certificate, setting forth the 

 

 10 

 
basis of such valuation, executed by the principal financial officer of the Company, less the amount of cash or Cash Equivalents received in connection with a subsequent sale of or collection on
such Designated Non-cash Consideration. 
 “Designated Preferred Stock” means Preferred Stock of the Company
or any parent corporation thereof (in each case other than Disqualified Stock) that is issued for cash (other than to a Restricted Subsidiary or an employee stock ownership plan or trust established by the Company or any of its Subsidiaries) and is
so designated as Designated Preferred Stock, pursuant to an Officer’s Certificate executed by the principal financial officer of the Company or the applicable parent corporation thereof, as the case may be, on the issuance date thereof, the
cash proceeds of which are excluded from the calculation set forth in clause (3) of Section 4.07(a) hereof. 

“Disqualified Stock” means, with respect to any Person, any Capital Stock of such Person which, by its terms, or by the
terms of any security into which it is convertible or for which it is putable or exchangeable, or upon the happening of any event, matures or is mandatorily redeemable (other than solely as a result of a change of control or asset sale) pursuant to
a sinking fund obligation or otherwise, or is redeemable at the option of the holder thereof (other than solely as a result of a change of control or asset sale), in whole or in part, in each case prior to the date 91 days after the maturity date of
the Notes of the applicable series; 
 provided, however, that if such Capital Stock is issued to any plan for the benefit of
employees of the Company or its Subsidiaries or by any such plan to such employees, such Capital Stock shall not constitute Disqualified Stock solely because it may be required to be repurchased by the Company or its Subsidiaries in order to satisfy
applicable statutory or regulatory obligations. 
 “EBITDA” means, with respect to any Person for any period,
the Consolidated Net Income of such Person for such period 
 (1) increased (without duplication) by: 

(a) provision for taxes based on income or profits or capital gains, including, without limitation, state, franchise and
similar taxes and foreign withholding taxes of such Person paid or accrued during such period to the extent the same was deducted (and not added back) in computing Consolidated Net Income; plus 

(b) Fixed Charges of such Person for such period (including (x) net losses on Hedging Obligations or other
derivative instruments entered into for the purpose of hedging interest rate risk and (y) costs of surety bonds in connection with financing activities, in each case, to the extent included in Fixed Charges) to the extent the same was deducted
(and not added back) in calculating such Consolidated Net Income; plus 
 (c) Consolidated Depreciation
and Amortization Expense of such Person for such period to the extent the same were deducted (and not added back) in computing Consolidated Net Income; plus 

(d) the amount of any integration costs or other business optimization expenses or reserves deducted (and not added back)
in such period in computing Consolidated Net Income, including any one-time costs incurred in connection with acquisitions after the Issue Date and costs related to the closure and/or consolidation of facilities; plus 

 

 11 

 (e) any other non-cash charges, including any write-offs or write-downs,
reducing Consolidated Net Income for such period (provided that if any such non-cash charges represent an accrual or reserve for potential cash items in any future period, the cash payment in respect thereof in such future period shall be
subtracted from EBITDA to such extent, and excluding amortization of a prepaid cash item that was paid in a prior period); plus 

(f) the amount of any minority interest expense consisting of Subsidiary income attributable to minority equity interests
of third parties in any non-Wholly-Owned Subsidiary deducted (and not added back) in such period in calculating Consolidated Net Income; plus 

(g) the amount of management, monitoring, consulting and advisory fees and related expenses paid in such period to the
Investors to the extent otherwise permitted under Section 4.11 hereof; plus 
 (h) the amount of net
cost savings and synergies projected by the Company in good faith to be realized as a result of specified actions taken or with respect to which substantial steps have been taken (in the good faith determination of the Company) and which are
expected to be realized within 12 months of the date thereof in connection with the Acquisition, future acquisitions and cost saving, restructuring and other similar initiatives (which cost savings shall be added to EBITDA until fully realized and
calculated on a pro forma basis as though such cost savings had been realized on the first day of such period), net of the amount of actual benefits realized during such period from such actions; provided that such cost savings are reasonably
identifiable and factually supportable (which adjustments may be incremental to pro forma adjustments made pursuant to the second paragraph of the definition of “Fixed Charge Coverage Ratio”) (notwithstanding the foregoing, all net cost
savings and synergies described in the Offering Memorandum may be added back to EBITDA); plus 
 (i) the
amount of loss on sale of receivables and related assets to the Receivables Subsidiary in connection with a Receivables Facility; plus 

(j) any costs or expense incurred by the Company or a Restricted Subsidiary pursuant to any management equity plan or
stock option plan or any other management or employee benefit plan or agreement or any stock subscription or shareholder agreement, to the extent that such cost or expenses are funded with cash proceeds contributed to the capital of the Company or
net cash proceeds of an issuance of Equity Interests of the Company (other than Disqualified Stock) solely to the extent that such net cash proceeds are excluded from the calculation set forth in clause (3) of Section 4.07(a) hereof.

 (2) decreased by (without duplication) non-cash gains increasing Consolidated Net Income of such Person for
such period, excluding any non-cash gains to the extent they represent the reversal of an accrual or reserve for a potential cash item that reduced EBITDA in any prior period; and 

 

 12 

 (3) increased or decreased by (without duplication): 

(a) any net gain or loss resulting in such period from Hedging Obligations and the application of Statement of Financial
Accounting Standards No. 133; plus or minus, as applicable, 
 (b) any net gain or loss
resulting in such period from currency translation gains or losses related to currency remeasurements of Indebtedness (including any net loss or gain resulting from hedge agreements for currency exchange risk). 

“EMU” means economic and monetary union as contemplated in the Treaty on European Union. 

“Equity Interests” means Capital Stock and all warrants, options or other rights to acquire Capital Stock, but
excluding any debt security that is convertible into, or exchangeable for, Capital Stock. 
 “Equity Offering”
means any public or private sale of common stock or Preferred Stock of the Company (excluding Disqualified Stock) or any of its direct or indirect parent companies to the extent the proceeds thereof are contributed to the Company as equity (other
than Disqualified Stock), other than: 
 (1) public offerings with respect to the Company’s or any direct or
indirect parent company’s common stock registered on Form S-8; 
 (2) issuances to any Subsidiary of the
Company; and 
 (3) any such public or private sale that constitutes an Excluded Contribution. 

“€” means the single currency of participating member states of the EMU. 

“Euroclear” means Euroclear Bank S.A./N.V., as operator of the Euroclear system. 

“Event of Loss” means, with respect to any Collateral, any (1) Casualty of such Collateral, (2) Condemnation
or seizure (other than pursuant to foreclosure or confiscation or requisition of the use of such Collateral) or (3) settlement in lieu of clause (2) above, in each case having a fair market value in excess of $10.0 million. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC
promulgated thereunder. 
 “Exchange Notes” means the Exchange Series A-1 Notes and the Exchange Series A-2
Notes. 
 “Exchange Series A-1 Notes” means the Series A-1 Notes issued in the Exchange Offer pursuant to
Section 2.06(f) hereof. 
 “Exchange Series A-2 Notes” means the Series A-2 Notes issued in the Exchange
Offer pursuant to Section 2.06(f) hereof. 
  

 13 

 “Exchange Offer” has the meaning set forth in the applicable Registration
Rights Agreement. 
 “Exchange Offer Registration Statement” has the meaning set forth in the applicable
Registration Rights Agreement. 
 “Excluded Assets” means the collective reference to: (1) any property
or assets owned by any Foreign Subsidiary; (2) Excluded Contracts; (3) Excluded Equipment; (4) any interest in fee-owned real property of the Company and the Guarantors if the greater of its cost and book value is less than $5.0
million; (5) any interest in leased real property of the Company and the Guarantors; (6) motor vehicles and other assets subject to certificates of title; (7) letter of credit rights; (8) commercial tort claims of less than $20.0
million; (9) assets requiring perfection through control agreements (other than with respect to assets consisting of Equity Interests of the Company or any of its Subsidiaries); (10) pledges and security interests prohibited by law;
(11) assets to the extent a security interest in such assets would result in material adverse tax consequences as reasonably determined by the Company; and (12) proceeds and products from any and all of the foregoing excluded collateral
described in clauses (1) through (11), unless such proceeds or products would otherwise constitute Collateral; provided, however, that Excluded Assets shall not include any asset which secures obligations with respect to ABL
Lenders Debt. 
 “Excluded Contract” means at any date any rights or interest of the Company or any Guarantor
in any assets or under any agreement, contract, license, instrument, document or other general intangible (referred to solely for purposes of this definition as a “Contract”) to the extent that such Contract by the terms of a restriction
in favor of a Person who is not the Company or any Guarantor, or any requirement of law, prohibits, or requires any consent or establishes any other condition for or would terminate because of an assignment thereof or a grant of a security interest
therein by the Company or a Guarantor; provided that: (i) rights to payment under any such Contract otherwise constituting an Excluded Contract by virtue of this definition shall be included in the Collateral to the extent permitted thereby or
by Section 9-406 or Section 9-408 of the Uniform Commercial Code and (ii) all proceeds paid or payable to any of the Company or any Guarantor from any sale, transfer or assignment of such Contract and all rights to receive such
proceeds shall be included in the Collateral. 
 “Excluded Contribution” means net cash proceeds, marketable
securities or Qualified Proceeds received by the Company from 
 (1) contributions to its common equity capital,
and 
 (2) the sale (other than to a Subsidiary of the Company or to any management equity plan or stock option
plan or any other management or employee benefit plan or agreement of the Company) of Capital Stock (other than Disqualified Stock and Designated Preferred Stock) of the Company, 

in each case after the Issue Date and in each case designated as Excluded Contributions pursuant to an officer’s certificate executed by the
principal financial officer of the Company on the date such capital contributions are made or the date such Equity Interests are sold, as the case may be, which are excluded from the calculation set forth in clause (3) of Section 4.07(a)
hereof. 
 “Excluded Equipment” means at any date any equipment or other assets of the Company or any
Guarantor which is subject to, or secured by, a Capitalized Lease Obligation or a purchase money obligation if and to the extent that (i) a restriction in favor of a Person who is not the Company or a Restricted Subsidiary contained in the
agreements or documents granting or governing 
  

 14 

 
such Capitalized Lease Obligation or purchase money obligation prohibits, or requires any consent or establishes any other conditions for or would result in the termination of such agreement or
document because of an assignment thereof, or a grant of a security interest therein, by the Company or any Guarantor and (ii) such restriction relates only to the asset or assets acquired by the Company or any Guarantor with the proceeds of
such Capitalized Lease Obligation or purchase money obligation and attachments thereto, improvements thereof or substitutions therefor; provided that all proceeds paid or payable to any of the Company or any Guarantor from any sale, transfer
or assignment or other voluntary or involuntary disposition of such assets and all rights to receive such proceeds shall be included in the Collateral to the extent not otherwise required to be paid to the holder of any Capitalized Lease Obligations
or purchase money obligations secured by such assets. 
 “Fixed Charge Coverage Ratio” means, with respect to
any Person for any period, the ratio of EBITDA of such Person for such period to the Fixed Charges of such Person for such period. In the event that the Company or any Restricted Subsidiary incurs, assumes, guarantees, redeems, retires or
extinguishes any Indebtedness (other than Indebtedness incurred under any revolving credit facility unless such Indebtedness has been permanently repaid and has not been replaced) or issues or redeems Disqualified Stock or Preferred Stock subsequent
to the commencement of the period for which the Fixed Charge Coverage Ratio is being calculated but prior to or simultaneously with the event for which the calculation of the Fixed Charge Coverage Ratio is made (the “Fixed Charge Coverage
Ratio Calculation Date”), then the Fixed Charge Coverage Ratio shall be calculated giving pro forma effect to such incurrence, assumption, guarantee, redemption, retirement or extinguishment of Indebtedness, or such issuance or
redemption of Disqualified Stock or Preferred Stock, as if the same had occurred at the beginning of the applicable four-quarter period. 

For purposes of making the computation referred to above, Investments, acquisitions, dispositions, mergers, consolidations and disposed
operations (as determined in accordance with GAAP) that have been made by the Company or any of its Restricted Subsidiaries during the four-quarter reference period or subsequent to such reference period and on or prior to or simultaneously with the
Fixed Charge Coverage Ratio Calculation Date shall be calculated on a pro forma basis, assuming that all such Investments, acquisitions, dispositions, mergers, consolidations and disposed operations (and the change in any associated fixed
charge obligations and the change in EBITDA resulting therefrom) had occurred on the first day of the four-quarter reference period. If since the beginning of such period any Person that subsequently became a Restricted Subsidiary or was merged with
or into the Company or any of its Restricted Subsidiaries since the beginning of such period shall have made any Investment, acquisition, disposition, merger, consolidation or disposed operation that would have required adjustment pursuant to this
definition, then the Fixed Charge Coverage Ratio shall be calculated giving pro forma effect thereto for such period as if such Investment, acquisition, disposition, merger, consolidation or disposed operation had occurred at the beginning of
the applicable four-quarter period. 
 For purposes of this definition, whenever pro forma effect is to be given to an
Investment, acquisition, disposition, merger or consolidation (including the Transaction and the Coram Acquisition) or any other transaction, the pro forma calculations shall be made in good faith by a responsible financial or accounting
officer of the Company (and may include, for the avoidance of doubt and without duplication, cost savings, synergies and operating expense resulting from such Investment, acquisition, disposition, merger or consolidation (including the Transaction
and the Coram Acquisition) or other transaction, in each case calculated in the manner described in the definition of “EBITDA” herein). If any Indebtedness bears a floating rate of interest and is being given pro forma effect, the
interest on such Indebtedness shall be calculated as if the rate in effect on the Fixed Charge Coverage Ratio Calculation Date had been the applicable rate for the entire period (taking into account any Hedging Obligations applicable to such
Indebtedness). Interest on a Capitalized Lease Obligation shall be deemed to accrue at an interest rate reasonably determined by a responsible financial or accounting officer of the 

 

 15 

 
Company to be the rate of interest implicit in such Capitalized Lease Obligation in accordance with GAAP. For purposes of making the computation referred to above, interest on any Indebtedness
under a revolving credit facility computed on a pro forma basis shall be computed based upon the average daily balance of such Indebtedness during the applicable period except as set forth in the first paragraph of this definition. Interest
on Indebtedness that may optionally be determined at an interest rate based upon a factor of a prime or similar rate, a Eurocurrency interbank offered rate, or other rate, shall be deemed to have been based upon the rate actually chosen, or, if
none, then based upon such optional rate chosen as the Company may designate. 
 “Fixed Charges” means, with
respect to any Person for any period, the sum of: 
 (1) Consolidated Interest Expense of such Person for such
period; 
 (2) all cash dividends or other distributions paid (excluding items eliminated in consolidation) on
any series of Preferred Stock of any Restricted Subsidiary during such period; and 
 (3) all dividends or other
distributions accrued (excluding items eliminated in consolidation) on any series of Disqualified Stock during such period. 

“Foreign Subsidiary” means, with respect to any Person, any Restricted Subsidiary of such Person that is not organized
or existing under the laws of the United States, any state thereof, or the District of Columbia and any Restricted Subsidiary of such Foreign Subsidiary. 

“GAAP” means generally accepted accounting principles in the United States which are in effect on the Issue Date.

 “Global Note Legend” means the legend set forth in Section 2.06(g)(2) hereof, which is required to be
placed on all Global Notes issued under this Indenture. 
 “Global Notes” means, individually and
collectively, each of the Restricted Global Notes and the Unrestricted Global Notes, substantially in the form of, in the case of Series A-1 Notes, Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved
in the board resolution authorizing such Series A-2 Notes or Annex A attached to the Form of Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E, issued in accordance with Section 2.01,
2.06(b), 2.06(d) or 2.06(f) hereof. 
 “Governmental Authority” means the government of the United States or
any other nation, or of any political subdivision thereof, whether state or local, and any agency, authority, instrumentality, regulatory body, court, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or
administrative powers or functions of or pertaining to government including any supra national bodies such as the European Union or the European Central bank). 

“Government Securities” means securities that are: 

(1) direct obligations of the United States of America for the timely payment of which its full faith and credit is
pledged; or 
 (2) obligations of a Person controlled or supervised by and acting as an agency or instrumentality
of the United States of America the timely payment of which is unconditionally guaranteed as a full faith and credit obligation by the United States of America, 
  

 16 

 which, in either case, are not callable or redeemable at the option of the issuers thereof, and shall also
include a depository receipt issued by a bank (as defined in Section 3(a)(2) of the Securities Act), as custodian with respect to any such Government Securities or a specific payment of principal of or interest on any such Government Securities
held by such custodian for the account of the holder of such depository receipt; provided that (except as required by law) such custodian is not authorized to make any deduction from the amount payable to the holder of such depository receipt
from any amount received by the custodian in respect of the Government Securities or the specific payment of principal of or interest on the Government Securities evidenced by such depository receipt. 

“Grantors” means the Company and the Guarantors. 

“guarantee” means a guarantee (other than by endorsement of negotiable instruments for collection in the ordinary
course of business), direct or indirect, in any manner (including letters of credit and reimbursement agreements in respect thereof), of all or any part of any Indebtedness or other obligations. 

“Guarantee” means the guarantee by any Guarantor of the Company’s Obligations under this Indenture. 

“Guarantor” means each Restricted Subsidiary that Guarantees the Notes in accordance with the terms of this Indenture
and its successors and assigns, until released from its obligations under its Guarantee in accordance with the terms of this Indenture. 

“Hedging Obligations” means, with respect to any Person, the obligations of such Person under any interest rate swap
agreement, interest rate cap agreement, interest rate collar agreement, commodity swap agreement, commodity cap agreement, commodity collar agreement, foreign exchange contract, currency swap agreement or similar agreement providing for the
transfer, modification or mitigation of interest rate, commodity or currency risks either generally or under specific contingencies. 

“Holder” means the Person in whose name a Note of a particular series is registered on the Registrar’s books.

 “Holdings” means Sky Acquisition LLC, a Delaware limited liability company. 

“Indebtedness” means, with respect to any Person, without duplication: 

(1) any indebtedness of such Person, whether or not contingent: 

(a) in respect of borrowed money; 

(b) evidenced by bonds, notes, debentures or similar instruments or letters of credit or bankers’ acceptances (or,
without duplication, reimbursement agreements in respect thereof); 
 (c) representing the balance deferred and
unpaid of the purchase price of any property (including Capitalized Lease Obligations), except (i) any such balance that constitutes a trade payable or similar obligation to a trade creditor, in each case accrued in the ordinary course of
business and (ii) any earn-out obligations until such obligation becomes a liability on the balance sheet of such Person in accordance with GAAP; or 
  

 17 

 (d) representing net obligations under any Hedging Obligations; 

if and to the extent that any of the foregoing Indebtedness (other than letters of credit and Hedging Obligations) would appear as a
liability upon a balance sheet (excluding the footnotes thereto) of such Person prepared in accordance with GAAP; 

(2) to the extent not otherwise included, any obligation by such Person to be liable for, or to pay, as obligor, guarantor
or otherwise on, the obligations of the type referred to in clause (1) of a third Person (whether or not such items would appear upon the balance sheet of the such obligor or guarantor), other than by endorsement of negotiable instruments for
collection in the ordinary course of business; and 
 (3) to the extent not otherwise included, the obligations
of the type referred to in clause (1) of a third Person secured by a Lien on any asset owned by such first Person, whether or not such Indebtedness is assumed by such first Person; 

provided, however, that notwithstanding the foregoing, Indebtedness shall be deemed not to include (a) Contingent Obligations incurred
in the ordinary course of business or (b) obligations under or in respect of Receivables Facilities. 

“Indenture” means this Indenture, as amended or supplemented from time to time. 

“Independent Financial Advisor” means an accounting, appraisal, investment banking firm or consultant to Persons
engaged in Similar Businesses of nationally recognized standing that is, in the good faith judgment of the Company, qualified to perform the task for which it has been engaged. 

“Indirect Participant” means a Person who holds a beneficial interest in a Global Note through a Participant.

 “Initial Notes” has the meaning set forth in the recitals hereto. 

“Initial Purchasers” means Banc of America Securities LLC, Wachovia Capital Markets, LLC, Barclays Capital Inc. and
Scotia Capital (USA) Inc. 
 “Intercreditor Agreements” means, collectively, the ABL Intercreditor Agreement
and the Notes/Term Intercreditor Agreement. 
 “Interest Payment Date” means, as applicable, the Series A-1
Notes Interest Payment Date and, if any Series A-2 Notes are issued, the Series A-2 Notes Interest Payment Date. 

“Investment Grade Rating” means a rating equal to or higher than Baa3 (or the equivalent) by Moody’s and BBB- (or
the equivalent) by S&P, or an equivalent rating by any other Rating Agency. 
 “Investment Grade
Securities” means: 
 (1) securities issued or directly and fully guaranteed or insured by the United
States government or any agency or instrumentality thereof (other than Cash Equivalents); 
  

 18 

 (2) debt securities or debt instruments with an Investment Grade Rating, but
excluding any debt securities or instruments constituting loans or advances among the Company and its Subsidiaries; 

(3) investments in any fund that invests exclusively in investments of the type described in clauses (1) and
(2) which fund may also hold immaterial amounts of cash pending investment or distribution; and 
 (4)
corresponding instruments in countries other than the United States customarily utilized for high quality investments. 

“Investments” means, with respect to any Person, all investments by such Person in other Persons (including Affiliates)
in the form of loans (including guarantees), advances or capital contributions (excluding accounts receivable, trade credit, advances to customers, commission, travel and similar advances to officers and employees, in each case made in the ordinary
course of business), purchases or other acquisitions for consideration of Indebtedness, Equity Interests or other securities issued by any other Person and investments that are required by GAAP to be classified on the balance sheet (excluding the
footnotes) of the Company in the same manner as the other investments included in this definition to the extent such transactions involve the transfer of cash or other property. For purposes of the definition of “Unrestricted Subsidiary”
and Section 4.07 hereof: 
 (1) “Investments” shall include the portion (proportionate to the
Company’s equity interest in such Subsidiary) of the fair market value of the net assets of a Subsidiary of the Company at the time that such Subsidiary is designated an Unrestricted Subsidiary; provided, however, that upon a
redesignation of such Subsidiary as a Restricted Subsidiary, the Company shall be deemed to continue to have a permanent “Investment” in an Unrestricted Subsidiary in an amount (if positive) equal to: 

(a) the Company’s “Investment” in such Subsidiary at the time of such redesignation; less 

(b) the portion (proportionate to the Company’s equity interest in such Subsidiary) of the fair market value of the
net assets of such Subsidiary at the time of such redesignation; and 
 (2) any property transferred to or from
an Unrestricted Subsidiary shall be valued at its fair market value at the time of such transfer, in each case as determined in good faith by the Company. 

“Investors” means The Blackstone Group and each of its Affiliates, but not including any of its portfolio companies.

 “Issue Date” means May 27, 2009. 

“Legal Holiday” means a Saturday, a Sunday or a day on which commercial banking institutions are not required to be
open in the State of New York. 
  

 19 

 “Letter of Transmittal” means the letter of transmittal to be prepared by
the Company and sent to all Holders of the applicable Notes for use by such Holders in connection with the applicable Exchange Offer. 

“Lien” means, with respect to any asset, any mortgage, lien (statutory or otherwise), pledge, hypothecation, charge,
security interest, preference, priority or encumbrance of any kind in respect of such asset, whether or not filed, recorded or otherwise perfected under applicable law, including any conditional sale or other title retention agreement, any lease in
the nature thereof, any option or other agreement to sell or give a security interest in and any filing of or agreement to give any financing statement under the Uniform Commercial Code (or equivalent statutes) of any jurisdiction; provided
that in no event shall an operating lease be deemed to constitute a Lien. 
 “Moody’s” means Moody’s
Investors Service, Inc. and any successor to its rating agency business. 
 “Net Income” means, with respect
to any Person, the net income (loss) of such Person, determined in accordance with GAAP and before any reduction in respect of Preferred Stock dividends. 

“Net Loss Proceeds” means, with respect to any Event of Loss, the proceeds in the form of (a) cash or Cash
Equivalents, (b) insurance proceeds, (c) Condemnation Awards or (d) damages awarded by any judgment, in each case received by the Company or any of its Restricted Subsidiaries from such Event of Loss, net of: 

(1) reasonable out-of-pocket expenses and fees relating to such Event of Loss (including without limitation legal,
accounting and appraisal or insurance adjuster fees); 
 (2) taxes paid or payable after taking into account any
reduction in consolidated tax liability due to available tax credits or deductions and any tax sharing arrangements; 

(3) any repayment of Indebtedness that is secured by, or directly related to, the property or assets that are the subject
of such Event of Loss; 
 (4) amounts required to be paid to any Person (other than the Company or any Restricted
Subsidiary) owning a beneficial interest in the assets subject to the Event of Loss or having a Lien thereon; and 

(5) appropriate amounts to be provided by the Company or any Restricted Subsidiary, as the case may be, as a reserve, in
accordance with GAAP, against any liabilities associated with such Event of Loss and retained by the Company or any Restricted Subsidiary, as the case may be, after such Event of Loss, including, without limitation, liabilities related to
environmental matters and liabilities under any indemnification obligations associated with such Event of Loss. 
 “Net
Proceeds” means the aggregate cash proceeds and Cash Equivalents received by the Company or any of its Restricted Subsidiaries in respect of any Asset Sale, including any cash and Cash Equivalents received upon the sale or other disposition
of any Designated Non-cash Consideration received in any Asset Sale, net of the direct costs relating to such Asset Sale and the sale or disposition of such Designated Non-cash Consideration, including legal, accounting and investment

  

 20 

 
banking fees, and brokerage and sales commissions, any relocation expenses incurred as a result thereof, taxes paid or payable as a result thereof (after taking into account any available tax
credits or deductions and any tax sharing arrangements), amounts required to be applied to the repayment of Indebtedness secured by a Lien on such assets (other than as required by clause (1) of Section 4.10(b) hereof) and any deduction of
appropriate amounts to be provided by the Company or any of its Restricted Subsidiaries as a reserve in accordance with GAAP against any liabilities associated with the asset disposed of in such transaction and retained by the Company or any of its
Restricted Subsidiaries after such sale or other disposition thereof, including pension and other post-employment benefit liabilities and liabilities related to environmental matters or against any indemnification obligations associated with such
transaction. 
 “Non-U.S. Person” means a Person who is not a U.S. Person. 

“Notes” means the Initial Notes and any other Note authenticated and delivered under this Indenture. For all purposes
of this Indenture, the term “Notes” shall also include any Additional Notes that may be issued under a supplemental indenture. For purposes of this Indenture, all references to Notes to be issued or authenticated upon transfer, replacement
or exchange shall be deemed to refer to Notes of the applicable series. For the avoidance of doubt, no Series A-1 Note, or any interest therein, may be transferred, replaced or exchanged for a Series A-2 Note, or any interest therein, and no Series
A-2 Note, or any interest therein, may be transferred, replaced or exchanged for a Series A-1 Note, or any interest therein. 

“Notes/Term Collateral” means “Senior Secured Term Debt First Lien Collateral” as defined in the ABL
Intercreditor Agreement. 
 “Notes/Term Collateral Agent” means Bank of America, N.A., in its capacity as the
“Term Debt Collateral Agent” under the ABL Intercreditor Agreement, and in its capacity as the “Collateral Agent” under the Notes/Term Intercreditor Agreement and the other Collateral Documents, and any successor thereto in such
capacities. The Trustee will succeed Bank of America, N.A. as Notes/Term Collateral Agent if there are no loans under the Term Loan Facility outstanding. 

“Notes/Term Intercreditor Agreement” means the Intercreditor and Collateral Agency Agreement, dated as of the Issue
Date, among the Company, Banc of America Bridge LLC, as Bridge Loan Agent, Bank of America, N.A., as Notes/Term Collateral Agent, and U.S. Bank National Association, as Trustee, and as it may be amended from time to time in accordance with this
Indenture. The Notes/Term Intercreditor Agreement will remain in full force and effect with respect to the Series A-1 Notes and Series A-2 Notes whether or not any Indebtedness under the Term Loan Facility remains outstanding and whether or not the
Bridge Loan Agent remains a party thereto. 
 “Obligations” means any principal, interest (including any
interest accruing subsequent to the filing of a petition in bankruptcy, reorganization or similar proceeding at the rate provided for in the documentation with respect thereto, whether or not such interest is an allowed claim under applicable state,
federal or foreign law), penalties, fees, indemnifications, reimbursements (including reimbursement obligations with respect to letters of credit and banker’s acceptances), damages and other liabilities, and guarantees of payment of such
principal, interest, penalties, fees, indemnifications, reimbursements, damages and other liabilities, payable under the documentation governing any Indebtedness. 

“Offering Memorandum” means the offering memorandum, dated May 21, 2009, relating to the sale of the Initial
Series A-1 Notes. 
  

 21 

 “Officer” means the Chairman of the Board, the Chief Executive Officer,
the Chief Financial Officer, the Chief Operating Officer, the President, any Executive Vice President, Senior Vice President or Vice President, the Treasurer or the Secretary of the Company or a Guarantor. 

“Officer’s Certificate” means a certificate signed on behalf of the Company by an Officer of the Company or on
behalf of a Guarantor by an Officer of such Guarantor, who must be the principal executive officer, the principal financial officer, the treasurer or the principal accounting officer of the Company or any officer of such Guarantor that meets the
requirements set forth in this Indenture. 
 “Opinion of Counsel” means a written opinion from legal counsel
who is acceptable to the Trustee. The counsel may be an employee of or counsel to the Company, a Subsidiary of the Company or the Trustee. 

“Participant” means, with respect to the Depositary, Euroclear or Clearstream, a Person who has an account with the
Depositary, Euroclear or Clearstream, respectively (and, with respect to DTC, shall include Euroclear and Clearstream). 

“Perfection Certificate” means the Perfection Certificate substantially in the form of Exhibit B to the Security
Agreement. 
 “Permitted Asset Swap” means the concurrent purchase and sale or exchange of Related Business
Assets or a combination of Related Business Assets and cash or Cash Equivalents between the Company or any of its Restricted Subsidiaries and another Person; provided, that any cash or Cash Equivalents received must be applied in accordance
with Section 4.10 hereof; provided further that the assets received are pledged as Collateral to the extent required by the Collateral Documents to the extent that the assets disposed of constituted Collateral. 

“Permitted Holders” means each of the Investors and members of management of the Company (or its direct or indirect
parent or Subsidiary) on the Issue Date who are holders of Equity Interests of the Company (or any of its direct or indirect parent companies) and any group (within the meaning of Section 13(d)(3) or Section 14(d)(2) of the Exchange Act or
any successor provision) of which any of the foregoing are members; provided that, in the case of such group and without giving effect to the existence of such group or any other group, such Investors and members of management, collectively,
have beneficial ownership of more than 50% of the total voting power of the Voting Stock of the Company or any of its direct or indirect parent companies. 

“Permitted Investment” means: 

(1) any Investment in the Company or any of its Restricted Subsidiaries; 

(2) any Investment in cash and Cash Equivalents or Investment Grade Securities; 

(3) any Investment by the Company or any of its Restricted Subsidiaries in a Person that is engaged in a Similar Business
if as a result of such Investment: 
 (a) such Person becomes a Restricted Subsidiary; or 

(b) such Person, in one transaction or a series of related transactions, is merged or consolidated with or into, or
transfers or conveys substantially all of its assets to, or is liquidated into, the Company or a Restricted Subsidiary, and, in each case, any Investment held by such Person; provided, that such Investment was not acquired by such
Person in contemplation of such acquisition, merger, consolidation or transfer; 
  

 22 

 (4) any Investment in securities or other assets, including earnouts, not
constituting cash and Cash Equivalents and received in connection with an Asset Sale made pursuant to the provisions of Section 4.10 hereof or any other disposition of assets not constituting an Asset Sale; 

(5) any Investment existing on the Issue Date; 

(6) any Investment acquired by the Company or any of its Restricted Subsidiaries: 

(a) in exchange for any other Investment or accounts receivable held by the Company or any such Restricted Subsidiary in
connection with or as a result of a bankruptcy, workout, reorganization or recapitalization of the issuer of such other Investment or accounts receivable; or 

(b) as a result of a foreclosure by the Company or any of its Restricted Subsidiaries with respect to any secured
Investment or other transfer of title with respect to any secured Investment in default; 
 (7) Hedging
Obligations permitted under clause (10) of Section 4.09(b) hereof; 
 (8) [intentionally omitted];

 (9) Investments the payment for which consists of Equity Interests (exclusive of Disqualified Stock) of the
Company, or any of its direct or indirect parent companies; provided, however, that such Equity Interests will not increase the amount available for Restricted Payments under clause (3) of Section 4.07(a) hereof; 

(10) guarantees of Indebtedness of the Company and any Restricted Subsidiary permitted under Section 4.09 hereof;

 (11) any transaction to the extent it constitutes an Investment that is permitted and made in accordance with
the provisions of Section 4.11(b) hereof (except transactions described in clauses (2), (5) and (9) of Section 4.11(b) hereof); 

(12) Investments consisting of purchases and acquisitions of inventory, supplies, material or equipment; 

(13) additional Investments having an aggregate fair market value, taken together with all other Investments made pursuant
to this clause (13) that are at that time outstanding (without giving effect to the sale of an Unrestricted Subsidiary to the extent the proceeds of such sale do not consist of cash or marketable securities), not to exceed the greater of
(x) $95.0 million and (y) 3.5% of Total Assets at the time of such Investment (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent changes in value); 

 

 23 

 (14) Investments relating to a Receivables Subsidiary that, in the good
faith determination of the Company are necessary or advisable to effect any Receivables Facility; 
 (15) loans
and advances to officers, directors and employees, in each case incurred in the ordinary course of business or consistent with past practices or to fund such Person’s purchase of Equity Interests of the Company or any direct or indirect parent
company thereof; 
 (16) Investments (including debt obligations and Equity Interests) received in connection
with the bankruptcy or reorganization of suppliers and customers or in settlement of delinquent obligations of, or other disputes with, customers and suppliers arising in the ordinary course of business or upon the foreclosure with respect to any
secured Investment or other transfer of title with respect to any secured Investment; and 
 (17) Investments in
joint ventures of the Company or any of its Restricted Subsidiaries existing on the Issue Date or created after the Issue Date in an aggregate amount not to exceed $20.0 million. 

“Permitted Liens” means, with respect to any Person: 

(1) pledges or deposits by such Person under workmen’s compensation laws, unemployment insurance laws or similar
legislation, or good faith deposits in connection with bids, tenders, contracts (other than for the payment of Indebtedness) or leases to which such Person is a party, or deposits to secure public or statutory obligations of such Person or deposits
of cash or U.S. government bonds to secure surety or appeal bonds to which such Person is a party, or deposits as security for contested taxes or import duties or for the payment of rent, in each case incurred in the ordinary course of business;

 (2) Liens imposed by law, such as carriers’, warehousemen’s and mechanics’ Liens, in each case
for sums not yet overdue for a period of more than 30 days or being contested in good faith by appropriate proceedings or other Liens arising out of judgments or awards against such Person with respect to which such Person shall then be proceeding
with an appeal or other proceedings for review if adequate reserves with respect thereto are maintained on the books of such Person in accordance with GAAP; 

(3) Liens for taxes, assessments or other governmental charges not yet overdue for a period of more than 30 days or
payable or subject to penalties for nonpayment or which are being contested in good faith by appropriate proceedings diligently conducted, if adequate reserves with respect thereto are maintained on the books of such Person in accordance with GAAP;

 (4) Liens in favor of issuers of performance and surety bonds or bid bonds or with respect to other regulatory
requirements or letters of credit issued pursuant to the request of and for the account of such Person in the ordinary course of its business; 

(5) minor survey exceptions, minor encumbrances, easements or reservations of, or rights of others for, licenses,
rights-of-way, sewers, electric lines, telegraph and telephone lines and other similar purposes, or zoning or other restrictions as to the use of real properties or Liens incidental, to the conduct of the business of such

  

 24 

 
Person or to the ownership of its properties which were not incurred in connection with Indebtedness and which do not in the aggregate materially adversely affect the value of said properties or
materially impair their use in the operation of the business of such Person; 
 (6) Liens (including Liens on
Collateral) securing Indebtedness permitted to be incurred pursuant to clauses (4), (10) and (12)(b) of Section 4.09(b) hereof; provided, however, that Liens securing Indebtedness permitted to be incurred pursuant to
such clause (12)(b) shall not secure such Indebtedness in excess of $100.0 million at any one time outstanding; 

(7) Liens existing on the Issue Date; 

(8) Liens on property or shares of stock of a Person at the time such Person becomes a Subsidiary; provided,
however, such Liens are not created or incurred in connection with, or in contemplation of, such other Person becoming such a Subsidiary; provided further, however, that such Liens may not extend to any other property
owned by the Company or any of its Restricted Subsidiaries; 
 (9) Liens on property at the time the Company or a
Restricted Subsidiary acquired the property, including any acquisition by means of a merger or consolidation with or into the Company or any of its Restricted Subsidiaries; provided, however, that such Liens are not created or incurred
in connection with, or in contemplation of, such acquisition; provided further, however, that the Liens may not extend to any other property owned by the Company or any of its Restricted Subsidiaries; 

(10) Liens securing Indebtedness or other obligations of a Restricted Subsidiary owing to the Company or another
Restricted Subsidiary permitted to be incurred in accordance with Section 4.09 hereof; 
 (11) Liens
securing Hedging Obligations so long as related Indebtedness is, and is permitted to be under this Indenture, secured by a Lien on the same property securing such Hedging Obligations; 

(12) Liens on specific items of inventory of other goods and proceeds of any Person securing such Person’s
obligations in respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods; 

(13) leases, subleases, licenses or sublicenses granted to others in the ordinary course of business which do not
materially interfere with the ordinary conduct of the business of the Company or any of its Restricted Subsidiaries and do not secure any Indebtedness; 

(14) Liens arising from Uniform Commercial Code financing statement filings regarding operating leases entered into by the
Company and its Restricted Subsidiaries in the ordinary course of business; 
 (15) Liens in favor of the Company
or any Guarantor; 
  

 25 

 (16) Liens on equipment of the Company or any of its Restricted Subsidiaries
granted in the ordinary course of business to the Company’s clients; 
 (17) Liens on accounts receivable
and related assets incurred in connection with a Receivables Facility; 
 (18) Liens to secure any refinancing,
refunding, extension, renewal or replacement (or successive refinancing, refunding, extensions, renewals or replacements) as a whole, or in part, of any Indebtedness secured by any Lien referred to in the foregoing clauses (7), (8) and (9);
provided, however, that (a) such new Lien shall be limited to all or part of the same property that secured the original Lien (plus improvements on such property), and (b) the Indebtedness secured by such Lien at such time is
not increased to any amount greater than the sum of (i) the outstanding principal amount or, if greater, committed amount of the Indebtedness described under clauses (7), (8) and (9) at the time the original Lien became a Permitted
Lien under this Indenture, and (ii) an amount necessary to pay any fees and expenses, including premiums, related to such refinancing, refunding, extension, renewal or replacement; 

(19) deposits made in the ordinary course of business to secure liability to insurance carriers; 

(20) other Liens (including Liens on Collateral) securing obligations not to exceed $100.0 million at any one time
outstanding; 
 (21) Liens securing Indebtedness of any Foreign Subsidiary permitted to be incurred under this
Indenture, to the extent such Liens relate only to the assets and properties of such Foreign Subsidiary; 
 (22)
Liens securing judgments for the payment of money not constituting an Event of Default under clause (5) under Section 6.01(a) hereof so long as such Liens are adequately bonded and any appropriate legal proceedings that may have been duly
initiated for the review of such judgment have not been finally terminated or the period within which such proceedings may be initiated has not expired; 

(23) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in
connection with the importation of goods in the ordinary course of business; 
 (24) Liens (i) of a
collection bank arising under Section 4-210 of the Uniform Commercial Code or any comparable or successor provision on items in the course of collection, (ii) attaching to commodity trading accounts or other commodity brokerage accounts
incurred in the ordinary course of business, and (iii) in favor of banking institutions arising as a matter of law encumbering deposits (including the right of set-off) and which are within the general parameters customary in the banking
industry; 
 (25) Liens deemed to exist in connection with Investments in repurchase agreements permitted under
Section 4.09 hereof; provided that such Liens do not extend to any assets other than those that are the subject of such repurchase agreement; 
  

 26 

 (26) Liens encumbering reasonable customary initial deposits and margin
deposits and similar Liens attaching to commodity trading accounts or other brokerage accounts incurred in the ordinary course of business and not for speculative purposes; 

(27) Liens that are contractual rights of set-off (i) relating to the establishment of depository relations with
banks not given in connection with the issuance of Indebtedness, (ii) relating to pooled deposit or sweep accounts of the Company or any of its Restricted Subsidiaries to permit satisfaction of overdraft or similar obligations incurred in the
ordinary course of business of the Company and its Restricted Subsidiaries or (iii) relating to purchase orders and other agreements entered into with customers of the Company or any of its Restricted Subsidiaries in the ordinary course of
business; 
 (28) (a) Liens (including Liens on Collateral) securing the Series A-1 Notes and the related
Guarantees of the Series A-1 Notes (and exchange notes in respect thereof), up to $150.0 million of Additional Notes or Term Loans or a combination thereof and up to $150.0 million of Additional Notes or Term Loans or a combination thereof the
proceeds of which will be used solely to finance acquisitions (solely to the extent the Fixed Charge Coverage Ratio following any such acquisition and debt incurrence would have been at least 3.50 to 1.00, determined on a pro forma basis) and
(b) Liens (including Liens on Collateral) securing the Series A-2 Debt, in an amount no greater than $310.0 million (plus up to an additional $15.0 million of Series A-2 Notes), so long as the Series A-1 Notes are equally and ratably secured
and such Series A-2 Debt is subject to the priority of payment provisions contained in the Notes/Term Intercreditor Agreement; 

(29) Liens securing (x) Indebtedness and other obligations permitted to be incurred under Credit Facilities,
including any letter of credit facility relating thereto, that was incurred pursuant to clause (1) of Section 4.09(b) hereof in an amount up to the greater of (A) $175.0 million and (B) the Borrowing Base, and
(y) obligations of the Company or any Subsidiary in respect of any Bank Products provided by any lender party to the ABL Facility or any Affiliate of such lender (or any Person that was a lender or an Affiliate of a lender at the time the
applicable agreements pursuant to which such Bank Products are provided were entered into); provided, however, that any Liens on Notes/Term Collateral granted pursuant to this clause (29) must be junior in priority to the Liens on
such Collateral granted in favor of the Notes/Term Collateral Agent for the benefit of the Trustee and the holders of the Series A-1 Notes and the Series A-2 Notes and the benefit of the Term Loan Lenders and the holders of the Term Loans pursuant
to the Collateral Documents and the terms of such junior interest may be no more favorable to the beneficiaries thereof than the terms contained in the Intercreditor Agreements; and provided, further, that no Liens may be granted
pursuant to this clause (29) unless the Series A-1 Notes, the Series A-2 Notes and the Term Loans are secured by a second-priority Lien that is junior in priority to the Liens on such Collateral but senior in priority to any other Liens granted
on such Collateral; 
 (30) Liens on the Collateral to secure obligations in respect of any Indebtedness
permitted to be incurred pursuant to Section 4.09(a) hereof; provided, however, that such Liens on the Collateral are junior in priority to the Liens granted to holders of the Series A-1 Notes, the Series A-2 Notes and the Term
Loans; 
  

 27 

 (31) any encumbrance or restriction (including put and call arrangements)
with respect to capital stock of any joint venture or similar arrangement pursuant to any joint venture or similar agreement; 

(32) Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale or purchase
of goods entered into by the Company or any of its Restricted Subsidiaries in the ordinary course of business; and 

(33) Liens solely on any cash earnest money deposits made by the Company or any of its Restricted Subsidiaries in
connection with any letter of intent or purchase agreement permitted hereunder. 
 For purposes of this definition, the term
“Indebtedness” shall be deemed to include interest on such Indebtedness. 
 “Person” means any
individual, corporation, limited liability company, partnership, joint venture, association, joint stock company, trust, unincorporated organization, government or any agency or political subdivision thereof or any other entity. 

“Preferred Stock” means any Equity Interest with preferential rights of payment of dividends or upon liquidation,
dissolution, or winding up. 
 “Private Placement Legend” means the legend set forth in
Section 2.06(g)(1) hereof to be placed on all Notes issued under this Indenture, except where otherwise permitted by the provisions of this Indenture. 

“QIB” means a “qualified institutional buyer” as defined in Rule 144A. 

“Qualified Proceeds” means assets that are used or useful in, or Capital Stock of any Person engaged in, a Similar
Business; provided that the fair market value of any such assets or Capital Stock shall be determined by the Company in good faith. 

“Rating Agencies” means Moody’s and S&P or if Moody’s or S&P or both shall not make a rating on the
applicable series of Notes publicly available, a nationally recognized statistical rating agency or agencies, as the case may be, selected by the Company which shall be substituted for Moody’s or S&P or both, as the case may be. 

“Receivables Facility” means any of one or more receivables financing facilities as amended, supplemented, modified,
extended, renewed, restated or refunded from time to time, the Obligations of which are non-recourse (except for customary representations, warranties, covenants and indemnities made in connection with such facilities) to the Company or any of its
Restricted Subsidiaries (other than a Receivables Subsidiary) pursuant to which the Company or any of its Restricted Subsidiaries sells its accounts receivable to either (a) a Person that is not a Restricted Subsidiary or (b) a Receivables
Subsidiary that in turn sells its accounts receivable to a Person that is not a Restricted Subsidiary. 
 “Receivables
Fees” means distributions or payments made directly or by means of discounts with respect to any accounts receivable or participation interest therein issued or sold in connection with, and other fees paid to a Person that is not a
Restricted Subsidiary in connection with, any Receivables Facility. 
  

 28 

 “Receivables Subsidiary” means any Subsidiary formed for the purpose of,
and that solely engages only in one or more Receivables Facilities and other activities reasonably related thereto. 

“Record Date” means the Series A-1 Notes Record Date and, if any Series A-2 Notes are issued, the Series A-2 Notes
Record Date, as applicable. 
 “Registration Rights Agreement” means (x) the Registration Rights
Agreement with respect to the Series A-1 Notes dated as of the Issue Date, among the Company, the Guarantors and the Initial Purchasers, as such agreement may be amended, modified or supplemented from time to time, (y) with respect to any
Additional Notes, one or more registration rights agreements among the Company and the other parties thereto, as such agreement(s) may be amended, modified or supplemented from time to time, relating to rights given by the Company to the purchasers
of Additional Notes to register such Additional Notes under the Securities Act, and (z) with respect to the Series A-2 Notes, a registration rights agreement among the Company, the Guarantors and the other parties thereto, as such agreement may
be amended, modified or supplemented from time to time, relating to rights given by the Company to the holders of Series A-2 Notes to register the Series A-2 Notes under the Securities Act. 

“Regulation S” means Regulation S promulgated under the Securities Act. 

“Regulation S Global Note” means a Regulation S Temporary Global Note or Regulation S Permanent Global Note, as
applicable. 
 “Regulation S Permanent Global Note” means a permanent Global Note in the form of, in the case
of Series A-1 Notes, Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved in the board resolution authorizing such Series A-2 Notes or Annex A attached to the Form of Supplemental
Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E, bearing the Global Note Legend and the Private Placement Legend and deposited with or on behalf of and registered in the name of the Depositary or its nominee,
issued in a denomination equal to the outstanding principal amount of the applicable Regulation S Temporary Global Note upon expiration of the Restricted Period. 

“Regulation S Temporary Global Note” means a temporary Global Note in the form of, in the case of Series A-1 Notes,
Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved in the board resolution authorizing such Series A-2 Notes or Annex A attached to the board resolution authorizing such Note or the Form
of Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E, bearing the Global Note Legend, the Private Placement Legend and the Regulation S Temporary Global Note Legend and deposited with or on behalf of and
registered in the name of the Depositary or its nominee, issued in a denomination equal to the outstanding principal amount of the Series A-1 Notes and Series A-2 Notes, as applicable, initially sold in reliance on Rule 903. 

“Regulation S Temporary Global Note Legend” means the legend set forth in Section 2.06(g)(3) hereof. 

“Related Business Assets” means assets (other than cash or Cash Equivalents) used or useful in a Similar Business,
provided that any assets received by the Company or a Restricted Subsidiary in exchange for assets transferred by the Company or a Restricted Subsidiary shall not be deemed to be Related Business Assets if they consist of securities of a
Person, unless upon receipt of the securities of such Person, such Person would become a Restricted Subsidiary. 
  

 29 

 “Related Person” means, with respect to any specified Person, such
Person’s Affiliates, and the respective officers, directors, employees, agents, advisors and attorneys-in-fact of such Person and its Affiliates. 

“Responsible Officer” means, when used with respect to the Trustee, any officer within the corporate trust department
of the Trustee, including any vice president, assistant vice president, assistant secretary, assistant treasurer, trust officer or any other officer of the Trustee who customarily performs functions similar to those performed by the Persons who at
the time shall be such officers, respectively, or to whom any corporate trust matter is referred because of such Person’s knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration
of this Indenture. 
 “Restricted Definitive Note” means a Definitive Note bearing the Private Placement
Legend. 
 “Restricted Global Note” means a Global Note bearing the Private Placement Legend. 

“Restricted Investment” means an Investment other than a Permitted Investment. 

“Restricted Period” means the 40-day distribution compliance period as defined in Regulation S. 

“Restricted Subsidiary” means, at any time, any direct or indirect Subsidiary of the Company (including any Foreign
Subsidiary) that is not then an Unrestricted Subsidiary; provided, however, that upon the occurrence of an Unrestricted Subsidiary ceasing to be an Unrestricted Subsidiary, such Subsidiary shall be included in the definition of
“Restricted Subsidiary.” 
 “Rule 144” means Rule 144 promulgated under the Securities Act.

 “Rule 144A” means Rule 144A promulgated under the Securities Act. 

“Rule 903” means Rule 903 promulgated under the Securities Act. 

“Rule 904” means Rule 904 promulgated under the Securities Act. 

“S&P” means Standard & Poor’s, a division of The McGraw-Hill Companies, Inc., and any successor to
its rating agency business. 
 “Sale and Lease-Back Transaction” means any arrangement providing for the
leasing by the Company or any of its Restricted Subsidiaries of any real or tangible personal property, which property has been or is to be sold or transferred by the Company or such Restricted Subsidiary to a third Person in contemplation of such
leasing. 
 “SEC” means the U.S. Securities and Exchange Commission. 

“Secured Indebtedness” means any Indebtedness of the Company or any of its Restricted Subsidiaries secured by a Lien.

 “Secured Parties” means (a) the Holders, (b) the Trustee, (c) the Notes/Term Collateral
Agent, (d) the beneficiaries of each indemnification obligation undertaken by the Company or any Guarantor under the Indenture, the Notes, the Security Agreement, the Intercreditor Agreements or the other Collateral Documents and (e) the
successors and assigns of each of the foregoing. 
  

 30 

 “Securities Act” means the Securities Act of 1933, as amended, and the
rules and regulations of the SEC promulgated thereunder. 
 “Security Agreement” means the Security Agreement
dated as of October 28, 2008 among the Company, certain subsidiaries of the Company named therein and the Notes/Term Collateral Agent. 

“Senior Indebtedness” means: 

(1) all Indebtedness of the Company or any Guarantor outstanding under the ABL Facility, any Term Loan Facility or the
Notes (including interest accruing on or after the filing of any petition in bankruptcy or similar proceeding or for reorganization of the Company or any Guarantor (at the rate provided for in the documentation with respect thereto, regardless of
whether or not a claim for post-filing interest is allowed in such proceedings)), and any and all other fees, expense reimbursement obligations, indemnification amounts, penalties, and other amounts (whether existing on the Issue Date or thereafter
created or incurred) and all obligations of the Company or any Guarantor to reimburse any bank or other Person in respect of amounts paid under letters of credit, acceptances or other similar instruments; 

(2) all Hedging Obligations (and guarantees thereof) owing to a Lender (as defined in the ABL Facility) or any Affiliate
of such Lender (or any Person that was a Lender or an Affiliate of such Lender at the time the applicable agreement giving rise to such Hedging Obligation was entered into), provided that such Hedging Obligations are permitted to be incurred
under the terms of this Indenture; 
 (3) all Series A-2 Debt; 

(4) any other Indebtedness of the Company or any Guarantor permitted to be incurred under the terms of this Indenture,
unless the instrument under which such Indebtedness is incurred expressly provides that it is subordinate in right of payment to the Notes of the applicable series or any related Guarantee; and 

(5) all Obligations with respect to the items listed in the preceding clauses (1), (2), (3) and (4); 

provided, however, that Senior Indebtedness shall not include: 

(a) any obligation of such Person to the Company or any of its Subsidiaries; 

(b) any liability for federal, state, local or other taxes owed or owing by such Person; 

(c) any accounts payable or other liability to trade creditors arising in the ordinary course of business; 

 

 31 

 (d) any Indebtedness or other Obligation of such Person which is
subordinate or junior in any respect to any other Indebtedness or other Obligation of such Person; or 
 (e)
that portion of any Indebtedness which at the time of incurrence is incurred in violation of this Indenture; provided, however that such Indebtedness shall be deemed not to have been incurred in violation of this Indenture for purposes
of this clause if the holder(s) of such Indebtedness or their agent or representative (i) had no actual knowledge at the time of incurrence that the incurrence of such Indebtedness violated this Indenture and (ii) shall have received a
certificate from an officer of the Company to the effect that the incurrence of such Indebtedness does not violate the provisions of this Indenture. 

“Series A-1 Notes” means the Initial Series A-1 Notes and any other Series A-1 Note authenticated and delivered under
this Indenture. 
 “Series A-1 Notes Applicable Premium” means, with respect to any Series A-1 Note on any
Series A-1 Notes Redemption Date, the greater of: 
 (1) 1.0% of the principal amount of such Series A-1 Note;
and 
 (2) the excess, if any, of (a) the present value at such Series A-1 Notes Redemption Date of
(i) the redemption price of such Series A-1 Note at November 1, 2011 (each such redemption price being set forth in Section 3.07(e) hereof), plus (ii) all required interest payments due on such Series A-1 Note through
November 1, 2011 (excluding accrued but unpaid interest to the Series A-1 Notes Redemption Date), computed using a discount rate equal to the Series A-1 Notes Treasury Rate as of such Series A-1 Notes Redemption Date plus 50 basis points; over
(b) the principal amount of such Series A-1 Note. 
 “Series A-1 Notes Interest Payment Date” means
May 1 and November 1 of each year to stated maturity. 
 “Series A-1 Notes Record Date” for the
interest or Additional Interest, if any, payable on any Series A-1 Notes Interest Payment Date means April 15 and October 15 (whether or not a Business Day) next preceding such Series A-1 Notes Interest Payment Date. 

“Series A-1 Notes Treasury Rate” means, as of any Series A-1 Notes Redemption Date, the yield to maturity as of such
Series A-1 Notes Redemption Date of United States Treasury securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available at least two Business
Days prior to the Series A-1 Notes Redemption Date (or, if such Statistical Release is no longer published, any publicly available source of similar market data)) most nearly equal to the period from the Series A-1 Notes Redemption Date to
November 1, 2011; provided, however, that if the period from the Series A-1 Notes Redemption Date to November 1, 2011 is less than one year, the weekly average yield on actually traded United States Treasury securities
adjusted to a constant maturity of one year will be used. 
 “Series A-2 Debt” means (i) any Indebtedness
outstanding from time to time under the Term Loan Facility, including without limitation any “Rollover Loans” as defined therein, (ii) any Series A-2 Notes, and (iii) all obligations with respect to such Indebtedness and any
Hedging Obligations permitted under any Series A-2 Debt owed or owing to any lender (or its affiliates) under the Term Loan Facility or ABL Facility which qualifies as a “Secured Hedge Agreement” under the Term Loan Facility. 

 

 32 

 “Series A-2 Notes” means the Initial Series A-2 Notes and any other Series
A-2 Note authenticated and delivered under this Indenture. 
 “Series A-2 Notes Applicable Premium” means,
with respect to any Series A-2 Note on any Series A-2 Notes Redemption Date, the greater of: 
 (1) 1.0% of the
principal amount of such Series A-2 Note; and 
 (2) the excess, if any, of (a) the present value at such
Series A-2 Notes Redemption Date of (i) the redemption price of such Series A-2 Note at November 1, 2011 (each such redemption price being set forth in a board resolution or supplemental indenture entered into pursuant to 9.01(16) of this
Indenture providing for the issuance of the Series A-2 Notes), plus (ii) all required interest payments due on such Series A-2 Note through November 1, 2011 (excluding accrued but unpaid interest to the Series A-2 Notes Redemption Date),
computed using a discount rate equal to the Series A-2 Notes Treasury Rate as of such Series A-2 Notes Redemption Date plus 50 basis points; over (b) the principal amount of such Series A-2 Note. 

“Series A-2 Notes Interest Payment Date” means May 1 and November 1 of each year to stated maturity.

 “Series A-2 Notes Record Date” for the interest or Additional Interest, if any, payable on any Series A-2
Notes Interest Payment Date means April 15 and October 15 (whether or not a Business Day) next preceding such Series A-2 Notes Interest Payment Date. 

“Series A-2 Notes Treasury Rate” means, as of any Series A-2 Notes Redemption Date, the yield to maturity as of such
Series A-2 Notes Redemption Date of United States Treasury securities with a constant maturity (as compiled and published in the most recent Federal Reserve Statistical Release H.15 (519) that has become publicly available at least two Business
Days prior to the Series A-2 Notes Redemption Date (or, if such Statistical Release is no longer published, any publicly available source of similar market data)) most nearly equal to the period from the Series A-2 Notes Redemption Date to
November 1, 2011; provided, however, that if the period from the Series A-2 Notes Redemption Date to November 1, 2011 is less than one year, the weekly average yield on actually traded United States Treasury securities
adjusted to a constant maturity of one year will be used. 
 “Series of Debt” means, separately, each of the
Series A-1 Notes, the Series A-2 Notes and the Term Loans. 
 “Series of Notes” means either the Series A-1
Notes or the Series A-2 Notes. 
 “Shelf Registration Statement” means the Shelf Registration Statement as
defined in the applicable Registration Rights Agreement. 
 “Significant Subsidiary” means any Restricted
Subsidiary that would be a “significant subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the Issue Date. 

 

 33 

 “Similar Business” means any business conducted or proposed to be
conducted by the Company and its Restricted Subsidiaries on the Issue Date or any business that is similar, reasonably related, incidental or ancillary thereto. 

“Sponsor Management Agreement” means the management agreement between certain of the management companies associated
with the Investors and the Company and/or one of its direct or indirect parent companies as in effect on the Issue Date. 

“Subordinated Indebtedness” means, with respect to the Notes, 

(1) any Indebtedness of the Company which is by its terms subordinated in right of payment to the Notes, and 

(2) any Indebtedness of any Guarantor which is by its terms subordinated in right of payment to the Guarantee of such
entity of the Notes. 
 For the avoidance of doubt, the Series A-2 Debt is not “Subordinated Indebtedness” hereunder
by virtue of the provisions contained in the Notes/Term Intercreditor Agreement. 
 “Subsidiary” means, with
respect to any Person: 
 (1) any corporation, association, or other business entity (other than a partnership,
joint venture, limited liability company or similar entity) of which more than 50% of the total voting power of shares of Capital Stock entitled (without regard to the occurrence of any contingency) to vote in the election of directors, managers or
trustees thereof is at the time of determination owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof or is consolidated under GAAP with such Person at such
time; and 
 (2) any partnership, joint venture, limited liability company or similar entity of which 

(a) more than 50% of the capital accounts, distribution rights, total equity and voting interests or general or limited
partnership interests, as applicable, are owned or controlled, directly or indirectly, by such Person or one or more of the other Subsidiaries of that Person or a combination thereof whether in the form of membership, general, special or limited
partnership or otherwise, and 
 (b) such Person or any Restricted Subsidiary of such Person is a general
partner or otherwise controls such entity. 
 “Term Loans” means loans made pursuant to and in accordance with
the Term Loan Facility, including the Rollover Loans as defined therein. 
 “Term Loan Lenders” means the
lenders under the Term Loan Facility. 
 “Term Loan Facility” means the Senior Secured Bridge Credit
Agreement, dated as of October 28, 2008, by and among the Company, the Guarantors, the lenders party thereto in their capacities as lenders thereunder, Bank of America Bridge LLC, as Administrative Agent, and

  

 34 

 
the other parties thereto, including any guarantees, collateral documents, instruments and agreements executed in connection therewith, and any amendments, supplements, modifications, extensions,
renewals, restatements, refundings or refinancings thereof and any indentures or credit facilities or commercial paper facilities with banks or other institutional lenders or investors that replace, refund or refinance any part of the loans, notes,
other credit facilities or commitments thereunder, including any such replacement, refunding or refinancing facility or indenture that increases the amount borrowable thereunder or alters the maturity thereof (provided that such increase in
borrowings is permitted under Section 4.09 hereof). 
 “Total Assets” means the total assets of the
Company, except where expressly provided otherwise, and its Restricted Subsidiaries on a consolidated basis, as shown on the most recent balance sheet of the Company; provided, however, that in no event at any time shall Total Assets
be deemed to equal an amount less than the amount of total assets of the Company and its Restricted Subsidiaries on a consolidated basis as of the Issue Date. 

“Transaction” means the merger contemplated by the Transaction Agreement, the issuance of the Notes, and borrowings
under the ABL Facility and the Term Loan Facility on October 28, 2008 in order to finance the merger and repay certain debt as described in the Offering Memorandum under “The Transactions.” 

“Transaction Agreement” means the Agreement and Plan of Merger, dated as of June 18, 2008, by and among Apria
Healthcare Group Inc., Sky Acquisition LLC and Sky Merger Sub Corporation, as the same may be amended on or prior to October 28, 2008. 

“Trust Indenture Act” means the Trust Indenture Act of 1939, as amended (15 U.S.C. §§ 77aaa-777bbbb).

 “Trustee” means the party named as the “Trustee” in the preamble of this Indenture until a
successor replaces it in accordance with the applicable provisions of this Indenture and thereafter means the successor serving hereunder. 

“Unrestricted Definitive Note” means one or more Definitive Notes that do not bear and are not required to bear the
Private Placement Legend. 
 “Unrestricted Global Note” means a permanent Global Note, substantially in the
form of, in the case of Series A-1 Notes, Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved in the board resolution authorizing such Series A-2 Notes or Annex A attached to the Form of
Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E, that bears the Global Note Legend and that has the “Schedule of Exchanges of Interests in the Global Note” attached thereto, and that is
deposited with or on behalf of and registered in the name of the Depositary, representing Series A-1 Notes and Series A-2 Notes, as applicable, that do not bear the Private Placement Legend. 

“Unrestricted Subsidiary” means: 

(1) (A) each subsidiary of the Company listed on Schedule A attached hereto as an Unrestricted Subsidiary and (B) any
Subsidiary of the Company which at the time of determination is an Unrestricted Subsidiary (as designated by the Company, as provided below); and 

(2) any Subsidiary of an Unrestricted Subsidiary. 

 

 35 

 The Company may designate any Subsidiary of the Company (including any existing Subsidiary
and any newly acquired or newly formed Subsidiary) to be an Unrestricted Subsidiary unless such Subsidiary or any of its Subsidiaries owns any Equity Interests or Indebtedness of, or owns or holds any Lien on, any property of, the Company or any
Subsidiary of the Company (other than solely any Subsidiary of the Subsidiary to be so designated); provided that 

(1) any Unrestricted Subsidiary must be an entity of which the Equity Interests entitled to cast at least a majority of
the votes that may be cast by all Equity Interests having ordinary voting power for the election of directors or Persons performing a similar function are owned, directly or indirectly, by the Company; 

(2) such designation complies with Section 4.07 hereof; and 

(3) each of: 

(a) the Subsidiary to be so designated; and 

(b) its Subsidiaries 

has not at the time of designation, and does not thereafter, create, incur, issue, assume, guarantee or otherwise become directly or
indirectly liable with respect to any Indebtedness pursuant to which the lender has recourse to any of the assets of the Company or any Restricted Subsidiary. 

The Company may designate any Unrestricted Subsidiary to be a Restricted Subsidiary; provided that, immediately after giving
effect to such designation, no Default shall have occurred and be continuing and either: 
 (1) the Company could
incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test described in Section 4.09(a) hereof; or 

(2) the Fixed Charge Coverage Ratio for the Company and its Restricted Subsidiaries would be greater than such ratio for
the Company and its Restricted Subsidiaries immediately prior to such designation, in each case on a pro forma basis taking into account such designation. 

Any such designation by the Company shall be notified by the Company to the Trustee by promptly filing with the Trustee a copy of the
resolution of the board of directors of the Company or any committee thereof giving effect to such designation and an Officer’s Certificate certifying that such designation complied with the foregoing provisions. 

“U.S. Person” means a U.S. person as defined in Rule 902(k) under the Securities Act. 

“Voting Stock” of any Person as of any date means the Capital Stock of such Person that is at the time entitled to vote
in the election of the board of directors of such Person. 
 “Weighted Average Life to Maturity” means, when
applied to any Indebtedness, Disqualified Stock or Preferred Stock, as the case may be, at any date, the quotient obtained by dividing: 

(1) the sum of the products of the number of years from the date of determination to the date of each successive scheduled
principal payment of such Indebtedness or redemption or similar payment with respect to such Disqualified Stock or Preferred Stock multiplied by the amount of such payment; by 

 

 36 

 (2) the sum of all such payments. 

“Wholly-Owned Subsidiary” of any Person means a Subsidiary of such Person, 100% of the outstanding Equity Interests of
which (other than directors’ qualifying shares) shall at the time be owned by such Person or by one or more Wholly-Owned Subsidiaries of such Person. 

Section 1.02 Other Definitions. 
  

			
	 Term
	  	Defined in
Section
	 “Acceptable Commitment”
	  	4.10
	 “Affiliate Transaction”
	  	4.11
	 “Asset Sale Offer”
	  	4.10
	 “Authentication Order”
	  	2.02
	 “Change of Control Offer”
	  	4.14
	 “Change of Control Payment”
	  	4.14
	 “Change of Control Payment Date”
	  	4.14
	 “Covenant Defeasance”
	  	8.03
	 “DTC”
	  	2.03
	 “Event of Default”
	  	6.01
	 “Excess Proceeds”
	  	4.10
	 “Excess Loss Proceeds”
	  	4.15
	 “incur”
	  	4.09
	 “incurrence”
	  	4.09
	 “Indemnified Parties”
	  	7.07
	 “Indemnified Party”
	  	7.07
	 “Initial Lien”
	  	4.12
	 “Initial Notes”
	  	Preamble
	 “Initial Series A-1 Notes”
	  	Preamble
	 “Initial Series A-2 Notes”
	  	Preamble
	 “Legal Defeasance”
	  	8.02
	 “Loss Proceeds Offer”
	  	4.15
	 “Note Register”
	  	2.03
	 “Offer Amount”
	  	3.09
	 “Offer Period”
	  	3.09
	 “Original Issue Discount Legend”
	  	2.06
	 “Pari Passu Indebtedness”
	  	4.10
	 “Paying Agent”
	  	2.03
	 “Purchase Date”
	  	3.09
	 “Refinancing Indebtedness”
	  	4.09
	 “Refunding Capital Stock”
	  	4.07
	 “Registrar”
	  	2.03
	 “Restricted Payments”
	  	4.07
	 “Rule 3-16”
	  	10.01
	 “Series A-1 Notes Redemption Date”
	  	3.07
	 “Successor Company”
	  	5.01
	 “Successor Person”
	  	5.01
	 “Treasury Capital Stock”
	  	4.07

  

 37 

 Section 1.03 Incorporation by Reference of Trust Indenture Act. 

Whenever this Indenture refers to a provision of the Trust Indenture Act, the provision is incorporated by reference in and made a part
of this Indenture. 
 The following Trust Indenture Act terms used in this Indenture have the following meanings: 

“indenture securities” means the Notes; 

“indenture security Holder” means a Holder of a Note; 

“indenture to be qualified” means this Indenture; 

“indenture trustee” or “institutional trustee” means the Trustee; and 

“obligor” on the Notes and the Guarantees means the Company and the Guarantors, respectively, and any successor obligor upon
the Notes and the Guarantees, respectively. 
 All other terms used in this Indenture that are defined by the Trust Indenture
Act, defined by Trust Indenture Act reference to another statute or defined by SEC rule under the Trust Indenture Act have the meanings so assigned to them. 

Notwithstanding any of the foregoing, the Trust Indenture Act and the terms and provisions thereof shall not apply to this Indenture
until the Company and the Guarantors qualify this Indenture under the Trust Indenture Act. 
 Section 1.04 Rules of Construction.

 Unless the context otherwise requires: 

(a) a term has the meaning assigned to it; 

(b) an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(c) “or” is not exclusive; 

(d) words in the singular include the plural, and in the plural include the singular; 

(e) “will” shall be interpreted to express a command; 

(f) provisions apply to successive events and transactions; 

(g) references to sections of, or rules under, the Securities Act shall be deemed to include substitute, replacement or successor
sections or rules adopted by the SEC from time to time; 
 (h) unless the context otherwise requires, any reference to an
“Article,” “Section” or “clause” refers to an Article, Section or clause, as the case may be, of this Indenture; and 
  

 38 

 (i) the words “herein,” “hereof” and “hereunder” and other
words of similar import refer to this Indenture as a whole and not any particular Article, Section, clause or other subdivision. 

Section 1.05 Acts of Holders. 

(a) Any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be given or
taken by Holders may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such Holders in person or by an agent duly appointed in writing. Except as herein otherwise expressly provided, such action shall
become effective when such instrument or instruments or record or both are delivered to the Trustee and, where it is hereby expressly required, to the Company. Proof of execution of any such instrument or of a writing appointing any such agent, or
the holding by any Person of a Note, shall be sufficient for any purpose of this Indenture and (subject to Section 7.01 hereof) conclusive in favor of the Trustee and the Company, if made in the manner provided in this Section 1.05.

 (b) The fact and date of the execution by any Person of any such instrument or writing may be proved by the affidavit of a
witness of such execution or by the certificate of any notary public or other officer authorized by law to take acknowledgments of deeds, certifying that the individual signing such instrument or writing acknowledged to him the execution thereof.
Where such execution is by or on behalf of any legal entity other than an individual, such certificate or affidavit shall also constitute proof of the authority of the Person executing the same. The fact and date of the execution of any such
instrument or writing, or the authority of the Person executing the same, may also be proved in any other manner that the Trustee deems sufficient. 

(c) The ownership of Notes shall be proved by the Note Register. 

(d) Any request, demand, authorization, direction, notice, consent, waiver or other action by the Holder of any Note shall bind every
future Holder of the same Note and the Holder of every Note issued upon the registration of transfer thereof or in exchange therefor or in lieu thereof, in respect of any action taken, suffered or omitted by the Trustee or the Company in reliance
thereon, whether or not notation of such action is made upon such Note. 
 (e) The Company may, in the circumstances permitted
by the Trust Indenture Act, set a record date for purposes of determining the identity of Holders entitled to give any request, demand, authorization, direction, notice, consent, waiver or take any other act, or to vote or consent to any action by
vote or consent authorized or permitted to be given or taken by Holders. Unless otherwise specified, if not set by the Company prior to the first solicitation of a Holder made by any Person in respect of any such action, or in the case of any such
vote, prior to such vote, any such record date shall be the later of 30 days prior to the first solicitation of such consent or the date of the most recent list of Holders furnished to the Trustee prior to such solicitation. 

(f) Without limiting the foregoing, a Holder entitled to take any action hereunder with regard to any particular Note may do so with
regard to all or any part of the principal amount of such Note or by one or more duly appointed agents, each of which may do so pursuant to such appointment with regard to all or any part of such principal amount. Any notice given or action taken by
a Holder or its agents with regard to different parts of such principal amount pursuant to this paragraph shall have the same effect as if given or taken by separate Holders of each such different part. 

(g) Without limiting the generality of the foregoing, a Holder, including DTC that is the Holder of a Global Note, may make, give or
take, by a proxy or proxies duly appointed in 
  

 39 

 
writing, any request, demand, authorization, direction, notice, consent, waiver or other action provided in this Indenture to be made, given or taken by Holders, and DTC as the Holder of a Global
Note may provide its proxy or proxies to the beneficial owners of interests in any such Global Note through such depositary’s standing instructions and customary practices. 

(h) The Company may fix a record date for the purpose of determining the Persons who are beneficial owners of interests in any Global
Note held by DTC entitled under the procedures of such depositary to make, give or take, by a proxy or proxies duly appointed in writing, any request, demand, authorization, direction, notice, consent, waiver or other action provided in this
Indenture to be made, given or taken by Holders. If such a record date is fixed, the Holders on such record date or their duly appointed proxy or proxies, and only such Persons, shall be entitled to make, give or take such request, demand,
authorization, direction, notice, consent, waiver or other action, whether or not such Holders remain Holders after such record date. No such request, demand, authorization, direction, notice, consent, waiver or other action shall be valid or
effective if made, given or taken more than 90 days after such record date. 
 Section 1.06 Timing of Payment. 

Notwithstanding anything herein to the contrary, if the date on which any payment is to be made pursuant to this Indenture or the Notes
is not a Business Day, the payment otherwise payable on such date shall be payable on the next succeeding Business Day with the same force and effect as if made on such scheduled date and (provided such payment is made on such succeeding Business
Day) no interest shall accrue on the amount of such payment from and after such scheduled date to the time of such payment on such next succeeding Business Day and the amount of any such payment that is an interest payment will reflect accrual only
through the original payment date and not through the next succeeding Business Day. 
 ARTICLE 2 

THE NOTES 
 Section 2.01
Form and Dating; Terms. 
 (a) General. The Notes and the Trustee’s certificate of authentication shall be
substantially in the form of, in the case of Series A-1 Notes, Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved in the board resolution authorizing such Series A-2 Notes or Annex A attached
to the Form of Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E. The Notes may have notations, legends or endorsements required by law, stock exchange rules or usage. Each Note shall be dated the date
of its authentication. The Notes shall be in denominations of $2,000 and integral multiples of $1,000 in excess thereof. The terms of the Series A-2 Notes may be set forth in a board resolution or in an indenture supplemental hereto in the form of
Exhibit E. The terms of the Series A-2 Notes shall include the terms included in Annex A attached to Exhibit E hereto and/or such other terms approved by the board of directors of the Issuer, which may be in addition to, different
then, or inconsistent with the terms of this Indenture and the terms included in Annex A attached to Exhibit E hereto. 
 (b)
Global Notes. Notes issued in global form shall be substantially in the form of, in the case of Series A-1 Notes, Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved in the board resolution
authorizing such Series A-2 Notes or Annex A attached to the Form of Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E (including the Global Note Legend thereon and the “Schedule of Exchanges
of Interests in the 
  

 40 

 
Global Note” attached thereto). Notes issued in definitive form shall be substantially in the form of, in the case of Series A-1 Notes, Exhibit A attached hereto, and, in the case of
Series A-2 Notes (if issued), the form approved in the board resolution authorizing such Series A-2 Notes or Annex A attached to the Form of Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E (but
without the Global Note Legend thereon and without the “Schedule of Exchanges of Interests in the Global Note” attached thereto). Each Global Note shall represent such of the outstanding Notes as shall be specified in the “Schedule of
Exchanges of Interests in the Global Note” attached thereto and each shall provide that it shall represent up to the aggregate principal amount of Notes from time to time endorsed thereon and that the aggregate principal amount of outstanding
Notes represented thereby may from time to time be reduced or increased, as applicable, to reflect exchanges and redemptions. Any endorsement of a Global Note to reflect the amount of any increase or decrease in the aggregate principal amount of
outstanding Notes represented thereby shall be made by the Trustee or the Custodian, at the direction of the Trustee, in accordance with instructions given by the Holder thereof as required by Section 2.06 hereof. 

(c) Temporary Global Notes. Notes offered and sold in reliance on Regulation S shall be issued initially in the form of the
Regulation S Temporary Global Note, which shall be deposited on behalf of the purchasers of the Notes represented thereby with the Trustee, as custodian for the Depositary, and registered in the name of the Depositary or the nominee of the
Depositary for the accounts of designated agents holding on behalf of Euroclear or Clearstream, duly executed by the Company and authenticated by the Trustee as hereinafter provided. The Restricted Period shall be terminated upon the receipt by the
Trustee of: 
 (1) a written certificate from the Depositary, if available, together with copies of certificates
from Euroclear and Clearstream, if available, certifying that they have received certification of non-United States beneficial ownership of 100% of the aggregate principal amount of the Regulation S Temporary Global Note (except to the extent of any
beneficial owners thereof who acquired an interest therein during the Restricted Period pursuant to another exemption from registration under the Securities Act and who shall take delivery of a beneficial ownership interest in a 144A Global Note
bearing a Private Placement Legend, all as contemplated by Section 2.06(b) hereof); and 
 (2) an
Officer’s Certificate from the Company. 
 Following the termination of the Restricted Period, beneficial interests in the
Regulation S Temporary Global Note shall be exchanged for beneficial interests in the Regulation S Permanent Global Note pursuant to the Applicable Procedures. Simultaneously with the authentication of the Regulation S Permanent Global Note, the
Trustee shall cancel the Regulation S Temporary Global Note. The aggregate principal amount of the Regulation S Temporary Global Note and the Regulation S Permanent Global Note may from time to time be increased or decreased by adjustments made on
the records of the Trustee and the Depositary or its nominee, as the case may be, in connection with transfers of interest as hereinafter provided. 

(d) Terms. The aggregate principal amount of Initial Series A-1 Notes that may be authenticated and delivered under this
Indenture is $700,000,000 and the aggregate principal amount of Initial Series A-2 Notes that may be authenticated and delivered under this Indenture is $310,000,000 (plus up to an additional $15.0 million of Series A-2 Notes); provided that
Additional Notes may be issued in accordance with the fifth paragraph of this Section 2.01(d). 
 The terms and provisions
contained in the Notes shall constitute, and are hereby expressly made, a part of this Indenture and the Company, the Guarantors and the Trustee, by their execution and delivery of this Indenture, expressly agree to such terms and provisions and to
be bound thereby. 
  

 41 

 However, to the extent any provision of any Note conflicts with the express provisions of
this Indenture, the provisions of this Indenture shall govern and be controlling. 
 The Notes shall be subject to repurchase
by the Company pursuant to an Asset Sale Offer as provided in Section 4.10 hereof or a Change of Control Offer as provided in Section 4.14 hereof. The Notes shall not be redeemable, other than, with respect to the Series A-1 Notes, as
provided in Article 3, and with respect to the Series A-2 Notes, as set forth in an appropriate board resolution or supplemental indenture hereto in the form of Exhibit E. 

Additional Notes may be either Series A-1 Notes or Series A-2 Notes. Additional Notes which are Series A-1 Notes will rank pari
passu with the Initial Series A-1 Notes, may be created and issued from time to time by the Company without notice to or consent of the Holders and shall be consolidated with and form a single class with the Initial Series A-1 Notes and shall
have the same terms as to status, redemption or otherwise as the Initial Series A-1 Notes; Additional Notes which are Series A-2 Notes will rank pari passu with the Initial Series A-2 Notes, may be created and issued from time to time by the
Company without notice to or consent of the Holders and shall be consolidated with and form a single class with the Initial Series A-2 Notes and shall have the same terms as to status, redemption or otherwise as the Initial Series A-2 Notes;
provided that the aggregate principal amount of Additional Notes that may be authenticated and delivered under this Indenture is limited to (i) $150.0 million of Additional Notes, plus (ii) $150.0 million of Additional Notes
the proceeds of which shall be used solely to finance acquisitions (solely to the extent the Fixed Charge Coverage Ratio following any such acquisition and debt incurrence would have been at least 3.50 to 1.00, determined on a pro forma
basis); provided, further, that the Company’s ability to issue Additional Notes shall be subject to the Company’s compliance with Section 4.09 hereof. Any Additional Notes shall be issued with the benefit of an indenture
supplemental to this Indenture. 
 (e) Euroclear and Clearstream Procedures Applicable. The provisions of the
“Operating Procedures of the Euroclear System” and “Terms and Conditions Governing Use of Euroclear” and the “General Terms and Conditions of Clearstream Banking” and “Customer Handbook” of Clearstream shall
be applicable to transfers of beneficial interests in the Regulation S Temporary Global Notes and the Regulation S Permanent Global Notes that are held by Participants through Euroclear or Clearstream. 

Section 2.02 Execution and Authentication. 

At least one Officer of the Company shall execute the Notes on behalf of the Company by manual or facsimile signature. 

If an Officer whose signature is on a Note no longer holds that office at the time a Note is authenticated, the Note shall nevertheless
be valid. 
 A Note shall not be entitled to any benefit under this Indenture or be valid or obligatory for any purpose until
authenticated substantially in the form of, in the case of Series A-1 Notes, Exhibit A attached hereto, and, in the case of Series A-2 Notes (if issued), the form approved in the board resolution authorizing such Series A-2 Notes or
Annex A attached to the Form of Supplemental Indenture for the Issuance of Series A-2 Notes attached hereto as Exhibit E, as the case may be, by the manual signature of the Trustee. The signature shall be conclusive evidence that the
Note has been duly authenticated and delivered under this Indenture. 
  

 42 

 On the Issue Date, the Trustee shall, upon receipt of a Company Order (an
“Authentication Order”), authenticate and deliver the Initial Series A-1 Notes. In addition, at any time, from time to time, the Trustee shall upon an Authentication Order authenticate and deliver the Series A-2 Notes and any
Additional Notes and Exchange Notes for an aggregate principal amount specified in such Authentication Order for such Series A-2 Notes or Additional Notes or Exchange Notes issued hereunder. 

The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Notes. An authenticating agent may
authenticate Notes whenever the Trustee may do so. Each reference in this Indenture to authentication by the Trustee includes authentication by such agent. An authenticating agent has the same rights as an Agent to deal with Holders or an Affiliate
of the Company. 
 Section 2.03 Registrar and Paying Agent. 

The Company shall maintain an office or agency where Notes may be presented for registration of transfer or for exchange
(“Registrar”) and an office or agency where Notes may be presented for payment (“Paying Agent”). The Registrar shall keep a register of the Notes (“Note Register”) and of their transfer and
exchange. The Company may appoint one or more co-registrars and one or more additional paying agents. The term “Registrar” includes any co-registrar and the term “Paying Agent” includes any additional paying agent. The Company
may change any Paying Agent or Registrar without prior notice to any Holder. The Company shall notify the Trustee in writing of the name and address of any Agent not a party to this Indenture. If the Company fails to appoint or maintain another
entity as Registrar or Paying Agent, the Trustee shall act as such and shall be entitled to appropriate compensation therefor pursuant to Section 7.07 hereof. The Company or any of its Subsidiaries may act as Paying Agent or Registrar.

 The Company initially appoints The Depository Trust Company (“DTC”) to act as Depositary with respect to
the Global Notes. 
 The Company initially appoints the Trustee to act as the Paying Agent and Registrar for the Notes and to
act as Custodian with respect to the Global Notes. 
 Section 2.04 Paying Agent to Hold Money in Trust. 

The Company shall require each Paying Agent other than the Trustee to agree in writing that the Paying Agent shall hold in trust for the
benefit of Holders or the Trustee all money held by the Paying Agent for the payment of principal, premium, if any, or Additional Interest, if any, or interest on the Notes, and will notify the Trustee of any default by the Company in making any
such payment. While any such default continues, the Trustee may require a Paying Agent to pay all money held by it to the Trustee. The Company at any time may require a Paying Agent to pay all money held by it to the Trustee. Upon payment over to
the Trustee, the Paying Agent (if other than the Company or a Subsidiary) shall have no further liability for the money. If the Company or a Subsidiary acts as Paying Agent, it shall segregate and hold in a separate trust fund for the benefit of the
Holders all money held by it as Paying Agent. Upon any bankruptcy or reorganization proceedings relating to the Company, the Trustee shall serve as Paying Agent for the Notes. 

Section 2.05 Holder Lists. 

The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and
addresses of all Holders and shall otherwise comply with Trust Indenture Act Section 312(a). If the Trustee is not the Registrar, the Company shall furnish to the Trustee 

 

 43 

 
at least five Business Days before each applicable Interest Payment Date and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may
reasonably require of the names and addresses of the Holders of Notes and the Company shall otherwise comply with Trust Indenture Act Section 312(a). 

Section 2.06 Transfer and Exchange. 

(a) Transfer and Exchange of Global Notes. Except as otherwise set forth in this Section 2.06, a Global Note may be
transferred, in whole and not in part, only to another nominee of the Depositary or to a successor Depositary or a nominee of such successor Depositary. A beneficial interest in a Global Note may not be exchanged for a Definitive Note unless
(i) the Depositary (x) notifies the Company that it is unwilling or unable to continue as Depositary for such Global Note or (y) has ceased to be a clearing agency registered under the Exchange Act and, in either case, a successor
Depositary is not appointed by the Company within 120 days or (ii) there shall have occurred and be continuing an Event of Default with respect to the Notes. Upon the occurrence of any of the preceding events in (i) or (ii) above,
Definitive Notes delivered in exchange for any Global Note or beneficial interests therein will be registered in the names, and issued in any approved denominations, requested by or on behalf of the Depositary (in accordance with its customary
procedures). Global Notes also may be exchanged or replaced, in whole or in part, as provided in Sections 2.07 and 2.10 hereof. Every Note authenticated and delivered in exchange for, or in lieu of, a Global Note or any portion thereof, pursuant to
this Section 2.06 or Section 2.07 or 2.10 hereof, shall be authenticated and delivered in the form of, and shall be, a Global Note, except for Definitive Notes issued subsequent to any of the preceding events in (i) or (ii) above
and pursuant to Section 2.06(c) hereof. A Global Note may not be exchanged for another Note other than as provided in this Section 2.06(a); provided, however, beneficial interests in a Global Note may be transferred and
exchanged as provided in Section 2.06(b), (c) or (f) hereof. 
 (b) Transfer and Exchange of Beneficial
Interests in the Global Notes. The transfer and exchange of beneficial interests in the Global Notes shall be effected through the Depositary, in accordance with the provisions of this Indenture and the Applicable Procedures. Beneficial
interests in the Restricted Global Notes shall be subject to restrictions on transfer comparable to those set forth herein to the extent required by the Securities Act. Transfers of beneficial interests in the Global Notes also shall require
compliance with either subparagraph (1) or (2) below, as applicable, as well as one or more of the other following subparagraphs, as applicable: 

(1) Transfer of Beneficial Interests in the Same Global Note. Beneficial interests in any Restricted Global Note
may be transferred to Persons who take delivery thereof in the form of a beneficial interest in the same Restricted Global Note in accordance with the transfer restrictions set forth in the Private Placement Legend; provided, however,
that prior to the expiration of the Restricted Period, transfers of beneficial interests in the Regulation S Temporary Global Note may not be made to a U.S. Person or for the account or benefit of a U.S. Person (other than an Initial Purchaser).
Beneficial interests in any Unrestricted Global Note may be transferred to Persons who take delivery thereof in the form of a beneficial interest in an Unrestricted Global Note. No written orders or instructions shall be required to be delivered to
the Registrar to effect the transfers described in this Section 2.06(b)(1). 
 (2) All Other Transfers
and Exchanges of Beneficial Interests in Global Notes. In connection with all transfers and exchanges of beneficial interests that are not subject to Section 2.06(b)(1) hereof, the transferor of such beneficial interest must deliver to the
Registrar either (A) (1) a written order from a Participant or an Indirect Participant given to the Depositary in accordance with the Applicable Procedures directing the 

 

 44 

 
Depositary to credit or cause to be credited a beneficial interest in another Global Note in an amount equal to the beneficial interest to be transferred or exchanged and (2) instructions
given in accordance with the Applicable Procedures containing information regarding the Participant account to be credited with such increase or (B) (1) a written order from a Participant or an Indirect Participant given to the Depositary
in accordance with the Applicable Procedures directing the Depositary to cause to be issued a Definitive Note in an amount equal to the beneficial interest to be transferred or exchanged and (2) instructions given by the Depositary to the
Registrar containing information regarding the Person in whose name such Definitive Note shall be registered to effect the transfer or exchange referred to in (1) above; provided that in no event shall Definitive Notes be issued upon the
transfer or exchange of beneficial interests in the Regulation S Temporary Global Note prior to (A) the expiration of the Restricted Period and (B) the receipt by the Registrar of any certificates required pursuant to Rule 903. Upon
consummation of an Exchange Offer by the Company in accordance with Section 2.06(f) hereof, the requirements of this Section 2.06(b)(2) shall be deemed to have been satisfied upon receipt by the Registrar of the instructions contained in
the Letter of Transmittal delivered by the Holder of such beneficial interests in the Restricted Global Notes. Upon satisfaction of all of the requirements for transfer or exchange of beneficial interests in Global Notes contained in this Indenture
and the Notes or otherwise applicable under the Securities Act, the Trustee shall adjust the principal amount of the relevant Global Note(s) pursuant to Section 2.06(h) hereof. 

(3) Transfer of Beneficial Interests to Another Restricted Global Note. A beneficial interest in any Restricted
Global Note may be transferred to a Person who takes delivery thereof in the form of a beneficial interest in another Restricted Global Note if the transfer complies with the requirements of Section 2.06(b)(2) hereof and the Registrar receives
the following: 
 (A) if the transferee will take delivery in the form of a beneficial interest in the 144A
Global Note, then the transferor must deliver a certificate in the form of Exhibit B hereto, including the certifications in item (1) thereof; or 

(B) if the transferee will take delivery in the form of a beneficial interest in the Regulation S Global Note, then the
transferor must deliver a certificate in the form of Exhibit B hereto, including the certifications in item (2) thereof. 

(4) Transfer and Exchange of Beneficial Interests in a Restricted Global Note for Beneficial Interests in an
Unrestricted Global Note. A beneficial interest in any Restricted Global Note may be exchanged by any holder thereof for a beneficial interest in an Unrestricted Global Note or transferred to a Person who takes delivery thereof in the form of a
beneficial interest in an Unrestricted Global Note if the exchange or transfer complies with the requirements of Section 2.06(b)(2) hereof and: 

(A) such exchange or transfer is effected pursuant to the Exchange Offer in accordance with the Registration Rights
Agreement and the holder of the beneficial interest to be transferred, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (1) a Broker-Dealer, (2) a
Person participating in the distribution of the Exchange Notes or (3) a Person who is an affiliate (as defined in Rule 144) of the Company; 
  

 45 

 (B) such transfer is effected pursuant to the Shelf Registration Statement
in accordance with the Registration Rights Agreement; 
 (C) such transfer is effected by a Broker-Dealer
pursuant to the Exchange Offer Registration Statement in accordance with the Registration Rights Agreement; or 

(D) the Registrar receives the following: 

(1) if the holder of such beneficial interest in a Restricted Global Note proposes to exchange such beneficial interest
for a beneficial interest in an Unrestricted Global Note, a certificate from such Holder substantially in the form of Exhibit C hereto, including the certifications in item (1)(a) thereof; or 

(2) if the holder of such beneficial interest in a Restricted Global Note proposes to transfer such beneficial interest
to a Person who shall take delivery thereof in the form of a beneficial interest in an Unrestricted Global Note, a certificate from such holder in the form of Exhibit B hereto, including the certifications in item (4) thereof;

 and, in each such case set forth in this subparagraph (D), if the Registrar so requests or if the Applicable Procedures so
require, an Opinion of Counsel in form reasonably acceptable to the Registrar to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement
Legend are no longer required in order to maintain compliance with the Securities Act. 
 If any such transfer is
effected pursuant to subparagraph (B) or (D) above at a time when an Unrestricted Global Note has not yet been issued, the Company shall issue and, upon receipt of an Authentication Order in accordance with Section 2.02 hereof, the
Trustee shall authenticate one or more Unrestricted Global Notes in an aggregate principal amount equal to the aggregate principal amount of beneficial interests transferred pursuant to subparagraph (B) or (D) above. 

Beneficial interests in an Unrestricted Global Note cannot be exchanged for, or transferred to Persons who take delivery
thereof in the form of, a beneficial interest in a Restricted Global Note. 
 (c) Transfer or Exchange of Beneficial
Interests for Definitive Notes. 
 (1) Beneficial Interests in Restricted Global Notes to Restricted
Definitive Notes. If any holder of a beneficial interest in a Restricted Global Note proposes to exchange such beneficial interest for a Restricted Definitive Note or to transfer such beneficial interest to a Person who takes delivery thereof in
the form of a Restricted Definitive Note, then, upon the occurrence of any of the events in paragraph (1) or (2) of Section 2.06(a) hereof and receipt by the Registrar of the following documentation: 

(A) if the holder of such beneficial interest in a Restricted Global Note proposes to exchange such beneficial interest
for a Restricted Definitive Note, a certificate from such holder substantially in the form of Exhibit C hereto, including the certifications in item (2)(a) thereof; 

 

 46 

 (B) if such beneficial interest is being transferred to a QIB in accordance
with Rule 144A, a certificate substantially in the form of Exhibit B hereto, including the certifications in item (1) thereof; 

(C) if such beneficial interest is being transferred to a Non-U.S. Person in an offshore transaction in accordance with
Rule 903 or Rule 904, a certificate substantially in the form of Exhibit B hereto, including the certifications in item (2) thereof; 

(D) if such beneficial interest is being transferred pursuant to an exemption from the registration requirements of the
Securities Act in accordance with Rule 144, a certificate substantially in the form of Exhibit B hereto, including the certifications in item (3)(a) thereof; 

(E) if such beneficial interest is being transferred to the Company or any of its Restricted Subsidiaries, a certificate
substantially in the form of Exhibit B hereto, including the certifications in item (3)(b) thereof; or 

(F) if such beneficial interest is being transferred pursuant to an effective registration statement under the Securities
Act, a certificate substantially in the form of Exhibit B hereto, including the certifications in item (3)(c) thereof, 
 the
Trustee shall cause the aggregate principal amount of the applicable Global Note to be reduced accordingly pursuant to Section 2.06(h) hereof, and the Company shall execute and the Trustee shall authenticate and mail to the Person designated in
the instructions a Definitive Note in the applicable principal amount. Any Definitive Note issued in exchange for a beneficial interest in a Restricted Global Note pursuant to this Section 2.06(c) shall be registered in such name or names and
in such authorized denomination or denominations as the holder of such beneficial interest shall instruct the Registrar through instructions from the Depositary and the Participant or Indirect Participant. The Trustee shall mail such Definitive
Notes to the Persons in whose names such Notes are so registered. Any Definitive Note issued in exchange for a beneficial interest in a Restricted Global Note pursuant to this Section 2.06(c)(1) shall bear the Private Placement Legend and shall
be subject to all restrictions on transfer contained therein. 
 (2) Beneficial Interests in Regulation S
Temporary Global Note to Definitive Notes. Notwithstanding Sections 2.06(c)(1)(A) and (C) hereof, a beneficial interest in the Regulation S Temporary Global Note may not be exchanged for a Definitive Note or transferred to a Person who
takes delivery thereof in the form of a Definitive Note prior to (A) the expiration of the Restricted Period and (B) the receipt by the Registrar of any certificates required pursuant to Rule 903(b)(3)(ii)(B) of the Securities Act, except
in the case of a transfer pursuant to an exemption from the registration requirements of the Securities Act other than Rule 903 or Rule 904. 
  

 47 

 (3) Beneficial Interests in Restricted Global Notes to Unrestricted
Definitive Notes. A holder of a beneficial interest in a Restricted Global Note may exchange such beneficial interest for an Unrestricted Definitive Note or may transfer such beneficial interest to a Person who takes delivery thereof in the form
of an Unrestricted Definitive Note only upon the occurrence of any of the events in subsection (1) or (2) of Section 2.06(a) hereof and if: 

(A) such exchange or transfer is effected pursuant to the Exchange Offer in accordance with the Registration Rights
Agreement and the holder of such beneficial interest, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (1) a Broker-Dealer, (2) a Person
participating in the distribution of the Exchange Notes or (3) a Person who is an affiliate (as defined in Rule 144) of the Company; 

(B) such transfer is effected pursuant to the Shelf Registration Statement in accordance with the Registration Rights
Agreement; 
 (C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer Registration
Statement in accordance with the Registration Rights Agreement; or 
 (D) the Registrar receives the following:

 (1) if the holder of such beneficial interest in a Restricted Global Note proposes to exchange such
beneficial interest for an Unrestricted Definitive Note, a certificate from such holder substantially in the form of Exhibit C hereto, including the certifications in item (1)(b) thereof; or 

(2) if the holder of such beneficial interest in a Restricted Global Note proposes to transfer such beneficial interest
to a Person who shall take delivery thereof in the form of an Unrestricted Definitive Note, a certificate from such holder substantially in the form of Exhibit B hereto, including the certifications in item (4) thereof; 

and, in each such case set forth in this subparagraph (D), if the Registrar so requests or if the Applicable Procedures so require, an
Opinion of Counsel in form reasonably acceptable to the Registrar to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement Legend are no
longer required in order to maintain compliance with the Securities Act. 
 (4) Beneficial Interests in
Unrestricted Global Notes to Unrestricted Definitive Notes. If any holder of a beneficial interest in an Unrestricted Global Note proposes to exchange such beneficial interest for a Definitive Note or to transfer such beneficial interest to a
Person who takes delivery thereof in the form of a Definitive Note, then, upon the occurrence of any of the events in subsection (1) or (2) of Section 2.06(a) hereof and satisfaction of the conditions set forth in
Section 2.06(b)(2) hereof, the Trustee shall cause the aggregate principal amount of the applicable Global Note to be reduced accordingly pursuant to Section 2.06(h) hereof, and the Company shall execute and the

  

 48 

 
Trustee shall authenticate and mail to the Person designated in the instructions a Definitive Note in the applicable principal amount. Any Definitive Note issued in exchange for a beneficial
interest pursuant to this Section 2.06(c)(4) shall be registered in such name or names and in such authorized denomination or denominations as the holder of such beneficial interest shall instruct the Registrar through instructions from or
through the Depositary and the Participant or Indirect Participant. The Trustee shall mail such Definitive Notes to the Persons in whose names such Notes are so registered. Any Definitive Note issued in exchange for a beneficial interest pursuant to
this Section 2.06(c)(4) shall not bear the Private Placement Legend. 
 (d) Transfer and Exchange of
Definitive Notes for Beneficial Interests. 
 (1) Restricted Definitive Notes to Beneficial Interests in
Restricted Global Notes. If any Holder of a Restricted Definitive Note proposes to exchange such Note for a beneficial interest in a Restricted Global Note or to transfer such Restricted Definitive Note to a Person who takes delivery thereof in
the form of a beneficial interest in a Restricted Global Note, then, upon receipt by the Registrar of the following documentation: 

(A) if the Holder of such Restricted Definitive Note proposes to exchange such Note for a beneficial interest in a
Restricted Global Note, a certificate from such Holder substantially in the form of Exhibit C hereto, including the certifications in item (2)(b) thereof; 

(B) if such Restricted Definitive Note is being transferred to a QIB in accordance with Rule 144A, a certificate
substantially in the form of Exhibit B hereto, including the certifications in item (1) thereof; 

(C) if such Restricted Definitive Note is being transferred to a Non-U.S. Person in an offshore transaction in accordance
with Rule 903 or Rule 904, a certificate substantially in the form of Exhibit B hereto, including the certifications in item (2) thereof; 

(D) if such Restricted Definitive Note is being transferred pursuant to an exemption from the registration requirements
of the Securities Act in accordance with Rule 144, a certificate substantially in the form of Exhibit B hereto, including the certifications in item (3)(a) thereof; 

(E) if such Restricted Definitive Note is being transferred to the Company or any of its Restricted Subsidiaries, a
certificate substantially in the form of Exhibit B hereto, including the certifications in item (3)(b) thereof; or 

(F) if such Restricted Definitive Note is being transferred pursuant to an effective registration statement under the
Securities Act, a certificate substantially in the form of Exhibit B hereto, including the certifications in item (3)(c) thereof, 

the Trustee shall cancel the Restricted Definitive Note, increase or cause to be increased the aggregate principal amount of, in the case of clause
(A) above, the applicable Restricted Global Note, in the case of clause (B) above, the applicable 144A Global Note, and in the case of clause (C) above, the applicable Regulation S Global Note. 

 

 49 

 (2) Restricted Definitive Notes to Beneficial Interests in Unrestricted
Global Notes. A Holder of a Restricted Definitive Note may exchange such Note for a beneficial interest in an Unrestricted Global Note or transfer such Restricted Definitive Note to a Person who takes delivery thereof in the form of a beneficial
interest in an Unrestricted Global Note only if: 
 (A) such exchange or transfer is effected pursuant to the
Exchange Offer in accordance with the Registration Rights Agreement and the Holder, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (1) a Broker-Dealer,
(2) a Person participating in the distribution of the Exchange Notes or (3) a Person who is an affiliate (as defined in Rule 144) of the Company; 

(B) such transfer is effected pursuant to the Shelf Registration Statement in accordance with the Registration Rights
Agreement; 
 (C) such transfer is effected by a Broker-Dealer pursuant to the Exchange Offer Registration
Statement in accordance with the Registration Rights Agreement; or 
 (D) the Registrar receives the following:

 (1) if the Holder of such Definitive Notes proposes to exchange such Notes for a beneficial interest in the
Unrestricted Global Note, a certificate from such Holder substantially in the form of Exhibit C hereto, including the certifications in item (1)(c) thereof; or 

(2) if the Holder of such Definitive Notes proposes to transfer such Notes to a Person who shall take delivery thereof in
the form of a beneficial interest in the Unrestricted Global Note, a certificate from such Holder substantially in the form of Exhibit B hereto, including the certifications in item (4) thereof; 

and, in each such case set forth in this subparagraph (D), if the Registrar so requests or if the Applicable Procedures so require, an
Opinion of Counsel in form reasonably acceptable to the Registrar to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement Legend are no
longer required in order to maintain compliance with the Securities Act. 
 Upon satisfaction of the conditions of any of the
subparagraphs in this Section 2.06(d)(2), the Trustee shall cancel the Definitive Notes and increase or cause to be increased the aggregate principal amount of the Unrestricted Global Note. 

 

 50 

 (3) Unrestricted Definitive Notes to Beneficial Interests in Unrestricted
Global Notes. A Holder of an Unrestricted Definitive Note may exchange such Note for a beneficial interest in an Unrestricted Global Note or transfer such Definitive Notes to a Person who takes delivery thereof in the form of a beneficial
interest in an Unrestricted Global Note at any time. Upon receipt of a request for such an exchange or transfer, the Trustee shall cancel the applicable Unrestricted Definitive Note and increase or cause to be increased the aggregate principal
amount of one of the Unrestricted Global Notes. 
 If any such exchange or transfer from a Definitive Note to a beneficial
interest is effected pursuant to subparagraph (2)(B), (2)(D) or (3) above at a time when an Unrestricted Global Note has not yet been issued, the Company shall issue and, upon receipt of an Authentication Order in accordance with
Section 2.02 hereof, the Trustee shall authenticate one or more Unrestricted Global Notes in an aggregate principal amount equal to the principal amount of Definitive Notes so transferred. 

(e) Transfer and Exchange of Definitive Notes for Definitive Notes. Upon request by a Holder of Definitive Notes and such
Holder’s compliance with the provisions of this Section 2.06(e), the Registrar shall register the transfer or exchange of Definitive Notes. Prior to such registration of transfer or exchange, the requesting Holder shall present or
surrender to the Registrar the Definitive Notes duly endorsed or accompanied by a written instruction of transfer in form satisfactory to the Registrar duly executed by such Holder or by its attorney, duly authorized in writing. In addition, the
requesting Holder shall provide any additional certifications, documents and information, as applicable, required pursuant to the following provisions of this Section 2.06(e): 

(1) Restricted Definitive Notes to Restricted Definitive Notes. Any Restricted Definitive Note may be transferred
to and registered in the name of Persons who take delivery thereof in the form of a Restricted Definitive Note if the Registrar receives the following: 

(A) if the transfer will be made pursuant to a QIB in accordance with Rule 144A, then the transferor must deliver a
certificate substantially in the form of Exhibit B hereto, including the certifications in item (1) thereof; 

(B) if the transfer will be made pursuant to Rule 903 or Rule 904 then the transferor must deliver a certificate in the
form of Exhibit B hereto, including the certifications in item (2) thereof; or 
 (C) if the
transfer will be made pursuant to any other exemption from the registration requirements of the Securities Act, then the transferor must deliver a certificate in the form of Exhibit B hereto, including the certifications required by item
(3) thereof, if applicable. 
 (2) Restricted Definitive Notes to Unrestricted Definitive Notes. Any
Restricted Definitive Note may be exchanged by the Holder thereof for an Unrestricted Definitive Note or transferred to a Person or Persons who take delivery thereof in the form of an Unrestricted Definitive Note if: 

(A) such exchange or transfer is effected pursuant to the Exchange Offer in accordance with the Registration Rights
Agreement and the Holder, in the case of an exchange, or the transferee, in the case of a transfer, certifies in the applicable Letter of Transmittal that it is not (1) a Broker-Dealer, (2) a Person participating in the distribution of the
Exchange Notes or (3) a Person who is an affiliate (as defined in Rule 144) of the Company; 
  

 51 

 (B) any such transfer is effected pursuant to the Shelf Registration
Statement in accordance with the Registration Rights Agreement; 
 (C) any such transfer is effected by a
Broker-Dealer pursuant to the Exchange Offer Registration Statement in accordance with the Registration Rights Agreement; or 

(D) the Registrar receives the following: 

(1) if the Holder of such Restricted Definitive Notes proposes to exchange such Notes for an Unrestricted Definitive
Note, a certificate from such Holder substantially in the form of Exhibit C hereto, including the certifications in item (1)(d) thereof; or 

(2) if the Holder of such Restricted Definitive Notes proposes to transfer such Notes to a Person who shall take delivery
thereof in the form of an Unrestricted Definitive Note, a certificate from such Holder substantially in the form of Exhibit B hereto, including the certifications in item (4) thereof; 

and, in each such case set forth in this subparagraph (D), if the Registrar so requests, an Opinion of Counsel in form reasonably
acceptable to the Registrar to the effect that such exchange or transfer is in compliance with the Securities Act and that the restrictions on transfer contained herein and in the Private Placement Legend are no longer required in order to maintain
compliance with the Securities Act. 
 (3) Unrestricted Definitive Notes to Unrestricted Definitive Notes.
A Holder of Unrestricted Definitive Notes may transfer such Notes to a Person who takes delivery thereof in the form of an Unrestricted Definitive Note. Upon receipt of a request to register such a transfer, the Registrar shall register the
Unrestricted Definitive Notes pursuant to the instructions from the Holder thereof. 
 (f) Exchange Offer. Upon the
occurrence of the Exchange Offer in accordance with the Registration Rights Agreement, the Company shall issue and, upon receipt of an Authentication Order in accordance with Section 2.02 hereof, the Trustee shall authenticate (i) one or
more Unrestricted Global Notes in an aggregate principal amount equal to the principal amount of the beneficial interests in the Restricted Global Notes tendered for acceptance by Persons that certify in the applicable Letters of Transmittal or
through an Agent’s Message through the DTC Automated Tender Offer Program that (x) they are not Broker-Dealers, (y) they are not participating in a distribution of the Exchange Notes and (z) they are not affiliates (as defined in
Rule 144) of the Company, and accepted for exchange in the Exchange Offer and (ii) Unrestricted Definitive Notes in an aggregate principal amount equal to the principal amount of the Restricted Definitive Notes tendered for acceptance by
Persons that certify in the applicable Letters of Transmittal that (x) they are not Broker-Dealers, (y) they are not participating in a distribution of the Exchange Notes and (z) they are not affiliates (as defined in Rule 144) of the
Company, and accepted for exchange in the Exchange Offer. Concurrently with the issuance 
  

 52 

 
of such Notes, the Trustee shall cause the aggregate principal amount of the applicable Restricted Global Notes to be reduced accordingly, and the Company shall execute and the Trustee shall
authenticate and mail to the Persons designated by the Holders of Definitive Notes so accepted Unrestricted Definitive Notes in the applicable principal amount. Any Notes of a series that remain outstanding after the consummation of the Exchange
Offer, and Exchange Notes of that series issued in connection with the Exchange Offer, shall be treated as a single class of securities under this Indenture. 

(g) Legends. The following legends shall appear on the face of all Global Notes and Definitive Notes issued under this Indenture
unless specifically stated otherwise in the applicable provisions of this Indenture: 
 (1) Private Placement
Legend. 
 (A) Except as permitted by subparagraph (B) below, each Global Note and each Definitive Note
(and all Notes issued in exchange therefor or substitution thereof) shall bear the legend in substantially the following form: 

“THE SECURITY EVIDENCED HEREBY WAS ORIGINALLY ISSUED IN A TRANSACTION EXEMPT FROM REGISTRATION UNDER SECTION 5 OF THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND THE SECURITY EVIDENCED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THE
SECURITY EVIDENCED HEREBY IS HEREBY NOTIFIED THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER. THE HOLDER OF THE SECURITY EVIDENCED HEREBY AGREES FOR THE BENEFIT
OF THE COMPANY THAT (A) SUCH SECURITY MAY BE RESOLD, PLEDGED OR OTHERWISE TRANSFERRED, ONLY (1)(a) INSIDE THE UNITED STATES TO A PERSON WHO THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL BUYER (AS DEFINED IN RULE 144A UNDER
THE SECURITIES ACT) PURCHASING FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A UNDER THE SECURITIES ACT, (b) OUTSIDE THE UNITED STATES TO A FOREIGN PERSON IN A
TRANSACTION MEETING THE REQUIREMENTS OF RULE 903 OR RULE 904 OF REGULATION S UNDER THE SECURITIES ACT, (c) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF APPLICABLE) OR (d) IN
ACCORDANCE WITH ANOTHER EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT (AND BASED UPON AN OPINION OF COUNSEL ACCEPTABLE TO THE COMPANY IF THE COMPANY SO REQUESTS), (2) TO THE COMPANY OR (3) PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT AND, IN EACH CASE, IN ACCORDANCE WITH ANY APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION AND (B) THE HOLDER WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY
PURCHASER OF THE SECURITY EVIDENCED HEREBY OF THE RESALE RESTRICTIONS SET FORTH IN CLAUSE (A) ABOVE. NO REPRESENTATION CAN BE MADE AS TO THE AVAILABILITY OF THE EXEMPTION PROVIDED BY RULE 144 FOR RESALE OF THE SECURITY EVIDENCED HEREBY.”

  

 53 

 (B) Notwithstanding the foregoing, any Global Note or Definitive Note
issued pursuant to subparagraph (b)(4), (c)(3), (c)(4), (d)(2), (d)(3), (e)(2), (e)(3) or (f) of this Section 2.06 (and all Notes issued in exchange therefor or substitution thereof) shall not bear the Private Placement Legend. 

(2) Global Note Legend. Each Global Note shall bear a legend in substantially the following form: 

“THIS GLOBAL NOTE IS HELD BY THE DEPOSITARY (AS DEFINED IN THE INDENTURE GOVERNING THIS NOTE) OR ITS NOMINEE IN CUSTODY FOR THE
BENEFIT OF THE BENEFICIAL OWNERS HEREOF, AND IS NOT TRANSFERABLE TO ANY PERSON UNDER ANY CIRCUMSTANCES EXCEPT THAT (I) THE TRUSTEE MAY MAKE SUCH NOTATIONS HEREON AS MAY BE REQUIRED PURSUANT TO SECTION 2.06(h) OF THE INDENTURE, (II) THIS GLOBAL
NOTE MAY BE EXCHANGED IN WHOLE BUT NOT IN PART PURSUANT TO SECTION 2.06(a) OF THE INDENTURE, (III) THIS GLOBAL NOTE MAY BE DELIVERED TO THE TRUSTEE FOR CANCELLATION PURSUANT TO SECTION 2.11 OF THE INDENTURE AND (IV) THIS GLOBAL NOTE MAY BE
TRANSFERRED TO A SUCCESSOR DEPOSITARY WITH THE PRIOR WRITTEN CONSENT OF THE COMPANY. UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITARY TO A NOMINEE
OF THE DEPOSITARY OR BY A NOMINEE OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS CERTIFICATE IS
PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET, NEW YORK, NEW YORK) (“DTC”) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED
IN THE NAME OF CEDE & CO. OR SUCH OTHER NAME AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR SUCH OTHER ENTITY AS MAY BE REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY
TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN.” 

(3) Regulation S Temporary Global Note Legend. The Regulation S Temporary Global Note shall bear a legend in
substantially the following form: 
 “THE RIGHTS ATTACHING TO THIS REGULATION S TEMPORARY GLOBAL NOTE, AND THE CONDITIONS
AND PROCEDURES GOVERNING ITS EXCHANGE FOR CERTIFICATED NOTES, ARE AS SPECIFIED IN THE INDENTURE (AS DEFINED HEREIN).” 

(4) Original Issue Discount Legend. 

(A) Except as provided in subparagraph (B) below, each Global Note and each Definitive Note (and all Notes issued in
exchange therefor or substitution thereof) shall bear the legend in substantially the following form (the “Original Issue Discount Legend”): 
  

 54 

 “THE FOLLOWING INFORMATION IS PROVIDED PURSUANT TO TREAS. REG. SEC. 1.1275-3:

 THIS NOTE IS BEING ISSUED WITH ORIGINAL ISSUE DISCOUNT. 

THE CHIEF FINANCIAL OFFICER OF THE COMPANY, AS A REPRESENTATIVE OF THE COMPANY, WILL PROMPTLY MAKE AVAILABLE TO HOLDER(S) OF THIS NOTE
UPON REQUEST THE ISSUE PRICE, THE AMOUNT OF ORIGINAL ISSUE DISCOUNT, THE ISSUE DATE, AND THE YIELD TO MATURITY OF THIS NOTE. THE ADDRESS OF THE CHIEF FINANCIAL OFFICER IS C/O APRIA HEALTHCARE GROUP INC., 26220 ENTERPRISE COURT, LAKE FOREST,
CALIFORNIA 92630.” 
 (B) Notwithstanding the foregoing, any Global Note or Definitive Note (and all Notes
issued in exchange therefor or substitution thereof) issued without “original issue discount”, as defined in Section 1273(a) of the Internal Revenue Code of 1986, as amended, shall not bear the Original Issue Discount Legend.

 (h) Cancellation and/or Adjustment of Global Notes. At such time as all beneficial interests in a particular Global
Note have been exchanged for Definitive Notes or a particular Global Note has been redeemed, repurchased or canceled in whole and not in part, each such Global Note shall be returned to or retained and canceled by the Trustee in accordance with
Section 2.11 hereof. At any time prior to such cancellation, if any beneficial interest in a Global Note is exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Note or
for Definitive Notes, the principal amount of Notes represented by such Global Note shall be reduced accordingly and an endorsement shall be made on such Global Note by the Trustee or by the Depositary at the direction of the Trustee to reflect such
reduction; and if the beneficial interest is being exchanged for or transferred to a Person who will take delivery thereof in the form of a beneficial interest in another Global Note, such other Global Note shall be increased accordingly and an
endorsement shall be made on such Global Note by the Trustee or by the Depositary at the direction of the Trustee to reflect such increase. 

(1) General Provisions Relating to Transfers and Exchanges. 

(2) To permit registrations of transfers and exchanges, the Company shall execute and the Trustee shall authenticate
Global Notes and Definitive Notes upon receipt of an Authentication Order in accordance with Section 2.02 hereof or at the Registrar’s request. 

(3) No service charge shall be made to a holder of a beneficial interest in a Global Note or to a Holder of a Definitive
Note for any registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any transfer tax or similar governmental charge payable in connection therewith (other than any such transfer taxes or similar
governmental charge payable upon exchange or transfer pursuant to Sections 2.07, 2.10, 3.06, 3.09, 4.10, 4.14 and 9.06 hereof). 

(4) Neither the Registrar nor the Company shall be required to register the transfer of or exchange any Note selected for
redemption in whole or in part, except the unredeemed portion of any Note being redeemed in part. 
  

 55 

 (5) All Global Notes and Definitive Notes issued upon any registration of
transfer or exchange of Global Notes or Definitive Notes shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Global Notes or Definitive Notes surrendered upon such
registration of transfer or exchange. 
 (6) The Company shall not be required (A) to issue, to register the
transfer of or to exchange any Notes during a period beginning at the opening of business 15 days before the day of any selection of Notes for redemption under Section 3.02 hereof and ending at the close of business on the day of selection,
(B) to register the transfer of or to exchange any Note so selected for redemption in whole or in part, except the unredeemed portion of any Note being redeemed in part or (C) to register the transfer of or to exchange a Note between an
applicable Record Date and the next succeeding applicable Interest Payment Date. 
 (7) Prior to due presentment
for the registration of a transfer of any Note, the Trustee, any Agent and the Company may deem and treat the Person in whose name any Note is registered as the absolute owner of such Note for the purpose of receiving payment of principal of (and
premium, if any) and interest (including Additional Interest, if any) on such Notes and for all other purposes, and none of the Trustee, any Agent or the Company shall be affected by notice to the contrary. 

(8) Upon surrender for registration of transfer of any Note at the office or agency of the Company designated pursuant to
Section 4.02 hereof, the Company shall execute, and the Trustee shall authenticate and mail, in the name of the designated transferee or transferees, one or more replacement Notes of any authorized denomination or denominations of a like
aggregate principal amount. 
 (9) At the option of the Holder, Notes may be exchanged for other Notes of any
authorized denomination or denominations of a like aggregate principal amount upon surrender of the Notes to be exchanged at such office or agency. Whenever any Global Notes or Definitive Notes are so surrendered for exchange, the Company shall
execute, and the Trustee shall authenticate and mail, the replacement Global Notes and Definitive Notes which the Holder making the exchange is entitled to in accordance with the provisions of Section 2.02 hereof. 

(10) All certifications, certificates and Opinions of Counsel required to be submitted to the Registrar pursuant to this
Section 2.06 to effect a registration of transfer or exchange may be submitted by facsimile. 
 Section 2.07 Replacement Notes.

 If any mutilated Note is surrendered to the Trustee, the Registrar or the Company and the Trustee receives evidence to its
satisfaction of the ownership and destruction, loss or theft of any Note, the Company shall issue and the Trustee, upon receipt of an Authentication Order, shall authenticate a replacement Note if the Trustee’s requirements are met. If required
by the Trustee or the Company, an indemnity bond must be supplied by the Holder that is sufficient in the judgment of the Trustee and the Company to protect the Company, the Trustee, any Agent and any authenticating agent from any loss that any of
them may suffer if a Note is replaced. The Company and the Trustee may charge for their expenses in replacing a Note. 
  

 56 

 Every replacement Note is a contractual obligation of the Company and shall be entitled to
all of the benefits of this Indenture equally and proportionately with all other Notes duly issued hereunder. 
 Section 2.08
Outstanding Notes. 
 The Notes outstanding at any time are all the Notes authenticated by the Trustee except for those
canceled by it, those delivered to it for cancellation, those reductions in the interest in a Global Note effected by the Trustee in accordance with the provisions hereof, and those described in this Section 2.08 as not outstanding. Except as
set forth in Section 2.09 hereof, a Note does not cease to be outstanding because the Company or an Affiliate of the Company holds the Note. 

If a Note is replaced pursuant to Section 2.07 hereof, it ceases to be outstanding unless the Trustee receives proof satisfactory
to it that the replaced Note is held by a bona fide purchaser. 
 If the principal amount of any Note is considered paid under
Section 4.01 hereof, it ceases to be outstanding and interest on it ceases to accrue. 
 If the Paying Agent (other than
the Company, a Subsidiary or an Affiliate of any thereof) holds, on a redemption date or maturity date, money sufficient to pay Notes payable on that date, then on and after that date such Notes shall be deemed to be no longer outstanding and shall
cease to accrue interest. 
 Section 2.09 Treasury Notes. 

In determining whether the Holders of the required principal amount of Notes (and/or Term Loans, if applicable) have concurred in any
direction, waiver or consent, Notes (and/or Term Loans, if applicable) owned by the Company, or by any Affiliate of the Company, shall be considered as though not outstanding, except that for the purposes of determining whether the Trustee shall be
protected in relying on any such direction, waiver or consent, only Notes that a Responsible Officer of the Trustee knows are so owned shall be so disregarded. Notes (and/or Term Loans, if applicable) so owned which have been pledged in good faith
shall not be disregarded if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right to deliver any such direction, waiver or consent with respect to the Notes (and/or Term Loans, if applicable) and that the pledgee is not
the Company or any obligor upon the Notes (and/or Term Loans, if applicable) or any Affiliate of the Company or of such other obligor. 

Section 2.10 Temporary Notes. 

Until certificates representing Notes are ready for delivery, the Company may prepare and the Trustee, upon receipt of an Authentication
Order, shall authenticate temporary Notes. Temporary Notes shall be substantially in the form of certificated Notes but may have variations that the Company considers appropriate for temporary Notes and as shall be reasonably acceptable to the
Trustee. Without unreasonable delay, the Company shall prepare and the Trustee shall authenticate definitive Notes in exchange for temporary Notes. 

Holders and beneficial holders, as the case may be, of temporary Notes shall be entitled to all of the benefits accorded to Holders, or
beneficial holders, respectively, of Notes under this Indenture. 
  

 57 

 Section 2.11 Cancellation. 

The Company at any time may deliver Notes to the Trustee for cancellation. The Registrar and Paying Agent shall forward to the Trustee
any Notes surrendered to them for registration of transfer, exchange or payment. The Trustee or, at the direction of the Trustee, the Registrar or the Paying Agent and no one else shall cancel all Notes surrendered for registration of transfer,
exchange, payment, replacement or cancellation and shall destroy cancelled Notes (subject to the record retention requirement of the Exchange Act). Certification of the destruction of all cancelled Notes shall be delivered to the Company. The
Company may not issue new Notes to replace Notes that they have paid or that have been delivered to the Trustee for cancellation. 

Section 2.12 Defaulted Interest. 

If the Company defaults in a payment of interest on the Notes of any series, it shall pay the defaulted interest in any lawful manner
plus, to the extent lawful, interest payable on the defaulted interest to the Persons who are Holders of Notes of such series on a subsequent special record date, in each case at the rate provided in the Notes of such series and in Section 4.01
hereof. The Company shall notify the Trustee in writing of the amount of defaulted interest proposed to be paid on each Note of such series and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an
amount of money equal to the aggregate amount proposed to be paid in respect of such defaulted interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to
be held in trust for the benefit of the Persons entitled to such defaulted interest as provided in this Section 2.12. The Trustee shall fix or cause to be fixed each such special record date and payment date; provided that no such
special record date shall be less than ten days prior to the related payment date for such defaulted interest. The Trustee shall promptly notify the Company of such special record date. At least 15 days before the special record date, the Company
(or, upon the written request of the Company, the Trustee in the name and at the expense of the Company) shall mail or cause to be mailed, first-class postage prepaid, to each Holder of Notes of such series a notice at his or her address as it
appears in the Note Register that states the special record date, the related payment date and the amount of such interest to be paid. 

Subject to the foregoing provisions of this Section 2.12 and for greater certainty, each Note delivered under this Indenture upon
registration of transfer of or in exchange for or in lieu of any other Note shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Note. 

Section 2.13 CUSIP and ISIN Numbers. 

The Company in issuing the Notes may use CUSIP and/or ISIN numbers (if then generally in use) and, if so, the Trustee shall use CUSIP
and/or ISIN numbers in notices of redemption as a convenience to Holders; provided, that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Notes or as contained in any
notice of redemption and that reliance may be placed only on the other identification numbers printed on the Notes, and any such redemption shall not be affected by any defect in or omission of such numbers. The Company will as promptly as
practicable notify the Trustee of any change in the CUSIP or the ISIN numbers. 
  

 58 

 ARTICLE 3 

REDEMPTION 
 Section 3.01
Notices to Trustee. 
 If the Company elects to redeem Notes of any series pursuant to Section 3.07 hereof or
pursuant to the terms of any Notes issued hereunder, it shall furnish to the Trustee, at least two Business Days before notice of redemption is required to be mailed or caused to be mailed to Holders pursuant to Section 3.03 hereof but not more
than 60 days before a redemption date, an Officer’s Certificate setting forth (i) the paragraph or subparagraph of such Note and/or Section of this Indenture pursuant to which the redemption shall occur, (ii) the redemption date,
(iii) the principal amount of the Notes to be redeemed and (iv) the redemption price. 
 Section 3.02 Selection of Notes to Be
Redeemed or Purchased. 
 If less than all of the Notes of any series are to be redeemed or purchased in an offer to
purchase at any time, the Trustee shall select the Notes of such series to be redeemed or purchased (a) if the Notes of such series are listed on any national securities exchange, in compliance with the requirements of the principal national
securities exchange on which such Notes are listed or (b) on a pro rata basis or, to the extent that selection on a pro rata basis is not practicable, by lot or by such other similar method in accordance with the procedures of
DTC. In the event of partial redemption or purchase by lot, the particular Notes of such series to be redeemed or purchased shall be selected, unless otherwise provided herein, not less than 30 days nor more than 60 days prior to the redemption date
by the Trustee from the outstanding Notes of such series not previously called for redemption or purchase. 
 The Trustee shall
promptly notify the Company in writing of the Notes of such series selected for redemption or purchase and, in the case of any Note selected for partial redemption or purchase, the principal amount thereof to be redeemed or purchased. Notes and
portions of Notes selected shall be in an integral multiple of $1,000 (but in a minimum amount of $2,000); no Notes of $2,000 or less can be redeemed in part, except that if all of the Notes of such series of a Holder are to be redeemed or
purchased, the entire outstanding amount of Notes of such series held by such Holder, even if not a multiple of $1,000 (or a minimum amount of $2,000), shall be redeemed or purchased. Except as provided in the preceding sentence, provisions of this
Indenture that apply to Notes called for redemption or purchase also apply to portions of Notes called for redemption or purchase. 

Section 3.03 Notice of Redemption. 

Subject to Section 3.09 hereof, the Company shall mail or cause to be mailed by first-class mail notices of redemption at least 30
days but not more than 60 days prior to the redemption date to each Holder of Notes to be redeemed at such Holder’s registered address, except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is
issued in connection with Article 8 or Article 13 hereof. Except as set forth in Section 3.07(c) hereof, notices of redemption may not be conditional. 

The notice shall identify the Notes to be redeemed and shall state: 

(a) the redemption date; 

(b) the redemption price; 
  

 59 

 (c) if any Note is to be redeemed in part only, the portion of the principal amount of that
Note that is to be redeemed and that, after the redemption date upon surrender of such Note, a new Note or Notes in principal amount equal to the unredeemed portion of the original Note representing the same indebtedness to the extent not redeemed
will be issued in the name of the Holder of the Notes upon cancellation of the original Note; 
 (d) the name and address of
the Paying Agent; 
 (e) that Notes called for redemption must be surrendered to the Paying Agent to collect the redemption
price; 
 (f) that, unless the Company defaults in making such redemption payment, interest on Notes called for redemption
ceases to accrue on and after the redemption date; 
 (g) the paragraph or subparagraph of the Notes and/or Section of this
Indenture pursuant to which the Notes called for redemption are being redeemed; 
 (h) that no representation is made as to the
correctness or accuracy of the CUSIP number, if any, listed in such notice or printed on the Notes; and 
 (i) if in connection
with a redemption pursuant to Section 3.07(c) hereof, any condition to such redemption. 
 At the Company’s’
request, the Trustee shall give the notice of redemption in the name of the Company and at its expense; provided that the Company shall have delivered to the Trustee, at least two Business Days before notice of redemption is required to be
mailed or caused to be mailed to Holders pursuant to this Section 3.03 (unless a shorter notice shall be agreed to by the Trustee), an Officer’s Certificate requesting that the Trustee give such notice and setting forth the information to
be stated in such notice as provided in the preceding paragraph. 
 Section 3.04 Effect of Notice of Redemption. 

Once notice of redemption is mailed in accordance with Section 3.03 hereof, Notes called for redemption become irrevocably due and
payable on the redemption date at the redemption price (except as provided for in Section 3.07(c) hereof). The notice, if mailed in a manner herein provided, shall be conclusively presumed to have been given, whether or not the Holder receives
such notice. In any case, failure to give such notice by mail or any defect in the notice to the Holder of any Note designated for redemption in whole or in part shall not affect the validity of the proceedings for the redemption of any other Note.
Subject to Section 3.05 hereof, on and after the redemption date, interest ceases to accrue on Notes or portions of Notes called for redemption. 

Section 3.05 Deposit of Redemption or Purchase Price. 

Prior to 10:00 a.m. (New York City time) on the redemption or purchase date, the Company shall deposit with the Trustee or with the
Paying Agent money sufficient to pay the redemption or purchase price of and accrued and unpaid interest (including Additional Interest, if any) on all Notes to be redeemed or purchased on that date. The Trustee or the Paying Agent shall promptly
return to the Company any money deposited with the Trustee or the Paying Agent by the Company in excess of the amounts necessary to pay the redemption price of, and accrued and unpaid interest on, all Notes to be redeemed or purchased. 

 

 60 

 If the Company complies with the provisions of the preceding paragraph, on and after the
redemption or purchase date, interest shall cease to accrue on the Notes or the portions of Notes called for redemption or purchase. If a Note is redeemed or purchased on or after an applicable Record Date but on or prior to the related applicable
Interest Payment Date, then any accrued and unpaid interest to the redemption or purchase date shall be paid to the Person in whose name such Note was registered at the close of business on such applicable Record Date. If any Note called for
redemption or purchase shall not be so paid upon surrender for redemption or purchase because of the failure of the Company to comply with the preceding paragraph, interest shall be paid on the unpaid principal, from the redemption or purchase date
until such principal is paid, and to the extent lawful on any interest accrued to the redemption or purchase date not paid on such unpaid principal, in each case at the rate provided in the Notes and in Section 4.01 hereof. 

Section 3.06 Notes Redeemed or Purchased in Part. 

Upon surrender of a Note that is redeemed or purchased in part, the Company shall issue and the Trustee shall authenticate for the Holder
at the expense of the Company a new Note equal in principal amount to the unredeemed or unpurchased portion of the Note surrendered representing the same indebtedness to the extent not redeemed or purchased; provided that each new Note will
be in a principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. It is understood that, notwithstanding anything in this Indenture to the contrary, only an Authentication Order and not an Opinion of Counsel or Officer’s
Certificate is required for the Trustee to authenticate such new Note. 
 Section 3.07 Optional Redemption. 

(a) The optional redemption provisions of Series A-1 Notes are set forth herein. The optional redemption provisions of any Series A-2
Notes issued hereunder will be included in the Series A-2 Notes or in any board resolution or supplemental indenture pursuant to which such Series A-2 Notes are issued. The Company may elect to redeem only Series A-1 Notes, only Series A-2 Notes or
all Notes collectively, to the extent permitted by the redemption provisions contained herein and in the Notes. 
 (b) At any
time prior to November 1, 2011, the Company may redeem all or a part of the Series A-1 Notes, upon not less than 30 nor more than 60 days prior notice mailed by first-class mail to the registered address of each Holder or otherwise delivered in
accordance with the procedures of DTC, at a redemption price equal to 100% of the principal amount of the Series A-1 Notes redeemed plus the Series A-1 Notes Applicable Premium as of, and accrued and unpaid interest and Additional Interest, if any,
to the date of redemption (the “Series A-1 Notes Redemption Date”), subject to the rights of Holders on the relevant Series A-1 Notes Record Date to receive interest due on the relevant Series A-1 Notes Interest Payment Date.

 (c) Until November 1, 2011, the Company may, at its option, redeem up to 35% of the aggregate principal amount of
Series A-1 Notes issued by it at a redemption price equal to 111.25% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-1 Notes Redemption Date, subject to
the right of Holders of Series A-1 Notes of record on the relevant Series A-1 Notes Record Date to receive interest due on the relevant Series A-1 Notes Interest Payment Date, with the net cash proceeds of one or more Equity Offerings;
provided that at least 65% of the aggregate principal amount of Series A-1 Notes originally issued under this Indenture and any Additional Notes that are Series A-1 Notes issued under this Indenture after the Issue Date (excluding Series A-1
Notes and Additional Notes that are Series A-1 Notes held by the Company or Subsidiaries or Affiliates of the Company) remains outstanding immediately after the occurrence of each such redemption; provided further that each such
redemption 
  

 61 

 
occurs within 180 days of the date of closing of each such Equity Offering. Notice of any redemption upon any Equity Offering may be given prior to the completion thereof, and any such redemption
or notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited to, the completion of the related Equity Offering. 

(d) Except pursuant to clause (b) or (c) of this Section 3.07, the Series A-1 Notes will not be redeemable at the
Company’s option prior to November 1, 2011. 
 (e) On and after November 1, 2011, the Company may redeem the
Series A-1 Notes, in whole or in part, upon not less than 30 nor more than 60 days prior notice by first-class mail, postage prepaid, with a copy to the Trustee, to each Holder at the address of such Holder appearing in the security register, at the
redemption prices (expressed as percentages of principal amount of the Series A-1 Notes to be redeemed) set forth below, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-1 Notes Redemption Date,
subject to the right of Holders of record on the relevant Series A-1 Notes Record Date to receive interest due on the relevant Series A-1 Notes Interest Payment Date, if redeemed during the twelve-month period beginning on November 1 of each of
the years indicated below: 
  

				
	 Year
	  	Percentage	 
		
	 2011
	  	105.625	% 
	 2012
	  	102.813	% 
	 2013 and thereafter
	  	100.000	% 

 (f) Any
redemption pursuant to this Section 3.07 or pursuant to the terms of any Series A-2 Notes shall be made pursuant to the provisions of Sections 3.01 through 3.06 hereof. 

Section 3.08 Mandatory Redemption. 

The Company shall not be required to make mandatory redemption or sinking fund payments with respect to the Notes. 

Section 3.09 Offers to Repurchase by Application of Excess Proceeds. 

(a) In the event that, pursuant to Section 4.10 hereof, the Company shall be required to commence an Asset Sale Offer, it shall
follow the procedures specified below. Any Asset Sale Offer will be made to Holders of Series A-1 Notes and, if Series A-2 Notes are issued, Holders of Series A-2 Notes. 

(b) The Asset Sale Offer shall remain open for a period of 20 Business Days following its commencement and no longer, except to the
extent that a longer period is required by applicable law (the “Offer Period”). No later than five Business Days after the termination of the Offer Period (the “Purchase Date”), the Company shall apply all Excess
Proceeds (the “Offer Amount”) to the purchase of Notes and, if required, Pari Passu Indebtedness (on a pro rata basis, if applicable), or, if less than the Offer Amount has been tendered, all Notes and Pari Passu Indebtedness
tendered in response to the Asset Sale Offer. Payment for any Notes so purchased shall be made in the same manner as interest payments are made. 

(c) If the Purchase Date is on or after an applicable Record Date and on or before the related applicable Interest Payment Date, any
accrued and unpaid interest and Additional Interest, if any, up to but excluding the Purchase Date, shall be paid to the Person in whose name a Note is registered at the close of business on such applicable Record Date, and no additional interest
shall be payable to Holders who tender Notes pursuant to the Asset Sale Offer. 
  

 62 

 (d) Upon the commencement of an Asset Sale Offer, the Company shall send, by first-class
mail, a notice to each of the Holders, with a copy to the Trustee. The notice shall contain all instructions and materials necessary to enable such Holders to tender Notes pursuant to the Asset Sale Offer. The Asset Sale Offer shall be made to all
Holders and holders of Pari Passu Indebtedness. The notice, which shall govern the terms of the Asset Sale Offer, shall state: 

(1) that the Asset Sale Offer is being made pursuant to this Section 3.09 and Section 4.10 hereof and the
length of time the Asset Sale Offer shall remain open; 
 (2) the Offer Amount, the purchase price and the
Purchase Date; 
 (3) that any Note not tendered or accepted for payment shall continue to accrue interest;

 (4) that, unless the Company defaults in making such payment, any Note accepted for payment pursuant to the
Asset Sale Offer shall cease to accrue interest after the Purchase Date; 
 (5) that Holders electing to have a
Note purchased pursuant to an Asset Sale Offer may elect to have Notes purchased in integral multiples of $1,000 (but in a minimum amount of $2,000); 

(6) that Holders electing to have a Note purchased pursuant to any Asset Sale Offer shall be required to surrender the
Note, with the form entitled “Option of Holder to Elect Purchase” attached to the Note completed, or transfer by book-entry transfer, to the Company, the Depositary, if appointed by the Company, or a Paying Agent at the address specified
in the notice at least three days before the Purchase Date; 
 (7) that Holders shall be entitled to withdraw
their election if the Company, the Depositary or the Paying Agent, as the case may be, receives, not later than the expiration of the Offer Period, a telegram, facsimile transmission or letter setting forth the name of the Holder, the principal
amount of the Note the Holder delivered for purchase and a statement that such Holder is withdrawing his election to have such Note purchased; 

(8) that, if the aggregate principal amount of Notes and Pari Passu Indebtedness surrendered by the holders thereof
exceeds the Offer Amount, the Trustee shall select the Notes and such Pari Passu Indebtedness to be purchased on a pro rata basis based on the accreted value or principal amount of the Notes or such Pari Passu Indebtedness tendered (with such
adjustments as may be deemed appropriate by the Trustee so that only Notes in denominations of $2,000, or integral multiples of $1,000 in excess thereof, shall be purchased); and 

(9) that Holders whose Notes were purchased only in part shall be issued new Notes equal in principal amount to the
unpurchased portion of the Notes surrendered (or transferred by book-entry transfer) representing the same indebtedness to the extent not repurchased. 
  

 63 

 (e) On or before the Purchase Date, the Company shall, to the extent lawful,
(1) accept for payment, on a pro rata basis to the extent necessary, the Offer Amount of Notes or portions thereof validly tendered pursuant to the Asset Sale Offer, or if less than the Offer Amount has been tendered, all Notes tendered
and (2) deliver or cause to be delivered to the Trustee the Notes properly accepted together with an Officer’s Certificate stating the aggregate principal amount of Notes or portions thereof so tendered. 

(f) The Company, the Depositary or the Paying Agent, as the case may be, shall promptly mail or deliver to each tendering Holder an
amount equal to the purchase price of the Notes properly tendered by such Holder and accepted by the Company for purchase, and the Company shall promptly issue a new Note, and the Trustee, upon receipt of an Authentication Order, shall authenticate
and mail or deliver (or cause to be transferred by book-entry) such new Note to such Holder (it being understood that, notwithstanding anything in this Indenture to the contrary, no Opinion of Counsel or Officer’s Certificate is required for
the Trustee to authenticate and mail or deliver such new Note) in a principal amount equal to any unpurchased portion of the Note surrendered representing the same indebtedness to the extent not repurchased; provided, that each such new Note
shall be in a principal amount of $2,000 or an integral multiple of $1,000 in excess thereof. Any Note not so accepted shall be promptly mailed or delivered by the Company to the Holder thereof. The Company shall publicly announce the results of the
Asset Sale Offer on or as soon as practicable after the Purchase Date. 
 Other than as specifically provided in this
Section 3.09 or Section 4.10 hereof, any purchase pursuant to this Section 3.09 shall be made pursuant to the applicable provisions of Sections 3.01 through 3.06 hereof. 

ARTICLE 4 

COVENANTS 
 Section 4.01
Payment of Notes. 
 The Company shall pay or cause to be paid the principal of, premium, if any, Additional Interest, if
any, and interest on the Notes of the applicable series on the dates and in the manner provided in such Notes. Principal, premium, if any, Additional Interest, if any, and interest shall be considered paid on the date due if the Paying Agent, if
other than the Company or a Subsidiary, holds as of noon Eastern Time on the due date money deposited by the Company in immediately available funds and designated for and sufficient to pay all principal, premium, if any, and interest then due.

 The Company shall pay all Additional Interest, if any, with respect to Notes of an applicable series in the same manner on
the dates and in the amounts set forth in the applicable Registration Rights Agreement. 
 The Company shall pay interest
(including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal at the rate equal to the then applicable interest rate on the applicable series of Notes to the extent lawful; it shall pay interest (including
post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest and Additional Interest (without regard to any applicable grace period) at the same rate to the extent lawful. 

Section 4.02 Maintenance of Office or Agency. 

The Company shall maintain in the Borough of Manhattan in the City of New York an office or agency (which may be an office of the Trustee
or an affiliate of the Trustee, Registrar or 
  

 64 

 
co-registrar) where Notes may be surrendered for registration of transfer or for exchange and where notices and demands to or upon the Company in respect of the Notes and this Indenture may be
served. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the Company shall fail to maintain any such required office or agency or shall fail to
furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the Corporate Trust Office of the Trustee. 

The Company may also from time to time designate one or more other offices or agencies where the Notes of any series may be presented or
surrendered for any or all such purposes and may from time to time rescind such designations; provided that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in the
Borough of Manhattan in the City of New York for such purposes. The Company shall give prompt written notice to the Trustee of any such designation or rescission and of any change in the location of any such other office or agency. 

The Company hereby designates the Corporate Trust Office of the Trustee as one such office or agency of the Company in accordance with
Section 2.03 hereof. 
 Section 4.03 Reports and Other Information. 

(a) Notwithstanding that the Company may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act or
otherwise report on an annual and quarterly basis on forms provided for such annual and quarterly reporting pursuant to rules and regulations promulgated by the SEC, the Company shall file with the SEC (and make available to the Trustee and Holders
of the Notes (without exhibits), without cost to any Holder, within 15 days after the Company files them with the SEC) from and after the Issue Date, 

(1) within 90 days (or any other time period then in effect under the rules and regulations of the Exchange Act with
respect to the filing of a Form 10-K by a non-accelerated filer) after the end of each fiscal year, annual reports on Form 10-K, or any successor or comparable form, containing the information required to be contained therein, or required
in such successor or comparable form; 
 (2) within 45 days after the end of each of the first three fiscal
quarters of each fiscal year, reports on Form 10-Q containing all quarterly information that would be required to be contained in Form 10-Q, or any successor or comparable form; 

(3) promptly from time to time after the occurrence of an event required to be therein reported, such other reports on
Form 8-K, or any successor or comparable form; and 
 (4) any other information, documents and other
reports which the Company would be required to file with the SEC if it were subject to Section 13 or 15(d) of the Exchange Act; 
 in each
case, in a manner that complies in all material respects with the requirements specified in such form; provided that the Company shall not be so obligated to file such reports with the SEC if the SEC does not permit such filing, in which
event the Company shall make available such information to prospective purchasers of Notes, in addition to providing such information to the Trustee and the Holders of the Notes, in each case within 15 days after the time the Company would be
required to file such 
  

 65 

 
information with the SEC, if it were subject to Section 13 or 15(d) of the Exchange Act. In addition, to the extent not satisfied by the foregoing, for so long as any Notes are outstanding,
the Company shall furnish to Holders and to securities analysts and prospective investors, upon their request, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act. 

(b) In the event that any direct or indirect parent company of the Company becomes a guarantor of the Notes, the Company may satisfy its
obligations under this Section 4.03 with respect to financial information relating to the Company by furnishing financial information relating to such parent company; provided that the same is accompanied by consolidating information
that explains in reasonable detail the differences between the information relating to such parent, on the one hand, and the information relating to the Company and its Restricted Subsidiaries on a standalone basis, on the other hand. 

(c) Notwithstanding the foregoing, the requirements of this Section 4.03 shall be deemed satisfied prior to the commencement of the
Exchange Offer or the effectiveness of the Shelf Registration Statement (but in no event later than the date specified in the applicable Registration Rights Agreement by which the applicable Exchange Offer must be consummated) (1) by the filing
with the SEC of the Exchange Offer Registration Statement or Shelf Registration Statement (or any other registration statement), and any amendments thereto, with such financial information that satisfies Regulation S-X of the Securities Act or
(2) by posting reports that would be required to be filed substantially in the form required by the SEC on the Company’s website (or on the website of any of its parent companies) or providing such reports to the Trustee, with financial
information that satisfied Regulation S-X of the Securities Act, subject to exceptions consistent with the presentation of financial information in the Offering Memorandum, to the extent filed within the times specified above. 

(d) Notwithstanding anything herein to the contrary, the Company shall not be deemed to have failed to comply with any of its
obligations hereunder for purposes of Section 6.01(a)(3) hereof until 90 days after the date any report hereunder is due. 

Section 4.04 Compliance Certificate. 

(a) The Company and each Guarantor (to the extent that such Guarantor is so required under the Trust Indenture Act) shall deliver to the
Trustee, within 90 days after the end of each fiscal year ending after the Issue Date, a certificate from the principal executive officer, principal financial officer or principal accounting officer stating that a review of the activities of the
Company and its Restricted Subsidiaries during the preceding fiscal year has been made under the supervision of the signing Officer with a view to determining whether the Company has kept, observed, performed and fulfilled its obligations under this
Indenture, and further stating, as to such Officer signing such certificate, that to the best of his or her knowledge the Company has kept, observed, performed and fulfilled each and every condition and covenant contained in this Indenture and is
not in default in the performance or observance of any of the terms, provisions, covenants and conditions of this Indenture (or, if a Default shall have occurred, describing all such Defaults of which he or she may have knowledge and what action the
Company is taking or proposes to take with respect thereto). 
 (b) When any Default has occurred and is continuing under this
Indenture, or if the Trustee or the holder of any other evidence of Indebtedness of the Company or any of their respective Subsidiaries gives any notice or takes any other action with respect to a claimed Default, the Company shall promptly (which
shall be no more than 30 days) deliver to the Trustee by registered or certified mail or by facsimile transmission an Officer’s Certificate specifying such event and what action the Company proposes to take with respect thereto. 

 

 66 

 Section 4.05 Taxes. 

The Company shall pay, and the Company shall cause each of its Restricted Subsidiaries to pay, prior to delinquency, all material taxes,
assessments, and governmental levies except such as are contested in good faith and by appropriate negotiations or proceedings or where the failure to effect such payment is not adverse in any material respect to the Holders of the Notes of the
applicable series. 
 Section 4.06 Stay, Extension and Usury Laws. 

The Company and the Guarantors covenant (to the extent that they may lawfully do so) that they shall not at any time insist upon, plead,
or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension or usury law wherever enacted, now or at any time hereafter in force, that may affect the covenants or the performance of this Indenture; and the Company and
each of the Guarantors (to the extent that they may lawfully do so) hereby expressly waive all benefit or advantage of any such law, and covenant that they shall not, by resort to any such law, hinder, delay or impede the execution of any power
herein granted to the Trustee, but shall suffer and permit the execution of every such power as though no such law has been enacted. 

Section 4.07 Limitation on Restricted Payments. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly: 

(I) declare or pay any dividend or make any payment or distribution on account of the Company’s, or any of its
Restricted Subsidiaries’ Equity Interests, including, without limitation, payable in connection with any merger or consolidation other than: 

(A) dividends or distributions by the Company payable solely in Equity Interests (other than Disqualified Stock) of the
Company; or 
 (B) dividends, payments or distributions by a Restricted Subsidiary so long as, in the case of
any dividend, payment or distribution payable on or in respect of any class or series of securities issued by a Restricted Subsidiary other than a Wholly-Owned Subsidiary, the Company or a Restricted Subsidiary receives at least its pro rata
share of such dividend or distribution in accordance with its Equity Interests in such class or series of securities; 

(II) purchase, redeem, defease or otherwise acquire or retire for value any Equity Interests of the Company, or any
direct or indirect parent of the Company, including, without limitation, in connection with any merger or consolidation; 

(III) make any principal payment on, or redeem, repurchase, defease or otherwise acquire or retire for value in each
case, prior to any scheduled repayment, sinking fund payment or maturity, any Subordinated Indebtedness, other than (a) Indebtedness permitted under clauses (7) and (8) of the covenant described under Section 4.09(b) or
(b) the purchase, repurchase or other acquisition of Subordinated Indebtedness purchased in anticipation of satisfying a sinking fund obligation, principal installment or final maturity, in each case due within one year of the date of purchase,
repurchase or acquisition; or 
 (IV) make any Restricted Investment 

 

 67 

 (all such payments and other actions set forth in clauses (I) through (IV) above (other than any
exceptions thereof) being collectively referred to as “Restricted Payments”), unless, at the time of such Restricted Payment: 

(1) no Default or Event of Default shall have occurred and be continuing or would occur as a consequence thereof;

 (2) immediately after giving effect to such transaction on a pro forma basis, the Company could incur
$1.00 of additional Indebtedness under Section 4.09(a); and 
 (3) such Restricted Payment, together with
the aggregate amount of all other Restricted Payments made by the Company and its Restricted Subsidiaries after the Issue Date (including Restricted Payments permitted by clauses (1), (2) (with respect to the payment of dividends on Refunding
Capital Stock pursuant to clause (b) thereof only), (6)(c), (7), (9) and (14) (to the extent not deducted in calculating Consolidated Net Income) of Section 4.07(b), but excluding all other Restricted Payments permitted by
Section 4.07(b)), is less than the sum of (without duplication): 
 (a) 50% of the Consolidated Net Income
of the Company for the period (taken as one accounting period) beginning October 1, 2008 to the end of the Company’s most recently ended fiscal quarter for which internal financial statements are available at the time of such Restricted
Payment, or, in the case such Consolidated Net Income for such period is a deficit, minus 100% of such deficit; plus 

(b) 100% of the aggregate net cash proceeds and the fair market value, as determined in good faith by the Company, of
marketable securities or other property (other than assets or Equity Interests constituting entire portfolio companies owned by the Permitted Holders) received by the Company since immediately after the Issue Date (other than net cash proceeds to
the extent such net cash proceeds have been used to incur Indebtedness, Disqualified Stock or Preferred Stock pursuant to clause (12)(a) of Section 4.09(b) hereof) from the issue or sale of: 

(i) (A) Equity Interests of the Company, including Treasury Capital Stock, but excluding cash proceeds and the fair
market value, as determined in good faith by the Company, of marketable securities or other property received from the sale of: 

(x) Equity Interests to employees, directors or consultants of the Company, any direct or indirect parent company of the
Company and the Company’s Subsidiaries after the Issue Date to the extent such amounts have been applied to Restricted Payments made in accordance with clause (4) of Section 4.07(b) hereof; and 

(y) Designated Preferred Stock; and 

(B) to the extent such net cash proceeds are actually contributed to the Company as equity (other than Disqualified
Stock), Equity Interests of any of the Company’s direct or indirect parent companies (excluding contributions of the proceeds from the sale of Designated Preferred 

 

 68 

 
Stock of any such companies or contributions to the extent such amounts have been applied to Restricted Payments made in accordance with clause (4) of Section 4.07(b) hereof); or

 (ii) debt securities of the Company that have been converted into or exchanged for such Equity Interests of
the Company; 
 provided, however, that this clause (b) shall not include the proceeds from
(W) Refunding Capital Stock, (X) Equity Interests or debt securities of the Company sold to a Restricted Subsidiary, as the case may be, (Y) Disqualified Stock or debt securities that have been converted into Disqualified Stock or
(Z) Excluded Contributions; plus 
 (c) 100% of the aggregate amount of cash and the fair market
value, as determined in good faith by the Company, of marketable securities or other property (other than assets or Equity Interests constituting entire portfolio companies owned by the Permitted Holders) contributed to the capital of the Company
(other than as Disqualified Stock) following the Issue Date (other than (i) net cash proceeds to the extent such net cash proceeds have been used to incur Indebtedness, Disqualified Stock or Preferred Stock pursuant to clause (12)(a) of
Section 4.09(b) hereof, (ii) contributions from a Restricted Subsidiary or (iii) any Excluded Contribution); plus 

(d) 100% of the aggregate amount received in cash and the fair market value, as determined in good faith by the Company,
of marketable securities or other property (other than assets or Equity Interests constituting entire portfolio companies owned by the Permitted Holders) received by the Company or any Restricted Subsidiary by means of: 

(i) the sale or other disposition (other than to the Company or a Restricted Subsidiary) of Restricted Investments made
by the Company or its Restricted Subsidiaries and repurchases and redemptions of such Restricted Investments from the Company or its Restricted Subsidiaries and repayments of loans or advances, and releases of guarantees, which constitute Restricted
Investments by the Company or its Restricted Subsidiaries, in each case after the Issue Date; or 
 (ii) the
sale (other than to the Company or a Restricted Subsidiary) of the stock of an Unrestricted Subsidiary (other than to the extent the Investment in such Unrestricted Subsidiary was made by the Company or a Restricted Subsidiary pursuant to
clause (7) of Section 4.07(b) hereof or to the extent such Investment constituted a Permitted Investment) or a distribution or dividend from an Unrestricted Subsidiary, in each case, after the Issue Date; plus 

(e) in the case of the redesignation of an Unrestricted Subsidiary as a Restricted Subsidiary after the Issue Date, the
fair market value of the Investment in such Unrestricted Subsidiary, as determined by the Company in good faith or if, in the case of an Unrestricted Subsidiary, such fair market value may exceed $35.0 million, in writing by an Independent
Financial Advisor, at the time of the redesignation of such Unrestricted Subsidiary as a Restricted Subsidiary other than an Unrestricted Subsidiary to the extent the Investment in such Unrestricted Subsidiary was made by the Company or a Restricted
Subsidiary pursuant to clause (7) of Section 4.07(b) hereof or to the extent such Investment constituted a Permitted Investment; 
  

 69 

 provided, however, that for purposes of determining the fair market value of such other
property received by the Company or any Restricted Subsidiary or contributed to the capital of the Company, as the case may be, pursuant to clauses (3)(b), (c) and (d) above, the Company shall deliver to the Trustee an Officer’s
Certificate signed by the Chief Financial Officer of the Company certifying as to the fair market value of such other property and, if the fair market value is at least $75.0 million, a written opinion of a recognized independent expert stating the
fair market value of such other property. 
 (b) The foregoing provisions of Section 4.07(a) hereof shall not prohibit:

 (1) the payment of any dividend or distribution or the consummation of any irrevocable redemption within 60
days after the date of declaration thereof or the giving of the irrevocable redemption notice, as applicable, if at the date of declaration or notice such payment would have complied with the provisions of this Indenture; 

(2) (a) the redemption, repurchase, defeasance, retirement or other acquisition of any Equity Interests
(“Treasury Capital Stock”) or Subordinated Indebtedness of the Company or any Equity Interests of any direct or indirect parent company of the Company, in exchange for, or out of the proceeds of the substantially concurrent sale
(other than to a Restricted Subsidiary) of, Equity Interests of the Company or any direct or indirect parent company of the Company to the extent contributed to the Company (in each case, other than any Disqualified Stock or Designated Preferred
Stock) (“Refunding Capital Stock”) and (b) if immediately prior to the retirement of Treasury Capital Stock, the declaration and payment of dividends thereon was permitted under clause (6) of this Section 4.07(b), the
declaration and payment of dividends on the Refunding Capital Stock (other than Refunding Capital Stock the proceeds of which were used to redeem, repurchase, retire or otherwise acquire any Equity Interests of any direct or indirect parent company
of the Company) in an aggregate amount no greater than the aggregate amount per year of dividends per annum that were declarable and payable on such Treasury Capital Stock immediately prior to such retirement; 

(3) the redemption, repurchase, defeasance or other acquisition or retirement of Subordinated Indebtedness of the Company
or a Guarantor made in exchange for, or out of the proceeds of the substantially concurrent sale of, new Indebtedness of the Company or a Guarantor, as the case may be, which is incurred in compliance with Section 4.09 hereof so long as:

 (a) the principal amount (or accreted value, if applicable) of such new Indebtedness does not exceed the
principal amount of (or accreted value, if applicable), plus any accrued and unpaid interest on, the Subordinated Indebtedness being so redeemed, repurchased, acquired or retired for value, plus the amount of any reasonable premium to be paid
(including reasonable premiums) and any reasonable fees and expenses incurred in connection with the issuance of such new Indebtedness; 

(b) such new Indebtedness is subordinated to the Notes of the applicable series or the applicable Guarantee at least to
the same extent as such Subordinated Indebtedness so purchased, exchanged, redeemed, repurchased, defeased, acquired or retired for value; 
  

 70 

 (c) such new Indebtedness has a final scheduled maturity date equal to or
later than the final scheduled maturity date of the Subordinated Indebtedness being so redeemed, repurchased, defeased, acquired or retired; and 

(d) such new Indebtedness has a Weighted Average Life to Maturity equal to or greater than the remaining Weighted Average
Life to Maturity of the Subordinated Indebtedness being so redeemed, repurchased, defeased, acquired or retired; 

(4) a Restricted Payment to pay for the repurchase, redemption or other acquisition or retirement for value of Equity
Interests (other than Disqualified Stock) of the Company or any of its direct or indirect parent companies held by any future, present or former employee, director or consultant of the Company, any of its Restricted Subsidiaries or any of its direct
or indirect parent companies pursuant to any management equity plan or stock option plan or any other management or employee benefit plan or agreement, including any Equity Interests rolled over by management of the Company in connection with the
Transaction, (x) upon the death or disability of such employee, director or consultant or (y) upon the resignation or other termination of employment of such employee, director or consultant; provided, however, that the
aggregate Restricted Payments made under this clause (4) do not exceed in any calendar year $15.0 million (which shall increase to $25.0 million subsequent to the consummation of an underwritten public Equity Offering by the Company or any
direct or indirect parent corporation of the Company) (with unused amounts in any calendar year being carried over to succeeding calendar years subject to a maximum (without giving effect to the following proviso) of $25.0 million in any
calendar year (which shall increase to $40.0 million subsequent to the consummation of an underwritten public Equity Offering by the Company or any direct or indirect parent of the Company)); provided further that such amount in any
calendar year may be increased by an amount not to exceed: 
 (a) the cash proceeds from the sale of Equity
Interests (other than Disqualified Stock) of the Company and, to the extent contributed to the Company, Equity Interests of any of the Company’s direct or indirect parent companies, in each case to members of management, directors or
consultants of the Company, any of its Subsidiaries or any of its direct or indirect parent companies that occurs after the Issue Date, to the extent the cash proceeds from the sale of such Equity Interests have not otherwise been applied to the
payment of Restricted Payments by virtue of clause (3) of Section 4.07(a) hereof; plus 
 (b)
the cash proceeds of key man life insurance policies received by the Company or its Restricted Subsidiaries after the Issue Date; less 

(c) the amount of any Restricted Payments previously made with the cash proceeds described in clauses (a) and
(b) of this clause (4); 
 and provided further that cancellation of Indebtedness owing to the Company or
any of its Restricted Subsidiaries from members of management of the Company, any of the Company’s direct or indirect parent companies or any of the Company’s Subsidiaries in connection with a

  

 71 

 
repurchase of Equity Interests of the Company or any of its direct or indirect parent companies will not be deemed to constitute a Restricted Payment for purposes of this Section 4.07 or any
other provision of this Indenture; 
 (5) the declaration and payment of dividends to holders of any class or
series of Disqualified Stock of the Company or any of its Restricted Subsidiaries and of Preferred Stock of any Restricted Subsidiary issued in accordance with Section 4.09 hereof to the extent such dividends are included in the definition of
“Fixed Charges”; 
 (6) (a) the declaration and payment of dividends to holders of any class or series
of Designated Preferred Stock (other than Disqualified Stock) issued by the Company after the Issue Date; 
 (b)
the declaration and payment of dividends to a direct or indirect parent company of the Company, the proceeds of which will be used to fund the payment of dividends to holders of any class or series of Designated Preferred Stock (other than
Disqualified Stock) of such parent corporation issued after the Issue Date, provided that the amount of dividends paid pursuant to this clause (b) shall not exceed the aggregate amount of cash actually contributed to the Company from the
sale of such Designated Preferred Stock; or 
 (c) the declaration and payment of dividends on Refunding Capital
Stock that is Preferred Stock in excess of the dividends declarable and payable thereon pursuant to clause (2) of this Section 4.07(b); 

provided, however, in the case of each of (a), (b) and (c) of this clause (6), that for the most recently ended
four full fiscal quarters for which internal financial statements are available immediately preceding the date of issuance of such Designated Preferred Stock or the declaration of such dividends on Refunding Capital Stock that is Preferred Stock,
after giving effect to such issuance or declaration on a pro forma basis, the Company and its Restricted Subsidiaries on a consolidated basis would have had a Fixed Charge Coverage Ratio of at least 2.00 to 1.00; 

(7) Investments in Unrestricted Subsidiaries having an aggregate fair market value, taken together with all other
Investments made pursuant to this clause (7) that are at the time outstanding, without giving effect to the sale of an Unrestricted Subsidiary to the extent the proceeds of such sale do not consist of cash or marketable securities, not to
exceed the greater of (x) $30.0 million and (y) 1.0% of Total Assets at the time of such Investment (with the fair market value of each Investment being measured at the time made and without giving effect to subsequent changes in value);

 (8) repurchases of Equity Interests deemed to occur upon exercise of stock options or warrants if such Equity
Interests represent a portion of the exercise price of such options or warrants; 
 (9) the declaration and
payment of dividends on the Company’s common stock (or payments of dividends to any direct or indirect parent entity to fund payments of dividends on such entity’s common stock), following the consummation of an underwritten public
offering of the Company’s common stock or the common stock of any of its direct or indirect parent companies after the Issue Date, of up to 6% per annum of the net cash proceeds received by or contributed to the Company in or from any such
public offering, other than public offerings with respect to the Company’s common stock registered on Form S-4 or Form S-8 and other than any public sale constituting an Excluded Contribution; 

 

 72 

 (10) Restricted Payments in an aggregate amount equal to the amount of
Excluded Contributions previously received by the Company and its Restricted Subsidiaries; 
 (11) other
Restricted Payments in an aggregate amount taken together with all other Restricted Payments made pursuant to this clause (11) not to exceed the greater of (x) $30.0 million and (y) 1.0% of Total Assets at the time made; 

(12) distributions or payments of Receivables Fees; 

(13) any Restricted Payment made as part of the Transaction (including payments made after the Issue Date in respect of
long-term incentive plans or tax gross-ups or other deferred compensation), and the fees and expenses related thereto, or used to fund amounts owed to Affiliates (including dividends to any direct or indirect parent of the Company to permit payment
by such parent of such amounts), in each case to the extent permitted by (or, in the case of a dividend to fund such payment, to the extent such payment, if made by the Company, would be permitted by) Section 4.11 hereof; 

(14) the repurchase, redemption or other acquisition or retirement for value of any Subordinated Indebtedness in
accordance with the provisions similar to those described under Sections 4.10 and Section 4.14 hereof; provided that all Notes of any applicable series tendered in connection with a Change of Control Offer or Asset Sale Offer, as
applicable, have first been repurchased, redeemed or acquired for value; 
 (15) the declaration and payment of
dividends by the Company to, or the making of loans to, any direct or indirect parent in amounts required for any direct or indirect parent companies to pay, in each case without duplication: 

(a) franchise and excise taxes and other fees, taxes and expenses, in each case to the extent required to maintain their
corporate existence; 
 (b) federal, state and local income taxes, to the extent such income taxes are
attributable to the income of the Company and its Restricted Subsidiaries and, to the extent of the amount actually received from its Unrestricted Subsidiaries, in amounts required to pay such taxes to the extent attributable to the income of such
Unrestricted Subsidiaries; provided that in each case the amount of such payments in any fiscal year does not exceed the amount that the Company and its Restricted Subsidiaries would be required to pay in respect of federal, state and local
taxes for such fiscal year were the Company, its Restricted Subsidiaries and its Unrestricted Subsidiaries (to the extent described above) to pay such taxes separately from any such parent entity; 

(c) customary salary, bonus and other benefits payable to officers and employees of any direct or indirect parent company
of the Company to the extent such salaries, bonuses and other benefits are attributable to the ownership or operation of the Company and its Restricted Subsidiaries; 

 

 73 

 (d) general corporate operating and overhead costs and expenses of any
direct or indirect parent company of the Company to the extent such costs and expenses are attributable to the ownership or operation of the Company and its Restricted Subsidiaries; and 

(e) fees and expenses other than to Affiliates of the Company related to any unsuccessful equity or debt offering of such
parent entity; and 
 (16) the distribution, by dividend or otherwise, of shares of Capital Stock of, or
Indebtedness owed to the Company or a Restricted Subsidiary by Unrestricted Subsidiaries (other than Unrestricted Subsidiaries, the primary assets of which are cash and/or Cash Equivalents or were contributed to such Unrestricted Subsidiary in
anticipation of such distribution, dividend or other payment); 
 provided, however, that at the time of, and after giving effect
to, any Restricted Payment permitted under clauses (7), (11) and (16) of this Section 4.07(b), no Default shall have occurred and be continuing or would occur as a consequence thereof. 

(c) The Company shall not permit any Unrestricted Subsidiary to become a Restricted Subsidiary except pursuant to the last sentence of
the definition of “Unrestricted Subsidiary.” For purposes of designating any Restricted Subsidiary as an Unrestricted Subsidiary, all outstanding Investments by the Company and its Restricted Subsidiaries (except to the extent repaid) in
the Subsidiary so designated shall be deemed to be Restricted Payments in an amount determined as set forth in the last sentence of the definition of “Investments.” Such designation shall be permitted only if a Restricted Payment in such
amount would be permitted at such time, whether pursuant to Section 4.07(a) hereof or under clause (7), (10) or (11) of Section 4.07(b) hereof, or pursuant to the definition of “Permitted Investment,” and if such
Subsidiary otherwise meets the definition of an Unrestricted Subsidiary. 
 Section 4.08 Dividend and Other Payment Restrictions
Affecting Restricted Subsidiaries. 
 (a) The Company shall not, and shall not permit any of its Restricted Subsidiaries
that are not Guarantors to, directly or indirectly, create or otherwise cause or suffer to exist or become effective any consensual encumbrance or consensual restriction on the ability of any Restricted Subsidiary that is not a Guarantor to:

 (1) (A) pay dividends or make any other distributions to the Company or any of its Restricted Subsidiaries on
its Capital Stock or with respect to any other interest or participation in, or measured by, its profits, or 

(B) pay any liabilities owed to the Company or any of its Restricted Subsidiaries; 

(2) make loans or advances to the Company or any of its Restricted Subsidiaries; or 

(3) sell, lease or transfer any of its properties or assets to the Company or any of its Restricted Subsidiaries.

 (b) The restrictions in Section 4.08(a) hereof shall not apply to encumbrances or restrictions existing under or by
reason of: 
 (1) contractual encumbrances or restrictions in effect on the Issue Date, including pursuant to
the ABL Facility, the Term Loan Facility and the related documentation; 
  

 74 

 (2) this Indenture and the Notes; 

(3) purchase money obligations for property acquired in the ordinary course of business that impose restrictions of the
nature discussed in clause (3) of Section 4.08(a) hereof on the property so acquired; 
 (4)
applicable law or any applicable rule, regulation or order; 
 (5) any agreement or other instrument of a Person
acquired by the Company or any Restricted Subsidiaries in existence at the time of such acquisition (but not created in contemplation thereof), which encumbrance or restriction is not applicable to any Person, or the properties or assets of any
Person, other than the Person and its Subsidiaries, or the property or assets of the Person and its Subsidiaries, so acquired; 

(6) contracts for the sale of assets, including customary restrictions with respect to a Subsidiary of the Company
pursuant to an agreement that has been entered into for the sale or disposition of all or substantially all of the Capital Stock or assets of such Subsidiary; 

(7) Secured Indebtedness otherwise permitted to be incurred pursuant to Section 4.09 hereof and Section 4.12
hereof that limit the right of the debtor to dispose of the assets securing such Indebtedness; 
 (8)
restrictions on cash or other deposits or net worth imposed by customers under contracts entered into in the ordinary course of business; 

(9) other Indebtedness, Disqualified Stock or Preferred Stock of Foreign Subsidiaries permitted to be incurred subsequent
to the Issue Date pursuant to the provisions of Section 4.09 hereof; 
 (10) customary provisions in joint
venture agreements and other similar agreements relating solely to such joint venture; 
 (11) customary
provisions contained in leases or licenses of intellectual property and other agreements, in each case, entered into in the ordinary course of business; 

(12) any encumbrances or restrictions of the type referred to in clauses (1), (2) and (3) of
Section 4.08(a) hereof imposed by any amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings of the contracts, instruments or obligations referred to in clauses (1) through
(11) of this Section 4.08(b); provided that such amendments, modifications, restatements, renewals, increases, supplements, refundings, replacements or refinancings are, in the good faith judgment of the Company, no more restrictive
with respect to such encumbrance and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal, increase, supplement, refunding, replacement or refinancing; and 

 

 75 

 (13) restrictions created in connection with any Receivables Facility that,
in the good faith determination of the Company are necessary or advisable to effect the transactions contemplated under such Receivables Facility. 

Section 4.09 Limitation on Incurrence of Indebtedness and Issuance of Disqualified Stock and Preferred Stock. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, directly or indirectly, create, incur, issue,
assume, guarantee or otherwise become directly or indirectly liable, contingently or otherwise (collectively, “incur” and collectively, an “incurrence”) with respect to any Indebtedness (including Acquired
Indebtedness) and the Company shall not issue any shares of Disqualified Stock and shall not permit any Restricted Subsidiary to issue any shares of Disqualified Stock or Preferred Stock; provided, however, that the Company may incur
Indebtedness (including Acquired Indebtedness) or issue shares of Disqualified Stock, and subject to the second proviso in this Section 4.09(a), any of its Restricted Subsidiaries may incur Indebtedness (including Acquired Indebtedness), issue
shares of Disqualified Stock and issue shares of Preferred Stock, if the Fixed Charge Coverage Ratio on a consolidated basis for the Company and its Restricted Subsidiaries’ most recently ended four fiscal quarters for which internal financial
statements are available immediately preceding the date on which such additional Indebtedness is incurred or such Disqualified Stock or Preferred Stock is issued would have been at least 2.00 to 1.00, determined on a pro forma basis
(including a pro forma application of the net proceeds therefrom), as if the additional Indebtedness had been incurred, or the Disqualified Stock or Preferred Stock had been issued, as the case may be, and the application of proceeds
therefrom had occurred at the beginning of such four-quarter period; provided further, that Restricted Subsidiaries that are not Guarantors may not incur Indebtedness or issue Disqualified Stock or Preferred Stock pursuant to this
Section 4.09(a) if, after giving pro forma effect to such incurrence or issuance (including a pro forma application of the net proceeds therefrom), the aggregate amount of Indebtedness, Disqualified Stock and Preferred Stock of Restricted
Subsidiaries that are not Guarantors incurred or issued pursuant to this Section 4.09(a) would exceed $25.0 million. 

(b) The provisions of Section 4.09(a) hereof shall not apply to: 

(1) the incurrence of Indebtedness under Credit Facilities by the Company or any of its Restricted Subsidiaries and the
issuance and creation of letters of credit and bankers’ acceptances thereunder (with letters of credit and bankers’ acceptances being deemed to have a principal amount equal to the face amount thereof), up to an aggregate principal amount
at any one time outstanding not to exceed the greater of (x) $175.0 million and (y) the Borrowing Base; 

(2) the incurrence by the Company and any Guarantor of (a) Indebtedness represented by the Series A-1 Notes
(including any Guarantee) (other than any Additional Notes) and any notes (including Guarantees thereof) issued in exchange for the Series A-1 Notes pursuant to the Registration Rights Agreement or similar agreement and (b) Indebtedness under
the Term Loan Facility and/or Series A-2 Notes (including Guarantees thereof) (other than any Additional Notes) and any notes (including Guarantees thereof) issued in exchange for the Series A-2 Notes pursuant to a registration rights agreement, up
to an aggregate principal amount of $310.0 million (plus up to an additional $15.0 million of Series A-2 Notes); 

(3) Indebtedness of the Company and its Restricted Subsidiaries in existence on the Issue Date (other than Indebtedness
described in clauses (1) and (2) of this Section 4.09(b)); 
  

 76 

 (4) Indebtedness (including Capitalized Lease Obligations) and Disqualified
Stock incurred or issued by the Company or any of its Restricted Subsidiaries, and Preferred Stock issued by any of the Company’s Restricted Subsidiaries, to finance the purchase, lease or improvement of property (real or personal) or equipment
(other than software) that is used or useful in a Similar Business, whether through the direct purchase of assets or the Capital Stock of any Person owning such assets, in an aggregate principal amount at the date of such incurrence (including all
Refinancing Indebtedness incurred to refinance any other Indebtedness incurred pursuant to this Section 4.09(b)(4)) not to exceed 4.0% of Total Assets; provided, however, that such Indebtedness exists at the date of such purchase
or transaction or is created within 270 days thereafter (it being understood that any Indebtedness, Disqualified Stock or Preferred Stock incurred pursuant to this clause (4) shall cease to be deemed incurred or outstanding for purposes of this
Section 4.09(b)(4) but shall be deemed incurred for the purposes of Section 4.09(a) hereof from and after the first date on which the Company or such Restricted Subsidiary could have incurred such Indebtedness, Disqualified Stock or
Preferred Stock under Section 4.09(a) hereof without reliance on this Section 4.09(b)(4)); 
 (5)
Indebtedness incurred by the Company or any of its Restricted Subsidiaries constituting reimbursement obligations with respect to letters of credit issued in the ordinary course of business, including letters of credit in respect of workers’
compensation claims, or other Indebtedness with respect to reimbursement type obligations regarding workers’ compensation claims; provided, however, that upon the drawing of such letters of credit or the incurrence of such
Indebtedness, such obligations are reimbursed within 30 days following such drawing or incurrence; 
 (6)
Indebtedness arising from agreements of the Company or its Restricted Subsidiaries providing for indemnification, adjustment of purchase price or similar obligations, in each case, incurred or assumed in connection with the disposition of any
business, assets or a Subsidiary, other than guarantees of Indebtedness incurred by any Person acquiring all or any portion of such business, assets or a Subsidiary for the purpose of financing such acquisition; provided, however, that

 (A) such Indebtedness is not reflected on the balance sheet of the Company, or any of its Restricted
Subsidiaries (Contingent Obligations referred to in a footnote to financial statements and not otherwise reflected on the balance sheet will not be deemed to be reflected on such balance sheet for purposes of this subclause (A)); and 

(B) the maximum assumable liability in respect of all such Indebtedness shall at no time exceed the gross proceeds
including non-cash proceeds (the fair market value of such non-cash proceeds being measured at the time received and without giving effect to any subsequent changes in value) actually received by the Company and its Restricted Subsidiaries in
connection with such disposition; 
 (7) Indebtedness of the Company to a Restricted Subsidiary; provided
that any such Indebtedness owing to a Restricted Subsidiary that is not a Guarantor is expressly subordinated in right of payment to the Notes; provided further that any subsequent issuance or transfer of any Capital Stock or any other event
which results in the Restricted Subsidiary holding such Indebtedness ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such Indebtedness (except to the Company or another Restricted Subsidiary) shall be deemed, in each
case, to be an incurrence of such Indebtedness not permitted by this clause (7); 
  

 77 

 (8) Indebtedness of a Restricted Subsidiary to the Company or another
Restricted Subsidiary; provided that if a Guarantor incurs such Indebtedness to a Restricted Subsidiary that is not a Guarantor, such Indebtedness is expressly subordinated in right of payment to the Guarantee of the Notes of the applicable
series of such Guarantor; provided further that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Indebtedness being held by a person other than the Company or a Restricted Subsidiary
or any subsequent transfer of any such Indebtedness (except to the Company or another Restricted Subsidiary) shall be deemed, in each case, to be an incurrence of such Indebtedness not permitted by this clause (8); 

(9) shares of Preferred Stock of a Restricted Subsidiary issued to the Company or another Restricted Subsidiary,
provided that any subsequent issuance or transfer of any Capital Stock or any other event which results in any such Restricted Subsidiary ceasing to be a Restricted Subsidiary or any other subsequent transfer of any such shares of Preferred
Stock (except to the Company or another Restricted Subsidiary) shall be deemed in each case to be an issuance of such shares of Preferred Stock not permitted by this clause (9); 

(10) Hedging Obligations (excluding Hedging Obligations entered into for speculative purposes) for the purpose of
limiting interest rate risk with respect to any Indebtedness of the Company or any Restricted Subsidiary permitted to be incurred pursuant to this Section 4.09, exchange rate risk or commodity pricing risk; 

(11) obligations in respect of performance, bid, appeal and surety bonds and completion guarantees provided by the
Company or any of its Restricted Subsidiaries in the ordinary course of business; 
 (12) (a) Indebtedness or
Disqualified Stock of the Company and Indebtedness, Disqualified Stock or Preferred Stock of any Restricted Subsidiary equal to 100.0% of the net cash proceeds received by the Company since immediately after the Issue Date from the issue or sale of
Equity Interests of the Company or cash contributed to the capital of the Company (in each case, other than proceeds of Disqualified Stock or sales of Equity Interests to the Company or any of its Subsidiaries) as determined in accordance with
clauses (3)(b) and (3)(c) of Section 4.07(a) hereof to the extent such net cash proceeds or cash have not been applied pursuant to such clauses to make Restricted Payments or to make other Investments, payments or exchanges pursuant
to Section 4.07(b) or to make Permitted Investments (other than Permitted Investments specified in clauses (1), (2) and (3) of the definition thereof) and (b) Indebtedness or Disqualified Stock of the Company and Indebtedness,
Disqualified Stock or Preferred Stock of any Restricted Subsidiary not otherwise permitted hereunder in an aggregate principal amount or liquidation preference, which when aggregated with the principal amount and liquidation preference of all other
Indebtedness, Disqualified Stock and Preferred Stock then outstanding and incurred pursuant to this Section 4.09(b)(12)(b), does not at any one time outstanding exceed the greater of (x) $150.0 million and (y) 5.0% of Total Assets (it
being understood that any Indebtedness, Disqualified Stock or Preferred Stock incurred pursuant to this Section 4.09(b)(12)(b) shall cease to be deemed incurred or outstanding for purposes of this Section 4.09(b)(12)(b) but shall be deemed
incurred for the purposes of Section 4.09(a) from and after the first date on which the Company or such Restricted Subsidiary could have incurred such Indebtedness, Disqualified Stock or Preferred Stock under Section 4.09(a) without
reliance on this Section 4.09(b)(12)(b)); 
  

 78 

 (13) the incurrence or issuance by the Company or any Restricted Subsidiary
of Indebtedness or Disqualified Stock, and the issuance by any Restricted Subsidiary of Preferred Stock, in each case which serves to refund, refinance, replace, renew, extend or defease any Indebtedness, Disqualified Stock or Preferred Stock of the
Company or any Restricted Subsidiary incurred as permitted under Section 4.09(a) hereof and clauses (2), (3), (4) and (12)(a) of this Section 4.09(b), this clause (13) and clause (14) of this Section 4.09(b)
or any Indebtedness, Disqualified Stock or Preferred Stock issued to so refund, refinance, replace, renew, extend or defease such Indebtedness, Disqualified Stock or Preferred Stock including additional Indebtedness, Disqualified Stock or Preferred
Stock incurred to pay premiums (including reasonable tender premiums), defeasance costs and fees in connection therewith (the “Refinancing Indebtedness”) prior to its respective maturity; provided, however, that such
Refinancing Indebtedness: 
 (A) has a Weighted Average Life to Maturity at the time such Refinancing
Indebtedness is incurred which is not less than the remaining Weighted Average Life to Maturity of the Indebtedness, Disqualified Stock or Preferred Stock being refunded, refinanced, replaced, renewed, extended or defeased, 

(B) to the extent such Refinancing Indebtedness refinances (i) Indebtedness subordinated or pari passu to the
Notes of the applicable series or any Guarantee thereof, such Refinancing Indebtedness is subordinated or pari passu to the Notes of the applicable series or the Guarantee at least to the same extent as the Indebtedness being refinanced or
refunded or (ii) Disqualified Stock or Preferred Stock, such Refinancing Indebtedness must be Disqualified Stock or Preferred Stock, respectively, and 

(C) shall not include (i) Indebtedness, Disqualified Stock or Preferred Stock of a Subsidiary of the Company that is
not a Guarantor that refinances Indebtedness or Disqualified Stock of the Company, (ii) Indebtedness, Disqualified Stock or Preferred Stock of a Subsidiary of the Company that is not a Guarantor that refinances Indebtedness, Disqualified Stock
or Preferred Stock of a Guarantor, or (iii) Indebtedness or Disqualified Stock of the Company or Indebtedness, Disqualified Stock or Preferred Stock of a Restricted Subsidiary that refinances Indebtedness, Disqualified Stock or Preferred Stock
of an Unrestricted Subsidiary; 
 provided further that subclause (A) of this clause (13) will not apply
to any refunding or refinancing of any Secured Indebtedness; 
 (14) (x) Indebtedness or Disqualified Stock of
the Company and Indebtedness, Disqualified Stock or Preferred Stock of a Restricted Subsidiary, incurred or issued to finance an acquisition or (y) Indebtedness, Disqualified Stock or Preferred Stock of Persons that are acquired by the Company
or any Restricted Subsidiary or merged into the Company or a Restricted Subsidiary in accordance with the terms of this Indenture; provided that in the case of (x) and (y) after giving effect to such acquisition or merger, either
(a) the Company would be permitted to incur at least $1.00 of additional 
  

 79 

 
Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section 4.09(a) hereof, or (b) the Fixed Charge Coverage Ratio of the Company and the Restricted Subsidiaries
is greater than immediately prior to such acquisition or merger; 
 (15) Indebtedness arising from the honoring
by a bank or other financial institution of a check, draft or similar instrument drawn against insufficient funds in the ordinary course of business, provided that such Indebtedness is extinguished within two Business Days of its incurrence;

 (16) Indebtedness of the Company or any of its Restricted Subsidiaries supported by a letter of credit issued
pursuant to the Credit Facilities, in a principal amount not in excess of the stated amount of such letter of credit; 

(17) (A) any guarantee by the Company or a Restricted Subsidiary of Indebtedness or other obligations of any Restricted
Subsidiary so long as the incurrence of such Indebtedness incurred by such Restricted Subsidiary is permitted under the terms of this Indenture, or 

(B) any guarantee by a Restricted Subsidiary of Indebtedness of the Company provided that such guarantee is
incurred in accordance with Section 4.16 hereof, 
 (18) Indebtedness of Foreign Subsidiaries of the
Company in an amount not to exceed, at any one time outstanding and together with any other Indebtedness incurred under this clause (18) of Section 4.09(b) hereof, the greater of (x) $50.0 million and (y) 10.0% of the total
assets of the Foreign Subsidiaries on a consolidated basis as shown on the Company’s most recent balance sheet (it being understood that any Indebtedness incurred pursuant to this clause (18) of Section 4.09(b) hereof shall cease to
be deemed incurred or outstanding for purposes of this clause (18) of Section 4.09(b) hereof but shall be deemed incurred for the purposes of Section 4.09(a) hereof from and after the first date on which the Company or its Restricted
Subsidiaries could have incurred such Indebtedness under Section 4.09(a) hereof without reliance on this clause (18) of Section 4.09(b) hereof); 

(19) Indebtedness of the Company or any of its Restricted Subsidiaries consisting of (i) the financing of insurance
premiums or (ii) take-or-pay obligations contained in supply arrangements in each case, incurred in the ordinary course of business; and 

(20) Indebtedness consisting of Indebtedness issued by the Company or any of its Restricted Subsidiaries to current or
former officers, directors and employees thereof, their respective estates, spouses or former spouses, in each case to finance the purchase or redemption of Equity Interests of the Company or any direct or indirect parent company of the Company to
the extent described in clause (4) of Section 4.07(b) hereof. 
 (c) For purposes of determining compliance with this
Section 4.09: 
 (1) in the event that an item of Indebtedness, Disqualified Stock or Preferred Stock (or
any portion thereof) meets the criteria of more than one of the categories of permitted Indebtedness, Disqualified Stock or Preferred Stock described in 

 

 80 

 
clauses (1) through (20) of Section 4.09(b) hereof or is entitled to be incurred pursuant to Section 4.09(a) hereof, the Company, in its sole discretion, shall classify or
reclassify such item of Indebtedness, Disqualified Stock or Preferred Stock (or any portion thereof) and shall only be required to include the amount and type of such Indebtedness, Disqualified Stock or Preferred Stock in one of the above clauses;
and 
 (2) at the time of incurrence, the Company shall be entitled to divide and classify an item of
Indebtedness in more than one of the types of Indebtedness described in Sections 4.09(a) and 4.09(b) hereof; provided that all Indebtedness outstanding under the Credit Facilities on the Issue Date will be treated as incurred on the Issue
Date under clause (1) of Section 4.09(b) hereof. 
 Accrual of interest or dividends, the accretion of accreted
value, the accretion or amortization of original issue discount, the payment of interest in the form of additional Indebtedness and the payment of dividends in the form of additional Disqualified Stock or Preferred Stock, as applicable, shall in
each case not be deemed to be an incurrence of Indebtedness, Disqualified Stock or Preferred Stock for purposes of this Section 4.09. 

For purposes of determining compliance with any U.S. dollar-denominated restriction on the incurrence of Indebtedness, the U.S.
dollar-equivalent principal amount of Indebtedness denominated in a foreign currency shall be calculated based on the relevant currency exchange rate in effect on the date such Indebtedness was incurred, in the case of term debt, or first committed,
in the case of revolving credit debt; provided that if such Indebtedness is incurred to refinance other Indebtedness denominated in a foreign currency, and such refinancing would cause the applicable U.S. dollar denominated restriction to be
exceeded if calculated at the relevant currency exchange rate in effect on the date of such refinancing, such U.S. dollar-denominated restriction shall be deemed not to have been exceeded so long as the principal amount of such refinancing
Indebtedness does not exceed the principal amount of such Indebtedness being refinanced, plus the amount of any reasonable premium (including reasonable tender premiums), defeasance costs and any reasonable fees and expenses incurred in connection
with the issuance of such new Indebtedness. 
 The principal amount of any Indebtedness incurred to refinance other
Indebtedness, if incurred in a different currency from the Indebtedness being refinanced, shall be calculated based on the currency exchange rate applicable to the currencies in which such respective Indebtedness is denominated that is in effect on
the date of such refinancing. 
 The Company shall not, and shall not permit any Guarantor to, directly or indirectly, incur
any Indebtedness (including Acquired Indebtedness) that is subordinated or junior in right of payment to any Indebtedness of the Company or such Guarantor, as the case may be, unless such Indebtedness is expressly subordinated in right of payment to
the Notes of the applicable series or such Guarantor’s Guarantee to the extent and in the same manner as such Indebtedness is subordinated to other Indebtedness of the Company or such Guarantor, as the case may be. 

Unsecured Indebtedness shall not be treated as subordinated or junior to Secured Indebtedness merely because it is unsecured. Senior
Indebtedness shall not be treated as subordinated or junior to any other Senior Indebtedness merely because it has a junior priority with respect to the same collateral. 
  

 81 

 Section 4.10 Asset Sales. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to consummate an Asset Sale, unless: 

(1) the Company or such Restricted Subsidiary, as the case may be, receives consideration at the time of such Asset Sale
at least equal to the fair market value (as determined in good faith by the Company or, if $40.0 million or more, the board of directors of the Company) of the assets sold or otherwise disposed of; 

(2) except in the case of a Permitted Asset Swap, at least 75% of the consideration therefor received by the Company or
such Restricted Subsidiary, as the case may be, is in the form of cash or Cash Equivalents; provided that the following shall be deemed to be cash for purposes of this Section 4.10 and for no other purpose: 

(A) any liabilities (as reflected in the Company’s or such Restricted Subsidiary’s most recent balance sheet or
in the footnotes thereto) of the Company or such Restricted Subsidiary (other than liabilities that are by their terms subordinated to the Notes of the applicable series or liabilities to the extent owed to the Company or any Affiliate of the
Company) that are assumed by the transferee of any such assets and for which the Company and all of its Restricted Subsidiaries have been validly released by all applicable creditors in writing; 

(B) any securities, notes or other similar obligations received by the Company or such Restricted Subsidiary from such
transferee that are converted by the Company or such Restricted Subsidiary into cash (to the extent of the cash received) within 180 days following the closing of such Asset Sale; 

(C) any Designated Non-cash Consideration received by the Company or such Restricted Subsidiary in such Asset Sale having
an aggregate fair market value, taken together with all other Designated Non-cash Consideration received pursuant to this clause (C) that is at that time outstanding, not to exceed the greater of (i) $50.0 million and (ii) 2.5% of
Total Assets at the time of the receipt of such Designated Non-cash Consideration, with the fair market value of each item of Designated Non-cash Consideration being measured at the time received and without giving effect to subsequent changes in
value; and 
 (3) to the extent that any assets received by the Company and its Restricted Subsidiaries in such
Asset Sale constitute securities or may be used or useful in a Similar Business, such assets are concurrently with their acquisition added to the Notes/Term Collateral securing the Notes, other than Excluded Assets and subject to the limitations and
exclusions described in Section 10.01(b) hereof. 
 (b) Within 365 days after the receipt of any Net Proceeds of any Asset
Sale, the Company or such Restricted Subsidiary, at its option, may apply the Net Proceeds from such Asset Sale, 

(1) to permanently reduce Indebtedness as follows: 

(A) if the assets subject of such Asset Sale constitute Notes/Term Collateral, to permanently reduce (or offer to reduce,
as applicable) Obligations under the Series A-1 Notes and the Series A-2 Debt on a pro rata basis; provided further that all reductions of obligations under the Notes shall be made as provided under Section 3.07 hereof with
respect to Series A-1 Notes and as provided by the optional redemption provisions of any Series A-2 Notes with respect to the Series A-2 Notes, through open-market purchases (to the extent such purchases are at or above 100% of the principal amount
thereof plus accrued unpaid interest) or by making an offer (in accordance with the procedures set forth under Section 4.10(c) hereof for an Asset Sale Offer) to all Holders of Notes to purchase their Notes at 100% of the principal amount
thereof, plus the amount of accrued but unpaid interest, if any, on the amount of Notes that would otherwise be prepaid; 
  

 82 

 (B) if the assets subject of such Asset Sale do not constitute Collateral,
but constitute collateral for other Senior Indebtedness, which Lien is permitted by this Indenture, to permanently reduce Obligations under such other Senior Indebtedness that is secured by a Lien, which Lien is permitted by this Indenture, and to
correspondingly reduce commitments with respect thereto; 
 (C) if the assets subject of such Asset Sale do not
constitute Collateral, to permanently reduce Obligations under other Senior Indebtedness (and to correspondingly reduce commitments with respect thereto), provided that the Company shall equally and ratably reduce (or offer to reduce, as
applicable) Obligations under the Series A-1 Notes and the Series A-2 Debt on a pro rata basis; provided further that all reductions of Obligations under the Notes shall be made as provided under Section 3.07 hereof with respect
to Series A-1 Notes and as provided by the optional redemption provisions of any Series A-2 Notes with respect to the Series A-2 Notes, through open-market purchases (to the extent such purchases are at or above 100% of the principal amount thereof
plus accrued and unpaid interest) or by making an offer (in accordance with the procedures set forth under Section 4.10(c) hereof) to all Holders of Notes to purchase their Notes at 100% of the principal amount thereof, plus the amount of
accrued but unpaid interest, if any, on the amount of Notes that would otherwise be prepaid; or 
 (D) if the
assets subject of such Asset Sale do not constitute Collateral, to permanently reduce Indebtedness of a Restricted Subsidiary that is not a Guarantor, other than Indebtedness owed to the Company or any Restricted Subsidiary; 

(2) to make (A) an Investment in any one or more businesses; provided that such Investment in any business is
in the form of the acquisition of Capital Stock and results in the Company or another of its Restricted Subsidiaries, as the case may be, owning an amount of the Capital Stock of such business such that it constitutes a Restricted Subsidiary,
(B) capital expenditures or (C) acquisitions of other assets, in each of (A), (B) and (C), used or useful in a Similar Business provided that the assets (including Capital Stock) acquired with the Net Proceeds of a disposition
of Collateral are pledged as Collateral to the extent required under the Collateral Documents, or 
  

 83 

 (3) to make an investment in (A) any one or more businesses;
provided that such Investment in any business is in the form of the acquisition of Capital Stock and results in the Company or another of its Restricted Subsidiaries, as the case may be, owning an amount of the Capital Stock of such business
such that it constitutes a Restricted Subsidiary, (B) properties or (C) acquisitions of other assets that, in each of (A), (B) and (C), replace the businesses, properties and/or assets that are the subject of such Asset Sale
provided that the assets (including Capital Stock) acquired with the Net Proceeds of a disposition of Collateral are pledged as Collateral to the extent required under the Collateral Documents; 

provided that, in the case of clauses (2) and (3) above, a binding commitment entered into not later than such 365
th day shall be treated as a permitted application of the
Net Proceeds from the date of such commitment so long as the Company, or such other Restricted Subsidiary enters into such commitment with the good faith expectation that such Net Proceeds shall be applied to satisfy such commitment within 120 days
of such commitment (an “Acceptable Commitment”) and, in the event any Acceptable Commitment is later cancelled or terminated for any reason before the Net Proceeds are applied in connection therewith, or such Net Proceeds are not
actually so invested or paid in accordance with clauses (2) or (3) above by the end of such 120-day period, then such Net Proceeds shall constitute Excess Proceeds. 

(c) Any Net Proceeds from the Asset Sale that are not invested or applied as provided and within the time period set forth in
Section 4.10(b) shall be deemed to constitute “Excess Proceeds.” When the aggregate amount of Excess Proceeds exceeds $30.0 million, the Company shall make an offer to all Holders of the Notes of the applicable series and,
if required by the terms of any Indebtedness that is pari passu with the Notes of such series or any Guarantee (“Pari Passu Indebtedness”), to the holders of such Pari Passu Indebtedness (an “Asset Sale
Offer”), to purchase the maximum aggregate principal amount of the Notes of such series and such Pari Passu Indebtedness that is an integral multiple of $1,000 (but in minimum amounts of $2,000) that may be purchased out of the Excess
Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid interest and Additional Interest, if any, to the date fixed for the closing of such offer, in accordance with the procedures set
forth in this Indenture. The Company shall commence an Asset Sale Offer with respect to Excess Proceeds within ten Business Days after the date that Excess Proceeds exceed $30.0 million by mailing the notice required pursuant to the terms of
this Indenture, with a copy to the Trustee. The Company may satisfy the foregoing obligations with respect to any Net Proceeds from an Asset Sale by making an Asset Sale Offer with respect to such Net Proceeds prior to the expiration of the relevant
365 days or with respect to Excess Proceeds of $30.0 million or less. 
 To the extent that the aggregate amount of Notes of
such series and such Pari Passu Indebtedness tendered pursuant to an Asset Sale Offer is less than the Excess Proceeds, the Company may use any remaining Excess Proceeds for general corporate purposes, subject to other covenants contained in this
Indenture. If the aggregate principal amount of Notes of such series or the Pari Passu Indebtedness surrendered by such holders thereof exceeds the amount of Excess Proceeds, the Trustee shall select the Notes of such series and such Pari Passu
Indebtedness to be purchased on a pro rata basis based on the accreted value or principal amount of the Notes of such series or such Pari Passu Indebtedness tendered. Additionally, the Company may, at its option, make an Asset Sale Offer
using proceeds from any Asset Sale at any time after consummation of such Asset Sale. Upon consummation of any Asset Sale Offer, any Net Proceeds not used to purchase Notes of such series in such Asset Sale Offer shall not be deemed Excess Proceeds
and the Company may use any Net Proceeds not required to be used for general corporate purposes, subject to other covenants contained in this Indenture. To the extent the Asset Sale giving rise to the Asset Sale Offer involves Notes/Term Collateral,
the Asset Sale Offer shall be made first to Holders of Series A-1 Notes and holders of Series A-2 Debt and, if any Excess Proceeds remain, second to holders of other Pari Passu Indebtedness. 

 

 84 

 (d) Pending the final application of any Net Proceeds pursuant to this Section 4.10,
the holder of such Net Proceeds may apply such Net Proceeds temporarily to reduce Indebtedness outstanding under a revolving credit facility or otherwise invest such Net Proceeds in any manner not prohibited by this Indenture. 

(e) Notwithstanding the foregoing, any Indebtedness secured by a Permitted Lien as permitted under the Indenture may share in the
proceeds of any Collateral securing such Permitted Lien in a manner consistent with the Notes/Term Intercreditor Agreement and ABL Intercreditor Agreement and the definition of Permitted Liens to the extent then applicable. 

(f) The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations
thereunder to the extent such laws or regulations are applicable in connection with the repurchase of the Notes of the applicable series pursuant to an Asset Sale Offer. To the extent that the provisions of any securities laws or regulations
conflict with the provisions of this Indenture, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached their obligations described in this Indenture by virtue thereof. 

(g) If any Series A-2 Notes are issued under this Indenture, the provisions described in this Section will apply to the Series A-1 Notes
and the Series A-2 Notes collectively on a pro rata basis. 
 Section 4.11 Transactions with Affiliates. 

(a) The Company shall not, and shall not permit any of its Restricted Subsidiaries to, make any payment to, or sell, lease, transfer or
otherwise dispose of any of its properties or assets to, or purchase any property or assets from, or enter into or make or amend any transaction, contract, agreement, understanding, loan, advance or guarantee with, or for the benefit of, any
Affiliate of the Company (each of the foregoing, an “Affiliate Transaction”) involving aggregate payments or consideration in excess of $12.5 million, unless: 

(1) such Affiliate Transaction is on terms that are not materially less favorable to the Company or its relevant
Restricted Subsidiary than those that would have been obtained in a comparable transaction by the Company or such Restricted Subsidiary with an unrelated Person on an arm’s-length basis; and 

(2) the Company delivers to the Trustee, with respect to any Affiliate Transaction or series of related Affiliate
Transactions involving aggregate payments or consideration in excess of $25.0 million, a resolution adopted by the majority of the board of directors of the Company approving such Affiliate Transaction and set forth in an Officer’s
Certificate certifying that such Affiliate Transaction complies with clause (1) of this Section 4.11(a). 
 (b) The
provisions of Section 4.11(a) hereof shall not apply to the following: 
 (1) transactions between or among
the Company or any of its Restricted Subsidiaries; 
  

 85 

 (2) Restricted Payments permitted by Section 4.07 hereof and the
definition of “Permitted Investment”; 
 (3) the payment of management, consulting, monitoring and
advisory fees and related expenses to the Investors pursuant to the Sponsor Management Agreement in an aggregate amount in any fiscal year not to exceed the greater of $7.0 million and 2.0% of EBITDA for such fiscal year (calculated, solely for the
purpose of this clause (3), assuming (a) that such fees and related expenses had not been paid, when calculating Net Income, and (b) without giving effect to clause (g) of the definition of EBITDA) (plus any unpaid management,
consulting, monitoring and advisory fees and related expenses within such amount accrued in any prior year) and the termination fees pursuant to the Sponsor Management Agreement not to exceed the amount set forth in the Sponsor Management Agreement
as in effect on the Issue Date or any amendment thereto (so long as any such amendment is not disadvantageous to the Holders when taken as a whole as compared to the Sponsor Management Agreement in effect on the Issue Date); 

(4) the payment of reasonable and customary fees paid to, and indemnities provided for the benefit of, former, current or
future officers, directors, employees or consultants of the Company, any of its direct or indirect parent companies or any of its Restricted Subsidiaries; 

(5) transactions in which the Company or any of its Restricted Subsidiaries, as the case may be, delivers to the Trustee
a letter from an Independent Financial Advisor stating that such transaction is fair to the Company or such Restricted Subsidiary from a financial point of view or stating that such terms are not materially less favorable to the Company or its
relevant Restricted Subsidiary than those that would have been obtained in a comparable transaction by the Company or such Restricted Subsidiary with an unrelated Person on an arm’s-length basis; 

(6) any agreement as in effect as of the Issue Date, or any amendment thereto (so long as any such amendment is not
disadvantageous to the Holders when taken as a whole as compared to the applicable agreement as in effect on the Issue Date); 

(7) the existence of, or the performance by the Company or any of its Restricted Subsidiaries of its obligations under
the terms of, any stockholders agreement (including any registration rights agreement or purchase agreement related thereto) to which it is a party as of the Issue Date and any similar agreements which it may enter into thereafter; provided,
however, that the existence of, or the performance by the Company or any of its Restricted Subsidiaries of obligations under any future amendment to any such existing agreement or under any similar agreement entered into after the Issue Date
shall only be permitted by this clause (7) to the extent that the terms of any such amendment or new agreement are not otherwise disadvantageous to the Holders when taken as a whole; 

(8) the Transaction and the payment of all fees and expenses related to the Transaction; 

(9) transactions with customers, clients, suppliers, or purchasers or sellers of goods or services, in each case in the
ordinary course of business and otherwise in compliance with the terms of this Indenture which are fair to the Company and its 

 

 86 

 
Restricted Subsidiaries, in the reasonable determination of the board of directors of the Company or the senior management thereof, or are on terms at least as favorable as might reasonably have
been obtained at such time from an unaffiliated party; 
 (10) the issuance of Equity Interests (other than
Disqualified Stock) of the Company to any Permitted Holder or to any director, officer, employee or consultant; 

(11) sales of accounts receivable, or participations therein, in connection with any Receivables Facility; 

(12) payments by the Company or any of its Restricted Subsidiaries to any of the Investors made for any financial
advisory, financing, underwriting or placement services or in respect of other investment banking activities, including, without limitation, in connection with acquisitions or divestitures which payments are approved by a majority of the board of
directors of the Company in good faith; 
 (13) payments or loans (or cancellation of loans) to employees or
consultants of the Company, any of its direct or indirect parent companies or any of its Restricted Subsidiaries and employment agreements, stock option plans and other similar arrangements with such employees or consultants which, in each case, are
approved by the Company in good faith; 
 (14) investments by the Investors in securities of the Company or any
of its Restricted Subsidiaries so long as (i) the investment is being offered generally to other investors on the same or more favorable terms and (ii) the investment constitutes less than 5.0% of the proposed or outstanding issue amount
of such class of securities; and 
 (15) the pledge of Equity Interests of any Unrestricted Subsidiary to
lenders to support the Indebtedness of such Unrestricted Subsidiary owed to such lenders. 
 Section 4.12 Liens. 

The Company shall not, and shall not permit any Guarantor to, directly or indirectly, create, incur, assume or otherwise cause or suffer
to exist any Lien (except Permitted Liens) that secures obligations under any Indebtedness or any related Guarantee of the Company or any Guarantor (any such Lien, the “Initial Lien”), on any asset or property of the Company or any
Guarantor, or any income or profits therefrom, or assign or convey any right to receive income therefrom except, in the case of any asset or property that does not constitute Collateral, any Initial Lien if the Notes of the applicable series are
equally and ratably secured with (or on a senior basis to, in the case such Initial Lien secures any Subordinated Indebtedness) the obligations secured by such Initial Lien. 

Any Lien created for the benefit of the Holders of the Notes of any series pursuant to the last clause of the preceding paragraph shall
provide by its terms that such Lien shall be automatically and unconditionally released and discharged upon the release and discharge of the Initial Lien which release and discharge in the case of any sale of any such asset or property shall not
affect any Lien that the Notes/Term Collateral Agent may have on the proceeds from such sale. 
  

 87 

 Section 4.13 Corporate Existence. 

Subject to Article 5 hereof, the Company shall do or cause to be done all things necessary to preserve and keep in full force and effect
(i) its corporate existence, and the corporate, partnership or other existence of each of its Restricted Subsidiaries, in accordance with the respective organizational documents (as the same may be amended from time to time) of the Company or
any such Restricted Subsidiary and (ii) the rights (charter and statutory), licenses and franchises of the Company and its Restricted Subsidiaries; provided that the Company shall not be required to preserve any such right, license or
franchise, or the corporate, partnership or other existence of any of its Restricted Subsidiaries, if the Company in good faith shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company and
its Restricted Subsidiaries, taken as a whole. 
 Section 4.14 Offer to Repurchase Upon Change of Control. 

(a) If a Change of Control occurs, unless the Company has previously or concurrently mailed a redemption notice with respect to all the
outstanding Notes of a particular series as described under Section 3.07 hereof with respect to Series A-1 Notes or the optional redemption provisions of any Series A-2 Notes with respect to the Series A-2 Notes, the Company shall make an offer
to purchase all of the Notes of such series pursuant to the offer described below (the “Change of Control Offer”) at a price in cash (the “Change of Control Payment”) equal to 101% of the aggregate principal amount
thereof plus accrued and unpaid interest and Additional Interest, if any, to the date of purchase, subject to the right of Holders of the Notes of record on the relevant applicable Record Date to receive interest due on the relevant applicable
Interest Payment Date. Within 30 days following any Change of Control, the Company shall send notice of such Change of Control Offer by first-class mail, with a copy to the Trustee, to each Holder of Notes of such series to the address of such
Holder appearing in the security register or otherwise in accordance with the procedures of DTC with a copy to the Trustee, with the following information: 

(1) that a Change of Control Offer is being made pursuant to this Section 4.14 and that all Notes properly tendered
pursuant to such Change of Control Offer will be accepted for payment by the Company; 
 (2) the purchase price
and the purchase date, which will be no earlier than 30 days nor later than 60 days from the date such notice is mailed (the “Change of Control Payment Date”); 

(3) that any Note not properly tendered will remain outstanding and continue to accrue interest; 

(4) that unless the Company defaults in the payment of the Change of Control Payment, all Notes accepted for payment
pursuant to the Change of Control Offer will cease to accrue interest on the Change of Control Payment Date; 

(5) that Holders electing to have any Notes purchased pursuant to a Change of Control Offer will be required to surrender
such Notes, with the form entitled “Option of Holder to Elect Purchase” on the reverse of such Notes completed, to the paying agent specified in the notice at the address specified in the notice prior to the close of business on the third
Business Day preceding the Change of Control Payment Date; 
 (6) that Holders shall be entitled to withdraw
their tendered Notes and their election to require the Company to purchase such Notes; provided that the 
  

 88 

 
paying agent receives, not later than the close of business on the expiration date of the Change of Control Offer, a telegram, telex, facsimile transmission or letter setting forth the name of
the Holder of the Notes, the principal amount of Notes tendered for purchase, and a statement that such Holder is withdrawing its tendered Notes and its election to have such Notes purchased; 

(7) that if the Company is repurchasing less than all of the Notes of any series, the remaining Notes of such series will
be equal in principal amount to the unpurchased portion of the Notes surrendered. The unpurchased portion of the Notes must be equal to $2,000 or an integral multiple of $1,000 in excess thereof; 

(8) the other instructions, as determined by the Company, consistent with this Section 4.14, that a Holder must
follow; and 
 (9) if such notice is mailed prior to the occurrence of a Change of Control, stating that the
Change of Control Offer is conditional upon the occurrence of such Change of Control. 
 The notice, if mailed in a manner
herein provided, shall be conclusively presumed to have been given, whether or not the Holder receives such notice. If (a) the notice is mailed in a manner herein provided and (b) any Holder fails to receive such notice or a Holder
receives such notice but it is defective, such Holder’s failure to receive such notice or such defect shall not affect the validity of the proceedings for the purchase of the Notes as to all other Holders that properly received such notice
without defect. The Company shall comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase of
Notes pursuant to a Change of Control Offer. To the extent that the provisions of any securities laws or regulations conflict with the provisions of this Section 4.14, the Company shall comply with the applicable securities laws and regulations
and shall not be deemed to have breached its obligations under this Section 4.14 by virtue thereof. 
 (b) On the Change
of Control Payment Date, the Company shall, to the extent permitted by law, 
 (1) accept for payment all Notes
issued by it or portions thereof properly tendered pursuant to the Change of Control Offer, 
 (2) deposit with
the Paying Agent an amount equal to the aggregate Change of Control Payment in respect of all Notes or portions thereof so tendered, and 

(3) deliver, or cause to be delivered, to the Trustee for cancellation the Notes so accepted together with an
Officer’s Certificate to the Trustee stating that such Notes or portions thereof have been tendered to, and purchased by, the Company. 

(c) The Company shall not be required to make a Change of Control Offer following a Change of Control if a third party makes the Change
of Control Offer in the manner, at the times and otherwise in compliance with the requirements set forth in this Section 4.14 applicable to a Change of Control Offer made by the Company and purchases all Notes validly tendered and not withdrawn
under such Change of Control Offer. Notwithstanding anything to the contrary herein, a Change of Control Offer may be made in advance of a Change of Control, conditional upon such Change of Control, if a definitive agreement is in place for the
Change of Control at the time of making of the Change of Control Offer. 
  

 89 

 (d) Other than as specifically provided in this Section 4.14, any purchase pursuant to
this Section 4.14 shall be made pursuant to the provisions of Sections 3.02, 3.05 and 3.06 hereof. 
 Section 4.15 Events of
Loss 
 (a) Subject to the ABL Intercreditor Agreement and the other Collateral Documents, in the case of an Event of Loss
with respect to any Notes/Term Collateral, the Company or the affected Restricted Subsidiary, as the case may be, will apply the Net Loss Proceeds from such Event of Loss, within 365 days after receipt, at its option to: 

(1) permanently reduce Obligations under the Series A-1 Notes and the Series A-2 Debt in accordance with
Section 4.10(b)(1)(A); 
 (2) rebuild, repair, replace or construct improvements to the affected property
or facility (or enter into a binding agreement to do so, provided that (x) such rebuilding, repair, replacement or construction has been completed within six months after the date of such binding agreement and (y) if such
rebuilding, repair, replacement or construction is not consummated within the period set forth in subclause (x), the Net Loss Proceeds not so applied will be deemed to be Excess Loss Proceeds); or 

(3) invest in assets and properties as described in Section 4.10(b)(2) and Section 4.10(b)(3), substituting the
term “Event of Loss” for the term “Asset Sale,” the term “Net Loss Proceeds” for the term “Net Proceeds” and the term “Excess Loss Proceeds” for the term “Excess Proceeds.” 

(b) In case of clauses (a)(2) or (a)(3) of this Section 4.15, any replacement assets or property shall be pledged as Notes/Term
Collateral, in accordance with the Collateral Documents and otherwise in compliance with Section 4.19. 
 (c) Any Net Loss
Proceeds from an Event of Loss that are not applied or invested as provided in Section 4.15(a) hereof will be deemed to constitute “Excess Loss Proceeds.” When the aggregate amount of Excess Loss Proceeds exceeds $30.0 million,
the Company will make an offer (a “Loss Proceeds Offer”) to all Holders of Series A-1 Notes and holders of Series A-2 Debt to purchase the maximum principal amount of Series A-1 Notes and Series A-2 Debt that may be purchased
out of such Excess Loss Proceeds, at an offer price in cash in an amount equal to 100% of the principal amount of the Series A-1 Notes and the Series A-2 Debt plus accrued and unpaid interest thereon, if any, to the date of purchase. If any Excess
Loss Proceeds remain after consummation of a Loss Proceeds Offer, such Excess Loss Proceeds may be used for any purpose not otherwise prohibited by this Indenture. If the aggregate principal amount of Series A-1 Notes and Series A-2 Debt tendered
into such Loss Proceeds Offer exceeds the amount of Excess Loss Proceeds, then the Series A-1 Notes and the Series A-2 Debt will be purchased on a pro rata basis based on the principal amount of Series A-1 Notes and Series A-2 Debt tendered. The
Company may satisfy the foregoing obligations with respect to any Net Loss Proceeds from an Event of Loss by making a Loss Proceeds Offer with respect to such Net Loss Proceeds prior to the expiration of the relevant 365 days or with respect to Net
Loss Proceeds of $30.0 million or less. 
 (d) The Company shall comply with the requirements of Rule 14e-1 under the Exchange
Act and any other securities laws and regulations thereunder to the extent such laws or regulations are applicable in connection with the repurchase of the Notes pursuant to a Loss Proceeds Offer. To the extent that the provisions of any securities
laws or regulations conflict with the provisions of this Indenture, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached their obligations described in this Indenture by virtue
thereof. 
  

 90 

 Section 4.16 Limitation on Guarantees of Indebtedness by Restricted Subsidiaries. 

The Company shall not permit any of its Wholly-Owned Subsidiaries that are Restricted Subsidiaries (and non-Wholly-Owned Subsidiaries if
such non-Wholly-Owned Subsidiaries guarantee other capital markets debt securities), other than a Guarantor or a Foreign Subsidiary guaranteeing Indebtedness of another Foreign Subsidiary, to guarantee the payment of any Indebtedness of the Company
or any other Guarantor unless: 
 (1) such Restricted Subsidiary within 30 days executes and delivers a
supplemental indenture to this Indenture, the form of which is attached as Exhibit D hereto, providing for a Guarantee by such Restricted Subsidiary, except that with respect to a guarantee of Indebtedness of the Company or any Guarantor:

 (i) if such Indebtedness is by its express terms subordinated in right of payment to the Notes of the
applicable series or such Guarantor’s Guarantee, any such guarantee by such Restricted Subsidiary with respect to such Indebtedness shall be subordinated in right of payment to such Guarantee substantially to the same extent as such
Indebtedness is subordinated to the Notes of the applicable series; and 
 (ii) such Restricted Subsidiary
waives and shall not in any manner whatsoever claim or take the benefit or advantage of, any rights of reimbursement, indemnity or subrogation or any other rights against the Company or any other Restricted Subsidiary as a result of any payment by
such Restricted Subsidiary under its Guarantee; and 
 (2) such Restricted Subsidiary within 30 days executes
and delivers a joinder agreement to the Collateral Documents providing for a pledge of its assets as Collateral for the Notes of the applicable series to the same extent as set forth in the Indenture and the Collateral Documents; 

provided that this Section 4.16 shall not be applicable to any guarantee of any Restricted Subsidiary that existed at the time such Person
became a Restricted Subsidiary and was not incurred in connection with, or in contemplation of, such Person becoming a Restricted Subsidiary. 

Section 4.17 Reserved. 

Section 4.18 Impairment of Security Interests. 

Subject to the rights of the holders of Permitted Liens, the Company shall not, and shall not permit any of its Restricted Subsidiaries
to take, or knowingly or negligently omit to take, any action which action or omission would or could reasonably be expected to have the result of materially impairing the security interest with respect to the Collateral for the benefit of the
Trustee and Holders of the Notes, subject to limited exceptions. The Company shall not amend, modify or supplement, or permit or consent to any amendment, modification or supplement of, the Collateral Documents in any manner that would be adverse to
the Holders of the Notes in any material respect, except as permitted under Article IX or X hereof, the Security Agreement or the Intercreditor Agreements. 
  

 91 

 Section 4.19 After-Acquired Property. 

Promptly following the acquisition by the Company or any Guarantor of any After-Acquired Property (but subject to the limitations, if
applicable, set forth in Section 10.01 hereof or otherwise included in the Collateral Documents), the Company or such Guarantor shall execute and deliver such mortgages, deeds of trust, security instruments, financing statements and
certificates and opinions of counsel as shall be reasonably necessary to vest in the Notes/Term Collateral Agent a perfected security interest in such After-Acquired Property and to have such After-Acquired Property added to the Notes/Term
Collateral or the ABL Collateral, as applicable, and thereupon all provisions of this Indenture relating to the Notes/Term Collateral or the ABL Collateral, as applicable, shall be deemed to relate to such After-Acquired Property to the same extent
and with the same force and effect. 
 Section 4.20 Information Regarding Collateral. 

The Company shall furnish to the Notes/Term Collateral Agent, with respect to the Company or any Guarantor, prompt written notice of any
change in such Person’s (i) corporate name, (ii) jurisdiction of organization or formation, (iii) identity or corporate structure or (iv) Federal Taxpayer Identification Number. The Company shall not effect or permit any
change referred to in the preceding sentence unless all filings have been made under the Uniform Commercial Code of the applicable jurisdiction or otherwise that are required in order for the Notes/Term Collateral Agent to continue at all times
following such change to have a valid, legal and perfected security interest in all the Collateral. The Company also shall promptly notify the Notes/Term Collateral Agent in writing if any material portion of the Collateral is damaged or destroyed.
Each year, at the time of delivery of the annual financial statements with respect to the preceding fiscal year, the Company shall deliver to the Notes/Term Collateral Agent a certificate of a financial officer setting forth the information required
pursuant to the Perfection Certificate or confirming that there has been no change in such information since the date of the prior delivered Perfection Certificate. 

Section 4.21 Further Assurances. 

The Company and the Guarantors shall execute any and all further documents, financing statements, agreements and instruments, and take
all further action that may be required under applicable law, or that the Trustee may reasonably request, in order to grant, preserve, protect and perfect the validity and priority of the security interests created or intended to be created by the
Collateral Documents in the Collateral. In addition, from time to time, the Company shall reasonably promptly secure the obligations under this Indenture and the Collateral Documents by pledging or creating, or causing to be pledged or created,
perfected security interests with respect to the Collateral. Such security interests and Liens will be created under the Collateral Documents and other security agreements, mortgages, deeds of trust and other instruments and documents in form and
substance reasonably satisfactory to the Notes/Term Collateral Agent (as to which the Notes/Term Collateral Agent will be entitled to receive and rely upon, without liability on its part, the advice of counsel and/or such direction as it may deem
necessary or advisable from Holders of a majority of the outstanding principal amount of the Notes). Notwithstanding anything to the contrary set forth in this Indenture, the Company and its subsidiaries shall not be required to obtain any landlord
waivers, estoppels or collateral access letters. 
  

 92 

 ARTICLE 5 

SUCCESSORS 
 Section 5.01
Merger, Consolidation or Sale of All or Substantially All Assets. 
 (a) Company. The Company shall not, directly
or indirectly, consolidate or merge with or into or wind up into (whether or not the Company is the surviving corporation), or sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of the Company’s properties or
assets, in one or more related transactions, to any Person unless: 
 (1) either: (x) the Company is the
surviving corporation; or (y) the Person formed by or surviving any such consolidation or merger (if other than the Company) or to which such sale, assignment, transfer, lease, conveyance or other disposition will have been made is a
corporation, partnership (including a limited partnership), trust or limited liability company organized or existing under the laws of the jurisdiction of organization of the Company or the laws of the United States, any state thereof, the District
of Columbia or any territory thereof (such Person, as the case may be, being herein called the “Successor Company”); provided that in the case where the Successor Company is not a corporation, a co-obligor of the Notes is a
corporation; 
 (2) the Successor Company, if other than the Company, expressly assumes all the obligations of
the Company under the Notes and the Collateral Documents pursuant to supplemental indentures or other documents or instruments in form reasonably satisfactory to the Trustee, and the Registration Rights Agreement if the exchange offer contemplated
therein has not been consummated or if the Company continues to have an obligation to file or maintain the effectiveness of a shelf registration statement as provided under such agreement; 

(3) immediately after such transaction, no Default or Event of Default exists; 

(4) immediately after giving pro forma effect to such transaction and any related financing transactions, as if
such transactions had occurred at the beginning of the applicable four-quarter period, 
 (A) the Company or the
Successor Company, as applicable, would be permitted to incur at least $1.00 of additional Indebtedness pursuant to the Fixed Charge Coverage Ratio test set forth in Section 4.09(a) hereof, or 

(B) the Fixed Charge Coverage Ratio for the Company (or, if applicable, the Successor Company) and its Restricted
Subsidiaries would be greater than such Ratio for the Company and its Restricted Subsidiaries immediately prior to such transaction; 

(5) each Guarantor, unless it is the other party to the transactions described above, in which case
Section 5.01(c)(1)(B) hereof shall apply, shall have by supplemental indenture confirmed that its Guarantee shall apply to such Person’s obligations under this Indenture, the Notes, the Collateral Documents and the Registration Rights
Agreement if the exchange offer contemplated therein has not been consummated or if the Company continues to have an obligation to file or maintain the effectiveness of a shelf registration statement as provided under such agreement; 

 

 93 

 (6) the Company (or, if applicable, the Successor Company) shall have
delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indentures, if any, comply with this Indenture; 

(7) the Collateral transferred to the Successor Company shall (a) continue to constitute Collateral under the
Indenture and the Collateral Documents, (b) be subject to the Lien in favor of the Notes/Term Collateral Agent for the benefit of the holders of the Notes, and (c) not be subject to any Lien, other than Liens permitted by the terms of the
Indenture; and 
 (8) to the extent that the assets of the Person which is merged or consolidated with or into
the Successor Company are assets of the type which would constitute Collateral under the Collateral Documents, the Successor Company shall take such actions as may be reasonably necessary to cause such property and assets to be made subject to the
Lien of the Collateral Documents in the manner and to the extent required in the Indenture. 
 (b) The Successor Company shall
succeed to, and be substituted for the Company, as the case may be, under this Indenture, the Guarantees and the Notes, as applicable. Notwithstanding clauses (3) and (4) of Section 5.01(a) hereof, 

(1) any Restricted Subsidiary may consolidate with or merge into or transfer all or part of its properties and assets to
the Company, and 
 (2) the Company may merge with an Affiliate of the Company, as the case may be, solely for
the purpose of reincorporating the Company in the United States, any state thereof, the District of Columbia or any territory thereof so long as the amount of Indebtedness of the Company and its Restricted Subsidiaries is not increased thereby.

 (c) Guarantors. Subject to certain limitations described in this Indenture governing release of a Guarantee upon the
sale, disposition or transfer of a guarantor, no Guarantor shall, and the Company shall not permit any Guarantor to, consolidate or merge with or into or wind up into (whether or not the Company or Guarantor is the surviving corporation), or sell,
assign, transfer, lease, convey or otherwise dispose of all or substantially all of its properties or assets, in one or more related transactions, to any Person unless: 

(1) (A) such Guarantor is the surviving corporation or the Person formed by or surviving any such consolidation or merger
(if other than such Guarantor) or to which such sale, assignment, transfer, lease, conveyance or other disposition will have been made is a corporation, partnership, trust or limited liability company organized or existing under the laws of the
jurisdiction of organization of such Guarantor, as the case may be, or the laws of the United States, any state thereof, the District of Columbia, or any territory thereof (such Guarantor or such Person, as the case may be, being herein called the
“Successor Person”); 
  

 94 

 (B) the Successor Person, if other than such Guarantor, expressly assumes
all the obligations of such Guarantor under this Indenture, such Guarantor’s related Guarantee and the Collateral Documents pursuant to supplemental indentures or other documents or instruments in form reasonably satisfactory to the Trustee;

 (C) immediately after such transaction, no Default or Event of Default exists; 

(D) the Company shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating
that such consolidation, merger or transfer and such supplemental indentures, if any, comply with this Indenture; 

(E) the Collateral transferred to the Successor Person shall (i) continue to constitute Collateral under the
Indenture and the Collateral Documents, (ii) be subject to the Lien in favor of the Notes/Term Collateral Agent for the benefit of the holders of the Notes, and (iii) not be subject to any Lien, other than Liens permitted by the terms of
this Indenture; and 
 (F) to the extent that the assets of the Person which is merged or consolidated with or
into the Successor Person are assets of the type which would constitute Collateral under the Collateral Documents, the Successor Person will take such action as may be reasonably necessary to cause such property and assets to be made subject to the
Lien of the Collateral Documents in the manner and to the extent required in this Indenture; or 
 (2) the
transaction is made in compliance with Section 4.10 hereof. 
 (d) Subject to certain limitations described in this
Indenture, the Successor Person shall succeed to, and be substituted for, such Guarantor under this Indenture and such Guarantor’s Guarantee. Notwithstanding the foregoing, any Guarantor may (i) merge into or transfer all or part of its
properties and assets to another Guarantor or the Company, (ii) merge with an Affiliate of the Company solely for the purpose of reincorporating the Guarantor in the United States, any state thereof, the District of Columbia or any territory
thereof or (iii) convert into a corporation, partnership, limited partnership, limited liability company or trust organized under the laws of the jurisdiction of organization of such Guarantor, in each case without regard to the requirements
set forth in Section 5.01(c) hereof. 
 Section 5.02 Successor Corporation Substituted. 

Upon any consolidation or merger, or any sale, assignment, transfer, lease, conveyance or other disposition of all or substantially all
of the assets of the Company or any Guarantor in accordance with Section 5.01 hereof, the successor corporation formed by such consolidation or into or with which the Company or such Guarantor, as the case may be, is merged or to which such
sale, assignment, transfer, lease, conveyance or other disposition is made shall succeed to, and be substituted for (so that from and after the date of such consolidation, merger, sale, lease, conveyance or other disposition, the provisions of this
Indenture referring to the Company or such Guarantor, as the case may be, shall refer instead to the successor corporation and not to the Company or such Guarantor, as the case may be), and may exercise every right and power of the Company or such
Guarantor, as the case may be, under this Indenture with the same effect as if such successor Person had been named as the Company or such Guarantor, as the case may be, herein; provided that the predecessor, as the case may be, shall not be

  

 95 

 
relieved from the obligation to pay the principal of and interest and Additional Interest, if any, on the Notes except in the case of a sale, assignment, transfer, conveyance or other disposition
of all of the assets of the Company or such Guarantor, as the case may be, that meets the requirements of Section 5.01 hereof. 

ARTICLE 6 

DEFAULTS AND REMEDIES 

Section 6.01 Events of Default. 

(a) An “Event of Default” wherever used herein, means any one of the following events (whatever the reason for such
Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body): 

(1) default in payment when due and payable (whether at maturity, upon redemption, acceleration or otherwise), of
principal of, or premium, if any, on (A) with respect to Holders of the Series A-1 Notes, the Series A-1 Notes and (B) with respect to Holders of any Series A-2 Notes, the Series A-2 Notes; 

(2) default for 30 days or more in the payment when due of interest or Additional Interest on or with respect to
(A) with respect to Holders of the Series A-1 Notes, the Series A-1 Notes and (B) with respect to Holders of any Series A-2 Notes, the Series A-2 Notes; 

(3) failure by the Company or any Guarantor for 60 days after receipt of written notice given by the Trustee or the
holders of not less than 25% of the aggregate principal amount of all then outstanding Series of Debt (unless such failure affects some but not all Series of Debt, in which case the notice of such failure may be given by the Trustee or the holders
of not less than 25% of the aggregate principal amount of the then outstanding Series of Debt that are affected by such failure) to comply with any of its obligations, covenants or agreements (other than a default referred to in clauses (1) and
(2) above) contained in the Indenture, the Notes or the Collateral Documents; 
 (4) default under any
mortgage, indenture or instrument under which there is issued or by which there is secured or evidenced any Indebtedness for money borrowed by the Company or any of its Restricted Subsidiaries or the payment of which is guaranteed by the Company or
any of its Restricted Subsidiaries, other than Indebtedness owed to the Company or a Restricted Subsidiary, whether such Indebtedness or guarantee now exists or is created after the issuance of the Notes, if both: 

(a) such default either results from the failure to pay any principal of such Indebtedness at its stated final maturity
(after giving effect to any applicable grace periods) or relates to an obligation other than the obligation to pay principal of any such Indebtedness at its stated final maturity and results in the holder or holders of such Indebtedness causing such
Indebtedness to become due prior to its stated maturity; and 
  

 96 

 (b) the principal amount of such Indebtedness, together with the principal
amount of any other such Indebtedness in default for failure to pay principal at stated final maturity (after giving effect to any applicable grace periods), or the maturity of which has been so accelerated, aggregate $50.0 million or more at any
one time outstanding; 
 (5) failure by the Company or any Significant Subsidiary to pay final judgments
aggregating in excess of $50.0 million, which final judgments remain unpaid, undischarged and unstayed for a period of more than 60 days after such judgment becomes final, and in the event such judgment is covered by insurance, an enforcement
proceeding has been commenced by any creditor upon such judgment or decree which is not promptly stayed; 
 (6)
the Company or any Significant Subsidiary, pursuant to or within the meaning of any Bankruptcy Law: 
 (i)
commences proceedings to be adjudicated bankrupt or insolvent; 
 (ii) consents to the institution of bankruptcy
or insolvency proceedings against it, or the filing by it of a petition or answer or consent seeking reorganization or relief under applicable Bankruptcy Law; 

(iii) consents to the appointment of a receiver, liquidator, assignee, trustee, sequestrator or other similar official of
it or for all or substantially all of its property; 
 (iv) makes a general assignment for the benefit of its
creditors; or 
 (v) generally is not paying its debts as they become due; 

(7) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(i) is for relief against the Company or any Significant Subsidiary, in a proceeding in which the Company or any
Significant Subsidiary is to be adjudicated bankrupt or insolvent; 
 (ii) appoints a receiver, liquidator,
assignee, trustee, sequestrator or other similar official of the Company or any Significant Subsidiary, or for all or substantially all of the property of the Company or any Significant Subsidiary; or 

(iii) orders the liquidation of the Company or any Significant Subsidiary; 

and the order or decree remains unstayed and in effect for 60 consecutive days; 

(8) the Guarantee of any Significant Subsidiary shall for any reason cease to be in full force and effect or be declared
null and void or any responsible officer 
  

 97 

 
of any Guarantor that is a Significant Subsidiary, as the case may be, denies that it has any further liability under its Guarantee or gives notice to such effect, other than by reason of the
termination of this Indenture or the release of any such Guarantee in accordance with this Indenture; or 
 (9)
any of the Collateral Documents ceases to be in full force and effect, or any of the Collateral Documents ceases to give the holders of the Notes the Liens purported to be created thereby, or any of the Collateral Documents is declared null and void
or the Company or any Restricted Subsidiary denies in writing that it has any further liability under any Collateral Document or gives written notice to such effect (in each case, other than in accordance with the terms of this Indenture or the
terms of the Collateral Documents), provided that if a failure of the sort described in this clause (9) is susceptible of cure, no Event of Default shall arise under this clause (9) with respect thereto until 30 days after notice of such
failure shall have been given to the Company by the Trustee or the holders of not less than 25% of the aggregate principal amount of all then outstanding Series of Debt (unless such failure affects some but not all Series of Debt, in which case the
notice of such failure may be given by the holders of not less than 25% of the aggregate principal amount of the then outstanding Series of Debt that are affected by such failure). 

(b) In the event of any Event of Default specified in clause (4) of Section 6.01(a) hereof, such Event of Default and all
consequences thereof (excluding any resulting payment default, other than as a result of acceleration of the Notes) shall be annulled, waived and rescinded, automatically and without any action by the Trustee or the Holders, if within 20 days after
such Event of Default arose: 
 (1) the Indebtedness or Guarantee that is the basis for such Event of Default
has been discharged; or 
 (2) holders thereof have rescinded or waived the acceleration, notice or action (as
the case may be) giving rise to such Event of Default; or 
 (3) the default that is the basis for such Event of
Default has been cured. 
 Section 6.02 Acceleration. 

If any Event of Default (other than an Event of Default specified in clause (6) or (7) of Section 6.01(a) hereof) occurs
and is continuing under this Indenture, the Trustee or the holders of not less than 25% of the aggregate principal amount of all then outstanding Series of Debt (unless such Event of Default affects some but not all Series of Debt, in which case the
holders of not less than 25% of the aggregate principal amount of the then outstanding Series of Debt that are affected by such Event of Default) may (subject to the terms and conditions of the Notes/Term Intercreditor Agreement) declare the
principal, premium, if any, interest and any other monetary obligations on all the then outstanding Notes to be due and payable immediately; provided, however, that (i) with respect to any Event of Default specified in clause
(1) or (2) of Section 6.01(a) hereof with respect to the Series A-1 Notes but not the Series A-2 Notes (if issued) or the Term Loans, the Trustee or the Holders of at least 25% in principal amount of the then outstanding Series A-1
Notes may declare the principal, premium, if any, interest and any other monetary obligations on all the then outstanding Series A-1 Notes to be due and payable immediately and (ii) with respect to any Event of Default specified in clause
(1) or (2) of Section 6.01(a) hereof with respect to the Series A-2 Notes (if issued), but not the Series A-1 Notes or the Term Loans, 

 

 98 

 
the Trustee or the holders of at least 25% in principal amount of the then outstanding Series A-2 Notes may declare the principal, premium, if any, interest and any other monetary obligations on
all the then outstanding Series A-2 Notes to be due and payable immediately. 
 Upon the effectiveness of such declaration,
such principal and interest shall be due and payable immediately. The Trustee shall have no obligation to accelerate the Notes if and so long as a committee of its Responsible Officers in good faith determines acceleration is not in the best
interest of the Holders. 
 Notwithstanding the foregoing, in the case of an Event of Default arising under clause (6) or
(7) of Section 6.01(a) hereof, all outstanding Notes shall be due and payable immediately without further action or notice. 

The holders of a majority of the aggregate principal amount of all then outstanding Series of Debt (unless such Event of Default affects
some but not all Series of Debt, in which case the holders of a majority of the aggregate principal amount of the then outstanding Series of Debt that are affected by such Event of Default), by notice to the Trustee, may rescind an acceleration and
its consequences if the rescission would not conflict with any judgment or decree and if all existing Events of Default (except nonpayment of principal, interest, Additional Interest, if any, or premium that has become due solely because of the
acceleration) have been cured or waived; provided that any rescission of acceleration of the Series A-1 Notes, which acceleration resulted from an Event of Default specified in clause (1) or (2) of Section 6.01(a) hereof, must
be approved by the Holders of more than 50% in principal amount of the then outstanding Series A-1 Notes, and any rescission of acceleration of the Series A-2 Notes (if issued), which acceleration resulted from an Event of Default specified in
clause (1) or (2) of Section 6.01(a) hereof, must be approved by the Holders of more than 50% in principal amount of the then outstanding Series A-2 Notes. 

Section 6.03 Other Remedies. 

If an Event of Default occurs and is continuing with respect to any series of Notes, the Trustee may pursue any available remedy to
collect the payment of principal, premium, if any, and interest on the Notes of such series or to enforce the performance of any provision of the Notes of such series or this Indenture. 

The Trustee may maintain a proceeding even if it does not possess any of the Notes or does not produce any of them in the proceeding. A
delay or omission by the Trustee or any Holder of a Note in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver of or acquiescence in the Event of Default. All remedies are
cumulative to the extent permitted by law. 
 In addition to the right of acceleration set forth in Section 6.02 hereof,
if an Event of Default occurs and is continuing under this Indenture, the Trustee or the Notes/Term Collateral Agent, as applicable, shall, subject to the provisions contained in the Intercreditor Agreements, have the right to exercise remedies with
respect to the Collateral such as foreclosure, as are available under this Indenture, the Collateral Documents and at law. 
 Section 6.04
Waiver of Past Defaults. 
 The holders of a majority of the aggregate principal amount of all then outstanding Series of
Debt (unless such Event of Default affects some but not all Series of Debt, in which case the holders of a majority of the aggregate principal amount of the then outstanding Series of Debt 

 

 99 

 
that are affected by such Event of Default), by notice to the Trustee, may waive any existing Default and its consequences under the Indenture or the Collateral Documents except a continuing
Default in the payment of interest on, premium, if any, or the principal of any Note held by a non-consenting Holder and rescind any acceleration with respect to the Notes and its consequences (provided such rescission would not conflict with any
judgment of a court of competent jurisdiction); provided that any rescission of acceleration of the Series A-1 Notes, which acceleration resulted from an Event of Default specified in clause (1) or (2) of Section 6.01(a)
hereof, must be approved by the Holders of more than 50% in principal amount of the then outstanding Series A-1 Notes, and any rescission of acceleration of the Series A-2 Notes (if issued), which acceleration resulted from an Event of Default
specified in clause (1) or (2) of Section 6.01(a) hereof, must be approved by the holders of more than 50% in principal amount of the then outstanding Series A-2 Notes. Upon any such waiver, such Default shall cease to exist, and any
Event of Default arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other Default or impair any right consequent thereon. 

Section 6.05 Control by Majority. 

Subject to the other provisions of this Article 6 and restrictions contained in the Intercreditor Agreements, Holders of a majority in
principal amount of the then outstanding Series A-1 Notes (together with any Series A-2 Notes, if issued) may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or of exercising any trust or power
conferred on the Trustee. The Trustee, however, may refuse to follow any direction that conflicts with law or this Indenture or that the Trustee determines is unduly prejudicial to the rights of any other Holder of a Note or that would involve the
Trustee in personal liability and the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction. In case an Event of Default shall occur (which shall not be cured), the Trustee shall be required, in
the exercise of its power, to use the degree of care of a prudent person in the conduct of its own affairs under the circumstances. Notwithstanding any provision to the contrary in this Indenture, the Trustee is under no obligation to exercise any
of its rights or powers under this Indenture unless the Trustee shall have received indemnity, security or pre-funding to its satisfaction, against any loss, liability or expense. 

Section 6.06 Limitation on Suits. 

Subject to Section 6.07 hereof, no Holder of a Note may pursue any remedy with respect to this Indenture or the Notes unless,
subject to the provisions of the Intercreditor Agreements: 
 (1) such Holder has previously given the Trustee written notice
that an Event of Default is continuing; 
 (2) holders of at least 25% in aggregate principal amount of all then outstanding
Series of Notes (or, in the case of an Event of Default that affects some but not all Series of Notes, holders of at least 25% in the aggregate principal amount of the then outstanding Series of Notes that are affected by such Event of Default) have
requested the Trustee to pursue the remedy; 
 (3) Holders of the Notes have offered the Trustee and the Trustee shall have
received, if requested, reasonable security, indemnity or pre-funding against any loss, liability or expense; 
 (4) the
Trustee has not complied with such request within 60 days after the receipt thereof and the offer of such security, indemnity or pre-funding; and 
  

 100 

 (5) holders of a majority in principal amount of all then outstanding Series of Notes (or,
in the case of an Event of Default that affects some but not all Series of Notes, holders of a majority in principal amount of the then outstanding Series of Notes that are affected by such Event of Default) have not given the Trustee a direction
inconsistent with such request within such 60-day period. 
 A Holder of a Note may not use this Indenture to prejudice the
rights of another Holder of a Note or to obtain a preference or priority over another Holder of a Note. 
 Section 6.07 Rights of
Holders of Notes to Receive Payment. 
 Notwithstanding any other provision of this Indenture or the Intercreditor
Agreements, the right of any Holder of a Note to receive payment of principal, premium, if any, and Additional Interest, if any, and interest on the Note, on or after the respective due dates expressed in the Note (including in connection with an
Asset Sale Offer or a Change of Control Offer), or to bring suit for the enforcement of any such payment on or after such respective dates, shall not be impaired or affected without the consent of such Holder. 

Section 6.08 Collection Suit by Trustee. 

If an Event of Default specified in Section 6.01(a)(1) or (2) hereof occurs and is continuing, the Trustee is authorized to
recover judgment in its own name and as trustee of an express trust against the Company for the whole amount of principal of, premium, if any, and Additional Interest, if any, and interest remaining unpaid on the Notes and interest on overdue
principal and, to the extent lawful, interest and such further amount as shall be sufficient to cover the costs and expenses of collection, including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and
counsel. 
 Section 6.09 Restoration of Rights and Remedies. 

If the Trustee or any Holder has instituted any proceeding to enforce any right or remedy under this Indenture and such proceeding has
been discontinued or abandoned for any reason, or has been determined adversely to the Trustee or to such Holder, then and in every such case, subject to any determination in such proceedings, the Company, the Trustee and the Holders shall be
restored severally and respectively to their former positions hereunder and thereafter all rights and remedies of the Trustee and the Holders shall continue as though no such proceeding has been instituted. 

Section 6.10 Rights and Remedies Cumulative. 

Except as otherwise provided with respect to the replacement or payment of mutilated, destroyed, lost or stolen Notes in
Section 2.07 hereof, no right or remedy herein conferred upon or reserved to the Trustee or to the Holders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative
and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or
employment of any other appropriate right or remedy. 
 Section 6.11 Delay or Omission Not Waiver. 

No delay or omission of the Trustee or of any Holder of any Note to exercise any right or remedy accruing upon any Event of Default shall
impair any such right or remedy or constitute a waiver of any such Event of Default or an acquiescence therein. Every right and remedy given by this Article 6 or by law to the Trustee or to the Holders may be exercised from time to time, and as
often as may be deemed expedient, by the Trustee or by the Holders, as the case may be. 
  

 101 

 Section 6.12 Trustee May File Proofs of Claim. 

The Trustee is authorized to file such proofs of claim and other papers or documents as may be necessary or advisable in order to have
the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Holders of the Notes allowed in any judicial proceedings relative to the Company (or
any other obligor upon the Notes including the Guarantors), its creditors or its property and shall be entitled and empowered to participate as a member in any official committee of creditors appointed in such matter and to collect, receive and
distribute any money or other property payable or deliverable on any such claims and any custodian in any such judicial proceeding is hereby authorized by each Holder to make such payments to the Trustee, and in the event that the Trustee shall
consent to the making of such payments directly to the Holders, to pay to the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the
Trustee under Section 7.07 hereof. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.07 hereof out of
the estate in any such proceeding, shall be denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other properties that the Holders may be
entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or accept or adopt on behalf
of any Holder any plan of reorganization, arrangement, adjustment or composition affecting the Notes or the rights of any Holder, or to authorize the Trustee to vote in respect of the claim of any Holder in any such proceeding. 

Section 6.13 Priorities. 

If the Trustee collects any money or property pursuant to this Article 6, it shall pay out the money or property in the following order:

 (i) to the Trustee firstly and the Notes/Term Collateral Agent secondly, their respective agents and attorneys for amounts
due under Section 7.07 hereof, including payment of all compensation, expenses and liabilities incurred, and all advances made, by the Trustee and the Notes/Term Collateral Agent and the costs and expenses of collection; 

(ii) subject to the terms of the Notes/Term Intercreditor Agreement, to Holders of Notes for amounts due and unpaid on the Notes for
principal, premium, if any, and Additional Interest, if any, and interest, ratably, without preference or priority of any kind, according to the amounts due and payable on the Notes for principal, premium, if any, and Additional Interest, if any,
and interest, respectively; and 
 (iii) to the Company or to such party as a court of competent jurisdiction shall direct,
including a Guarantor, if applicable. 
 The Trustee may fix a record date and payment date for any payment to Holders of Notes
pursuant to this Section 6.13. 
  

 102 

 Section 6.14 Undertaking for Costs. 

In any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken or
omitted by it as a Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable
attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.14 does not apply to a suit by the Trustee, a suit by a Holder of
a Note pursuant to Section 6.07 hereof, or a suit by Holders of more than 10% in principal amount of the then outstanding Notes. 

ARTICLE 7 

TRUSTEE 
 Section 7.01
Duties of Trustee. 
 (a) If an Event of Default has occurred and is continuing, the Trustee shall exercise such of the
rights and powers vested in it by this Indenture, and use the same degree of care and skill in its exercise, as a prudent person would exercise or use under the circumstances in the conduct of such person’s own affairs. 

(b) Except during the continuance of an Event of Default: 

(i) the duties of the Trustee shall be determined solely by the express provisions of this Indenture and the Trustee need
perform only those duties that are specifically set forth in this Indenture and no others, and no implied covenants or obligations shall be read into this Indenture against the Trustee (it being agreed that the permissive right of the Trustee to
take actions enumerated in this Indenture shall not be construed as a duty); and 
 (ii) in the absence of bad
faith on its part, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this
Indenture. However, in the case of any such certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall examine the certificates and opinions to determine whether or not they
conform to the requirements of this Indenture (but need not investigate the accuracy of mathematical calculations or other facts stated therein). 

(c) The Trustee may not be relieved from liabilities for its own negligent action, its own negligent failure to act, or its own willful
misconduct, except that: 
 (i) this paragraph (c) does not limit the effect of paragraph (b) of this
Section 7.01; 
 (ii) the Trustee shall not be liable for any error of judgment made in good faith by a
Responsible Officer, unless it is proved in a court of competent jurisdiction that the Trustee was negligent in ascertaining the pertinent facts; and 
  

 103 

 (iii) the Trustee shall not be liable with respect to any action it takes
or omits to take in good faith in accordance with a direction received by it pursuant to Section 6.05 hereof. 
 (d)
Whether or not therein expressly so provided, every provision of this Indenture that in any way relates to the Trustee is subject to paragraphs (a), (b) and (c) of this Section 7.01. 

(e) The Trustee shall be under no obligation to exercise any of its rights or powers under this Indenture at the request or direction of
any of the Holders of the Notes unless the Holders have offered to the Trustee and the Trustee shall have received, if requested, reasonable indemnity, pre-funding or security against any loss, liability or expense. 

(f) The Trustee shall not be liable for interest on any money received by it except as the Trustee may agree in writing with the
Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by law. 
 Section 7.02
Rights of Trustee. 
 (a) The Trustee may conclusively rely upon any document believed by it to be genuine and to have
been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see
fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally or by agent or attorney at the sole cost of the Company and shall
incur no liability or additional liability of any kind by reason of such inquiry or investigation. 
 (b) Before the Trustee
acts or refrains from acting, it may require an Officer’s Certificate or an Opinion of Counsel or both. The Trustee shall not be liable for any action it takes or omits to take in good faith in reliance on such Officer’s Certificate or
Opinion of Counsel. The Trustee may consult with counsel of its selection and the written advice of such counsel or any Opinion of Counsel shall be full and complete authorization and protection from liability in respect of any action taken,
suffered or omitted by it hereunder in good faith and in reliance thereon. 
 (c) The Trustee may act through its attorneys and
agents and shall not be responsible for the misconduct or negligence of any agent or attorney appointed with due care. 
 (d)
The Trustee shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within the rights or powers conferred upon it by this Indenture. 

(e) Unless otherwise specifically provided in this Indenture, any demand, request, direction or notice from the Company shall be
sufficient if signed by an Officer of the Company. 
 (f) None of the provisions of this Indenture shall require the Trustee to
expend or risk its own funds or otherwise to incur any liability, financial or otherwise, in the performance of any of its duties hereunder, or in the exercise of any of its rights or powers if it shall have reasonable grounds for believing that
repayment of such funds or indemnity satisfactory to it against such risk or liability is not assured to it. 
  

 104 

 (g) The Trustee shall not be deemed to have notice of any Default or Event of Default
unless a Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of any event which is in fact such a Default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the
Notes and this Indenture. 
 (h) In no event shall the Trustee be responsible or liable for special, indirect, or consequential
loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action. 

(i) The rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be
indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder. 

(j) In the event the Company is required to pay Additional Interest, the Company will provide written notice to the Trustee of the
Company’s obligation to pay Additional Interest no later than 15 days prior to the next applicable Interest Payment Date, which notice shall set forth the amount of the Additional Interest to be paid by the Company. The Trustee shall not at any
time be under any duty or responsibility to any Holders to determine whether the Additional Interest is payable and the amount thereof. 

(k) The Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement,
instrument, opinion, report, notice, request, consent, order, approval, bond, debenture, note or other paper or document unless requested in writing to do so by the Holders of not less than a majority in principal amount of the Notes at the time
outstanding, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to
examine the books, records and premises of the Company, personally or by agent or attorney, at the expense of the Company and shall incur no liability of any kind by reason of such inquiry or investigation. 

(l) The Trustee may request that the Company deliver an Officer’s Certificate setting forth the names of individuals and/or titles
of officers authorized at such time to take specified actions pursuant to this Indenture, which Officer’s Certificate may be signed by any Person authorized to sign an Officer’s Certificate, including any Person specified as so authorized
in any such certificate previously delivered and not superseded. 
 (m) The Trustee shall not be responsible or liable for any
failure or delay in the performance of its obligations under this Indenture arising out of or caused, directly or indirectly, by circumstances beyond its reasonable control, including, without limitation, acts of God; earthquakes; fire; flood;
terrorism; wars and other military disturbances; sabotage; epidemics; riots; loss or malfunction of utilities, computer (hardware or software) or communication services; strikes or similar labor disputes; and acts of civil or military authorities
and governmental action. 
 Section 7.03 Individual Rights of Trustee. 

The Trustee in its individual or any other capacity may become the owner or pledgee of Notes and may otherwise deal with the Company or
any Affiliate of the Company with the same rights it would have if it were not Trustee. However, in the event that the Trustee acquires any conflicting interest it must eliminate such conflict within 90 days, apply to the SEC for permission to
continue as trustee or resign. Any Agent may do the same with like rights and duties. The Trustee is also subject to Sections 7.10 and 7.11 hereof. 
  

 105 

 Section 7.04 Trustee’s Disclaimer. 

The Trustee shall not be responsible for and makes no representation as to the validity or adequacy of this Indenture or the Notes, it
shall not be accountable for the Company’s use of the proceeds from the Notes or any money paid to the Company or upon the Company’s direction under any provision of this Indenture, it shall not be responsible for the use or application of
any money received by any Paying Agent other than the Trustee, and it shall not be responsible for any statement or recital herein or any statement in the Notes or any other document in connection with the sale of the Notes or pursuant to this
Indenture other than its certificate of authentication. 
 Section 7.05 Notice of Defaults. 

If a Default with respect to a series of Notes occurs and is continuing and if it is known to the Trustee, the Trustee shall mail to
Holders of Notes of such series a notice of the Default within 90 days after it occurs. Except in the case of a Default relating to the payment of principal, premium, if any, or interest on any Note, the Trustee may withhold from the Holders notice
of any continuing Default if and so long as a committee of its Responsible Officers in good faith determines that withholding the notice is in the interests of the Holders of the Notes. The Trustee shall not be deemed to know of any Default unless a
Responsible Officer of the Trustee has actual knowledge thereof or unless written notice of any event which is such a Default is received by the Trustee at the Corporate Trust Office of the Trustee. 

Section 7.06 Reports by Trustee to Holders of the Notes. 

Within 60 days after each May 15, beginning with the May 15 following the date of this Indenture, and for so long as Notes of
any series remain outstanding, the Trustee shall mail to the Holders of the Notes a brief report dated as of such reporting date that complies with Section 313(a) of the Trust Indenture Act (but if no event described in Section 313(a) of
the Trust Indenture Act has occurred within the twelve months preceding the reporting date, no report need be transmitted). The Trustee also shall comply with Section 313(b) of the Trust Indenture Act. The Trustee shall also transmit by mail
all reports as required by Section 313(c) of the Trust Indenture Act. 
 A copy of each report at the time of its mailing
to the Holders of Notes shall be mailed to the Company and filed with the SEC and each stock exchange on which the Notes are listed in accordance with Section 313(d) of the Trust Indenture Act. The Company shall promptly notify the Trustee when
the Notes are listed on any stock exchange. 
 Section 7.07 Compensation and Indemnity. 

For the purposes of this Section 7.07, the Trustee and the Notes/Term Collateral Agent are referred to collectively as the
“Indemnified Parties,” and each as an “Indemnified Party.” The Company and the Guarantors, jointly and severally, shall pay to each Indemnified Party from time to time such compensation (with respect to the Trustee,
for its acceptance of this Indenture and services hereunder, and with respect to the Notes/Term Collateral Agent, for its acceptance of the Notes/Term Intercreditor Agreement and services thereunder) as the parties shall agree in writing from time
to time. Neither Indemnified Party’s compensation shall be limited by any law on compensation of a trustee of an express trust. The Company and the Guarantors, jointly and severally, shall reimburse each Indemnified Party promptly upon request
for all reasonable disbursements, advances and expenses (including costs of 
  

 106 

 
collection) incurred or made by it in addition to the compensation for its services. Such expenses shall include the reasonable compensation, disbursements and expenses of each Indemnified
Party’s agents, experts and counsel. 
 The Company and the Guarantors, jointly and severally, shall indemnify each
Indemnified Party for, and hold each Indemnified Party harmless against, any and all loss, damage, claims, liability or expense (including attorneys’ fees) incurred by it in connection with the acceptance or administration of this trust (in the
case of the Trustee) and the performance of its duties hereunder or under the Collateral Documents (including the costs and expenses of enforcing this Indenture or the Collateral Documents against the Company or any of the Guarantors (including this
Section 7.07) or defending itself against any claim whether asserted by any Holder, the Company or any Guarantor, or liability in connection with the acceptance, exercise or performance of any of its powers or duties hereunder or under the
Collateral Documents). Each Indemnified Party shall notify the Company promptly of any claim for which it may seek indemnity. Failure by such Indemnified Party to so notify the Company shall not relieve the Company of its obligations hereunder. The
Company shall defend the claim and such Indemnified Party may have separate counsel and the Company shall pay the fees and expenses of such counsel. The Company need not reimburse any expense or indemnify against any loss, liability or expense
incurred by such Indemnified Party through such Indemnified Party’s own willful misconduct or gross negligence. 
 The
obligations of the Company under this Section 7.07 shall survive the satisfaction and discharge of this Indenture or the earlier resignation or removal of the Indemnified Parties. 

Notwithstanding anything to the contrary in Section 4.12 hereof, to secure the payment obligations of the Company and the
Guarantors in this Section 7.07, the Indemnified Parties shall have a Lien prior to the Notes on all money or property held or collected by the Indemnified Parties, except that held in trust to pay principal and interest on particular Notes.
Such Lien shall survive the satisfaction and discharge of this Indenture. 
 When an Indemnified Party incurs expenses or
renders services after an Event of Default specified in Section 6.01(a)(6) or (7) hereof occurs, the expenses and the compensation for the services (including the fees and expenses of its agents and counsel) are intended to constitute
expenses of administration under any Bankruptcy Law. 
 Each Indemnified Party shall comply with the provisions of
Section 313(b)(2) of the Trust Indenture Act to the extent applicable. 
 Section 7.08 Replacement of Trustee. 

A resignation or removal of the Trustee and appointment of a successor Trustee shall become effective only upon the successor
Trustee’s acceptance of appointment as provided in this Section 7.08. The Trustee may resign in writing at any time and be discharged from the trust hereby created by so notifying the Company. The Holders of a majority in principal amount
of the then outstanding Notes may remove the Trustee by so notifying the Trustee and the Company in writing. The Company may remove the Trustee if: 

(a) the Trustee fails to comply with Section 7.10 hereof; 

(b) the Trustee is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the Trustee under any
Bankruptcy Law; 
  

 107 

 (c) a custodian or public officer takes charge of the Trustee or its property; or

 (d) the Trustee becomes incapable of acting. 

If the Trustee resigns or is removed or if a vacancy exists in the office of Trustee for any reason, the Company shall promptly appoint
a successor Trustee. Within one year after the successor Trustee takes office, the Holders of a majority in principal amount of the then outstanding Notes may appoint a successor Trustee to replace the successor Trustee appointed by the Company.

 If a successor Trustee does not take office within 60 days after the retiring Trustee resigns or is removed, the retiring
Trustee (at the Company’s expense), the Company or the Holders of at least 10% in principal amount of the then outstanding Notes may petition any court of competent jurisdiction for the appointment of a successor Trustee. 

If the Trustee, after written request by any Holder who has been a Holder for at least six months, fails to comply with
Section 7.10 hereof, such Holder may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 

A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Thereupon, the
resignation or removal of the retiring Trustee shall become effective, and the successor Trustee shall have all the rights, powers and duties of the Trustee under this Indenture. The successor Trustee shall mail a notice of its succession to
Holders. The retiring Trustee shall promptly transfer all property held by it as Trustee to the successor Trustee; provided all sums owing to the Trustee hereunder have been paid and subject to the Lien provided for in Section 7.07
hereof. Notwithstanding replacement of the Trustee pursuant to this Section 7.08, the Company’s obligations under Section 7.07 hereof shall continue for the benefit of the retiring Trustee. 

Section 7.09 Successor Trustee by Merger, etc. 

If the Trustee consolidates, merges or converts into, or transfers all or substantially all of its corporate trust business to, another
corporation, the successor corporation without any further act shall be the successor Trustee. 
 Section 7.10 Eligibility;
Disqualification. 
 There shall at all times be a Trustee hereunder that is a corporation organized and doing business
under the laws of the United States of America or of any state thereof that is authorized under such laws to exercise corporate trustee power, that is subject to supervision or examination by federal or state authorities and that has a combined
capital and surplus of at least $50,000,000 as set forth in its most recent published annual report of condition. 
 This
Indenture shall always have a Trustee who satisfies the requirements of Sections 310(a)(1), (2) and (5) of the Trust Indenture Act. The Trustee is subject to Section 310(b) of the Trust Indenture Act. 

Section 7.11 Preferential Collection of Claims Against Company. 

The Trustee is subject to Section 311(a) of the Trust Indenture Act, excluding any creditor relationship listed in
Section 311(b) of the Trust Indenture Act. A Trustee who has resigned or been removed shall be subject to Section 311(a) of the Trust Indenture Act to the extent indicated therein. 

 

 108 

 Section 7.12 Intercreditor Agreements, Security Agreement and Other Collateral Documents.

 The Trustee is hereby directed and authorized by the Holders of Notes to execute and deliver, or cause the Notes/Term
Collateral Agent to execute and deliver, the Intercreditor Agreements, the Security Agreement and any other Collateral Documents to the extent it is named as a party therein. Whether or not so expressly stated therein, in entering into, or taking
(or forbearing from) any action under or pursuant to, the Intercreditor Agreements, the Security Agreement or any other Collateral Documents, the Trustee and the Notes/Term Collateral Agent each shall have all of the rights, immunities, indemnities
and other protections granted to it under this Indenture (in addition to those that may be granted to it under the terms of such other agreement or agreements). The Trustee and each Holder of Series A-1 Notes (and, if issued, each Holder of Series
A-2 Notes) hereby authorizes the Notes/Term Collateral Agent to execute and deliver the Notes/Term Intercreditor Agreement for the benefit of the Holders of Notes and agrees to be bound by all of the provisions of the Notes/Term Intercreditor
Agreement. In addition, each of the Trustee and each Holder of Series A-1 Notes (and, if issued, each Holder of Series A-2 Notes) acknowledges and agrees that the Notes/Term Collateral Agent has entered into the ABL Intercreditor Agreement, the
Security Agreement and other Collateral Documents for the benefit of the Holders of Notes and agrees to be bound by all of the provisions thereof. In addition, each Holder of Series A-1 Notes (and, if issued, each Holder of Series A-2 Notes) hereby
authorizes the Trustee to replace the Notes/Term Collateral Agent as a party to each document to which the Notes/Term Collateral Agent is a party, including at such time as there are no Term Loans outstanding. 

ARTICLE 8 
 LEGAL
DEFEASANCE AND COVENANT DEFEASANCE 
 Section 8.01 Option to Effect Legal Defeasance or Covenant Defeasance. 

The Company may, at its option and at any time, elect to have either Section 8.02 or 8.03 hereof applied to all outstanding Notes
upon compliance with the conditions set forth below in this Article 8. To the extent the Company exercises its option under Section 8.02 or 8.03 hereof, such election may be made by the Company with respect to only the Series A-1 Notes, only
the Series A-2 Notes (if issued), or both Series of Notes collectively. 
 Section 8.02 Legal Defeasance and Discharge. 

Upon the Company’s exercise under Section 8.01 hereof of the option applicable to this Section 8.02, the Company and the
Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be deemed to have been discharged from their obligations with respect to all outstanding Notes of the applicable series and related Guarantees on
the date the conditions set forth below are satisfied (“Legal Defeasance”). For this purpose, Legal Defeasance means that the Company shall be deemed to have paid and discharged the entire Indebtedness represented by the outstanding
Notes of the applicable series, which shall thereafter be deemed to be “outstanding” only for the purposes of Section 8.05 hereof and the other Sections of this Indenture referred to in clauses (a) and (b) below, and to have
satisfied all their other obligations with respect to the Notes of such series under such Notes, this Indenture, including that of the Guarantors, and the Collateral Documents (and the Trustee, on demand of and at the expense of the Company, shall
execute proper instruments acknowledging the same), except for the following provisions which shall survive until otherwise terminated or discharged hereunder: 

(a) the rights of Holders of Notes of such series to receive payments in respect of the principal of, premium, if any, and interest on
the Notes of such series when such payments are due solely out of the trust created pursuant to this Indenture referred to in Section 8.04 hereof; 
  

 109 

 (b) the Company’s obligations with respect to Notes of such series concerning issuing
temporary Notes of such series, registration of such Notes, mutilated, destroyed, lost or stolen Notes of such series and the maintenance of an office or agency for payment and money for security payments held in trust; 

(c) the rights, powers, trusts, duties and immunities of the Trustee, and the Company’s obligations in connection therewith;

 (d) this Section 8.02; and 

(e) the priority of payment provisions between the Series A-1 Notes and the Series A-2 Debt contained in the Notes/Term Intercreditor
Agreement. 
 Subject to compliance with this Article 8, the Company may exercise its option under this Section 8.02
notwithstanding the prior exercise of its option under Section 8.03 hereof. 
 Section 8.03 Covenant Defeasance. 

Upon the Company’s exercise under Section 8.01 hereof of the option applicable to this Section 8.03, the Company and the
Guarantors shall, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, be released from their obligations under the covenants contained in Sections 4.03, 4.04, 4.05, 4.07, 4.08, 4.09, 4.10, 4.11, 4.12, 4.13, 4.14,
4.15, 4.16, 4.17, 4.18, 4.19, 4.20 and 4.21 hereof and clauses (4) and (5) of Section 5.01(a), Sections 5.01(c) and 5.01(d) hereof with respect to the outstanding Notes of a particular series on and after the date the conditions set
forth in Section 8.04 hereof are satisfied (“Covenant Defeasance”), and the Notes of such series shall thereafter be deemed not “outstanding” for the purposes of any direction, waiver, consent or declaration or act of
Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed “outstanding” for all other purposes hereunder (it being understood that such Notes shall not be deemed outstanding for
accounting purposes). For this purpose, Covenant Defeasance means that, with respect to the outstanding Notes of such series, the Company may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth
in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to
comply shall not constitute a Default or an Event of Default under Section 6.01 hereof, but, except as specified above, the remainder of this Indenture and such Notes shall be unaffected thereby. In addition, upon the Company’s exercise
under Section 8.01 hereof of the option applicable to this Section 8.03 hereof, subject to the satisfaction of the conditions set forth in Section 8.04 hereof, Sections 6.01(a)(3), 6.01(a)(4), 6.01(a)(5), 6.01(a)(6) (solely with
respect to Restricted Subsidiaries that are Significant Subsidiaries), 6.01(a)(7) (solely with respect to Restricted Subsidiaries that are Significant Subsidiaries), 6.01(a)(8) and 6.01(a)(9) hereof shall not constitute Events of Default with
respect to the Notes of such series. 
  

 110 

 Section 8.04 Conditions to Legal or Covenant Defeasance. 

The following shall be the conditions to the application of either Section 8.02 or 8.03 hereof to the outstanding Notes of a
particular series: 
 In order to exercise either Legal Defeasance or Covenant Defeasance with respect to the Notes of a
particular series: 
 (1) the Company must irrevocably deposit with the Trustee, in trust, for the benefit of
the Holders of the Notes of such series, cash in U.S. dollars, Government Securities, or a combination thereof, in such amounts as will be sufficient, in the opinion of a nationally recognized firm of independent public accountants, to pay the
principal of, premium, if any, and interest due on the Notes of such series on the stated maturity date or on the redemption date, as the case may be, of such principal, premium, if any, or interest on such Notes and the Company must specify whether
such Notes are being defeased to maturity or to a particular redemption date; 
 (2) in the case of Legal
Defeasance, the Company shall have delivered to the Trustee an Opinion of Counsel reasonably acceptable to the Trustee confirming that, subject to customary assumptions and exclusions, 

(a) the Company has received from, or there has been published by, the United States Internal Revenue Service a ruling,
or 
 (b) since the issuance of the Notes of such series, there has been a change in the applicable U.S. federal
income tax law, 
 in either case to the effect that, and based thereon such Opinion of Counsel shall confirm that, subject to
customary assumptions and exclusions, the Holders of the Notes of such series will not recognize income, gain or loss for U.S. federal income tax purposes, as applicable, as a result of such Legal Defeasance and will be subject to U.S. federal
income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred; 

(3) in the case of Covenant Defeasance, the Company shall have delivered to the Trustee an Opinion of Counsel reasonably
acceptable to the Trustee confirming that, subject to customary assumptions and exclusions, the Holders of the Notes of such series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance
and will be subject to such tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred; 

(4) no Default (other than that resulting from borrowing funds to be applied to make the deposit required to effect such
Legal Defeasance or Covenant Defeasance and any similar and simultaneous deposit relating to other Indebtedness, and, in each case, the granting of Liens in connection therewith) shall have occurred and be continuing on the date of such deposit;

 (5) such Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of, or constitute
a default under, the ABL Facility, the Term Loan Facility or any other material agreement or instrument (other than this Indenture only if all Notes are to be defeased) to which the Company or any Guarantor is a party or by which the Company or any
Guarantor is bound (other than that resulting with respect to any Indebtedness being defeased from any borrowing of funds to be applied to make the deposit required to effect such Legal Defeasance or Covenant Defeasance and any similar and
simultaneous deposit relating to such Indebtedness, and the granting of Liens in connection therewith); 
  

 111 

 (6) the Company shall have delivered to the Trustee an Opinion of Counsel
to the effect that, as of the date of such opinion and subject to customary assumptions and exclusions following the deposit, the trust funds will not be subject to the effect of Section 547 of Title 11 of the United States Code;

 (7) the Company shall have delivered to the Trustee an Officer’s Certificate stating that the deposit
was not made by the Company with the intent of defeating, hindering, delaying or defrauding any creditors of the Company or any Guarantor or others; and 

(8) the Company shall have delivered to the Trustee an Officer’s Certificate and an Opinion of Counsel (which
Opinion of Counsel may be subject to customary assumptions and exclusions) each stating that all conditions precedent provided for or relating to the Legal Defeasance or the Covenant Defeasance, as the case may be, have been complied with.

 Section 8.05 Deposited Money and Government Securities to Be Held in Trust; Other Miscellaneous Provisions. 

Subject to Section 8.06 hereof, all money and Government Securities (including the proceeds thereof) deposited with the Trustee (or
other qualifying trustee, collectively for purposes of this Section 8.05, the “Trustee”) pursuant to Section 8.04 hereof in respect of the outstanding Notes of the applicable series shall be held in trust and applied by
the Trustee, in accordance with the provisions of such Notes and this Indenture, to the payment, either directly or through any Paying Agent (including a Guarantor acting as Paying Agent) as the Trustee may determine, to the Holders of such Notes of
all sums due and to become due thereon in respect of principal, premium and Additional Interest, if any, and interest, but such money need not be segregated from other funds except to the extent required by law. 

The Company shall pay and indemnify the Trustee against any tax, fee or other charge imposed on or assessed against the cash or
Government Securities deposited pursuant to Section 8.04 hereof or the principal and interest received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Notes of
the applicable series. 
 Anything in this Article 8 to the contrary notwithstanding, the Trustee shall deliver or pay to the
Company from time to time upon the request of the Company any money or Government Securities held by it as provided in Section 8.04 hereof which, in the opinion of a nationally recognized firm of independent public accountants expressed in a
written certification thereof delivered to the Trustee (which may be the opinion delivered under Section 8.04 hereof), are in excess of the amount thereof that would then be required to be deposited to effect an equivalent Legal Defeasance or
Covenant Defeasance. 
 Section 8.06 Repayment to Company. 

Any money deposited with the Trustee or any Paying Agent, or then held by the Company, in trust for the payment of the principal of,
premium and Additional Interest, if any, or interest on any Note of the applicable series and remaining unclaimed for two years after such principal, and premium and Additional Interest, if any, or interest has become due and payable shall be paid
to the Company on its request or (if then held by the Company) shall be discharged from such trust; and the 
  

 112 

 
Holder of such Note shall thereafter look only to the Company for payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the
Company as trustee thereof, shall thereupon cease. 
 Section 8.07 Reinstatement. 

If the Trustee or Paying Agent is unable to apply any United States dollars or Government Securities in accordance with Section 8.02
or 8.03 hereof, as the case may be, by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, then the Company’s obligations under this Indenture with respect to
the Notes of a particular series and the Notes of such series shall be revived and reinstated as though no deposit had occurred pursuant to Section 8.02 or 8.03 hereof until such time as the Trustee or Paying Agent is permitted to apply all
such money in accordance with Section 8.02 or 8.03 hereof, as the case may be; provided that, if the Company makes any payment of principal of, premium and Additional Interest, if any, or interest on any Note of such series following the
reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Notes of such series to receive such payment from the money held by the Trustee or Paying Agent. 

ARTICLE 9 

AMENDMENT, SUPPLEMENT AND WAIVER 

Section 9.01 Without Consent of Holders of Notes. 

Notwithstanding Section 9.02 hereof, the Company, any Guarantor (with respect to a Guarantee or this Indenture) and the Trustee (and
to the extent applicable, the Notes/Term Collateral Agent) may amend or supplement this Indenture, the Collateral Documents and any Guarantee or Notes without the consent of any Holder: 

(1) to cure any ambiguity, omission, mistake, defect or inconsistency; 

(2) to provide for uncertificated Notes of such series in addition to or in place of certificated Notes; 

(3) to comply with Section 5.01 hereof; 

(4) to provide for the assumption of the Company’s or any Guarantor’s obligations to the Holders; 

(5) to make any change that would provide any additional rights or benefits to the Holders or that does not adversely affect the legal
rights under this Indenture of any such Holder; 
 (6) to add covenants for the benefit of the Holders or to surrender any
right or power conferred upon the Company or any Guarantor; 
 (7) to comply with requirements of the SEC in order to effect or
maintain the qualification of this Indenture under the Trust Indenture Act; 
 (8) to evidence and provide for the acceptance
and appointment under this Indenture of a successor Trustee thereunder pursuant to the requirements thereof; 
  

 113 

 (9) to provide for the issuance of exchange notes or private exchange notes, which are
identical to exchange notes except that they are not freely transferable; 
 (10) to provide for the issuance of Additional
Notes in accordance with this Indenture and to secure Additional Note Obligations, if any; 
 (11) to add a Guarantor under
this Indenture or to release a Guarantor in accordance with the terms of this Indenture; 
 (12) to conform the text of this
Indenture, Guarantees or the Notes to any provisions of the “Description of Series A-1 Notes” section of the Offering Memorandum (or any similar description with respect to the Series A-2 Notes) to the extent such provision in such
“Description of Series A-1 Notes” section (or any description of the Series A-2 Notes) was intended to be a verbatim recitation of a provision of this Indenture, Guarantee or Notes; 

(13) to make any amendment to the provisions of this Indenture relating to the transfer and legending of Notes as permitted by this
Indenture, including, without limitation to facilitate the issuance and administration of the Notes; provided, however, that (i) compliance with this Indenture as so amended would not result in the Notes being transferred in
violation of the Securities Act or any applicable securities law and (ii) such amendment does not materially and adversely affect the rights of Holders to transfer the Notes; or 

(14) to provide for the succession of any parties to the Collateral Documents or the Intercreditor Agreements (and other amendments that
are administrative or ministerial in nature) in connection with an amendment, renewal, extension, substitution, refinancing, restructuring, replacement, supplementing or other modification from time to time of the ABL Facility, the Term Loan
Facility or any other agreement that is not prohibited by this Indenture; 
 (15) to provide for the release or addition of
Collateral or Guarantees in accordance with the terms of this Indenture and the Collateral Documents; 
 (16) to provide for
the issuance of the Series A-2 Notes in a manner consistent with the terms of this Indenture, whether through a board resolution or supplemental indenture; or 

(17) to provide for the succession of the Trustee as collateral agent under this Indenture, the ABL Intercreditor Agreement, the
Notes/Term Intercreditor Agreement and the other Collateral Documents. 
 Upon the request of the Company accompanied by a
resolution of its boards of directors authorizing the execution of any such amendment or supplement, and upon receipt by the Trustee of the documents described in Section 7.02 hereof, the Trustee and the Notes/Term Collateral Agent shall join
with the Company and the Guarantors in the execution of any amendment or supplement authorized or permitted by the terms of this Indenture and to make any further appropriate agreements and stipulations that may be therein contained, but the Trustee
and the Notes/Term Collateral Agent shall not be obligated to enter into such amendment or supplement that affects its own rights, duties or immunities under this Indenture or otherwise. Notwithstanding the foregoing, no Opinion of Counsel shall be
required in connection with the addition of a Guarantor under this Indenture upon execution and delivery by such Guarantor and the Trustee of a supplemental indenture to this Indenture, the form of which is attached as Exhibit D hereto, and
delivery of an Officer’s Certificate. 
  

 114 

 Section 9.02 With Consent of Holders of Notes. 

Except as provided below in this Section 9.02, and subject to the provisions of the Intercreditor Agreements, the Company and the
Trustee (and the Notes/Term Collateral Agent to the extent a party to the applicable documents) may amend or supplement this Indenture, the Notes, the Guarantees and the Collateral Documents with the consent of the holders of at least a majority in
aggregate principal amount of the Series A-1 Notes and the Series A-2 Notes (if any) (in each case, including Additional Notes, if any) and the Term Loans then outstanding, collectively, voting as a single class (including, without limitation,
consents obtained in connection with a tender offer or exchange offer for, or purchase of, the Notes), and, subject to Sections 6.04 and 6.07 hereof, any existing Default or Event of Default (other than a Default or Event of Default in the payment
of the principal of, premium and Additional Interest, if any, or interest on the Notes, except a payment default resulting from an acceleration that has been rescinded) or compliance with any provision of this Indenture, the Notes, the Guarantees or
the Collateral Documents may be waived with the consent of the holders of a majority in aggregate principal amount of the Series A-1 Notes and the Series A-2 Notes (if any) (in each case, including Additional Notes, if any) and the Term Loans then
outstanding, collectively, voting as a single class (including, without limitation, consents obtained in connection with a tender offer or exchange offer for, or purchase of, the Notes); provided that any provision or Default that affects
some but not all Series of Debt may be amended, supplemented or waived, as the case may be, with the consent of the holders of a majority in aggregate principal amount of the then outstanding Series of Debt that are affected by such provision or
Default. Section 2.08 hereof and Section 2.09 hereof shall determine which Notes are considered to be “outstanding” for the purposes of this Section 9.02. 

Upon the request of the Company accompanied by a resolution of its boards of directors authorizing the execution of any such amendment
or supplement, and upon the filing with the Trustee of evidence satisfactory to the Trustee of the consent of the holders of the applicable Series of Debt, as applicable, as aforesaid, and upon receipt by the Trustee of the documents described in
Section 7.02 hereof, the Trustee (and the Notes/Term Collateral Agent to the extent a party to the applicable document) shall join with the Company in the execution of such amendment or supplement unless such amendment or supplement directly
affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such amendment or supplement. 

It shall not be necessary for the consent of the holders of the applicable Series of Debt, as applicable, under this Section 9.02
to approve the particular form of any proposed amendment or waiver, but it shall be sufficient if such consent approves the substance thereof. 

After an amendment, supplement or waiver under this Section 9.02 becomes effective, the Company shall mail to the Holders of Notes
affected thereby a notice briefly describing the amendment, supplement or waiver. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such amendment, supplement
or waiver. 
 Without the consent of each affected Holder of Notes of a particular series, an amendment or waiver under this
Section 9.02 may not (with respect to any Notes of such series held by a non-consenting Holder): 
 (1)
reduce the principal amount of such Notes whose Holders must consent to an amendment, supplement or waiver; 
  

 115 

 (2) reduce the principal of or change the fixed final maturity of any such
Note or alter or waive the provisions with respect to the redemption of such Notes (other than provisions relating to Section 3.09, Section 4.10 and Section 4.14 hereof to the extent that any such amendment or waiver does not have the
effect of reducing the principal of or changing the fixed final maturity of any such Note or altering or waiving the provisions with respect to the redemption of such Notes); 

(3) reduce the rate of or change the time for payment of interest on any Note of such series; 

(4) (A) waive a Default in the payment of principal of or premium, if any, or interest on the Notes of the applicable
series, except a rescission of acceleration of the Notes of such series by the holders of a majority in aggregate principal amount of all then outstanding Series of Debt (or, in the case of a Default that affects some but not all Series of Debt, by
the holders of a majority in aggregate principal amount of the then outstanding Series of Debt that are affected by such Default), and a waiver of the payment default that resulted from such acceleration, or (B) waive a Default in respect of a
covenant or provision contained in the Indenture or any Guarantee which cannot be amended or modified without the consent of all Holders of Notes of the applicable series; 

(5) make any Note of such series payable in money other than U.S. dollars; 

(6) make any change in the provisions of this Indenture relating to waivers of past Defaults or the rights of Holders to
receive payments of principal of or premium, if any, or interest or Additional Interest on the Notes of such series; 

(7) make any change in these amendment and waiver provisions; 

(8) impair the right of any Holder to receive payment of principal of, premium, if any, or interest on such Holder’s
Notes of such series on or after the due dates therefor or to institute suit for the enforcement of any payment on or with respect to such Holder’s Notes of such series or the Guarantees; 

(9) make any change to or modify the ranking of the Notes of the applicable series that would adversely affect the
Holders of the Notes of such series; 
 (10) except as expressly permitted by this Indenture, modify the
Guarantees of any Significant Subsidiary in any manner adverse to the Holders of the Notes of such series; 

(11) release the Liens created by the Collateral Documents on all or substantially all the Collateral (other than in
accordance with the terms of the ABL Facility, the Term Loan Facility and the Collateral Documents); or 
 (12)
make any change in the provisions of this Indenture or any Collateral Document dealing with the application of proceeds of the Collateral (including, without limitation, the provisions in Section 4.05 of the Notes/Term Intercreditor Agreement)
that would adversely affect the Holders of Notes of the applicable series. 
  

 116 

 Section 9.03 Class Voting. 

Holders of Series A-1 Notes, holders of Series A-2 Notes (if issued) and holders of any Term Loans then outstanding will vote as a single
class for all purposes under this Indenture and the Term Loan Facility and the Collateral Documents, including waivers, supplements and amendments, except that the holders of each Series of Debt then outstanding which is affected thereby will each
vote separately with respect to: 
 (1) matters that propose to amend or otherwise modify the priority of
payment provisions and other intercreditor arrangements in Section 4.05 of the Notes/Term Intercreditor Agreement; and 

(2) any matter that adversely and disproportionately affects the rights or obligations of one Series of Debt as compared
to any other Series of Debt. 
 Section 9.04 Compliance with Trust Indenture Act. 

Every amendment or supplement to this Indenture or the Notes shall be set forth in an amended or supplemental indenture that complies
with the Trust Indenture Act as then in effect. 
 Section 9.05 Revocation and Effect of Consents. 

Until an amendment, supplement or waiver becomes effective, a consent to it by a Holder of a Note is a continuing consent by the Holder
of a Note and every subsequent Holder of a Note or portion of a Note that evidences the same debt as the consenting Holder’s Note, even if notation of the consent is not made on any Note. However, any such Holder of a Note or subsequent Holder
of a Note may revoke the consent as to its Note if the Trustee receives written notice of revocation before the date the waiver, supplement or amendment becomes effective. Once an amendment, supplement or waiver becomes effective in accordance with
its terms and the terms hereof, it thereafter binds every subsequent Holder. 
 The Company may, but shall not be obligated to,
fix a record date for the purpose of determining the Holders entitled to consent to any amendment, supplement or waiver. If a record date is fixed, then, notwithstanding the preceding paragraph, those Persons who were Holders at such record date (or
their duly designated proxies), and only such Persons, shall be entitled to consent to such amendment, supplement or waiver or to revoke any consent previously given, whether or not such Persons continue to be Holders after such record date. No such
consent shall be valid or effective for more than 120 days after such record date unless the consent of the requisite number of Holders has been obtained. 

Section 9.06 Notation on or Exchange of Notes. 

The Trustee may place an appropriate notation about an amendment, supplement or waiver on any Note thereafter authenticated. The Company
in exchange for all Notes may issue and the Trustee shall, upon receipt of an Authentication Order, authenticate new Notes that reflect the amendment, supplement or waiver. 

Failure to make the appropriate notation or issue a new Note shall not affect the validity and effect of such amendment, supplement or
waiver. 
  

 117 

 Section 9.07 Trustee to Sign Amendments, etc. 

The Trustee shall sign any amendment, supplement or waiver authorized pursuant to this Article 9 if the amendment, supplement or waiver
does not adversely affect the rights, duties, liabilities or immunities of the Trustee. The Company may not sign an amendment, supplement or waiver until the board of directors approves it. In executing any amendment, supplement or waiver, the
Trustee shall be entitled to receive and (subject to Section 7.01 hereof) shall be fully protected in relying upon, in addition to the documents required by Section 14.04 hereof, an Officer’s Certificate and an Opinion of Counsel
stating that the execution of such amendment, supplement or waiver is authorized or permitted by this Indenture and that such amendment, supplement or waiver is the legal, valid and binding obligation of the Company and any Guarantors party thereto,
enforceable against them in accordance with its terms, subject to customary exceptions, and complies with the provisions hereof (including Section 9.04 hereof). Notwithstanding the foregoing, no Opinion of Counsel will be required for the
Trustee to execute any amendment or supplement adding a new Guarantor under this Indenture. 
 Section 9.08 Payment for Consent.

 Neither the Company nor any Affiliate of the Company shall, directly or indirectly, pay or cause to be paid any
consideration, whether by way of interest, fee or otherwise, to any Holder for or as an inducement to any consent, waiver or amendment of any of the terms or provisions of this Indenture, the Notes or the Collateral Documents unless such
consideration is offered to all Holders and is paid to all Holders that so consent, waive or agree to amend in the time frame set forth in solicitation documents relating to such consent, waiver or agreement. 

ARTICLE 10 

COLLATERAL DOCUMENTS 

Section 10.01 Collateral and Collateral Documents. 

(a) The due and punctual payment of the principal of and interest (including Additional Interest, if any) on the Notes when and as the
same shall be due and payable, whether on an Interest Payment Date, at maturity, by acceleration, repurchase, redemption or otherwise, and interest on the overdue principal of and interest (including Additional Interest, if any) on the Notes and
performance of all other Obligations of the Company and the Guarantors to the Holders, the Trustee or the Notes/Term Collateral Agent under this Indenture, the Notes, the Intercreditor Agreements and the Collateral Documents, according to the terms
hereunder or thereunder, shall be secured as provided in the Collateral Documents, which define the terms of the Liens that secure the Notes and such other Obligations, subject to the terms of the Intercreditor Agreements. The Trustee and the
Company hereby acknowledge and agree that the Notes/Term Collateral Agent holds the Collateral in trust for the benefit of the Trustee and the Holders, in each case pursuant to the terms of the Collateral Documents and the Intercreditor Agreements.
Each Holder, by accepting a Note, consents and agrees to the terms of the Collateral Documents (including the provisions providing for the possession, use, release and foreclosure of Collateral) and the Intercreditor Agreements as the same may be in
effect or may be amended from time to time in accordance with their terms and this Indenture and the Intercreditor Agreements, and authorizes and directs the Notes/Term Collateral Agent to enter into the Collateral Documents and the Intercreditor
Agreements and to perform its obligations and exercise its rights thereunder in accordance therewith; provided, however, that if any of the provisions of the Collateral Documents limit, qualify or conflict with the duties imposed by
the provisions of the Trust Indenture Act, the Trust Indenture Act shall control. The Company shall deliver to the Notes/Term Collateral Agent copies of all documents pursuant to the Collateral Documents, and will do or cause to be done all such
acts and things as may be reasonably 
  

 118 

 
required by the next sentence of this Section 10.01, to assure and confirm to the Notes/Term Collateral Agent the security interest in the Collateral contemplated hereby, by the Collateral
Documents or any part thereof, as from time to time constituted, so as to render the same available for the security and benefit of this Indenture and of the Notes secured hereby, according to the intent and purposes herein expressed. The Company
shall, and shall cause the Subsidiaries of the Company to, use its and their commercially reasonable efforts to take any and all actions reasonably required to cause the Collateral Documents to create and maintain, as security for the Obligations
under the Notes, a valid and enforceable perfected Lien and security interest in and on all of the Collateral (subject to the terms of the Intercreditor Agreements), in favor of the Notes/Term Collateral Agent for the benefit of the Secured Parties.

 (b) Notwithstanding the foregoing, 

(1) the Capital Stock and other securities of the Subsidiaries of the Company that are owned by the Company or any
Guarantor will constitute Notes/Term Collateral only to the extent that such Capital Stock and other securities can secure the Series A-1 Notes and the Series A-2 Debt without Rule 3-16 of Regulation S-X under the Securities Act
(“Rule 3-16”) (or any other law, rule or regulation) requiring separate financial statements of such Subsidiary to be filed with the SEC (or any other governmental agency); 

(2) in the event that either Rule 3-16 requires or is amended, modified or interpreted by the SEC to require (or is
replaced with another rule or regulation, or any other law, rule or regulation is adopted, which would require) the filing with the SEC (or any other governmental agency) of separate financial statements of any Subsidiary (other than the Company)
due to the fact that such Subsidiary’s Capital Stock and other securities secure the Series A-1 Notes and/or the Series A-2 Debt, then the Capital Stock and other securities of such Subsidiary shall automatically be deemed not to be part of the
Notes/Term Collateral, but only to the extent necessary to not be subject to such requirement (and, in such event, the Collateral Documents may be amended or modified, without the consent of any holder of the Series A-1 Notes and the Series A-2
Debt, to the extent necessary to release the security interests in the shares of Capital Stock and other securities that are so deemed to no longer constitute part of the Notes/Term Collateral); and 

(3) in the event that either Rule 3-16 is amended, modified or interpreted by the SEC to permit (or is replaced with
another rule or regulation, or any other law, rule or regulation is adopted, which would permit) such Subsidiary’s Capital Stock and other securities to secure the Series A-1 Notes and the Series A-2 Debt in excess of the amount then pledged
without the filing with the SEC (or any other governmental agency) of separate financial statements of such Subsidiary, then the Capital Stock and other securities of such Subsidiary shall automatically be deemed to be a part of the Notes/Term
Collateral but only to the extent necessary to not be subject to any such financial statement requirement (and, in such event, the Collateral Documents may be amended or modified, without the consent of any Holder of the Notes, to the extent
necessary to subject to the Liens under the Collateral Documents such additional Capital Stock and other securities). 
 (c) In
addition to the limitations described in Section 10.01(b), the Notes/Term Collateral will not include (i) property or assets as to which the Notes/Term Collateral Agent has notified any Grantor in writing that it has reasonably determined
that the costs of obtaining a security interest are excessive in relation to the value of the security to be afforded thereby and (ii) the Excluded Assets. 
  

 119 

 (d) In the case of any Foreign Subsidiary, the Notes/Term Collateral will be limited to 65%
of the Capital Stock of first-tier Foreign Subsidiaries. 
 Section 10.02 Recordings and Opinions. 

The Company will comply with the provisions of § 314(b) of the Trust Indenture Act following qualification of this Indenture
pursuant to the Trust Indenture Act, except to the extent not required as set forth in any SEC regulation or interpretation (including any no-action letter issued by the Staff of the SEC, whether issued to the Company or any other Person), subject
to the requirements of the Trust Indenture Act. Following such qualification, to the extent the Company is required to furnish to the Trustee an Opinion of Counsel pursuant to Trust Indenture Act Section 314(b)(2), the Company will furnish such
opinion as required by such Section. 
 Section 10.03 Release of Collateral. 

(a) Subject to Sections 10.03(b) and 10.04 hereof, Collateral may be released from the Lien and security interest created by the
Collateral Documents at any time or from time to time in accordance with the provisions of the Collateral Documents, the Intercreditor Agreements or as provided hereby. The Company and the Guarantors will be entitled to a release of property and
other assets included in the Collateral from the Liens securing the Notes, and the Trustee (subject to its receipt of an Officer Certificate and Opinion of Counsel as provided below) shall release, or instruct the Notes/Term Collateral Agent to
release, as applicable, the same from such Liens at the Company’s sole cost and expense, under one or more of the following circumstances: 

(1) to enable the Company or any Guarantor to sell, exchange or otherwise dispose of any of the Collateral to the extent
not prohibited under Section 4.10 hereof; 
 (2) in the case of a Guarantor that is released from its
Guarantee with respect to all of the Notes, the release of the property and assets of such Guarantor; 
 (3)
pursuant to an amendment or waiver in accordance with Article 9 hereof; 
 (4) if all of the Notes have
been defeased pursuant to Article 8 hereof or discharged pursuant to Article 13 hereof; or 
 (5) upon payment
in full of the principal of, together with accrued and unpaid interest (including Additional Interest, if any) on, all of the Notes and all other Obligations related thereto under this Indenture, the Guarantees and the Collateral Documents that are
due and payable at or prior to the time such principal, together with accrued and unpaid interest (including Additional Interest, if any) are paid. 

(b) Subject to the provisions contained in the Intercreditor Agreements, the second-priority lien on the ABL Collateral securing the
Series A-1 Notes and the Series A-2 Debt shall remain in full force and effect notwithstanding the termination and repayment in full of the ABL Facility and the release by the ABL Collateral Agent of the first-priority liens on the ABL Collateral.
The second-priority lien on the ABL Collateral securing the Series A-1 Notes and the Series A-2 Debt shall terminate 

 

 120 

 
and be released automatically if the first-priority liens on the ABL Collateral are released by the ABL Collateral Agent (unless, at the time of such release of such first-priority liens, an
Event of Default shall have occurred and be continuing under this Indenture). Notwithstanding the existence of an Event of Default, the second-priority lien on the ABL Collateral securing the Series A-1 Notes and the Series A-2 Debt shall also
terminate and be released automatically to the extent the first-priority liens on the ABL Collateral are released by the ABL Collateral Agent in connection with a sale, transfer or disposition of ABL Collateral that is either not prohibited under
this Indenture and the Series A-2 Debt or occurs in connection with the foreclosure of, or other exercise of remedies with respect to, such ABL Collateral by the ABL Collateral Agent (except with respect to any proceeds of such sale, transfer or
disposition that remain after satisfaction in full of the ABL Lenders Debt). The liens on the Collateral securing the Series A-1 Notes and the Series A-2 Debt that otherwise would have been released pursuant to the second sentence of this paragraph
but for the occurrence and continuation of an Event of Default shall be released when such Event of Default and all other Events of Default under this Indenture and the Series A-2 Debt cease to exist. 

(c) Upon receipt of an Officer’s Certificate and an Opinion of Counsel certifying that all conditions precedent under this
Indenture and the Collateral Documents (and Section 314(d) of the Trust Indenture Act), if any, to such release have been met and any necessary or proper instruments of termination, satisfaction or release prepared by the Company, the Trustee
shall, or shall cause the Notes/Term Collateral Agent, to execute, deliver or acknowledge (at the Company’s expense) such instruments or releases to evidence the release of any Collateral permitted to be released pursuant to this Indenture or
the Collateral Documents or the Intercreditor Agreements. Neither the Trustee nor the Notes/Term Collateral Agent shall be liable for any such release undertaken in good faith in reliance upon any such Officer’s Certificate or Opinion of
Counsel, and notwithstanding any term hereof or in any Collateral Document to the contrary, the Trustee and Notes/Term Collateral Agent shall not be under any obligation to release any such Lien and security interest, or execute and deliver any such
instrument of release, satisfaction or termination, unless and until it receives such Officer’s Certificate and Opinion of Counsel. 

Section 10.04 Permitted Releases Not To Impair Lien; Trust Indenture Act Requirements. 

(a) To the extent applicable, the Company will cause § 313(b) of the Trust Indenture Act, relating to reports, and
§ 314(d) of the Trust Indenture Act, relating to the release of property or securities subject to the Lien of the Collateral Documents, to be complied with. 

(b) Any release of Collateral permitted by Section 10.03 hereof will be deemed not to impair the Liens under this Indenture, the
Security Agreement and the other Collateral Documents in contravention thereof. Any certificate or opinion required by § 314(d) of the Trust Indenture Act may be made by an officer or legal counsel, as applicable, of the Company except in cases
where § 314(d) of the Trust Indenture Act requires that such certificate or opinion be made by an independent Person, which Person will be an independent engineer, appraiser or other expert selected by or reasonably satisfactory to the
Trustee. 
 (c) Notwithstanding anything to the contrary in this Section 10.04, the Company will not be required to comply
with all or any portion of § 314(d) of the Trust Indenture Act if it determines, in good faith based on the written advice of counsel, a copy of which written advice shall be provided to the Trustee, that under the terms of
§ 314(d) of the Trust Indenture Act or any interpretation or guidance as to the meaning thereof of the SEC and its staff, including “no action” letters or exemptive orders, all or any portion of § 314(d) of the Trust
Indenture Act is inapplicable to any release or series of releases of Collateral. 
  

 121 

 Section 10.05 Certificates of the Trustee. 

In the event that the Company wishes to release Collateral in accordance with this Indenture, the Collateral Documents and the
Intercreditor Agreements and the Company has delivered the certificates and documents required by the Collateral Documents and Section 10.03 hereof, if § 314(d) of the Trust Indenture Act is applicable to such releases (the
applicability of which will be established to the reasonable satisfaction of the Trustee pursuant to Section 10.04 hereof or otherwise), the Trustee shall determine whether it has received all documentation required by § 314(d) of the
Trust Indenture Act in connection with such release (which determination may be based upon the Opinion of Counsel hereafter described) and, based on an Opinion of Counsel pursuant to Section 14.04 hereof, will deliver a certificate to the
Notes/Term Collateral Agent setting forth such determination. The Trustee, however, shall have no duty to confirm the legality, genuineness, accuracy, contents or validity of such documents (or any signature appearing therein), its sole duty being
to certify its receipt of such documents which, on their face (and assuming that they are what they purport to be), conform to § 314(d) of the Trust Indenture Act. 

Section 10.06 Suits To Protect the Collateral. 

Subject to the provisions of Article 7 hereof and the Intercreditor Agreements, the Trustee in its sole discretion and without the
consent of the Holders, on behalf of the Holders, may direct the Notes/Term Collateral Agent to take all actions it deems necessary or appropriate in order to: 

(1) enforce any of the terms of the Collateral Documents; and 

(2) collect and receive any and all amounts payable in respect of the Obligations hereunder. 

Subject to the provisions of the Collateral Documents and the Intercreditor Agreements, the Trustee shall have power to institute and to
maintain such suits and proceedings as it may deem expedient to prevent any impairment of the Collateral by any acts which may be unlawful or in violation of any of the Collateral Documents or this Indenture, and such suits and proceedings as the
Trustee, in its sole discretion, may deem expedient to preserve or protect its interests and the interests of the Holders in the Collateral (including power to institute and maintain suits or proceedings to restrain the enforcement of or compliance
with any legislative or other governmental enactment, rule or order that may be unconstitutional or otherwise invalid if the enforcement of, or compliance with, such enactment, rule or order would impair the Lien on the Collateral or be prejudicial
to the interests of the Holders or the Trustee). Nothing in this Section 10.06 shall be considered to impose any such duty or obligation to act on the part of the Trustee. 

Section 10.07 Authorization of Receipt of Funds by the Trustee Under the Collateral Documents. 

Subject to the provisions of the Intercreditor Agreements, the Trustee is authorized to receive any funds for the benefit of the Holders
distributed under the Collateral Documents, and to make further distributions of such funds to the Holders according to the provisions of this Indenture. 

Section 10.08 Purchaser Protected. 

In no event shall any purchaser in good faith of any property purported to be released hereunder be bound to ascertain the authority of
the Notes/Term Collateral Agent or the Trustee to execute the release or to inquire as to the satisfaction of any conditions required by the provisions 

 

 122 

 
hereof for the exercise of such authority or to see to the application of any consideration given by such purchaser or other transferee; nor shall any purchaser or other transferee of any
property or rights permitted by this Article 10 to be sold be under any obligation to ascertain or inquire into the authority of the Company or the applicable Guarantor to make any such sale or other transfer. 

Section 10.09 Powers Exercisable by Receiver or Trustee. 

In case the Collateral shall be in the possession of a receiver or trustee, lawfully appointed, the powers conferred in this
Article 10 upon the Company or a Guarantor with respect to the release, sale or other disposition of such property may be exercised by such receiver or trustee, and an instrument signed by such receiver or trustee shall be deemed the equivalent
of any similar instrument of the Company or a Guarantor or of any officer or officers thereof required by the provisions of this Article 10; and if the Trustee shall be in the possession of the Collateral under any provision of this Indenture,
then such powers may be exercised by the Trustee. 
 Section 10.10 Release Upon Termination of the Company’s Obligations.

 In the event that the Company delivers to the Trustee, in form and substance reasonably acceptable to it, an Officer’s
Certificate certifying that (i) payment in full of the principal of, together with accrued and unpaid interest (including Additional Interest, if any) on, all of the Notes and all other Obligations under this Indenture, the Guarantees and the
Collateral Documents that are due and payable at or prior to the time such principal, together with accrued and unpaid interest (including Additional Interest, if any), are paid or (ii) the Company shall have exercised its legal defeasance
option or its covenant defeasance option, in compliance with the provisions of Article 8, or its discharge option, in compliance with the provisions of Article 13 hereof, in each case with respect to all of the Notes, the Trustee shall
deliver to the Company and the Notes/Term Collateral Agent a notice stating that the Trustee, on behalf of the Holders, disclaims and gives up any and all rights it has in or to the Collateral (other than with respect to funds held by the Trustee
pursuant to Article 8 and Article 13), and any rights it has under the Collateral Documents, and upon receipt by the Notes/Term Collateral Agent of such notice, the Notes/Term Collateral Agent shall be deemed not to hold a Lien in the Collateral on
behalf of the Trustee and shall do or cause to be done all acts reasonably necessary to release such Lien as soon as is reasonably practicable. 

Section 10.11 Notes/Term Collateral Agent. 

(a) The Trustee and each of the Holders by acceptance of the Notes hereby designates and appoints the Notes/Term Collateral Agent as its
agent under this Indenture, the Security Agreement, the Collateral Documents and the Intercreditor Agreements and the Trustee and each of the Holders by acceptance of the Notes hereby irrevocably authorizes the Notes/Term Collateral Agent to take
such action on its behalf under the provisions of this Indenture, the Security Agreement, the Collateral Documents and the Intercreditor Agreements and to exercise such powers and perform such duties as are expressly delegated to the Notes/Term
Collateral Agent by the terms of this Indenture, the Security Agreement, the Collateral Documents and the Intercreditor Agreements, together with such powers as are reasonably incidental thereto. The provisions of this Section 10.11 are solely
for the benefit of the Notes/Term Collateral Agent and none of the Trustee, any of the Holders nor any of the Grantors shall have any rights as a third party beneficiary of any of the provisions contained herein other than as expressly provided in
Section 10.03. Notwithstanding any provision to the contrary contained elsewhere in this Indenture, the Security Agreement, the Collateral Documents and the Intercreditor Agreements, the Notes/Term Collateral Agent shall not have any duties or
responsibilities hereunder nor shall the Notes/Term Collateral Agent have or be deemed to have any fiduciary relationship with the Trustee, any Holder or any Grantor, and no implied covenants, functions, responsibilities, duties, obligations or

  

 123 

 
liabilities shall be read into this Indenture, the Security Agreement, the Collateral Documents and the Intercreditor Agreements or otherwise exist against the Notes/Term Collateral Agent.
Without limiting the generality of the foregoing sentence, the use of the term “agent” in this Indenture with reference to the Notes/Term Collateral Agent is not intended to connote any fiduciary or other implied (or express) obligations
arising under agency doctrine of any applicable law. Instead, such term is used merely as a matter of market custom, and is intended to create or reflect only an administrative relationship between independent contracting parties. Except as
expressly otherwise provided in this Indenture, the Notes/Term Collateral Agent shall have and may use its sole discretion with respect to exercising or refraining from exercising any discretionary rights or taking or refraining from taking any
actions which the Notes/Term Collateral Agent is expressly entitled to take or assert under this Indenture, the Security Agreement, the Collateral Documents and the Intercreditor Agreements, including the exercise of remedies pursuant to Article 6,
and any action so taken or not taken shall be deemed consented to by the Trustee and the Holders. 
 (b) None of the Notes/Term
Collateral Agent or any of its respective Affiliates shall (i) be liable for any action taken or omitted to be taken by any of them under or in connection with this Indenture or the transactions contemplated hereby (except for its own gross
negligence or willful misconduct) or under or in connection with the Security Agreement, any Collateral Document or the Intercreditor Agreements or the transactions contemplated thereby (except for its own gross negligence or willful misconduct), or
(ii) be responsible in any manner to any of the Trustee or any Holder for any recital, statement, representation, warranty, covenant or agreement made by the Company or any Grantor or Affiliate of any Grantor, or any officer or Related Person
thereof, contained in this or any Indenture, or in any certificate, report, statement or other document referred to or provided for in, or received by the Notes/Term Collateral Agent under or in connection with, this or any other Indenture, the
Security Agreement, the Collateral Documents or the Intercreditor Agreements, or the validity, effectiveness, genuineness, enforceability or sufficiency of this or any other Indenture, the Security Agreement, the Collateral Documents or the
Intercreditor Agreements, or for any failure of any Grantor or any other party to this Indenture, the Security Agreement, the Collateral Documents or the Intercreditor Agreements to perform its obligations hereunder or thereunder. None of the
Notes/Term Collateral Agent or any of its respective Affiliates shall be under any obligation to the Trustee or any Holder to ascertain or to inquire as to the observance or performance of any of the agreements contained in, or conditions of, this
or any other Indenture, the Security Agreement, the Collateral Documents or the Intercreditor Agreements or to inspect the properties, books, or records of any Grantor or any Grantor’s Affiliates. 

(c) The Notes/Term Collateral Agent and its respective Affiliates may make loans to, issue letters of credit for the account of, accept
deposits from, acquire equity interests in and generally engage in any kind of banking, trust, financial advisory, underwriting, or other business with any Grantor and its Affiliates as though it was not the Notes/Term Collateral Agent hereunder and
without notice to or consent of the Trustee. The Trustee and the Holders acknowledge that, pursuant to such activities, the Notes/Term Collateral Agent or its respective Affiliates may receive information regarding any Grantor or its Affiliates
(including information that may be subject to confidentiality obligations in favor of any such Grantor or such Affiliate) and acknowledge that the Notes/Term Collateral Agent shall not be under any obligation to provide such information to the
Trustee or the Holders. Nothing herein shall impose or imply any obligation on the part of the Notes/Term Collateral Agent to advance funds. 

(d) The Notes/Term Collateral Agent is authorized and directed to (i) enter into the Security Agreement and the Collateral
Documents, (ii) enter into the Intercreditor Agreements, (iii) bind the Holders on the terms as set forth in the Security Agreement and the Collateral Documents and the Intercreditor Agreements and (iv) perform and observe its
obligations under the Security Agreement and the Collateral Documents and the Intercreditor Agreements. 
  

 124 

 (e) The Trustee agrees that it shall not (and shall not be obliged to), and shall not
instruct the Notes/Term Collateral Agent to, unless specifically requested to do so by a majority of the Holders, take or cause to be taken any action to enforce its rights under this Indenture or against any Grantor, including the commencement of
any legal or equitable proceedings, to foreclose any Lien on, or otherwise enforce any security interest in, any of the Collateral. 

If at any time or times the Trustee shall receive (i) by payment, foreclosure, set-off or otherwise, any proceeds of Collateral or
any payments with respect to the Obligations arising under, or relating to, this Indenture, except for any such proceeds or payments received by the Trustee from the Notes/Term Collateral Agent pursuant to the terms of this Indenture, or
(ii) payments from the Notes/Term Collateral Agent in excess of the amount required to be paid to the Trustee pursuant to Article 6, the Trustee shall promptly turn the same over to the Notes/Term Collateral Agent, in kind, and with such
endorsements as may be required to negotiate the same to the Notes/Term Collateral Agent. 
 (f) The Trustee is each
Holder’s agent for the purpose of perfecting the Holders’ security interest in assets which, in accordance with Article 9 of the Uniform Commercial Code can be perfected only by possession. Should the Trustee obtain possession of any
such Collateral, upon request from the Company, the Trustee shall notify the Notes/Term Collateral Agent thereof, and, promptly upon the Notes/Term Collateral Agent’s request therefor shall deliver such Collateral to the Notes/Term Collateral
Agent or otherwise deal with such Collateral in accordance with the Notes/Term Collateral Agent’s instructions. 
 (g) The
Notes/Term Collateral Agent shall have no obligation whatsoever to the Trustee or any of the Holders to assure that the Collateral exists or is owned by any Grantor or is cared for, protected, or insured or has been encumbered, or that the
Notes/Term Collateral Agent’s Liens have been properly or sufficiently or lawfully created, perfected, protected, maintained or enforced or are entitled to any particular priority, or to determine whether all or the Grantor’s property
constituting collateral intended to be subject to the Lien and security interest of the Collateral Documents has been properly and completely listed or delivered, as the case may be, or the genuineness, validity, marketability or sufficiency thereof
or title thereto, or to exercise at all or in any particular manner or under any duty of care, disclosure, or fidelity, or to continue exercising, any of the rights, authorities, and powers granted or available to the Notes/Term Collateral Agent
pursuant to this Indenture, any Collateral Document or the Intercreditor Agreements, it being understood and agreed that in respect of the Collateral, or any act, omission, or event related thereto, the Notes/Term Collateral Agent may act in any
manner it may deem appropriate, in its sole discretion given the Notes/Term Collateral Agent’s own interest in the Collateral and that the Notes/Term Collateral Agent shall have no other duty or liability whatsoever to the Trustee or any Holder
as to any of the foregoing. 
 (h) No provision of this Indenture, the Security Agreement, the Intercreditor Agreements or any
Collateral Document shall require the Notes/Term Collateral Agent (or the Trustee) to expend or risk its own funds or otherwise incur any financial liability in the performance of any of its duties hereunder or thereunder or to take or omit to take
any action hereunder or thereunder or take any action at the request or direction of Holders (or the Trustee in the case of the Notes/Term Collateral Agent) if it shall have reasonable grounds for believing that repayment of such funds is not
assured to it. 
 (i) The Notes/Term Collateral Agent (i) shall not be liable for any action it takes or omits to take in
good faith which it reasonably believes to be authorized or within its rights or powers, or for any error of judgment made in good faith by a Responsible Officer, unless it is proved that the Notes/Term Collateral Agent was grossly negligent in
ascertaining the pertinent facts, (ii) shall not be liable for interest on any money received by it except as the Notes/Term Collateral Agent may agree in writing with the Company (and money held in trust by the Notes/Term Collateral Agent need
not be 
  

 125 

 
segregated from other funds except to the extent required by law), (iii) the Notes/Term Collateral Agent may consult with counsel of its selection and the advice or opinion of such counsel
as to matters of law shall be full and complete authorization and protection from liability in respect of any action taken, omitted or suffered by it in good faith and in accordance with the advice or opinion of such counsel. The grant of permissive
rights or powers to the Notes/Term Collateral Agent shall not be construed to impose duties to act. 
 (j) Neither the
Notes/Term Collateral Agent nor the Trustee shall be liable for delays or failures in performance resulting from acts beyond its control. Such acts shall include but not be limited to acts of God, strikes, lockouts, riots, acts of war, epidemics,
governmental regulations superimposed after the fact, fire, communication line failures, computer viruses, power failures, earthquakes or other disasters. Neither the Notes/Term Collateral Agent nor the Trustee shall be liable for any indirect,
special or consequential damages (included but not limited to lost profits) whatsoever, even if it has been informed of the likelihood thereof and regardless of the form of action. 

(k) The Trustee agrees that at such time when no loans under the Term Loan Facility are outstanding, or in the event that the Notes/Term
Collateral Agent resigns or is removed from its role as collateral agent, the Trustee shall act as Notes/Term Collateral Agent under the Intercreditor Agreements and other Collateral Documents for the benefit of the Trustee and the Holders of the
Series A-1 Notes and the Series A-2 Debt. 
 Section 10.12 Designations. 

Except as provided in the next sentence, for purposes of the provisions hereof and the Intercreditor Agreements requiring the Company to
designate Indebtedness for the purposes of the term “ABL Lenders Debt” or any other such designations hereunder or under the Intercreditor Agreements, any such designation shall be sufficient if the relevant designation is set forth in
writing, signed on behalf of the Company by an Officer and delivered to the Trustee, the Notes/Term Collateral Agent and the ABL Collateral Agent. For all purposes hereof and the Intercreditor Agreements, the Company hereby designates the
Obligations pursuant to the ABL Facility as “ABL Lenders Debt.” 
 ARTICLE 11 

GUARANTEES 
 Section 11.01
Guarantee. 
 Subject to this Article 11, from and after the Issue Date, each of the Guarantors hereby, jointly and
severally, unconditionally guarantees to each Holder of a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of this Indenture, the Notes or the
obligations of the Company hereunder or thereunder, that: (a) the principal of, premium or interest on, or Additional Interest in respect of the Notes shall be promptly paid in full when due, whether at maturity, by acceleration, redemption or
otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, and all other obligations of the Company to the Holders or the Trustee hereunder or thereunder shall be promptly paid in full or performed, all in
accordance with the terms hereof and thereof; and (b) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, that same shall be promptly paid in full when due or performed in accordance with the
terms of the extension or renewal, whether at stated maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors shall be jointly and severally
obligated to pay the same immediately. Each Guarantor agrees that this is a guarantee of payment and not a guarantee of collection. 
  

 126 

 The Guarantors hereby agree that their obligations hereunder shall be unconditional,
irrespective of the validity, regularity or enforceability of the Notes or this Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery
of any judgment against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Guarantor hereby waives diligence, presentment, demand of
payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever and covenants that this Guarantee shall not be
discharged except by complete performance of the obligations contained in the Notes, this Indenture and the Collateral Documents. 

Each Guarantor also agrees to pay any and all costs and expenses (including reasonable attorneys’ fees) incurred by the Trustee or
any Holder in enforcing any rights under this Section 11.01. 
 If any Holder or the Trustee is required by any court or
otherwise to return to the Company, the Guarantors or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Guarantors, any amount paid either to the Trustee or such Holder, this Guarantee, to
the extent theretofore discharged, shall be reinstated in full force and effect. 
 Each Guarantor agrees that it shall not be
entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. Each Guarantor further agrees that, as between the Guarantors, on the one
hand, and the Holders and the Trustee, on the other hand, (x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 hereof for the purposes of this Guarantee, notwithstanding any stay, injunction or other
prohibition preventing such acceleration in respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6 hereof, such obligations (whether or not due and
payable) shall forthwith become due and payable by the Guarantors for the purpose of this Guarantee. The Guarantors shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the
rights of the Holders under the Guarantees. 
 Each Guarantee shall remain in full force and effect and continue to be
effective should any petition be filed by or against the Company for liquidation, reorganization, should the Company become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be appointed for all or any
significant part of the Company’s assets, and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Notes are, pursuant to applicable law,
rescinded or reduced in amount, or must otherwise be restored or returned by any obligee on the Notes or Guarantees, whether as a “voidable preference,” “fraudulent transfer” or otherwise, all as though such payment or
performance had not been made. In the event that any payment or any part thereof, is rescinded, reduced, restored or returned, the Notes shall, to the fullest extent permitted by law, be reinstated and deemed reduced only by such amount paid and not
so rescinded, reduced, restored or returned. 
 In case any provision of any Guarantee shall be invalid, illegal or
unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
  

 127 

 The Guarantee issued by any Guarantor shall be a general senior secured obligation of such
Guarantor, and shall be pari passu in right of payment with all existing and future Senior Indebtedness of such Guarantor, if any, and senior in right of payment to all existing and future Subordinated Indebtedness of such Guarantor.

 Each payment to be made by a Guarantor in respect of its Guarantee shall be made without set-off, counterclaim, reduction or
diminution of any kind or nature. 
 Section 11.02 Limitation on Guarantor Liability. 

Each Guarantor, and by its acceptance of Notes, each Holder, hereby confirms that it is the intention of all such parties that the
Guarantee of such Guarantor not constitute a fraudulent transfer or conveyance for purposes of Bankruptcy Law, the Uniform Fraudulent Conveyance Act, the Uniform Fraudulent Transfer Act or any similar federal or state law to the extent applicable to
any Guarantee. To effectuate the foregoing intention, the Trustee, the Holders and the Guarantors hereby irrevocably agree that the obligations of each Guarantor shall be limited to the maximum amount as will, after giving effect to such maximum
amount and all other contingent and fixed liabilities of such Guarantor that are relevant under such laws and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in
respect of the obligations of such other Guarantor under this Article 11, result in the obligations of such Guarantor under its Guarantee not constituting a fraudulent conveyance or fraudulent transfer under applicable law. Each Guarantor that makes
a payment under its Guarantee shall be entitled upon payment in full of all guaranteed obligations under this Indenture to a contribution from each other Guarantor in an amount equal to such other Guarantor’s pro rata portion of such
payment based on the respective net assets of all the Guarantors at the time of such payment determined in accordance with GAAP. 

Section 11.03 Execution and Delivery. 

To evidence its Guarantee set forth in Section 11.01 hereof, each Guarantor hereby agrees that this Indenture shall be executed on
behalf of such Guarantor by its President, one of its Vice Presidents or one of its Assistant Vice Presidents. 
 Each
Guarantor hereby agrees that its Guarantee set forth in Section 11.01 hereof shall remain in full force and effect notwithstanding the absence of the endorsement of any notation of such Guarantee on the Notes. 

If an Officer whose signature is on this Indenture no longer holds that office at the time the Trustee authenticates the Note, the
Guarantee shall be valid nevertheless. 
 The delivery of any Note by the Trustee, after the authentication thereof hereunder,
shall constitute due delivery of the Guarantee set forth in this Indenture on behalf of the Guarantors. 
 If required by
Section 4.16 hereof, the Company shall cause any newly created or acquired Restricted Subsidiary that is not a Guarantor to comply with the provisions of Section 4.16 hereof, Section 4.17 hereof and this Article 11, to the extent
applicable. 
 Section 11.04 Subrogation. 

Each Guarantor shall be subrogated to all rights of Holders of Notes against the Company in respect of any amounts paid by any Guarantor
pursuant to the provisions of Section 11.01 
  

 128 

 
hereof; provided that, if an Event of Default has occurred and is continuing, no Guarantor shall be entitled to enforce or receive any payments arising out of, or based upon, such right of
subrogation until all amounts then due and payable by the Company under this Indenture or the Notes shall have been paid in full. 

Section 11.05 Benefits Acknowledged. 

Each Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by this
Indenture and that the guarantee and waivers made by it pursuant to its Guarantee are knowingly made in contemplation of such benefits. 

Section 11.06 Release of Guarantees. 

A Guarantee by a Guarantor shall be automatically and unconditionally released and discharged with respect to any Series of Notes, and no
further action by such Guarantor, the Company or the Trustee is required for the release of such Guarantor’s Guarantee, upon: 

(1) (A) any sale, exchange or transfer (by merger or otherwise) of the Capital Stock of such Guarantor, after which the
applicable Guarantor is no longer a Restricted Subsidiary, if such sale, exchange or transfer is made in compliance with the applicable provisions of this Indenture; 

(B) the release or discharge of the guarantee by such Guarantor of the ABL Facility or the guarantee which resulted in
the creation of such Guarantee, except a discharge or release by or as a result of payment under such guarantee; 

(C) the proper designation of any Restricted Subsidiary that is a Guarantor as an Unrestricted Subsidiary in accordance
with Section 4.07 hereof and the definition of “Unrestricted Subsidiary” in Section 1.01 hereof; or 

(D) the Company exercising its Legal Defeasance option or Covenant Defeasance option with respect to the Notes of such
series in accordance with Article 8 hereof or the Company’s obligations under this Indenture with respect to the Notes of such series being discharged in accordance with the terms of this Indenture; and 

(2) such Guarantor delivering to the Trustee an Officer’s Certificate and an Opinion of Counsel, each stating that
all conditions precedent provided for in this Indenture relating to such transaction have been complied with. 
  

 129 

 ARTICLE 12 

[RESERVED] 

ARTICLE 13 

SATISFACTION AND DISCHARGE 

Section 13.01 Satisfaction and Discharge. 

This Indenture shall be discharged and shall cease to be of further effect as to only the Series A-1 Notes, only the Series A-2 Notes (if
issued) or both Series of Notes collectively, when: 
 (1) either 

(a) all Series A-1 Notes and/or Series A-2 Notes, as applicable, theretofore authenticated and delivered, except lost,
stolen or destroyed Series A-1 Notes and/or Series A-2 Notes, as applicable, which have been replaced or paid and Series A-1 Notes and/or Series A-2 Notes, as applicable, for whose payment money has theretofore been deposited in trust, have been
delivered to the Trustee for cancellation; or 
 (b) all Series A-1 Notes and/or Series A-2 Notes, as
applicable, not theretofore delivered to the Trustee for cancellation have become due and payable by reason of the making of a notice of redemption or otherwise, shall become due and payable within one year or are to be called for redemption within
one year under arrangements satisfactory to the Trustee for the giving of notice of redemption by the Trustee in the name, and at the expense, of the Company and the Company or any Guarantor has irrevocably deposited or caused to be deposited with
the Trustee as trust funds in trust solely for the benefit of the Holders of the Series A-1 Notes and/or Series A-2 Notes, as applicable, cash in U.S. dollars, Government Securities, or a combination thereof, in such amounts as will be sufficient
without consideration of any reinvestment of interest to pay and discharge the entire indebtedness on the Series A-1 Notes and/or Series A-2 Notes, as applicable, not theretofore delivered to the Trustee for cancellation for principal, premium, if
any, and accrued interest to the date of maturity or redemption; 
 (2) no Default (other than that resulting
from borrowing funds to be applied to make such deposit or any similar and simultaneous deposit relating to other Indebtedness) with respect to this Indenture or the Series A-1 Notes and/or Series A-2 Notes, as applicable, shall have occurred and be
continuing on the date of such deposit or shall occur as a result of such deposit and such deposit will not result in a breach or violation of, or constitute a default under the ABL Facility, the Term Loan Facility or any other material agreement or
instrument (other than this Indenture) to which the Company or any Guarantor is a party or by which the Company or any Guarantor is bound (other than resulting from any borrowing of funds to be applied to make such deposit and any similar deposit
relating to other Indebtedness and the granting of liens in connection therewith); 
 (3) the Company has paid or
caused to be paid all sums payable by it under this Indenture; and 
  

 130 

 (4) the Company has delivered irrevocable instructions to the Trustee to
apply the deposited money toward the payment of the Series A-1 Notes and/or Series A-2 Notes, as applicable, at maturity or the redemption date, as the case may be. 

In addition, the Company must deliver an Officer’s Certificate and an Opinion of Counsel to the Trustee stating that all conditions
precedent to satisfaction and discharge have been satisfied. 
 Notwithstanding the satisfaction and discharge of this
Indenture, if money shall have been deposited with the Trustee pursuant to subclause (b) of clause (1) of this Section 13.01, the provisions of Section 13.02 and Section 8.06 hereof shall survive. 

Section 13.02 Application of Trust Money. 

Subject to the provisions of Section 8.06 hereof, all money deposited with the Trustee pursuant to Section 13.01 hereof shall
be held in trust and applied by it, in accordance with the provisions of the Series A-1 Notes and/or Series A-2 Notes, as applicable, and this Indenture, to the payment, either directly or through any Paying Agent (including the Company acting as
its own Paying Agent) as the Trustee may determine, to the Persons entitled thereto, of the principal (and premium and Additional Interest, if any) and interest for whose payment such money has been deposited with the Trustee; but such money need
not be segregated from other funds except to the extent required by law. 
 If the Trustee or Paying Agent is unable to apply
any money or Government Securities in accordance with Section 13.01 hereof by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such
application, the Company’s and any Guarantor’s obligations under this Indenture and the Series A-1 Notes and/or Series A-2 Notes, as applicable, shall be revived and reinstated as though no deposit had occurred pursuant to
Section 13.01 hereof; provided that if the Company has made any payment of principal of, premium and Additional Interest, if any, or interest on any Series A-1 Notes and/or Series A-2 Notes, as applicable, because of the reinstatement of
its obligations, the Company shall be subrogated to the rights of the Holders of such Series A-1 Notes and/or Series A-2 Notes, as applicable, to receive such payment from the money or Government Securities held by the Trustee or Paying Agent.

 ARTICLE 14 

MISCELLANEOUS 

Section 14.01 Trust Indenture Act Controls. 

Subject to Section 14.16 hereof, if any provision of this Indenture limits, qualifies or conflicts with the duties imposed by
Section 318(c) of the Trust Indenture Act, the imposed duties shall control. 
 Section 14.02 Notices. 

Any notice or communication by the Company, any Guarantor or the Trustee to the others is duly given if in writing and delivered in
person or mailed by first-class mail (registered or certified, return receipt requested), fax or overnight air courier guaranteeing next day delivery, to the others’ address: 

If to the Company and/or any Guarantor: 

c/o Apria Healthcare Group Inc. 

26220 Enterprise Court 

Lake Forest, California 92630 

Attention: General Counsel 

Fax No.: (949) 639-4332 
  

 131 

 If to the Trustee: 

U.S. Bank, National Association 

EP-MN-WS3C 
 60
Livingston Avenue 
 St. Paul MN 55107-1419 

Attention: Corporate Trust Services, Raymond S. Haverstock 

Fax No.: (651) 495-8097 

The Company, any Guarantor or the Trustee, by notice to the others, may designate additional or different addresses for subsequent
notices or communications. 
 All notices and communications (other than those sent to Holders) shall be deemed to have been
duly given: at the time delivered by hand, if personally delivered; five calendar days after being deposited in the mail, postage prepaid, if mailed by first-class mail; when receipt acknowledged, if faxed; and the next Business Day after timely
delivery to the courier, if sent by overnight air courier guaranteeing next day delivery; provided that any notice or communication delivered to the Trustee shall be deemed effective upon actual receipt thereof. 

Any notice or communication to a Holder shall be mailed by first-class mail, certified or registered, return receipt requested, or by
overnight air courier guaranteeing next day delivery to its address shown on the register kept by the Registrar. Any notice or communication shall also be so mailed to any Person described in Section 313(c) of the Trust Indenture Act, to the
extent required by the Trust Indenture Act. Failure to mail a notice or communication to a Holder or any defect in it shall not affect its sufficiency with respect to other Holders. 

If a notice or communication is mailed in the manner provided above within the time prescribed, it is duly given, whether or not the
addressee receives it. 
 If the Company mails a notice or communication to Holders, it shall mail a copy to the Trustee and
each Agent at the same time. 
 Section 14.03 Communication by Holders of Notes with Other Holders of Notes. 

Holders may communicate pursuant to Section 312(b) of the Trust Indenture Act with other Holders with respect to their rights under
this Indenture or the Notes. The Company, the Trustee, the Registrar and anyone else shall have the protection of Section 312(c) of the Trust Indenture Act. 

Section 14.04 Certificate and Opinion as to Conditions Precedent. 

Upon any request or application by the Company or any of the Guarantors to the Trustee to take any action under this Indenture, the
Company or such Guarantor, as the case may be, shall furnish to the Trustee: 
 (a) An Officer’s Certificate in form and
substance reasonably satisfactory to the Trustee (which shall include the statements set forth in Section 14.05 hereof) stating that, in the opinion of the signers, all conditions precedent and covenants, if any, provided for in this Indenture
relating to the proposed action have been satisfied; and 
  

 132 

 (b) An Opinion of Counsel in form and substance reasonably satisfactory to the Trustee
(which shall include the statements set forth in Section 14.05 hereof) stating that, in the opinion of such counsel, all such conditions precedent and covenants have been satisfied. 

Section 14.05 Statements Required in Certificate or Opinion. 

Each certificate or opinion with respect to compliance with a condition or covenant provided for in this Indenture (other than a
certificate provided pursuant to Section 4.04 hereof or Section 314(a)(4) of the Trust Indenture Act) shall comply with the provisions of Section 314(e) of the Trust Indenture Act and shall include: 

(a) a statement that the Person making such certificate or opinion has read such covenant or condition; 

(b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in
such certificate or opinion are based; 
 (c) a statement that, in the opinion of such Person, he or she has made such
examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with (and, in the case of an Opinion of Counsel, may be limited to reliance on an
Officer’s Certificate as to matters of fact); and 
 (d) a statement as to whether or not, in the opinion of such Person,
such condition or covenant has been complied with. 
 Section 14.06 Rules by Trustee and Agents. 

The Trustee may make reasonable rules for action by or at a meeting of Holders. The Registrar or Paying Agent may make reasonable rules
and set reasonable requirements for its functions. 
 Section 14.07 No Personal Liability of Directors, Officers, Employees and
Stockholders. 
 No director, officer, employee, incorporator or stockholder of the Company or any Guarantor or any of their
parent companies shall have any liability for any obligations of the Company or the Guarantors under the Notes, the Guarantees, this Indenture or the Collateral Documents or for any claim based on, in respect of, or by reason of such obligations or
their creation. Each Holder by accepting Notes waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes. 

Section 14.08 Governing Law. 

THIS INDENTURE, THE NOTES AND ANY GUARANTEE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

  

 133 

 Section 14.09 Waiver of Jury Trial. 

EACH OF THE COMPANY, THE GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND
ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS INDENTURE, THE NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

Section 14.10 Force Majeure. 

In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations under this
Indenture arising out of or caused by, directly or indirectly, forces beyond its reasonable control, including without limitation strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural
catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software or hardware) services. 

Section 14.11 No Adverse Interpretation of Other Agreements. 

This Indenture may not be used to interpret any other indenture, loan or debt agreement of the Company or its Restricted Subsidiaries or
of any other Person. Any such indenture, loan or debt agreement may not be used to interpret this Indenture. 
 Section 14.12
Successors. 
 All agreements of the Company in this Indenture and the Notes shall bind its successors. All agreements of
the Trustee in this Indenture shall bind their successors. All agreements of each Guarantor in this Indenture shall bind its successors, except as otherwise provided in Section 11.06 hereof. 

Section 14.13 Severability. 

In case any provision in this Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and
enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 14.14 Counterpart
Originals. 
 The parties may sign any number of copies of this Indenture. Each signed copy shall be an original, but all of
them together represent the same agreement. 
 Section 14.15 Table of Contents, Headings, etc. 

The Table of Contents, Cross-Reference Table and headings of the Articles and Sections of this Indenture have been inserted for
convenience of reference only, are not to be considered a part of this Indenture and shall in no way modify or restrict any of the terms or provisions hereof. 

Section 14.16 Qualification of Indenture. 

The Company and the Guarantors shall qualify this Indenture under the Trust Indenture Act in accordance with the terms and conditions of
the Registration Rights Agreement and shall 
  

 134 

 
pay all reasonable costs and expenses (including attorneys’ fees and expenses for the Company, the Guarantors and the Trustee) incurred in connection therewith, including, but not limited
to, costs and expenses of qualification of this Indenture and the Notes and printing this Indenture and the Notes. The Trustee shall be entitled to receive from the Company and the Guarantors any such Officer’s Certificates, Opinions of Counsel
or other documentation as it may reasonably request in connection with any such qualification of this Indenture under the Trust Indenture Act. The Trust Indenture Act shall not apply to this Indenture prior to such qualification, and all references
herein to compliance with the Trust Indenture Act refer to such compliance following any such qualification. 
 The Company has
elected to exclude the provisions of Section 315(d)(3) and 316(a)(1) of the Trust Indenture Act from this Indenture. Following the qualification of this Indenture under the Trust Indenture Act, to the extent any Term Loans remain outstanding at
that time, and to the extent any of the voting provisions set forth in Articles 6 and 9 hereof are deemed by any court or governmental authority to be inconsistent with the Trust Indenture Act, any action under this Indenture that requires the vote
or participation of the holders of the then outstanding Term Loans shall be taken without the participation of the holders of the Term Loans. 

Section 14.17 Intercreditor Agreements Govern. 

Reference is made to the ABL Intercreditor Agreement. Each Holder of a Note, by its acceptance of a Note, (a) consents to the
subordination of Liens provided for in the ABL Intercreditor Agreement, (b) agrees that it will be bound by and will take no actions contrary to the provisions of the ABL Intercreditor Agreement and (c) authorizes and instructs the
Notes/Term Collateral Agent to enter into the ABL Intercreditor Agreement as “Term Debt Collateral Agent,” and on behalf of such Holder. The foregoing provisions are intended as an inducement to the lenders under the ABL Facility to extend
credit and such lenders are intended third party beneficiaries of such provisions and the provisions of the ABL Intercreditor Agreement. 

Reference is made to the Notes/Term Intercreditor Agreement. Each Holder of a Note, by its acceptance of a Note, (a) consents to
the terms of the Notes/Term Intercreditor Agreement, including the priority of payment provisions provided for in the Notes/Term Intercreditor Agreement, (b) agrees that it will be bound by and will take no actions contrary to the provisions of
the Notes/Term Intercreditor Agreement and (c) authorizes and instructs the Notes/Term Collateral Agent to enter into the Notes/Term Intercreditor Agreement as “Notes/Term Collateral Agent,” and on behalf of such Holder. 

[Signatures on following page] 
  

 135 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed as of
the day and year first above written. 
  

					
	Very truly yours,
	
	APRIA HEALTHCARE GROUP INC. 
		
	By	 	 /s/ Chris A. Karkenny

		 	Name:	 	Chris A. Karkenny
		 	Title:	 	Executive Vice President and Chief Financial Officer
	
	 APRIA HEALTHCARE OF NEW YORK STATE, INC.

	 APRIA HEALTHCARE, INC.

	 APRIACARE MANAGEMENT SYSTEMS, INC.

	 APRIADIRECT.COM, INC.

	 CORAM, INC.

		
	By	 	 /s/ Robert S. Holcombe

		 	Name:	 	Robert S. Holcombe
		 	Title:	 	 Executive Vice President

General Counsel and Secretary

  

 Signature Page to Senior Secured Indenture 

			
	 CORAM ALTERNATE SITE SERVICES, INC.

	 CORAM CLINICAL TRIALS, INC.

	 CORAM HEALTHCARE CORPORATION OF ALABAMA

	 CORAM HEALTHCARE CORPORATION OF FLORIDA

	 CORAM HEALTHCARE CORPORATION OF GREATER D.C.

	 CORAM HEALTHCARE CORPORATION OF GREATER NEW YORK

	 CORAM HEALTHCARE CORPORATION OF INDIANA

	 CORAM HEALTHCARE CORPORATION OF MASSACHUSETTS

	 CORAM HEALTHCARE CORPORATION OF MICHIGAN

	 CORAM HEALTHCARE CORPORATION OF MISSISSIPPI

	 CORAM HEALTHCARE CORPORATION OF NEVADA

	 CORAM HEALTHCARE CORPORATION OF NEW YORK

	 CORAM HEALTHCARE CORPORATION OF NORTH TEXAS

	 CORAM HEALTHCARE CORPORATION OF NORTHERN CALIFORNIA

	 CORAM HEALTHCARE CORPORATION OF SOUTH CAROLINA

	 CORAM HEALTHCARE CORPORATION OF SOUTHERN CALIFORNIA

	 CORAM HEALTHCARE CORPORATION OF SOUTHERN FLORIDA

	 CORAM HEALTHCARE CORPORATION OF UTAH

	 CORAM HEALTHCARE OF WYOMING, L.L.C.

	 CORAM HOMECARE OF MINNESOTA, INC.

	 CORAM SERVICE CORPORATION

	 CORAM SPECIALTY INFUSION SERVICES, INC.

	 CORAMRX, LLC

	 H.M.S.S., INC.

	 HEALTHINFUSION, INC.

	
T2
MEDICAL, INC.

		
	By	 	 /s/ Michael E. Dell

	Name:	 	Michael E. Dell
	Title:	 	V.P., General Counsel & Secretary

  

 Signature Page to Senior Secured Indenture 

					
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:	 	 /s/ Raymond S. Haverstock

		 	Name:	 	Raymond S. Haverstock
		 	Title:	 	Vice President

  

 Signature Page to Senior Secured Indenture 

 EXHIBIT A 

[Face of Note] 

[Insert the Global Note Legend, if applicable pursuant to the provisions of the Indenture] 

[Insert the Private Placement Legend, if applicable pursuant to the provisions of the Indenture] 

[Insert the Regulation S Temporary Global Note Legend, if applicable pursuant to the provisions of the Indenture] 

[Insert the Original Issue Discount Legend, if applicable pursuant to the provisions of the Indenture] 

 

 A-1 

					
		  	CUSIP	  	[037933 AD0]
		  	ISIN	  	[US037933AD09]

 [[RULE 144A][REGULATION S]
GLOBAL NOTE 
 representing up to 

$[            ] 

11.25% Senior Secured Notes due 2014 (Series A-1) 

(“Series A-1 Notes”) 
  

			
	 No. [    ]
	 	[$                    ]

APRIA HEALTHCARE GROUP INC. 

promises to pay to CEDE & CO. or registered assigns, the principal sum [of
                     United States Dollars] [, as revised by the Schedule of Exchanges of Interests in the Global Note attached hereto,] on
November 1, 2014. 
 Series A-1 Notes Interest Payment Dates: May 1 and November 1 

Series A-1 Notes Record Dates: April 15 and October 15 
  

 A-2 

 IN WITNESS HEREOF, Apria Healthcare Group Inc. has caused this instrument to be duly
executed. 
 Dated: 
  

			
	APRIA HEALTHCARE GROUP INC.
		
	By:	 	  

		 	Name:
		 	Title:

  

 A-3 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Series A-1 Notes referred to in the within-mentioned Indenture: 

Dated: 
  

			
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		 	Authorized Signatory

  

 A-4 

 [Back of Note] 

11.25% Senior Secured Notes due 2014 (Series A-1) 

(“Series A-1 Notes”) 

Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated.

 1. INTEREST. Apria Healthcare Group Inc., a Delaware corporation, promises to pay interest on the principal amount of this
Series A-1 Note at 11.25% per annum from May 27, 2009 until maturity and shall pay the Additional Interest, if any, payable pursuant to the Registration Rights Agreement referred to below. The Company will pay interest and Additional
Interest, if any, semi-annually in arrears on May 1 and November 1 of each year, or if any such day is not a Business Day, on the next succeeding Business Day (each, a “Series A-1 Notes Interest Payment Date”). Interest on
the Series A-1 Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid, from the date of issuance; provided that the first Series A-1 Notes Interest Payment Date shall be November 1,
2009. The Company will pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at the interest rate on the Series A-1 Notes to the extent
lawful; it shall pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest and Additional Interest, if any (without regard to any applicable grace periods) from time to time on
demand at the interest rate on the Series A-1 Notes to the extent lawful. Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months. 

2. METHOD OF PAYMENT. The Company will pay interest on the Series A-1 Notes and Additional Interest, if any, to the Persons who are
registered Holders of Series A-1 Notes at the close of business on the April 15 or October 15 (whether or not a Business Day), as the case may be, next preceding the Series A-1 Notes Interest Payment Date, even if such Series A-1 Notes are
cancelled after such record date and on or before such Series A-1 Notes Interest Payment Date, except as provided in Section 2.12 of the Indenture with respect to defaulted interest. Payment of interest and Additional Interest, if any, may be
made by check mailed to the Holders at their addresses set forth in the register of Holders; provided that payment by wire transfer of immediately available funds will be required with respect to principal of and interest, premium and
Additional Interest, if any, on, all Global Notes and all other Series A-1 Notes the Holders of which shall have provided wire transfer instructions to the Company or the Paying Agent. Such payment shall be in such coin or currency of the United
States of America as at the time of payment is legal tender for payment of public and private debts. 
 3. PAYING AGENT AND
REGISTRAR. Initially U.S. Bank National Association, the Trustee under the Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to the Holders. The Company or any of its Subsidiaries
may act in any such capacity. 
 4. INDENTURE. The Company issued the Series A-1 Notes under an Indenture, dated as of
May 27, 2009 (the “Indenture”), among Apria Healthcare Group Inc., the Guarantors named therein and the Trustee. This Series A-1 Note is one of a duly authorized issue of notes of the Company, designated as its 11.25% Senior
Secured Notes due 2014 (Series A-1). The Company shall be entitled to issue Additional Notes that are Series A-1 Notes pursuant to Section 2.01, Section 4.09 and Section 4.12 of the Indenture. The terms of the Series A-1 Notes include
those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). The Series A-1 Notes are subject to all such terms, and Holders are referred
to the Indenture and the Trust Indenture Act for a statement of such terms. To the extent any provision of this Series A-1 Note conflicts with the express provisions of the Indenture, the provisions of the Indenture shall govern and be controlling.

  

 A-5 

 5. OPTIONAL REDEMPTION. 

(a) Except as described below under clauses 5(b) and 5(c) hereof, the Series A-1 Notes will not be redeemable at the Company’s
option prior to November 1, 2011. 
 (b) At any time prior to November 1, 2011, the Company may redeem all or a part
of the Series A-1 Notes, upon not less than 30 nor more than 60 days prior notice mailed by first-class mail to the registered address of each Holder or otherwise delivered in accordance with the procedures of DTC, at a redemption price equal to
100% of the principal amount of the Series A-1 Notes redeemed plus the Series A-1 Notes Applicable Premium as of, and accrued and unpaid interest and Additional Interest, if any, to the date of redemption (the “Series A-1 Notes Redemption
Date”), subject to the rights of Holders on the relevant Series A-1 Notes Record Date to receive interest due on the relevant Series A-1 Notes Interest Payment Date. 

(c) Until November 1, 2011, the Company may, at its option, redeem up to 35% of the aggregate principal amount of Series A-1 Notes
issued by it at a redemption price equal to 111.25% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-1 Notes Redemption Date, subject to the right of
Holders of Series A-1 Notes of record on the relevant Series A-1 Notes Record Date to receive interest due on the relevant Series A-1 Notes Interest Payment Date, with the net cash proceeds of one or more Equity Offerings; provided that at
least 65% of the aggregate principal amount of Series A-1 Notes originally issued under the Indenture and any Additional Notes that are Series A-1 Notes issued under the Indenture after the Issue Date (excluding Series A-1 Notes and Additional Notes
that are Series A-1 Notes held by the Company or Subsidiaries or Affiliates of the Company) remains outstanding immediately after the occurrence of each such redemption; provided further that each such redemption occurs within 180 days
of the date of closing of each such Equity Offering. Notice of any redemption upon any Equity Offering may be given prior to the completion thereof, and any such redemption or notice may, at the Company’s discretion, be subject to one or more
conditions precedent, including, but not limited to, the completion of the related Equity Offering. 
 (d) On and after
November 1, 2011, the Company may redeem the Series A-1 Notes, in whole or in part, upon not less than 30 nor more than 60 days prior notice by first-class mail, postage prepaid, with a copy to the Trustee, to each Holder of Series A-1 Notes at
the address of such Holder appearing in the security register, at the redemption prices (expressed as percentages of principal amount of the Series A-1 Notes to be redeemed) set forth below, plus accrued and unpaid interest thereon and Additional
Interest, if any, to the applicable Series A-1 Notes Redemption Date, subject to the right of Holders of Series A-1 Notes of record on the relevant Series A-1 Notes Record Date to receive interest due on the relevant Series A-1 Notes Interest
Payment Date, if redeemed during the twelve-month period beginning on November 1 of each of the years indicated below: 
  

				
	 Year
	  	Percentage	 
		
	 2011
	  	105.625	% 
	 2012
	  	102.813	% 
	 2013 and thereafter
	  	100.000	% 

  

 A-6 

 (e) If the Company redeems less than all of the outstanding Series A-1 Notes, the Trustee
shall select the Series A-1 Notes to be redeemed in the manner described under Section 3.02 of the Indenture. 
 (f) Any
redemption pursuant to this paragraph 5 shall be made pursuant to the provisions of Sections 3.01 through 3.06 of the Indenture. 

6. MANDATORY REDEMPTION. The Company shall not be required to make mandatory redemption or sinking fund payments with respect to the
Series A-1 Notes. 
 7. NOTICE OF REDEMPTION. Subject to Section 3.03 of the Indenture, notice of redemption will be mailed
by first-class mail at least 30 days but not more than 60 days prior to the redemption date (except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with Article 8 or Article 13
of the Indenture) to each Holder whose Series A-1 Notes are to be redeemed at its registered address. Series A-1 Notes in denominations larger than $2,000 may be redeemed in part but only in integral multiples of $1,000 in excess thereof, unless all
of the Series A-1 Notes held by a Holder are to be redeemed. Subject to Section 3.05 of the Indenture, on and after the redemption date, interest will cease to accrue on Series A-1 Notes or portions thereof called for redemption. 

8. OFFERS TO REPURCHASE. 

(a) Upon the occurrence of a Change of Control, the Company shall make an offer (a “Change of Control Offer”) to each
Holder to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of each Holder’s Series A-1 Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof plus accrued and
unpaid interest and Additional Interest thereon, if any, to the date of purchase (the “Change of Control Payment”), subject to the right of the Holders of the Series A-1 Notes of record on the relevant applicable Record Date to
receive interest due on the relevant applicable Interest Payment Date. The Change of Control Offer shall be made in accordance with Section 4.14 of the Indenture. 

(b) If the Company or any of its Restricted Subsidiaries consummates an Asset Sale, within ten Business Days of each date that the
aggregate amount of Excess Proceeds exceeds $30.0 million, the Company shall make an offer to all Holders of the Series A-1 Notes and, if required by the terms of any Indebtedness that is pari passu with the Series A-1 Notes or any Guarantee
(including any Series A-2 Debt) (“Pari Passu Indebtedness”), to the holders of such Pari Passu Indebtedness (an “Asset Sale Offer”), to purchase the maximum aggregate principal amount of Series A-1 Notes (including
any Additional Notes which are Series A-1 Notes) and such other Pari Passu Indebtedness that may be purchased out of the Excess Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid
interest and Additional Interest thereon, if any, to the date fixed for the closing of such offer, in accordance with the procedures set forth in the Indenture. The Asset Sale Offer shall be made in accordance with Sections 3.09 and 4.10 of the
Indenture. 
 9. DENOMINATIONS, TRANSFER, EXCHANGE. The Series A-1 Notes are in registered form without coupons in denominations
of $2,000 and integral multiples of $1,000 in excess thereof. The transfer of Series A-1 Notes may be registered and Series A-1 Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other
things, to furnish appropriate endorsements and transfer documents and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Series A-1
Notes or portion of a Series A-1 Note selected for redemption, except for the unredeemed portion of any Series A-1 Notes being redeemed in part. 
  

 A-7 

 Also, the Company need not exchange or register the transfer of any Series A-1 Notes for a
period of 15 days before a selection of Series A-1 Notes to be redeemed. 
 10. SECURITY. The Series A-1 Notes will be secured
by the Collateral on the terms and subject to the conditions set forth in the Indenture and the Collateral Documents. The Notes/Term Collateral Agent holds the Collateral in trust for the benefit of the Secured Parties pursuant to the Collateral
Documents and the Intercreditor Agreements. Each Holder, by accepting this Series A-1 Note, consents and agrees to the terms of the Collateral Documents (including the provisions providing for the foreclosure and release of Collateral) and the
Intercreditor Agreements as the same may be in effect or may be amended from time to time in accordance with their terms and the Indenture and authorizes and directs the Trustee and/or the Notes/Term Collateral Agent, as applicable, to enter into
the Collateral Documents and the Intercreditor Agreements, and to perform its obligations and exercise its rights thereunder in accordance therewith. 

11. PERSONS DEEMED OWNERS. The registered Holder of a Series A-1 Note may be treated as its owner for all purposes. 

12. AMENDMENT, SUPPLEMENT AND WAIVER. The Indenture, the Collateral Documents, the Guarantees or the Series A-1 Notes may be amended or
supplemented as provided in the Indenture. 
 13. DEFAULTS AND REMEDIES. If an Event of Default with respect to the Series A-1
Notes shall occur and be continuing, the principal, premium, if any, interest and any other monetary obligations on all then outstanding Series A-1 Notes may be declared due and payable in the manner and with the effect provided in the Indenture.

 14. PRIORITIES OF PAYMENT AS BETWEEN SERIES A-1 NOTES AND SERIES A-2 DEBT. The Series A-1 Notes, the Series A-2 Notes (if
issued) and any Term Loans then outstanding will vote together as a single class for all purposes under the Indenture to the extent provided in Article 6 and Article 9 thereof. The Holders of the Series A-1 Notes shall be entitled to a priority of
payment over the holders of the Series A-2 Debt in the circumstances described in the Notes/Term Intercreditor Agreement. The Holders of Series A-1 Notes, the Bridge Loan Agent, the holders of Series A-2 Debt, the Trustee, the Notes/Term Collateral
Agent and the Company have agreed (or are deemed to have agreed) to certain other intercreditor arrangements in the Notes/Term Intercreditor Agreement pursuant to which Holders of Notes are bound. 

15. GUARANTEES. The Company’s obligations under the Series A-1 Notes are fully and unconditionally guaranteed, jointly and
severally, by the Guarantors. 
 16. AUTHENTICATION. This Series A-1 Note shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose until authenticated by the manual signature of the Trustee. 
 17.
ADDITIONAL RIGHTS OF HOLDERS OF RESTRICTED GLOBAL NOTES AND RESTRICTED DEFINITIVE NOTES. In addition to the rights provided to Holders of Series A-1 Notes under the Indenture, Holders of Restricted Global Notes and Restricted Definitive Notes, in
each case, that are Series A-1 Notes, shall have all the rights set forth in the Registration Rights Agreement, dated as of May 27, 2009, among Apria Healthcare Group Inc., the Guarantors named therein and the other parties named on the
signature pages thereof (the “Registration Rights Agreement”), including the right to receive Additional Interest (as defined in the Registration Rights Agreement). 

 

 A-8 

 18. GOVERNING LAW. THE INDENTURE, THE SERIES A-1 NOTES AND ANY GUARANTEE WILL BE GOVERNED BY
AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 19. CUSIP AND ISIN NUMBERS. Pursuant to a recommendation
promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP and ISIN numbers to be printed on the Series A-1 Notes and the Trustee may use CUSIP and ISIN numbers in notices of redemption as a convenience
to Holders. No representation is made as to the accuracy of such numbers either as printed on the Series A-1 Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon.

 The Company will furnish to any Holder upon written request and without charge a copy of the Indenture and/or the
Registration Rights Agreement. Requests may be made to the Company at the following address: 
 c/o Apria Healthcare Group Inc.

 26220 Enterprise Court 

Lake Forest, California 92630 

Facsimile: (949) 639-4332 

Attention: General Counsel 
  

 A-9 

 ASSIGNMENT FORM 

To assign this Series A-1 Note, fill in the form below: 
  

			
	(I) or (we) assign and transfer this Series A-1 Note to:	  	  

		  	(Insert assignee’ legal name)

	
	  

	(Insert assignee’s soc. sec. or tax I.D. no.)

  

 
  

 
  

 
  

 
 (Print or type assignee’s
name, address and zip code) 
  

			
	and irrevocably appoint	  	  

to transfer this Series A-1 Note on the books of the Company. The agent may substitute another to act for him. 

Date:
                     
  

			
	Your Signature:	 	  

		 	(Sign exactly as your name appears on the face of this Series A-1 Note)

  

					
	 Signature Guarantee:*
	 	  

 
  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

 

 A-10 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Series A-1 Note purchased by the Company pursuant to Section 4.10 or 4.14 of the Indenture, check
the appropriate box below: 

 ̈  Section 4.10    
 ̈  Section 4.14 
 If you want to elect to have only part of this
Series A-1 Note purchased by the Company pursuant to Section 4.10 or Section 4.14 of the Indenture, state the amount you elect to have purchased: 

$                      
                                       

Date:                      

 

			
	Your Signature:	 	  

		 	(Sign exactly as your name appears on the face of this Series A-1 Note)

  

			
	 Tax Identification No.:
	 	  

		
	 Signature Guarantee:*
	 	  

 
  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

 

 A-11 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE* 

The initial outstanding principal amount of this Global Note is
$[            ]. The following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Note, or exchanges of a part of another Global or
Definitive Note for an interest in this Global Note, have been made: 
  

									
	 Date of Exchange
	  	Amount of
Decrease in
Principal Amount	  	Amount of
Increase in
Principal Amount
of this Global
Note	  	Principal Amount
of this Global
Note following
such Decrease or
Increase	  	Signature of
Authorized
Officer of Trustee
or Custodian
		  		  		  		  	

  
  

	*	This schedule should be included only if the Series A-1 Note is issued in global form. 

 

 A-12 

 EXHIBIT B 

FORM OF CERTIFICATE OF TRANSFER 

Apria Healthcare Group Inc. 
 26220 Enterprise
Court 
 Lake Forest, California 92630 

Attention: General Counsel 
 Fax No.:
(949) 639-4332 
 U.S. Bank, National Association 

EP-MN-WS3C 
 60 Livingston Avenue 

St. Paul MN 55107-1419 
 Fax No.:
(651) 495-8097 
 Attention: Corporate Trust Services 
  

	 	Re:	[Series A-1 Notes] [Series A-2 Notes] 

Reference is hereby made to the Indenture, dated as of May 27, 2009 (the “Indenture”), among Apria Healthcare Group
Inc., the Guarantors named therein and the Trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. 

(the “Transferor”) owns and proposes to transfer the Note[s] or interest in such Note[s] specified in Annex A and/or
Annex B hereto, in the principal amount of $ in such Note[s] or interests (the “Transfer”), to (the “Transferee”), as further specified in Annex A and/or Annex B hereto. In connection with the Transfer, the
Transferor hereby certifies that: 
 [CHECK ALL THAT APPLY] 

1.     ̈    CHECK IF TRANSFEREE WILL TAKE DELIVERY
OF A BENEFICIAL INTEREST IN THE 144A GLOBAL NOTE OR A DEFINITIVE NOTE PURSUANT TO RULE 144A. The Transfer is being effected pursuant to and in accordance with Rule 144A under the United States Securities Act of 1933, as amended (the
“Securities Act”), and, accordingly, the Transferor hereby further certifies that the beneficial interest or Definitive Note is being transferred to a Person that the Transferor reasonably believes is purchasing the beneficial
interest or Definitive Note for its own account, or for one or more accounts with respect to which such Person exercises sole investment discretion, and such Person and each such account is a “qualified institutional buyer” within the
meaning of Rule 144A in a transaction meeting the requirements of Rule 144A and such Transfer is in compliance with any applicable blue sky securities laws of any state of the United States. 

2.     ̈    CHECK IF TRANSFEREE WILL TAKE DELIVERY
OF A BENEFICIAL INTEREST IN THE REGULATION S GLOBAL NOTE OR A DEFINITIVE NOTE PURSUANT TO REGULATION S. The Transfer is being effected pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act and, accordingly, the Transferor
hereby further certifies that (i) the Transfer is not being made to a person in the United States and (x) at the time the buy order was originated, the Transferee was outside the United States or such Transferor and any Person acting on
its behalf reasonably believed and believes that the Transferee was outside the United States or (y) the transaction was executed in, on or through the facilities of a designated offshore securities market and neither such Transferor nor any
Person acting on its behalf knows that the transaction was prearranged with a buyer in the United States, (ii) no directed selling efforts have been made in contravention of the 

 

 B-1 

 
requirements of Rule 903(b) or Rule 904(b) of Regulation S under the Securities Act (iii) the transaction is not part of a plan or scheme to evade the registration requirements of the
Securities Act and (iv) if the proposed transfer is being made prior to the expiration of the Restricted Period, the transfer is not being made to a U.S. Person or for the account or benefit of a U.S. Person (other than an Initial Purchaser).
Upon consummation of the proposed transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will be subject to the restrictions on Transfer enumerated in the Indenture and the Securities Act.

 3.     ̈    CHECK AND COMPLETE IF
TRANSFEREE WILL TAKE DELIVERY OF A BENEFICIAL INTEREST IN THE DEFINITIVE NOTE PURSUANT TO ANY PROVISION OF THE SECURITIES ACT OTHER THAN RULE 144A OR REGULATION S. The Transfer is being effected in compliance with the transfer restrictions
applicable to beneficial interests in Restricted Global Notes and Restricted Definitive Notes and pursuant to and in accordance with the Securities Act and any applicable blue sky securities laws of any state of the United States, and accordingly
the Transferor hereby further certifies that (check one): 

(a)     ̈    such Transfer is being effected
pursuant to and in accordance with Rule 144 under the Securities Act; 
 or 

(b)     ̈    such Transfer is being effected to
the Company or a subsidiary thereof; 
 or 

(c)     ̈    such Transfer is being effected
pursuant to an effective registration statement under the Securities Act and in compliance with the prospectus delivery requirements of the Securities Act. 

4.     ̈    CHECK IF TRANSFEREE WILL TAKE DELIVERY
OF A BENEFICIAL INTEREST IN AN UNRESTRICTED GLOBAL NOTE OR OF AN UNRESTRICTED DEFINITIVE NOTE. 

(a)     ̈    CHECK IF TRANSFER IS PURSUANT TO
RULE 144. (i) The Transfer is being effected pursuant to and in accordance with Rule 144 under the Securities Act and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities laws of any
state of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in
accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will no longer be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global Notes, on
Restricted Definitive Notes and in the Indenture. 

(b)     ̈    CHECK IF TRANSFER IS PURSUANT TO
REGULATION S. (i) The Transfer is being effected pursuant to and in accordance with Rule 903 or Rule 904 under the Securities Act and in compliance with the transfer restrictions contained in the Indenture and any applicable blue sky securities
laws of any state of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act. Upon consummation of the proposed
Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will no longer be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Global
Notes, on Restricted Definitive Notes and in the Indenture. 
  

 B-2 

(c)     ̈    CHECK IF TRANSFER IS PURSUANT TO
OTHER EXEMPTION. (i) The Transfer is being effected pursuant to and in compliance with an exemption from the registration requirements of the Securities Act other than Rule 144, Rule 903 or Rule 904 and in compliance with the transfer
restrictions contained in the Indenture and any applicable blue sky securities laws of any State of the United States and (ii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to
maintain compliance with the Securities Act. Upon consummation of the proposed Transfer in accordance with the terms of the Indenture, the transferred beneficial interest or Definitive Note will not be subject to the restrictions on transfer
enumerated in the Private Placement Legend printed on the Restricted Global Notes or Restricted Definitive Notes and in the Indenture. 

This certificate and the statements contained herein are made for your benefit and the benefit of the Company. 

 

			
	[Insert Name of Transferor]
		
	By:	 	  

		 	Name:
		 	Title:

 Dated:
                     
  

 B-3 

 ANNEX A TO CERTIFICATE OF TRANSFER 

 

									
	1.	  	The Transferor owns and proposes to transfer the following:
	
	[CHECK ONE OF (a) OR (b)]
				
		  	(a)	  	 ̈	  	a beneficial interest in the:
					
		  		  	(i)	  	 ̈	  	144A Global Note representing Series A-1 Notes (CUSIP 037933AD0), or
					
		  		  	(ii)	  	 ̈	  	Regulation S Global Note representing Series A-1 Notes (CUSIP U03846AB5), or
				
		  	(b)	  	 ̈	  	a Restricted Definitive Note representing Series A-1 Notes.
		
	2.	  	After the Transfer the Transferee will hold:
	
	[CHECK ONE]
				
		  	(a)	  	 ̈	  	a beneficial interest in the:
					
		  		  	(i)	  	 ̈	  	144A Global Note representing Series A-1 Notes (CUSIP 037933AD0), or
					
		  		  	(ii)	  	 ̈	  	Regulation S Global Note representing Series A-1 Notes (CUSIP U03846AB5), or
					
		  		  	(iii)	  	 ̈	  	Unrestricted Global Note representing Series A-1 Notes (CUSIP 037933AE8); or
				
		  	(b)	  	 ̈	  	a Restricted Definitive Note representing Series A-1 Notes, or
				
		  	(c)	  	 ̈	  	an Unrestricted Definitive Note representing Series A-1 Notes, in accordance with the terms of the Indenture.

 

 B-4 

 ANNEX B TO CERTIFICATE OF TRANSFER 

 

									
	1.	  	The Transferor owns and proposes to transfer the following:
	
	[CHECK ONE OF (a) OR (b)]
				
		  	(a)	  	 ̈	  	a beneficial interest in the:
					
		  		  	(i)	  	 ̈	  	144A Global Note representing Series A-2 Notes (CUSIP [        ]), or
					
		  		  	(ii)	  	 ̈	  	Regulation S Global Note representing Series A-2 Notes (CUSIP [        ]).
				
		  	(b)	  	 ̈	  	a Restricted Definitive Note representing Series A-2 Notes.
		
	2.	  	After the Transfer the Transferee will hold:
	
	[CHECK ONE]
				
		  	(a)	  	 ̈	  	a beneficial interest in the:
					
		  		  	(i)	  	 ̈	  	144A Global Note representing Series A-2 Notes (CUSIP [        ]), or
					
		  		  	(ii)	  	 ̈	  	Regulation S Global Note representing Series A-2 Notes (CUSIP [        ]), or
					
		  		  	(iii)	  	 ̈	  	Unrestricted Global Note representing Series A-2 Notes (CUSIP [        ]).
				
		  	(b)	  	 ̈	  	a Restricted Definitive Note representing Series A-2 Notes.
				
		  	(c)	  	 ̈	  	an Unrestricted Definitive Note representing Series A-2 Notes, in accordance with the terms of the Indenture.

 

 B-5 

 EXHIBIT C 

FORM OF CERTIFICATE OF EXCHANGE 

Apria Healthcare Group Inc. 
 26220 Enterprise
Court 
 Lake Forest, California 92630 

Attention: General Counsel 
 Fax No.:
(949) 639-4332 
 U.S. Bank, National Association 

EP-MN-WS3C 
 60 Livingston Avenue 

St. Paul MN 55107-1419 
 Fax No.:
(651) 495-8097 
 Attention: Corporate Trust Services 
  

	 	Re:	[Series A-1 Notes] [Series A-2 Notes] 

Reference is hereby made to the Indenture, dated as of May 27, 2009 (the “Indenture”), among Apria Healthcare Group
Inc., the Guarantors named therein and the Trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture. NO SERIES A-1 NOTE, OR ANY INTEREST THEREIN, MAY BE TRANSFERRED, REPLACED OR EXCHANGED FOR A
SERIES A-2 NOTE, OR ANY INTEREST THEREIN, AND NO SERIES A-2 NOTE, OR ANY INTEREST THEREIN, MAY BE TRANSFERRED, REPLACED OR EXCHANGED FOR A SERIES A-1 NOTE, OR ANY INTEREST THEREIN. 

[                         
               ] (the “Owner”) owns and proposes to exchange the Note[s] or interest in such Note[s] specified in Annex A or Annex B hereto, in the
principal amount of $             in such Note[s] or interests (the “Exchange”). In connection with the Exchange, the Owner hereby certifies that: 

1) EXCHANGE OF RESTRICTED DEFINITIVE NOTES OR BENEFICIAL INTERESTS IN A RESTRICTED GLOBAL NOTE FOR UNRESTRICTED DEFINITIVE NOTES OR
BENEFICIAL INTERESTS IN AN UNRESTRICTED GLOBAL NOTE 

a)     ̈    CHECK IF EXCHANGE IS
FROM BENEFICIAL INTEREST IN A RESTRICTED GLOBAL NOTE TO BENEFICIAL INTEREST IN AN UNRESTRICTED GLOBAL NOTE. In connection with the Exchange of the Owner’s beneficial interest in a Restricted Global Note for a beneficial interest in an
Unrestricted Global Note in an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer, (ii) such Exchange has been effected in compliance with the
transfer restrictions applicable to the Global Notes and pursuant to and in accordance with the United States Securities Act of 1933, as amended (the “Securities Act”), (iii) the restrictions on transfer contained in the
Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the beneficial interest in an Unrestricted Global Note is being acquired in compliance with any applicable blue sky
securities laws of any state of the United States. 

b)     ̈    CHECK IF EXCHANGE IS
FROM BENEFICIAL INTEREST IN A RESTRICTED GLOBAL NOTE TO UNRESTRICTED DEFINITIVE NOTE. In connection with the Exchange of the Owner’s beneficial interest in a Restricted Global Note for 

 

 C-1 

 
an Unrestricted Definitive Note, the Owner hereby certifies (i) the Definitive Note is being acquired for the Owner’s own account without transfer, (ii) such Exchange has been
effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in accordance with the Securities Act, (iii) the restrictions on transfer contained in the Indenture and the Private Placement
Legend are not required in order to maintain compliance with the Securities Act and (iv) the Definitive Note is being acquired in compliance with any applicable blue sky securities laws of any state of the United States. 

c)     ̈    CHECK IF EXCHANGE IS
FROM RESTRICTED DEFINITIVE NOTE TO BENEFICIAL INTEREST IN AN UNRESTRICTED GLOBAL NOTE. In connection with the Owner’s Exchange of a Restricted Definitive Note for a beneficial interest in an Unrestricted Global Note, the Owner hereby certifies
(i) the beneficial interest is being acquired for the Owner’s own account without transfer, (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to Restricted Definitive Notes and pursuant to
and in accordance with the Securities Act, (iii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the beneficial
interest is being acquired in compliance with any applicable blue sky securities laws of any state of the United States. 

d)     ̈    CHECK IF EXCHANGE IS
FROM RESTRICTED DEFINITIVE NOTE TO UNRESTRICTED DEFINITIVE NOTE. In connection with the Owner’s Exchange of a Restricted Definitive Note for an Unrestricted Definitive Note, the Owner hereby certifies (i) the Unrestricted Definitive Note
is being acquired for the Owner’s own account without transfer, (ii) such Exchange has been effected in compliance with the transfer restrictions applicable to Restricted Definitive Notes and pursuant to and in accordance with the
Securities Act, (iii) the restrictions on transfer contained in the Indenture and the Private Placement Legend are not required in order to maintain compliance with the Securities Act and (iv) the Unrestricted Definitive Note is being
acquired in compliance with any applicable blue sky securities laws of any state of the United States. 
 2) EXCHANGE OF
RESTRICTED DEFINITIVE NOTES OR BENEFICIAL INTERESTS IN RESTRICTED GLOBAL NOTES FOR RESTRICTED DEFINITIVE NOTES OR BENEFICIAL INTERESTS IN RESTRICTED GLOBAL NOTES 

a)     ̈    CHECK IF EXCHANGE IS
FROM BENEFICIAL INTEREST IN A RESTRICTED GLOBAL NOTE TO RESTRICTED DEFINITIVE NOTE. In connection with the Exchange of the Owner’s beneficial interest in a Restricted Global Note for a Restricted Definitive Note with an equal principal amount,
the Owner hereby certifies that the Restricted Definitive Note is being acquired for the Owner’s own account without transfer. Upon consummation of the proposed Exchange in accordance with the terms of the Indenture, the Restricted Definitive
Note issued will continue to be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the Restricted Definitive Note and in the Indenture and the Securities Act. 

b)     ̈    CHECK IF EXCHANGE IS
FROM RESTRICTED DEFINITIVE NOTE TO BENEFICIAL INTEREST IN A RESTRICTED GLOBAL NOTE. In connection with the Exchange of the Owner’s Restricted Definitive Note for a beneficial interest in the [CHECK ONE] [    ] 144A Global
Note [    ] Regulation S Global Note, with an equal principal amount, the Owner hereby certifies (i) the beneficial interest is being acquired for the Owner’s own account without transfer and (ii) such Exchange has
been effected in compliance with the transfer restrictions applicable to the Restricted Global Notes and pursuant to and in 
  

 C-2 

 
accordance with the Securities Act, and in compliance with any applicable blue sky securities laws of any state of the United States. Upon consummation of the proposed Exchange in accordance with
the terms of the Indenture, the beneficial interest issued will be subject to the restrictions on transfer enumerated in the Private Placement Legend printed on the relevant Restricted Global Note and in the Indenture and the Securities Act.

 This certificate and the statements contained herein are made for your benefit and the benefit of the Company and are dated
[                    ]. 
  

			
	[Insert Name of Transferor]
		
	By:	 	  

		 	Name:
		 	Title:

 Dated:
                     
  

 C-3 

 ANNEX A TO CERTIFICATE OF EXCHANGE 

 

							
	1.	  	The Owner owns and proposes to exchange the following:
	
	[CHECK ONE OF (a) OR (b)]
				
		  	(a)	  	 ̈	  	a Restricted Global Note representing Series A-1 Notes, or
				
		  	(b)	  	 ̈	  	a Restricted Definitive Note representing Series A-1 Notes.
		
	2.	  	After the Exchange the Owner will hold:
	
	[CHECK ONE]
				
		  	(a)	  	 ̈	  	an Unrestricted Global Note representing Series A-1 Notes, or
				
		  	(b)	  	 ̈	  	an Unrestricted Definitive Note representing Series A-1 Notes, or
				
		  	(c)	  	 ̈	  	a Restricted Definitive Note representing Series A-1 Notes, or
				
		  	(d)	  	 ̈	  	144A Global Note representing Series A-1 Notes (CUSIP 037933AD0), or
				
		  	(e)	  	 ̈	  	Regulation S Global Note representing Series A-1 Notes (CUSIP U03846AB5).

  

 C-4 

 ANNEX B TO CERTIFICATE OF EXCHANGE 

 

							
	1.	 	The Owner owns and proposes to exchange the following:
	
	[CHECK ONE OF (a) OR (b)]
				
		 	(a)	  	 ̈	  	a Restricted Global Note representing Series A-2 Notes, or
				
		 	(b)	  	 ̈	  	a Restricted Definitive Note representing Series A-2 Notes.
		
	2.	 	After the Exchange the Owner will hold:
	
	[CHECK ONE]
				
		 	(a)	  	 ̈	  	an Unrestricted Global Note representing Series A-2 Notes, or
				
		 	(b)	  	 ̈	  	an Unrestricted Definitive Note representing Series A-2 Notes, or
				
		 	(c)	  	 ̈	  	a Restricted Definitive Note representing Series A-2 Notes, or
				
		 	(d)	  	 ̈	  	144A Global Note representing Series A-2 Notes (CUSIP 037933AD0), or
				
		 	(e)	  	 ̈	  	Regulation S Global Note representing Series A-2 Notes (CUSIP U03846AB5).

  

 C-5 

 EXHIBIT D 

[FORM OF SUPPLEMENTAL INDENTURE 

TO BE DELIVERED BY SUBSEQUENT GUARANTORS] 

Supplemental Indenture (this “Supplemental Indenture”), dated as of
            , among (the “Guaranteeing Subsidiary”), a subsidiary of Apria Healthcare Group Inc., a Delaware corporation (the “Company”), and U.S. Bank
National Association, as trustee (the “Trustee”). 
 W I T N E S
S E T H 
 WHEREAS, Apria Healthcare Group Inc. and each of the Guarantors (as defined in the
Indenture referred to below) has heretofore executed and delivered to the Trustee an indenture (the “Indenture”), dated as of May 27, 2009, providing for the issuance of 11.25% Senior Secured Notes due 2014 (Series A-1) (the
“Series A-1 Notes”) and Senior Secured Notes due 2014 (Series A-2) (the “Series A-2 Notes” and, together with the Series A-1 Notes, the “Notes”); 

WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a
supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Company’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture (the
“Guarantee”); and 
 WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to
execute and deliver this Supplemental Indenture. 
 NOW THEREFORE, in consideration of the foregoing and for other good and
valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders of the Notes as follows: 

(1) Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.

 (2) Agreement to Guarantee. The Guaranteeing Subsidiary hereby agrees as follows: 

(a) Along with all Guarantors named in the Indenture, to jointly and severally unconditionally guarantee to each Holder of
a Note authenticated and delivered by the Trustee and to the Trustee and its successors and assigns, irrespective of the validity and enforceability of the Indenture, the Notes or the obligations of the Company hereunder or thereunder, that:

 (i) the principal of and interest, premium and Additional Interest, if any, on the Notes will be promptly
paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, and all other obligations of the Company to the Holders or the Trustee
hereunder or thereunder will be promptly paid in full or performed, all in accordance with the terms hereof and thereof; and 

(ii) in case of any extension of time of payment or renewal of any Notes or any of such other obligations, that same will
be promptly paid in full when due or performed in accordance with the terms of the extension or renewal, whether at stated 
  

 D-1 

 
maturity, by acceleration or otherwise. Failing payment when due of any amount so guaranteed or any performance so guaranteed for whatever reason, the Guarantors and the Guaranteeing Subsidiary
shall be jointly and severally obligated to pay the same immediately. This is a guarantee of payment and not a guarantee of collection. 

(b) The obligations hereunder shall be unconditional, irrespective of the validity, regularity or enforceability of the
Notes or the Indenture, the absence of any action to enforce the same, any waiver or consent by any Holder of the Notes with respect to any provisions hereof or thereof, the recovery of any judgment against the Company, any action to enforce the
same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. 

(c) The following is hereby waived: diligence, presentment, demand of payment, filing of claims with a court in the event
of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever. 

(d) This Guarantee shall not be discharged except by complete performance of the obligations contained in the Notes, the
Indenture, the Collateral Documents and this Supplemental Indenture, and the Guaranteeing Subsidiary accepts all obligations of a Guarantor under the Indenture. 

(e) If any Holder or the Trustee is required by any court or otherwise to return to the Company, the Guarantors (including
the Guaranteeing Subsidiary), or any custodian, trustee, liquidator or other similar official acting in relation to either the Company or the Guarantors, any amount paid either to the Trustee or such Holder, this Guarantee, to the extent theretofore
discharged, shall be reinstated in full force and effect. 
 (f) The Guaranteeing Subsidiary shall not be
entitled to any right of subrogation in relation to the Holders in respect of any obligations guaranteed hereby until payment in full of all obligations guaranteed hereby. 

(g) As between the Guaranteeing Subsidiary, on the one hand, and the Holders and the Trustee, on the other hand,
(x) the maturity of the obligations guaranteed hereby may be accelerated as provided in Article 6 of the Indenture for the purposes of this Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in
respect of the obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such obligations as provided in Article 6 of the Indenture, such obligations (whether or not due and payable) shall forthwith become due
and payable by the Guaranteeing Subsidiary for the purpose of this Guarantee. 
 (h) The Guaranteeing Subsidiary
shall have the right to seek contribution from any non-paying Guarantor so long as the exercise of such right does not impair the rights of the Holders under this Guarantee. 

(i) Pursuant to Section 11.02 of the Indenture, after giving effect to all other contingent and fixed liabilities
that are relevant under any applicable Bankruptcy Law or fraudulent conveyance laws, and after giving effect to any collections from, rights to receive contribution from or payments made by or on behalf of any other Guarantor in respect of the
obligations of such other Guarantor under Article 11 of the Indenture, this new Guarantee shall be limited to the maximum amount permissible such that the obligations of such Guaranteeing Subsidiary under this Guarantee will not constitute a
fraudulent transfer or conveyance. 
  

 D-2 

 (j) This Guarantee shall remain in full force and effect and continue to be
effective should any petition be filed by or against the Company for liquidation, reorganization, should the Company become insolvent or make an assignment for the benefit of creditors or should a receiver or trustee be appointed for all or any
significant part of the Company’s assets, and shall, to the fullest extent permitted by law, continue to be effective or be reinstated, as the case may be, if at any time payment and performance of the Notes are, pursuant to applicable law,
rescinded or reduced in amount, or must otherwise be restored or returned by any obligee on the Notes and Guarantee, whether as a “voidable preference”, “fraudulent transfer” or otherwise, all as though such payment or
performance had not been made. In the event that any payment or any part thereof, is rescinded, reduced, restored or returned, the Note shall, to the fullest extent permitted by law, be reinstated and deemed reduced only by such amount paid and not
so rescinded, reduced, restored or returned. 
 (k) In case any provision of this Guarantee shall be invalid,
illegal or unenforceable, the validity, legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 

(l) This Guarantee shall be a general senior secured obligation of such Guaranteeing Subsidiary, ranking pari passu
with any other future Senior Indebtedness of the Guaranteeing Subsidiary, if any, and senior in right of payment to all existing and future Subordinated Indebtedness of the Guaranteeing Subsidiary. 

(m) Each payment to be made by the Guaranteeing Subsidiary in respect of this Guarantee shall be made without set-off,
counterclaim, reduction or diminution of any kind or nature. 
 (3) Execution and Delivery. The Guaranteeing Subsidiary
agrees that the Guarantee shall remain in full force and effect notwithstanding the absence of the endorsement of any notation of such Guarantee on the Notes. 

(4) Merger, Consolidation or Sale of All or Substantially All Assets. 

(a) Except as otherwise provided in Section 5.01(c) of the Indenture, the Guaranteeing Subsidiary may not consolidate
or merge with or into or wind up into (whether or not the Company or Guaranteeing Subsidiary is the surviving corporation), or sell, assign, transfer, lease, convey or otherwise dispose of all or substantially all of its properties or assets, in one
or more related transactions, to any Person unless: 
 (i) (A) the Guaranteeing Subsidiary is the surviving
corporation or the Person formed by or surviving any such consolidation or merger (if other than the Guaranteeing Subsidiary) or to which such sale, assignment, transfer, lease, conveyance or other disposition will have been made is a corporation,
partnership, trust or limited liability company organized or existing under the laws of the jurisdiction of organization of the Guaranteeing Subsidiary, as the case may be, or the laws of the United States, any state thereof, the District of
Columbia, or any territory thereof (the Guaranteeing Subsidiary or such Person, as the case may be, being herein called the “Successor Person”); 

 

 D-3 

 (B) the Successor Person, if other than the Guaranteeing Subsidiary,
expressly assumes all the obligations of the Guaranteeing Subsidiary under the Indenture, the Guaranteeing Subsidiary’s related Guarantee and the Collateral Documents pursuant to supplemental indentures or other documents or instruments in form
reasonably satisfactory to the Trustee; 
 (C) immediately after such transaction, no Default or Event of
Default exists; 
 (D) the Company shall have delivered to the Trustee an Officer’s Certificate and an
Opinion of Counsel, each stating that such consolidation, merger or transfer and such supplemental indentures, if any, comply with the Indenture; 

(E) the Collateral transferred to the Successor Person shall (i) continue to constitute Collateral under the
Indenture and the Collateral Documents, (ii) be subject to the Lien in favor of the Trustee for the benefit of the holders of the Notes, and (iii) not be subject to any Lien, other than Liens permitted by the terms of the Indenture; and

 (F) to the extent that the assets of the Person which is merged or consolidated with or into the Successor
Person are assets of the type which would constitute Collateral under the Collateral Documents, the Successor Person will take such action as may be reasonably necessary to cause such property and assets to be made subject to the Lien of the
Collateral Documents in the manner and to the extent required in the Indenture; or 
 (ii) the transaction is
made in compliance with Section 4.10 of the Indenture. 
 (b) Subject to certain limitations described in
the Indenture, the Successor Person will succeed to, and be substituted for, the Guaranteeing Subsidiary under the Indenture and the Guaranteeing Subsidiary’s Guarantee. Notwithstanding the foregoing, the Guaranteeing Subsidiary may
(i) merge into or transfer all or part of its properties and assets to another Guarantor or the Company (ii) merge with an Affiliate of the Company solely for the purpose of reincorporating the Guarantor in the United States, any state
thereof, the District of Columbia or any territory thereof or (iii) convert into a corporation, partnership, limited partnership, limited liability company or trust organized under the laws of the jurisdiction of organization of such Guarantor,
in each case without regard to the requirements set forth in Section 5.01(c) of the Indenture. 
 (5) Releases.

 The Guarantee of the Guaranteeing Subsidiary shall be automatically and unconditionally released and discharged, and no
further action by the Guaranteeing Subsidiary, the Company or the Trustee is required for the release of the Guaranteeing Subsidiary’s Guarantee, upon: 

(1) (A) any sale, exchange or transfer (by merger or otherwise) of the Capital Stock of the Guaranteeing Subsidiary after
which the Guaranteeing Subsidiary is no longer a Restricted Subsidiary, if such sale, exchange or transfer is made in compliance with the applicable provisions of the Indenture; 

 

 D-4 

 (B) the release or discharge of the guarantee by the Guaranteeing
Subsidiary of the ABL Facility or the guarantee which resulted in the creation of the Guarantee, except a discharge or release by or as a result of payment under such guarantee; 

(C) the proper designation of the Guaranteeing Subsidiary as an Unrestricted Subsidiary in accordance with
Section 4.07 of the Indenture and the definition of “Unrestricted Subsidiary” in Section 1.01 of the Indenture; or 

(D) the Company exercising its Legal Defeasance option or Covenant Defeasance option in accordance with Article 8 of the
Indenture or the Company’s obligations under the Indenture being discharged in accordance with the terms of the Indenture; and 

(2) the Guaranteeing Subsidiary delivering to the Trustee an Officer’s Certificate and an Opinion of Counsel, each
stating that all conditions precedent provided for in the Indenture relating to such transaction have been complied with. 
 (6)
No Recourse Against Others. No director, officer, employee, incorporator or stockholder of the Guaranteeing Subsidiary shall have any liability for any obligations of the Company or the Guarantors (including the Guaranteeing Subsidiary) under
the Notes, any Guarantees, the Indenture, the Collateral Documents or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting Notes waives and releases all
such liability. The waiver and release are part of the consideration for issuance of the Notes. 
 (7) Governing Law.
THIS SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 (8)
Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. 

(9) Effect of Headings. The Section headings herein are for convenience only and shall not affect the construction hereof.

 (10) The Trustee. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or
sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary. 

(11) Subrogation. The Guaranteeing Subsidiary shall be subrogated to all rights of Holders of Notes against the Company in respect
of any amounts paid by the Guaranteeing Subsidiary pursuant to the provisions of Section 2 hereof and Section 11.01 of the Indenture; provided that, if an Event of Default has occurred and is continuing, the Guaranteeing Subsidiary
shall not be entitled to enforce or receive any payments arising out of, or based upon, such right of subrogation until all amounts then due and payable by the Company under the Indenture or the Notes shall have been paid in full. 

(12) Benefits Acknowledged. The Guaranteeing Subsidiary’s Guarantee is subject to the terms and conditions set forth in the
Indenture. The Guaranteeing Subsidiary acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by the Indenture and this Supplemental Indenture and that the guarantee and waivers made by it
pursuant to this Guarantee are knowingly made in contemplation of such benefits. 
  

 D-5 

 (13) Successors. All agreements of the Guaranteeing Subsidiary in this Supplemental
Indenture shall bind its Successors, except as otherwise provided in Section 2(k) hereof or elsewhere in this Supplemental Indenture. All agreements of the Trustee in this Supplemental Indenture shall bind its successors. 

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above
written. 
  

			
	[GUARANTEEING SUBSIDIARY]
		
	By:	 	  

		 	Name:
		 	Title:
	
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		 	Name:
		 	Title:

  

 D-6 

 EXHIBIT E 

[FORM OF SUPPLEMENTAL INDENTURE 

FOR THE ISSUANCE OF THE SERIES A-2 NOTES] 

Supplemental Indenture (this “Supplemental Indenture”), dated as of
            , among APRIA HEALTHCARE GROUP INC., a Delaware corporation (the “Company”), the Guarantors (as defined in the Indenture) listed on the signature pages hereto,
and U.S. Bank National Association, as trustee (the “Trustee”). 
 W I T N E
S S E T H 
 WHEREAS, Apria Healthcare Group Inc. and each of the Guarantors (as defined in
the Indenture referred to below) has heretofore executed and delivered to the Trustee an indenture (the “Indenture”), dated as of May 27, 2009, providing for the issuance of 11.25% Senior Secured Notes due 2014 (Series A-1)
(the “Series A-1 Notes”) and Senior Secured Notes due 2014 (Series A-2) (the “Series A-2 Notes” and, together with the Series A-1 Notes, the “Notes”); 

WHEREAS, Section 9.01(16) of the Indenture provides that the Company and the Trustee may at any time and from time to time enter
into an indenture supplemental thereto, in form satisfactory to the Trustee, to establish the form and additional terms of the Series A-2 Notes as permitted under the Indenture; 

WHEREAS, the Company has duly authorized the issuance of the Series A-2 Notes; 

WHEREAS, the Company proposes by this Supplemental Indenture to supplement and amend in certain respects the Indenture insofar as it
will apply to the Series A-2 Notes (and not the Series A-1 Notes) to provide for the form and additional terms and other provisions of the Series A-2 Notes as a separate series of securities to be issued under the Indenture; and 

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

 NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is
hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders of the Series A-2 Notes as follows: 

ARTICLE 1 

DEFINITIONS 
 Section 1.01
Capitalized Terms. 
 All capitalized terms contained in this Supplemental Indenture shall, except as specifically
provided for herein and except as the context may otherwise require, have the meanings given to such terms in the Indenture. In the event of any inconsistency between the Indenture and the Supplemental Indenture, this Supplemental Indenture shall
govern. 
  

 E-1 

 Section 1.02 Section References. 

Section references contained in this Supplemental Indenture are to sections in this Supplemental Indenture unless the context requires
otherwise. 
 ARTICLE 2 

Section 2.01 General. 

(a) The initial aggregate principal amount of the Series A-2 Notes shall be
$[            ]. 
 (b) The Series A-2 Notes shall accrue interest
at an annual interest rate of [    ]%. 
 (c) Interest shall be payable to the Holders of Series A-2 Notes
on the applicable Series A-2 Notes Record Date on each Series A-2 Notes Interest Payment Date. 
 (d) The Series A-2 Notes will
mature on November 1, 2014. 
 ARTICLE 3 

REDEMPTION 
 Section 3.01
Optional Redemption. 
 (a) At any time prior to November 1, 2011, the Company may redeem all or a part of the
Series A-2 Notes, upon not less than 30 nor more than 60 days prior notice mailed by first-class mail to the registered address of each Holder or otherwise delivered in accordance with the procedures of DTC, at a redemption price equal to 100% of
the principal amount of the Series A-2 Notes redeemed plus the Series A-2 Notes Applicable Premium as of, and accrued and unpaid interest and Additional Interest, if any, to the date of redemption (the “Series A-1 Notes Redemption
Date”), subject to the rights of Holders on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date. 

(b) Until November 1, 2011, the Company may, at its option, redeem up to 35% of the aggregate principal amount of Series A-2 Notes
issued by it at a redemption price equal to [    ]% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-2 Notes Redemption Date, subject
to the right of Holders of Series A-2 Notes of record on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date, with the net cash proceeds of one or more Equity Offerings;
provided that at least 65% of the aggregate principal amount of Series A-2 Notes originally issued under this Indenture (excluding Series A-2 Notes held by the Company or Subsidiaries or Affiliates of the Company) remains outstanding
immediately after the occurrence of each such redemption; provided further that each such redemption occurs within 180 days of the date of closing of each such Equity Offering. Notice of any redemption upon any Equity Offering may be
given prior to the completion thereof, and any such redemption or notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited to, the completion of the related Equity Offering. 

(c) Except pursuant to clause (a) or (b) of this Section 2.01, the Series A-2 Notes will not be redeemable at the
Company’s option prior to November 1, 2011. 
  

 E-2 

 (d) On and after November 1, 2011, the Company may redeem the Series A-2 Notes, in
whole or in part, upon not less than 30 nor more than 60 days prior notice by first-class mail, postage prepaid, with a copy to the Trustee, to each Holder at the address of such Holder appearing in the security register, at the redemption prices
(expressed as percentages of principal amount of the Series A-2 Notes to be redeemed) set forth below, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-2 Notes Redemption Date, subject to the right
of Holders of record on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date, if redeemed during the twelve-month period beginning on November 1 of each of the years indicated
below: 
  

				
	 Year
	  	Percentage	 
		
	 2011
	  	[    	]% 
	 2012
	  	[    	]% 
	 2013 and thereafter
	  	100.000	% 

 Any redemption
pursuant to this Section 3.01 shall be made pursuant to the provisions of Sections 3.01 through 3.06 of the Indenture. 

ARTICLE 4 

MISCELLANEOUS 

Section 4.01 Ratification of Indenture. 

The Indenture, as supplemented and amended by this Supplemental Indenture, is ratified and confirmed, and this Supplemental Indenture
shall be deemed part of the Indenture with respect to the Series A-2 Notes in the manner and to the extent herein and therein provided. If any provision of this Supplemental Indenture is inconsistent with a provision of the Indenture, the terms of
this Supplemental Indenture shall control with respect to the Series A-2 Notes. The Indenture, together with this Supplemental Indenture, shall govern the Series A-2 Notes. 

Section 4.02 No Personal Liability of Directors, Officers, Employees and Stockholders. 

No director, officer, employee, incorporator or stockholder of the Company or any Guarantor or any of their parent companies shall have
any liability for any obligations of the Company or the Guarantors under the Series A-2 Notes, the Guarantees, the Indenture, this Supplemental Indenture or the Collateral Documents or for any claim based on, in respect of, or by reason of such
obligations or their creation. Each Holder by accepting Series A-2 Notes waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Series A-2 Notes. 

Section 4.03 Governing Law. 

THIS SUPPLEMENTAL INDENTURE, THE SERIES A-2 NOTES AND ANY GUARANTEE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE
STATE OF NEW YORK. 
 Section 4.04 Waiver of Jury Trial. 

EACH OF THE COMPANY, THE GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE

  

 E-3 

 
LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE SERIES A-2 NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 Section 4.05 Severability. 

In case any provision in this Supplemental Indenture or in the Series A-2 Notes shall be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 4.06
Counterpart Originals. 
 The parties may sign any number of copies of this Supplemental Indenture. Each signed copy
shall be an original, but all of them together represent the same agreement. 
 IN WITNESS WHEREOF, the parties hereto have
caused this Supplemental Indenture to be duly executed, all as of the date first above written. 
  

			
	APRIA HEALTHCARE GROUP INC.
		
	By:	 	  

		 	Name:
		 	Title:
	
	[GUARANTORS]
		
	By:	 	  

		 	Name:
		 	Title:
	
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		 	Name:
		 	Title:

  

 E-4 

 ANNEX A 

[Face of Note] 

[Insert the Global Note Legend, if applicable pursuant to the provisions of the Indenture] 

[Insert the Private Placement Legend, if applicable pursuant to the provisions of the Indenture] 

[Insert the Regulation S Temporary Global Note Legend, if applicable pursuant to the provisions of the Indenture] 

[Insert the Original Issue Discount Legend, if applicable pursuant to the provisions of the Indenture] 

 

 E-5 

					
		  	CUSIP	  	[                    ]
		  	ISIN	  	[                    ]

[[RULE 144A][REGULATION S] GLOBAL NOTE 

representing up to 

$[            ] 

[    ]% Senior Secured Notes due 2014 (Series A-2) 

(“Series A-2 Notes”) 
  

			
	No. [    ]	 	[$                    ]

APRIA HEALTHCARE GROUP INC. 

promises to pay to CEDE & CO. or registered assigns, the principal sum [of
                     United States Dollars] [, as revised by the Schedule of Exchanges of Interests in the Global Note attached hereto,] on
[            ], 2014. 
 Series A-2 Notes Interest Payment Dates:
[            ] and [            ] 

Series A-2 Notes Record Dates: [            ] and
[            ] 
  

 E-6 

 IN WITNESS HEREOF, Apria Healthcare Group Inc. has caused this instrument to be duly
executed. 
 Dated: 
  

			
	APRIA HEALTHCARE GROUP INC.
		
	By:	 	  

		 	Name:
		 	Title:

  

 E-7 

 TRUSTEE’S CERTIFICATE OF AUTHENTICATION 

This is one of the Series A-2 Notes referred to in the within-mentioned Indenture: 

Dated: 
  

			
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		 	Authorized Signatory

  

 E-8 

 [Back of Note] 

[    ]% Senior Secured Notes due 2014 (Series A-2) 

(“Series A-2 Notes”) 

Capitalized terms used herein shall have the meanings assigned to them in the Indenture referred to below unless otherwise indicated.

 1. INTEREST. Apria Healthcare Group Inc., a Delaware corporation, promises to pay interest on the principal amount of this
Series A-2 Note at [    ]% per annum from [                    ] until maturity and shall pay the Additional Interest, if any,
payable pursuant to the Registration Rights Agreement referred to below. The Company will pay interest and Additional Interest, if any, semi-annually in arrears on May 1 and November 1 of each year, or if any such day is not a Business
Day, on the next succeeding Business Day (each, a “Series A-2 Notes Interest Payment Date”). Interest on the Series A-2 Notes will accrue from the most recent date to which interest has been paid or, if no interest has been paid,
from the date of issuance; provided that the first Series A-2 Notes Interest Payment Date shall be [                    ]. The Company will
pay interest (including post-petition interest in any proceeding under any Bankruptcy Law) on overdue principal and premium, if any, from time to time on demand at the interest rate on the Series A-2 Notes to the extent lawful; it shall pay interest
(including post-petition interest in any proceeding under any Bankruptcy Law) on overdue installments of interest and Additional Interest, if any (without regard to any applicable grace periods) from time to time on demand at the interest rate on
the Series A-2 Notes to the extent lawful. Interest will be computed on the basis of a 360-day year comprised of twelve 30-day months. 

2. METHOD OF PAYMENT. The Company will pay interest on the Series A-2 Notes and Additional Interest, if any, to the Persons who are
registered Holders of Series A-2 Notes at the close of business on the April 15 or October 15 (whether or not a Business Day), as the case may be, next preceding the Series A-2 Notes Interest Payment Date, even if such Series A-2 Notes are
cancelled after such record date and on or before such Series A-2 Notes Interest Payment Date, except as provided in Section 2.12 of the Indenture with respect to defaulted interest. Payment of interest and Additional Interest, if any, may be
made by check mailed to the Holders at their addresses set forth in the register of Holders; provided that payment by wire transfer of immediately available funds will be required with respect to principal of and interest, premium and
Additional Interest, if any, on, all Global Notes and all other Series A-2 Notes the Holders of which shall have provided wire transfer instructions to the Company or the Paying Agent. Such payment shall be in such coin or currency of the United
States of America as at the time of payment is legal tender for payment of public and private debts. 
 3. PAYING AGENT AND
REGISTRAR. Initially U.S. Bank National Association, the Trustee under the Indenture, will act as Paying Agent and Registrar. The Company may change any Paying Agent or Registrar without notice to the Holders. The Company or any of its Subsidiaries
may act in any such capacity. 
 4. INDENTURE. The Company issued the Series A-2 Notes under an Indenture, dated as of
May 27, 2009 (the “Indenture”), among Apria Healthcare Group Inc., the Guarantors named therein and the Trustee. This Series A-2 Note is one of a duly authorized issue of notes of the Company, designated as its
[    ]% Senior Secured Notes due 2014 (Series A-2). The Company shall be entitled to issue Additional Notes that are Series A-2 Notes pursuant to Section 2.01, Section 4.09 and Section 4.12 of the Indenture. The
terms of the Series A-2 Notes include those stated in the Indenture and those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (the “Trust Indenture Act”). The Series A-2 Notes are subject to
all such terms, and Holders are referred to the Indenture and the Trust Indenture Act for a statement of such terms. To the extent any provision of this Series A-2 Note (other than paragraph 5 below) conflicts with the express provisions of the
Indenture, the provisions of the Indenture shall govern and be controlling. 
  

 E-9 

 5. OPTIONAL REDEMPTION. 

(a) Except as described below under clauses 5(b) and 5(c) hereof, the Series A-2 Notes will not be redeemable at the Company’s
option prior to November 1, 2011. 
 (b) At any time prior to November 1, 2011, the Company may redeem all or a part
of the Series A-2 Notes, upon not less than 30 nor more than 60 days prior notice mailed by first-class mail to the registered address of each Holder or otherwise delivered in accordance with the procedures of DTC, at a redemption price equal to
100% of the principal amount of the Series A-2 Notes redeemed plus the Series A-2 Notes Applicable Premium as of, and accrued and unpaid interest and Additional Interest, if any, to the date of redemption (the “Series A-2 Notes Redemption
Date”), subject to the rights of Holders on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date. 

(c) Until November 1, 2011, the Company may, at its option, redeem up to 35% of the aggregate principal amount of Series A-2 Notes
issued by it at a redemption price equal to [    ]% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-2 Notes Redemption Date, subject
to the right of Holders of Series A-2 Notes of record on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date, with the net cash proceeds of one or more Equity Offerings;
provided that at least 65% of the aggregate principal amount of Series A-2 Notes originally issued under the Indenture and any Additional Notes that are Series A-2 Notes issued under the Indenture after the Issue Date (excluding Series A-2
Notes and Additional Notes that are Series A-2 Notes held by the Company or Subsidiaries or Affiliates of the Company) remains outstanding immediately after the occurrence of each such redemption; provided further that each such
redemption occurs within 180 days of the date of closing of each such Equity Offering. Notice of any redemption upon any Equity Offering may be given prior to the completion thereof, and any such redemption or notice may, at the Company’s
discretion, be subject to one or more conditions precedent, including, but not limited to, the completion of the related Equity Offering. 

(d) On and after November 1, 2011, the Company may redeem the Series A-2 Notes, in whole or in part, upon not less than 30 nor more
than 60 days prior notice by first-class mail, postage prepaid, with a copy to the Trustee, to each Holder of Series A-2 Notes at the address of such Holder appearing in the security register, at the redemption prices (expressed as percentages of
principal amount of the Series A-2 Notes to be redeemed) set forth below, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-2 Notes Redemption Date, subject to the right of Holders of Series A-2
Notes of record on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date, if redeemed during the twelve-month period beginning on November 1 of each of the years indicated
below: 
  

				
	 Year
	  	Percentage	 
		
	 2011
	  	[    	]% 
	 2012
	  	[    	]% 
	 2013 and thereafter
	  	100.000	% 

  

 E-10 

 (e) If the Company redeems less than all of the outstanding Series A-2 Notes, the Trustee
shall select the Series A-2 Notes to be redeemed in the manner described under Section 3.02 of the Indenture. 
 (f) Any
redemption pursuant to this paragraph 5 shall be made pursuant to the provisions of Sections 3.01 through 3.06 of the Indenture. 

6. MANDATORY REDEMPTION. The Company shall not be required to make mandatory redemption or sinking fund payments with respect to the
Series A-2 Notes. 
 7. NOTICE OF REDEMPTION. Subject to Section 3.03 of the Indenture, notice of redemption will be mailed
by first-class mail at least 30 days but not more than 60 days prior to the redemption date (except that redemption notices may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with Article 8 or Article 13
of the Indenture) to each Holder whose Series A-2 Notes are to be redeemed at its registered address. Series A-2 Notes in denominations larger than $2,000 may be redeemed in part but only in integral multiples of $1,000 in excess thereof, unless all
of the Series A-2 Notes held by a Holder are to be redeemed. Subject to Section 3.05 of the Indenture, on and after the redemption date, interest will cease to accrue on Series A-2 Notes or portions thereof called for redemption. 

8. OFFERS TO REPURCHASE. 

(a) Upon the occurrence of a Change of Control, the Company shall make an offer (a “Change of Control Offer”) to each
Holder to repurchase all or any part (equal to $2,000 or an integral multiple of $1,000 in excess thereof) of each Holder’s Series A-2 Notes at a purchase price in cash equal to 101% of the aggregate principal amount thereof plus accrued and
unpaid interest and Additional Interest thereon, if any, to the date of purchase (the “Change of Control Payment”), subject to the right of the Holders of the Series A-2 Notes of record on the relevant applicable Record Date to
receive interest due on the relevant applicable Interest Payment Date. The Change of Control Offer shall be made in accordance with Section 4.14 of the Indenture. 

(b) If the Company or any of its Restricted Subsidiaries consummates an Asset Sale, within ten Business Days of each date that the
aggregate amount of Excess Proceeds exceeds $30.0 million, the Company shall make an offer to all Holders of the Series A-2 Notes and, if required by the terms of any Indebtedness that is pari passu with the Series A-2 Notes or any Guarantee
(including any Series A-1 Notes) (“Pari Passu Indebtedness”), to the holders of such Pari Passu Indebtedness (an “Asset Sale Offer”), to purchase the maximum aggregate principal amount of Series A-2 Notes (including
any Additional Notes which are Series A-2 Notes) and such other Pari Passu Indebtedness that may be purchased out of the Excess Proceeds at an offer price in cash in an amount equal to 100% of the principal amount thereof, plus accrued and unpaid
interest and Additional Interest thereon, if any, to the date fixed for the closing of such offer, in accordance with the procedures set forth in the Indenture. The Asset Sale Offer shall be made in accordance with Sections 3.09 and 4.10 of the
Indenture. 
 9. DENOMINATIONS, TRANSFER, EXCHANGE. The Series A-2 Notes are in registered form without coupons in denominations
of $2,000 and integral multiples of $1,000 in excess thereof. The transfer of Series A-2 Notes may be registered and Series A-2 Notes may be exchanged as provided in the Indenture. The Registrar and the Trustee may require a Holder, among other
things, to furnish appropriate endorsements and transfer documents and the Company may require a Holder to pay any taxes and fees required by law or permitted by the Indenture. The Company need not exchange or register the transfer of any Series A-2
Notes or portion of a Series A-2 Note selected for redemption, except for the unredeemed portion of any Series A-2 Notes being redeemed in part. 
  

 E-11 

 Also, the Company need not exchange or register the transfer of any Series A-2 Notes for a
period of 15 days before a selection of Series A-2 Notes to be redeemed. 
 10. SECURITY. The Series A-2 Notes will be secured
by the Collateral on the terms and subject to the conditions set forth in the Indenture and the Collateral Documents. The Notes/Term Collateral Agent holds the Collateral in trust for the benefit of the Secured Parties pursuant to the Collateral
Documents and the Intercreditor Agreements. Each Holder, by accepting this Series A-2 Note, consents and agrees to the terms of the Collateral Documents (including the provisions providing for the foreclosure and release of Collateral) and the
Intercreditor Agreements as the same may be in effect or may be amended from time to time in accordance with their terms and the Indenture and authorizes and directs the Trustee and/or the Notes/Term Collateral Agent, as applicable, to enter into
the Collateral Documents and the Intercreditor Agreements, and to perform its obligations and exercise its rights thereunder in accordance therewith. 

11. PERSONS DEEMED OWNERS. The registered Holder of a Series A-2 Note may be treated as its owner for all purposes. 

12. AMENDMENT, SUPPLEMENT AND WAIVER. The Indenture, the Collateral Documents, the Guarantees or the Series A-2 Notes may be amended or
supplemented as provided in the Indenture. 
 13. DEFAULTS AND REMEDIES. If an Event of Default with respect to the Series A-2
Notes shall occur and be continuing, the principal, premium, if any, interest and any other monetary obligations on all then outstanding Series A-2 Notes may be declared due and payable in the manner and with the effect provided in the Indenture.

 14. PRIORITIES OF PAYMENT AS BETWEEN SERIES A-1 NOTES AND SERIES A-2 DEBT. The Series A-1 Notes, the Series A-2 Notes (if
issued) and any Term Loans then outstanding will vote together as a single class for all purposes under the Indenture to the extent provided in Article 6 and Article 9 thereof. The Holders of the Series A-1 Notes shall be entitled to a priority of
payment over the holders of the Series A-2 Debt in the circumstances described in the Notes/Term Intercreditor Agreement. The Holders of Series A-1 Notes, the Bridge Loan Agent, the holders of Series A-2 Debt, the Trustee, the Notes/Term Collateral
Agent and the Company have agreed (or are deemed to have agreed) to certain other intercreditor arrangements in the Notes/Term Intercreditor Agreement pursuant to which Holders of Notes are bound. 

15. GUARANTEES. The Company’s obligations under the Series A-2 Notes are fully and unconditionally guaranteed, jointly and
severally, by the Guarantors. 
 16. AUTHENTICATION. This Series A-2 Note shall not be entitled to any benefit under the
Indenture or be valid or obligatory for any purpose until authenticated by the manual signature of the Trustee. 
 17.
ADDITIONAL RIGHTS OF HOLDERS OF RESTRICTED GLOBAL NOTES AND RESTRICTED DEFINITIVE NOTES. In addition to the rights provided to Holders of Series A-2 Notes under the Indenture, Holders of Restricted Global Notes and Restricted Definitive Notes, in
each case, that are Series A-2 Notes, shall have all the rights set forth in the Registration Rights Agreement, dated as of [                    ],
among Apria Healthcare Group Inc., the Guarantors named therein and the other parties named on the signature pages thereof (the “Registration Rights Agreement”), including the right to receive Additional Interest (as defined in the
Registration Rights Agreement). 
  

 E-12 

 18. GOVERNING LAW. THE INDENTURE, THE SERIES A-2 NOTES AND ANY GUARANTEE WILL BE GOVERNED BY
AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
 19. CUSIP AND ISIN NUMBERS. Pursuant to a recommendation
promulgated by the Committee on Uniform Security Identification Procedures, the Company has caused CUSIP and ISIN numbers to be printed on the Series A-2 Notes and the Trustee may use CUSIP and ISIN numbers in notices of redemption as a convenience
to Holders. No representation is made as to the accuracy of such numbers either as printed on the Series A-2 Notes or as contained in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon.

 The Company will furnish to any Holder upon written request and without charge a copy of the Indenture and/or the
Registration Rights Agreement. Requests may be made to the Company at the following address: 
 c/o Apria Healthcare Group Inc.

 26220 Enterprise Court 

Lake Forest, California 92630 

Facsimile: (949) 639-4332 

Attention: General Counsel 
  

 E-13 

 ASSIGNMENT FORM 

To assign this Series A-2 Note, fill in the form below: 
  

			
	(I) or (we) assign and transfer this Series A-2 Note to:	  	  

		  	(Insert assignee’ legal name)

  

 
 (Insert assignee’s soc. sec.
or tax I.D. no.) 
  
  

 
  
  

 
  

 
 (Print or type assignee’s
name, address and zip code) 
  

			
	and irrevocably appoint	  	  

to transfer this Series A-2 Note on the books of the Company. The agent may substitute another to act for him. 

Date:                      

 

			
	Your Signature:	 	  

		 	(Sign exactly as your name appears on the face of this Series A-2 Note)

  

					
	 Signature Guarantee:*
	 	  

 
  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

 

 E-14 

 OPTION OF HOLDER TO ELECT PURCHASE 

If you want to elect to have this Series A-2 Note purchased by the Company pursuant to Section 4.10 or 4.14 of the Indenture, check
the appropriate box below: 

 ̈  Section 4.10    
 ̈  Section 4.14 
 If you want to elect to have only part of this
Series A-2 Note purchased by the Company pursuant to Section 4.10 or Section 4.14 of the Indenture, state the amount you elect to have purchased: 

$                      
                                       

Date:                      

 

			
	Your Signature:	 	  

		 	(Sign exactly as your name appears on the face of this Series A-2 Note)

  

			
	Tax Identification No.:	 	  

		
	Signature Guarantee:*	 	  

 
  

	*	Participant in a recognized Signature Guarantee Medallion Program (or other signature guarantor acceptable to the Trustee). 

 

 E-15 

 SCHEDULE OF EXCHANGES OF INTERESTS IN THE GLOBAL NOTE* 

The initial outstanding principal amount of this Global Note is
$[            ]. The following exchanges of a part of this Global Note for an interest in another Global Note or for a Definitive Note, or exchanges of a part of another Global or
Definitive Note for an interest in this Global Note, have been made: 
  

									
	 Date of Exchange
	  	Amount of
Decrease in
Principal Amount	  	Amount of
Increase in
Principal Amount
of this Global
Note	  	Principal Amount
of this Global
Note following
such Decrease or
Increase	  	Signature of
Authorized
Officer of Trustee
or Custodian
		  		  		  		  	

  
  

	*	This schedule should be included only if the Series A-2 Note is issued in global form. 

 

 E-16 

 SCHEDULE A 

UNRESTRICTED SUBSIDIARIES AS OF THE ISSUE DATE 

Coram Healthcare Ltd. 
 Coram
Healthcare/Carolina Home Therapeutics 
 Coram International Holdings Ltd.First Supplemental Indenture

 Exhibit 4.2 

EXECUTION COPY 

SUPPLEMENTAL INDENTURE 

FOR THE ISSUANCE OF THE SERIES A-2 NOTES 

Supplemental Indenture (this “Supplemental Indenture”), dated as of August 13, 2009, among APRIA HEALTHCARE GROUP
INC., a Delaware corporation (the “Company”), the Guarantors (as defined in the Indenture) listed on the signature pages hereto, and U.S. Bank National Association, as trustee (the “Trustee”). 

W I T N E S S E T H 

WHEREAS, Apria Healthcare Group Inc. and each of the Guarantors (as defined in the Indenture referred to below) has heretofore executed
and delivered to the Trustee an indenture (the “Indenture”), dated as of May 27, 2009, providing for the issuance of 11.25% Senior Secured Notes due 2014 (Series A-1) (the “Series A-1 Notes”) and Senior Secured
Notes due 2014 (Series A-2) (the “Series A-2 Notes” and, together with the Series A-1 Notes, the “Notes”); 

WHEREAS, Section 9.01(16) of the Indenture provides that the Company and the Trustee may at any time and from time to time enter
into an indenture supplemental thereto, in form satisfactory to the Trustee, to establish the form and additional terms of the Series A-2 Notes as permitted under the Indenture; 

WHEREAS, the Company has duly authorized the issuance of the Series A-2 Notes; 

WHEREAS, the Company proposes by this Supplemental Indenture to supplement and amend in certain respects the Indenture insofar as it
will apply to the Series A-2 Notes (and not the Series A-1 Notes) to provide for the form and additional terms and other provisions of the Series A-2 Notes as a separate series of securities to be issued under the Indenture; and 

WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.

 NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is
hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders of the Series A-2 Notes as follows: 

ARTICLE 1 

DEFINITIONS 
 Section 1.01
Capitalized Terms. 
 All capitalized terms contained in this Supplemental Indenture shall, except as specifically
provided for herein and except as the context may otherwise require, have the meanings given to such terms in the Indenture. In the event of any inconsistency between the Indenture and the Supplemental Indenture, this Supplemental Indenture shall
govern. 

 Section 1.02 Section References. 

Section references contained in this Supplemental Indenture are to sections in this Supplemental Indenture unless the context requires
otherwise. 
 ARTICLE 2 

Section 2.01 General. 

(a) The initial aggregate principal amount of the Series A-2 Notes shall be $317,500,000. 

(b) The Series A-2 Notes shall accrue interest at an annual interest rate of 12.375%. 

(c) Interest shall be payable to the Holders of Series A-2 Notes on the applicable Series A-2 Notes Record Date on each Series A-2 Notes
Interest Payment Date. 
 (d) The Series A-2 Notes will mature on November 1, 2014. 

ARTICLE 3 

REDEMPTION 
 Section 3.01
Optional Redemption. 
 (a) At any time prior to November 1, 2011, the Company may redeem all or a part of the
Series A-2 Notes, upon not less than 30 nor more than 60 days prior notice mailed by first-class mail to the registered address of each Holder or otherwise delivered in accordance with the procedures of DTC, at a redemption price equal to 100% of
the principal amount of the Series A-2 Notes redeemed plus the Series A-2 Notes Applicable Premium as of, and accrued and unpaid interest and Additional Interest, if any, to the date of redemption (the “Series A-1 Notes Redemption
Date”), subject to the rights of Holders on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date. 

(b) Until November 1, 2011, the Company may, at its option, redeem up to 35% of the aggregate principal amount of Series A-2 Notes
issued by it at a redemption price equal to 112.375% of the aggregate principal amount thereof, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-2 Notes Redemption Date, subject to the right of
Holders of Series A-2 Notes of record on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date, with the net cash proceeds of one or more Equity Offerings; provided that at
least 65% of the aggregate principal amount of Series A-2 Notes originally issued under this Indenture (excluding Series A-2 Notes held by the Company or Subsidiaries or Affiliates of the Company) remains outstanding immediately after the occurrence
of each such redemption; provided further that each such redemption occurs within 180 days of the date of closing of each such Equity Offering. Notice of any redemption upon any Equity Offering may be given prior to the completion thereof,
and any such redemption or notice may, at the Company’s discretion, be subject to one or more conditions precedent, including, but not limited to, the completion of the related Equity Offering. 

(c) Except pursuant to clause (a) or (b) of this Section 3.01, the Series A-2 Notes will not be redeemable at the
Company’s option prior to November 1, 2011. 

 (d) On and after November 1, 2011, the Company may redeem the Series A-2 Notes, in
whole or in part, upon not less than 30 nor more than 60 days prior notice by first-class mail, postage prepaid, with a copy to the Trustee, to each Holder at the address of such Holder appearing in the security register, at the redemption prices
(expressed as percentages of principal amount of the Series A-2 Notes to be redeemed) set forth below, plus accrued and unpaid interest thereon and Additional Interest, if any, to the applicable Series A-2 Notes Redemption Date, subject to the right
of Holders of record on the relevant Series A-2 Notes Record Date to receive interest due on the relevant Series A-2 Notes Interest Payment Date, if redeemed during the twelve-month period beginning on November 1 of each of the years indicated
below: 
  

				
	 Year
	  	Percentage	 
	 2011
	  	106.188	% 
	 2012
	  	103.094	% 
	 2013 and thereafter
	  	100.000	% 

 Any redemption
pursuant to this Section 3.01 shall be made pursuant to the provisions of Sections 3.01 through 3.06 of the Indenture. 

ARTICLE 4 

MISCELLANEOUS 

Section 4.01 Ratification of Indenture. 

The Indenture, as supplemented and amended by this Supplemental Indenture, is ratified and confirmed, and this Supplemental Indenture
shall be deemed part of the Indenture with respect to the Series A-2 Notes in the manner and to the extent herein and therein provided. If any provision of this Supplemental Indenture is inconsistent with a provision of the Indenture, the terms of
this Supplemental Indenture shall control with respect to the Series A-2 Notes. The Indenture, together with this Supplemental Indenture, shall govern the Series A-2 Notes. 

Section 4.02 No Personal Liability of Directors, Officers, Employees and Stockholders. 

No director, officer, employee, incorporator or stockholder of the Company or any Guarantor or any of their parent companies shall have
any liability for any obligations of the Company or the Guarantors under the Series A-2 Notes, the Guarantees, the Indenture, this Supplemental Indenture or the Collateral Documents or for any claim based on, in respect of, or by reason of such
obligations or their creation. Each Holder by accepting Series A-2 Notes waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Series A-2 Notes. 

Section 4.03 Governing Law. 

THIS SUPPLEMENTAL INDENTURE, THE SERIES A-2 NOTES AND ANY GUARANTEE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE
STATE OF NEW YORK. 
 Section 4.04 Waiver of Jury Trial. 

EACH OF THE COMPANY, THE GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE

 
LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE, THE SERIES A-2 NOTES OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 Section 4.05 Severability. 

In case any provision in this Supplemental Indenture or in the Series A-2 Notes shall be invalid, illegal or unenforceable, the validity,
legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 Section 4.06
Counterpart Originals. 
 The parties may sign any number of copies of this Supplemental Indenture. Each signed copy
shall be an original, but all of them together represent the same agreement. 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed, all as of the date first above written. 
  

					
	 APRIA HEALTHCARE GROUP INC.

		
	By:	 	 /s/ Chris A. Karkenny

		 	Name:	 	Chris A. Karkenny
		 	Title:	 	Executive Vice President and Chief Financial Officer
	
	GUARANTORS:
	
	 APRIA HEALTHCARE OF NEW YORK STATE, INC.

	 APRIA HEALTHCARE, INC.

	 APRIACARE MANAGEMENT SYSTEMS, INC.

	 APRIADIRECT.COM, INC.

	 CORAM, INC.

		
	By:	 	 /s/ Robert S. Holcombe

		 	Name:	 	Robert S. Holcombe
		 	Title:	 	 Executive Vice President

General Counsel and Secretary

Signature Page to Supplemental Indenture 

					
	 CORAM ALTERNATE SITE SERVICES, INC.

	 CORAM CLINICAL TRIALS, INC.

	 CORAM HEALTHCARE CORPORATION OF ALABAMA

	 CORAM HEALTHCARE CORPORATION OF FLORIDA

	 CORAM HEALTHCARE CORPORATION OF GREATER D.C.

	 CORAM HEALTHCARE CORPORATION OF GREATER NEW YORK

	 CORAM HEALTHCARE CORPORATION OF INDIANA

	 CORAM HEALTHCARE CORPORATION OF MASSACHUSETTS

	 CORAM HEALTHCARE CORPORATION OF MICHIGAN

	 CORAM HEALTHCARE CORPORATION OF MISSISSIPPI

	 CORAM HEALTHCARE CORPORATION OF NEVADA

	 CORAM HEALTHCARE CORPORATION OF NEW YORK

	 CORAM HEALTHCARE CORPORATION OF NORTH TEXAS

	 CORAM HEALTHCARE CORPORATION OF NORTHERN CALIFORNIA

	 CORAM HEALTHCARE CORPORATION OF SOUTH CAROLINA

	 CORAM HEALTHCARE CORPORATION OF SOUTHERN CALIFORNIA

	 CORAM HEALTHCARE CORPORATION OF SOUTHERN FLORIDA

	 CORAM HEALTHCARE CORPORATION OF UTAH

	 CORAM HEALTHCARE OF WYOMING, L.L.C.

	 CORAM HOMECARE OF MINNESOTA, INC.

	 CORAM SERVICE CORPORATION

	 CORAM SPECIALTY INFUSION SERVICES, INC.

	 CORAMRX, LLC

	 H.M.S.S., INC.

	 HEALTHINFUSION, INC.

	
T2
MEDICAL, INC.

		
	By:	 	 /s/ Robert T. Allen

		 	Name:	 	Robert T. Allen
		 	Title:	 	President

 Signature Page to
Supplemental Indenture 

					
	 U.S. BANK NATIONAL ASSOCIATION, as Trustee

		
	By:	 	 /s/ Raymond S. Haverstock

		 	Name:	 	Raymond S. Haverstock
		 	Title:	 	Vice President

 Signature Page to
Supplement Indenture

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00176-of-00352.parquet"}]]